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publications in peer-reviewed journals. I have previously worked in Palliative Medicine Unit 
(Academic Unit of Supportive Care) and Public Health at The University of Sheffield.  
I undertook my PhD doctoral study while working in the Academic Unit of Supportive Care, 
Department of Oncology (formerly the Academic Palliative Medicine Unit), School of 
Medicine, at The University of Sheffield.  
I graduated in 1995 with a BSc (Hons) degree in Pharmacology from the University of Leeds, 
and in 1997 with an M.Med.Sci. in Medical Science from The University of Sheffield. During 
my Master’s degree, I undertook a research project entitled ‘Altered ventricular 
repolarisation during hypoglycaemia invitro’. The study involved collaboration with clinical 
colleagues in order to examine the relationship between hypoglycaemia and sudden death in 
diabetic patients, and to further explore the concept of ‘dead in bed syndrome’. I have also 
worked as a Researcher (Systematic Reviewer) at Public Health Medicine, School of Health 
and Related Research (University of Sheffield), in the development of national clinical 
practice guidelines for the management and treatment of type 2 diabetes. It was during this 
time that I further developed an interest in medical and health services research. I have always 
had an interest in wanting to know more about how things work in the ‘real world’. 
I have worked on numerous research projects, and of particular relevance to this doctoral 
study, was my involvement with the early stages of development of a holistic needs 
assessment questionnaire in a supportive and palliative care service namely; the Sheffield 
Profile for Assessment and Referral for Care (SPARC). 
SPARC is a multidimensional holistic needs assessment tool which provides a profile of 
needs (including physical, psychological, social, and spiritual issues) to identify patients who 
may benefit from additional supportive or palliative care regardless of diagnosis or stage of 
disease (Ahmed, 2010; Ahmed et al., 2014).  
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I was part of the team that developed SPARC over a period of five years. SPARC has 
undergone rigorous psychometric development, preliminary field-testing, and validation 
(Ahmed et al., 2004; Ahmed et al., 2009; Ahmed et al., 2014; Ahmed et al., 2015; Ahmedzai 
et al., 2004b; Bestall et al., 2004). SPARC has been shown to be acceptable to patients in 
various settings including those in support groups (Hughes et al., 2015) and at diagnosis 
(Wilcock et al., 2010). Since its inception, I have been involved with all aspects and stages of 
SPARC development (Ahmed, 2010; Ahmed et al., 2014).  
There is evidence to indicate a lack of studies on the clinical utility of tools (Ahmed, 2010; 
Ahmed et al., 2014). Despite rigorous psychometric development, preliminary field-testing, 
and validation, the clinical utility of SPARC has yet to be established (Ahmed et al., 2015). 
The review I undertook as part of my doctoral study provided the evidence-base and the 
justification for a prospective randomised, controlled trial of the clinical utility of SPARC as 
an early holistic needs assessment, using the Medical Research Council framework for 
developing and evaluating complex interventions (Ahmed, 2010; Ahmed et al., 2014; Craig et 
al., 2008a; Craig et al., 2008b).  
Having developed SPARC, the next step was to test its clinical utility, and we were rather 
fortunate to receive funding from Macmillan Cancer Support for a further four years, to 
undertake a pilot study to explore recruitment, data quality and follow up procedures in a 
prospective randomised controlled trial of the clinical utility of SPARC as an early holistic 
needs assessment (Ahmed, 2010; Ahmed et al., 2014). The four-year study commenced in 
January 2010 and was completed in January 2014. I was the trial manager and a co-applicant 
on the original grant application, and was involved with: protocol development; seeking of 
ethical approval; recruitment; data collection and analysis; drafting of the reports to the 
funder; and preparing papers for publication; as well as presenting the work at national and 
international conferences. It must however be stressed that although I managed the trial, I did 
not contribute to selecting the overall RCT design of the trial nor to selecting the outcome 
measures. The design of these elements preceded my involvement with the trial. The PhD and 
study hypothesis was that the use of a validated multidimensional holistic screening tool for 
supportive and palliative care needs namely; SPARC, would lead to improved recognition of 
supportive and palliative care needs and improved health care outcomes for patients (Ahmed, 
2010; Ahmed et al., 2014).   
Palliative care trials are complex, and in light of this, the trial was developed, piloted, 
evaluated, reported and implemented in accordance with the Medical Research Council 
framework for developing and evaluating complex interventions (Ahmed, 2010; Ahmed et 
al., 2015; Craig et al., 2008a; Craig et al., 2008b). A complex intervention is described as 
having ‘several interacting components’ any of which could have an impact on the outcome. 
The control groups were placed on a ‘waiting-list’ and received the intervention at a later date 
(Craig et al., 2008a; Craig et al., 2008b; Higginson, 2005; Higginson et al., 2008). A multi-
method research methodology was employed using both qualitative and quantitative 
techniques. It was anticipated that data generated from this pilot study would guide the 
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development of a further, and larger definitive multicentre study. This trial was the first step 
in a process that would define the clinical utility of SPARC. This study provided an 
opportunity to ‘test-drive’ SPARC with patients that have supportive and palliative care 
needs. It would contribute to recognising the best methods for identifying patients’ needs, and 
determine the extent to which these needs are addressed by following patients prospectively 
(Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 2015). However, the results were counter 
intuitive, leading to concerns about the methodology and raising questions about the concept 
of holistic needs assessment (EAPC abstract, 2015), with the conclusion that standardised 
holistic needs assessment questionnaires may be counterproductive if not integrated with a 
clinical assessment that informs a care plan (Ahmed et al., 2015).  
The doctoral study in context 
In summary, this doctoral study was conducted within the context of this pragmatic 
randomised controlled trial and nested within the MRC framework for evaluating complex 
interventions. An embedded (or nested) concurrent mixed methods design was considered the  
most appropriate design for this study. The rationale for this design is discussed further within 
this thesis. The primary objective was to design and undertake a pilot study to evaluate 
clinical outcomes associated with the use of SPARC. The trial itself focussed primarily on 
outcomes, not on the processes involved in implementing the intervention. An additional 
element of this PhD and a secondary objective was to undertake a process evaluation. From 
reviewing the literature, it became increasingly apparent of the importance of combining 
quantitative and qualitative research methods approaches in the development and evaluation 
of complex interventions in palliative care research. The use of qualitative and secondary 
quantitative analysis approaches alongside randomised controlled trials of complex healthcare 
interventions, in order to gain a better understanding of ‘whether and how an intervention 
works (or does not work) and inform the design of subsequent studies’ is highly 
recommended (Craig et al., 2008a; Craig et al., 2008b; Ellard et al., 2011; Ezendam et al., 
2013; Farquhar et al., 2011; Flottorp et al., 2003; Francis et al., 2013; Grant et al., 2013; Hind 
et al., 2010; Moore et al., 2015; Toroyan et al., 2004; White, 2013).   
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Structureofthethesis
This programme of research comprises of two phases (outcome evaluation and process 
evaluation), both phases of the research were funded by Macmillan Cancer Support. This 
thesis will report on the findings from both phases of the research.  
Phase 1: Outcome evaluation study: The main randomised controlled trial.  
A pilot study of a holistic needs assessment questionnaire in a supportive and palliative care 
service using the Sheffield Profile for Assessment and Referral for Care (SPARC). The 
findings of the outcome evaluation together with some additional analysis undertaken are 
reported in full.
Phase 2: Process evaluation study: Qualitative study running alongside a RCT.  
The process evaluation study comprising of three additional strands of work namely:             
1) analysis of semi-structured interviews with patients; 2) analysis of semi-structured 
interviews with health care professionals; and 3) retrospective case note reviews (presented 
under findings and analysis of Phase I: outcome evaluation).   
Projectdevelopment
Professor Bill Noble was the principal investigator and project director. I was the trial 
manager and was responsible for the day to day management of the study, and I prepared 
applications for the relevant permissions, carried out the data collection, analysis and report 
writing. Professor Peter Bath carried out the major part of the statistical analysis (quantitative 
analysis: reported in Chapter 4). All team members were involved in design, planning and 
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implementing the study, as well as in the analysis and reporting. Some members were part of 
the internal project group, attending regular meetings and contributing to all stages of the 
study. Other personnel were co-opted as needed, and decisions were made consensually.  
Studyregistration
The Trial was registered with the following organisations: 
1. Sheffield Teaching Hospital (STH) NHS Foundation 
2. Current Controlled Trials Register  
 'A feasibility study of an holistic needs assessment questionnaire in a supportive 
 and palliative care service using the Sheffield Profile for Assessment and Referral 
 for Care (SPARC)’ 
International Standard Randomised Controlled Trial Number (ISRCTN):
ISRCTN25758268  http://www.controlled-trials.com/ISRCTN25758268/ (Appendix 
5). 
3. Cancer Research UK 
‘A study testing a questionnaire to work out the care needs of people using a 
supportive or palliative care service in Sheffield (SPARC feasibility)’ 
http://cancerhelp.cancerresearchuk.org/trials/a-study-testing-questionnaire-work-out-
care-needs-people-using-supportive-or-palliative-care-service-sheffield-SPARC-
feasibility
Funding
This programme of research was funded by Macmillan Cancer Support under its Programme 
Grants made to the Macmillan Palliative Care Collaborative (MacPacc) and approved by the 
Commissioning Group, which comprises of research, service and healthcare expertise within 
Macmillan. The study was independently reviewed by academic and service user reviewers.  
The research comprises of two phases (outcome and process evaluation), both phases of 
research were funded by Macmillan Cancer Support (funding letters 1 and 2: Appendix 6 
and Appendix 7 respectively), and I was a co-applicant on both of the successful grant 
applications.  
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Sponsor
The sponsor for the study was the Sheffield Teaching Hospitals (STH) NHS Foundation 
Trust. The trial insurance letter was issued on 28th October 2010 (Appendix 8).   
Steeringgroup
A research project steering group was convened to provide expertise and guidance and to 
ensure that project milestones were met. Steering group meetings were held twice a year over 
the study period. The following nine individuals from a range of backgrounds and with 
multidisciplinary skills were part of the steering group contributing to all stages of the study 
(Ahmed et al., 2015): 
 Four health service researchers Mr Nisar Ahmed1, Ms Philippa Hughes1, Professor 
Karen Collins3, Dr Michelle Winslow1;  
 A Palliative Medicine Consultant and Senior Lecturer in Palliative Medicine: 
Professor Bill Noble1; 
 A health informatics specialist/statistician: Professor Peter Bath2;
 A Project Administrator: Ms Pauline Hutchinson1; 
 Two consumer representatives: Ms Jacqui Gath, and Ms Alison Morton. 
1  Academic Unit of Supportive Care, School of Medicine and Biomedical Sciences, 
 University of Sheffield.  
2  Centre for Health Information Management Research, Information School, University of     
 Sheffield.  
3  Centre for Health and Social Care Research, Faculty of Health and Wellbeing, Sheffield   
 Hallam University.
(Ahmed et al., 2015).  
Consumerinvolvement
Consumer involvement particularly in the early stages of research development is viewed in 
the UK as both a medical and a political priority as a means of empowering patients (Ali et 
al., 2006; Allsop et al., 2004; Collins et al., 2005). The involvement of consumers and greater 
public involvement in shaping health care systems and delivery, particularly in the UK (Boote 
et al., 2006), and Western nations has gained momentum (Anderson, 1996). Some funders, 
for example, the Medical Research Council and the United Kingdom Co-ordinating 
Committee on Cancer Research have established consumer liaison groups (Hanley et al., 
2001). Patient and public perspectives were integral to this research. The North Trent Cancer 
Network Consumer Research Panel has been a contributor to many projects at The University 
of Sheffield. Developed within the Academic Unit of Supportive Care, panel members now 
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have considerable experience in working with researchers on projects and studies. The panel 
comprises of 40 former and current cancer patients and carers (Caldon et al., 2010; Collins et 
al., 2005; Collins & Ahmedzai, 2005). 
Representatives of the Consumer Research Panel (North Trent Cancer Network) were 
involved in earlier SPARC studies, including a research study to establish the acceptability 
and usability of the screening tool across a wide-range of conditions and at different stages of 
disease. The study demonstrated the acceptability of SPARC (Hughes et al., 2015).  
Representatives from the panel were invited to consider the study and give comments. Two 
service user representatives who expressed an interest in the study were consulted during the 
research study; this was done by co-opting representatives onto the project steering group. 
This meant that all aspects of the study benefited from the comments and insights of people 
receiving services.  
The two consumer representatives took part in ongoing discussions of the project, and were 
invited to be part of both the project group (consisting mainly of members of the research 
team), and the project steering group. This approach worked well during this study and in our 
previous work, and resulted in valuable and useful contributions to study design, documents, 
analysis and reporting. Project Group meetings involved members of the research team 
meeting on a much more regular basis than the Project Steering group meetings. The level 
and nature of user involvement is presented in Table 1.   
Table 1: Level and nature of user involvement
  Consultation Collaboration 
Development of the grant 
application

Design and management of 
the research
 
Undertaking the research 
Analysis 
Dissemination of research 
findings (proposed)
 
The two consumer representatives were involved in all phases of the study including protocol 
design and assisted the research team particularly with writing patient information sheets and 
with the ethics application (Patient and Public Involvement: PPI. www.rcpch.ac.uk).  
Researchers consulted the two consumer representatives about the research e.g. through 
individual contacts, and one-off meetings. The two service-user representatives were unable 
to attend the Steering Group Meetings, and made their contributions mainly via email/letter 
correspondence.  
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Abstract
Background: Studies suggest that cancer and non-cancer patients have needs (e.g. physical, 
psychological, religious, spiritual needs and information needs) that are not being adequately 
met. The review undertaken has presented a strong argument in favour of the case for a 
comprehensive holistic assessment of supportive and palliative care needs (Ahmed, 2010; 
Ahmed et al., 2014). At present, there is no widely used systematic, evidence-based, holistic 
approach to screening patients for supportive and palliative care needs. There is evidence to 
indicate a lack of studies on the clinical utility of tools (Ahmed, 2010; Ahmed et al., 2014; 
Ahmed et al., 2015). The Sheffield Profile for Assessment and Referral for Care (SPARC) is 
a multidimensional screening tool which gives a profile of needs to identify patients who may 
benefit from additional supportive or palliative care, regardless of diagnosis or stage of 
disease. Despite rigorous psychometric development, preliminary field-testing, and 
validation, the clinical utility of SPARC has yet to be established (Ahmed, 2010; Ahmed et 
al., 2014; Ahmed et al., 2015). This doctoral study was conducted within the context of a 
pragmatic randomised controlled trial and nested within the MRC framework for evaluating 
complex interventions. From reviewing the literature, it became increasingly apparent of the 
importance of combining quantitative and qualitative research methods approaches in the 
development and evaluation of complex interventions in palliative care research. This study 
provides an opportunity to ‘test-drive’ SPARC with patients that have supportive and 
palliative care needs. The hypothesis was that the use of a validated multidimensional holistic 
screening tool for supportive and palliative care needs, namely; SPARC, would lead to 
improved recognition of supportive and palliative care needs, and improved health care 
outcomes for patients (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 2015). 
Aims and Objectives: The primary objective was to design and undertake a pilot study to 
evaluate clinical outcomes associated with the use of SPARC. The trial itself focussed 
primarily on outcomes, not on the processes involved in implementing the intervention. An 
additional element of this doctoral study and a secondary objective was to undertake a 
process evaluation (comprising of retrospective case note reviews, semi-structured interviews 
with patients and health care professionals) (Ahmed et al., 2015). 
Methods: This was an open, pragmatic, randomised controlled trial. Patients (n=182) referred 
to the palliative care service were randomised to receive SPARC at baseline (n=87) or after a 
period of two weeks (waiting-list control n=95). Primary outcome measure is the difference 
in score between Measure Yourself Concerns and Wellbeing (MYCAW) patient-nominated 
Concern 1 on the patient self-scoring visual analogue scale at baseline and the two-week 
follow-up. Secondary outcomes include difference in scores in the MYCAW, EuroQoL (EQ-
5D), and Patient Enablement Instrument (PEI) scores at Weeks 2, 4, and 6. As part of a 
process evaluation, case notes were reviewed at week 8, and semi-structured interviews were 
undertaken with a sub-group of patients and health care professionals (Ahmed et al., 2015).
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Results: There was a significant association between change in MYCAW score and whether 
the patients were in the intervention or control group trend = 5.51; degrees of freedom = 
1; P = 0.019). A higher proportion of patients in the control group had an improvement in 
MYCAW score from baseline to Week 2: control (34 of 70 [48.6%]) vs. intervention (19 
of 66 [28.8%]). There were no significant differences (no detectable effect) between the 
control and intervention groups in the scores for EQ-5D and Patient Enablement Instrument at 
2, 4, or 6-week follow-up (Ahmed et al., 2015). Most patients interviewed [30/33], found 
SPARC either quite easy to complete, fairly straightforward, simple or had no problems in 
completing it. Only a small number of participants found questions on SPARC ‘too sensitive 
or upsetting’. A crucial finding in the context of the trial was the large proportion of patients 
interviewed [30/33] who did not experience or report any noticeable change, or beneficial 
effects after completing SPARC (EAPC abstract, 2015). Most health care professionals had 
something positive to say about SPARC and had previous experience of using SPARC, and 
most were considering using it at some point in the future. A number of barriers were 
identified to the relief of distress highlighted by SPARC. Only 5/164=3.0% patient notes 
made any direct reference to SPARC.  
Conclusion: This trial result identifies a potential negative effect of SPARC in specialist 
palliative care services, raising questions that standardised holistic needs assessment 
questionnaires may be counterproductive if not integrated with a clinical assessment that 
informs the care plan (Ahmed et al., 2015). This is supported by review of case notes, and the 
interview data from patients that indicate that most patients felt that no particular action or 
benefit followed from the completion of SPARC (Ahmed et al., 2015). Only a few patients 
who had no recent contact with palliative care service and scored high for some SPARC items 
were recalled by the service and reassessed. Overall, participants and health care 
professionals considered SPARC an acceptable and relevant tool for the clinical assessment 
of supportive and palliative care needs (EAPC abstract, 2015). The potential negative effect 
of SPARC in a specialist palliative care service could be due to the failure of health care 
professionals to act on identified needs in a timely manner, or related to the raising of 
patients’ expectations that are not subsequently met. The qualitative study helps in the 
interpretation of the outcome results, and provides useful insights into how SPARC might be 
used in practice. Early identification of and monitoring of symptoms is only useful if effective 
treatment programs or systems are in place to address identified needs, and we must consider 
and evaluate new methods to achieve practice change. The effective integration of SPARC 
into routine care and standard operating systems requires further investigation (Ahmed, 2010; 
Ahmed et al., 2014; Ahmed et al., 2015).  
Key Words: Palliative care, holistic needs assessment, pilot randomised trial, SPARC, 
MYCAW, EQ-5D, PEI, process evaluation, semi-structured patient and health care 
professional interviews, qualitative study (Ahmed et al., 2015). 
Trial registration: ISRCTN 25758268 
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Chapter1
BackgroundandLiteratureReview1
1.1 Abstract
Background
Studies suggest that cancer and non-cancer patients have physical, psychological, religious, 
spiritual needs and information needs that are not being adequately met. At present, there is 
no widely used systematic, evidence-based, holistic approach to screening patients for 
supportive and palliative care needs (Ahmed et al., 2015). A review of the literature was 
undertaken to research the evidence base (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 
2015). 
Aims 
The aim of the literature review was to provide an overview of holistic needs assessment in 
the fields of supportive and palliative care (Ahmed, 2010; Ahmed et al., 2014). 
Methods
A comprehensive review of the literature was undertaken to identify both published and 
unpublished material (papers/research) on holistic needs assessment in supportive and 
palliative care. The following sources were searched: electronic databases; grey literature 
sources; hand-searching of key journals; and contacting experts in the field (Ahmed, 2010; 
Ahmed et al., 2014). 
Results 
A total of 63 papers were included in the review. There is evidence to suggest that patients 
with cancer and other non-malignant chronic progressive illnesses can experience some very 
distressing symptoms, issues and problems, which can often remain unrecognised. Assessing 
patients’ holistic needs using routine systematic questioning (‘done or acting according to a 
fixed plan or system; methodical’) is useful in identifying symptoms, problems and issues, 
that would otherwise not be identified by other means, such as during a routine consultation, 
or by using open-ended questions. The need for systematic questioning is essential if holistic 
needs are to be identified and addressed. Recommendations for holistic needs assessment are 
also presented (Ahmed, 2010; Ahmed et al., 2014). 
Conclusions 
This review has presented a strong argument in favour of the need for a comprehensive 
holistic assessment of supportive and palliative care needs. There is evidence to indicate a 
lack of studies on the clinical utility of tools. Early identification of and monitoring of 
symptoms is only useful if effective treatment programs or systems are in place to address 
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identified needs, and we must consider and evaluate new methods to achieve practice change 
(Ahmed, 2010; Ahmed et al., 2014). 
1.2 ReviewProcedure
Literature review methodology: search strategy for identification of studies  
A detailed search strategy used to identify the literature and the evidence base is presented 
below (Ahmed et al., 2014). The review of the literature was conducted in the following 
stages (Ahmed et al., 2004): 
 SEARCH STRATEGY 
 INCLUSION AND EXCLUSION CRITERIA 
 ASSESSMENT OF RELEVANCE AND VALIDITY OF STUDIES 
 DATA EXTRACTION 
 RESULTS OF SEARCHES  
 DATA SYNTHESIS 
1.21 Searchstrategyforidentificationofstudies
The background literature review seeks to summarise present knowledge regarding patient 
holistic needs assessment in the fields of supportive and palliative care. The overall aim of the 
literature review was to add to the knowledge base by 1) providing an overview of patient 
holistic needs assessment in the fields of supportive and palliative care and reviewing the 
evidence of the value of routine systematic questioning; 2) identifying issues relating to 
access and referral to palliative care (barriers and timely referrals); 3) reviewing assessment 
tools and instruments currently used for assessing patients’ holistic needs; 4) identifying 
studies examining the clinical utility of tools; and 5) identifying research gaps.  
I undertook a narrative literature review (i.e. not a systematic review; methodologically 
speaking, no formal assessment of the quality of the studies was undertaken as would be the 
case in a systematic review, where only high quality RCTs or other forms of quantitative 
investigation would be eligible) including both published and unpublished materials. The 
literature was identified in a systematic manner using an all-inclusive approach (Ahmed et al., 
2004; Ahmed et al., 2014; Hawker et al., 2002; Payne et al., 2002). Free text searches and 
medical subject headings were combined to identify papers (Table 2). Thus, this 
methodology ensured that the literature review was substantial, comprehensive, relevant and 
up to date.  
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Table 2: The terms used in the literature search strategy  
Keywords used to search the literature 
Palliative care OR Supportive care OR Specialist palliative care OR Terminal care OR Hospice care 
OR End of life care. AND 
Access OR Assessment of need OR Assessment OR Care planning OR Case notes OR Clinical 
assessment OR Common approach to assessment OR Consultations OR Doctor-patient interaction OR 
Evaluation OR Evaluation tools OR Evaluation methods OR History taking OR Holistic assessment 
OR Holistic needs assessment OR Holistic self-assessment tools OR Interviews OR Measures OR 
Medical assessment OR Medical clerking OR Medical history OR Medical interview OR Narrative 
analysis OR Narrative medicine OR Narrative synthesis OR Needs assessment OR Nursing 
assessment OR Oral history OR Patient- physician OR Clinician communication OR Questionnaires 
OR Referral OR Routine assessment OR Scales OR Screening tools OR Standardised holistic 
assessment OR Symptom assessment OR Symptoms OR Systematic holistic approach OR Systems 
OR Toolkit OR Tools OR Unmet need OR Validated assessment. AND
Clinical outcomes OR Improved health OR Health care outcomes OR Improved patient management 
OR Improved patient well-being OR Patient centred care OR Patient experience OR Patient outcomes 
OR Psychological morbidity OR Anxiety OR Depression OR Distress OR Quality of life OR Relief of 
suffering OR Satisfaction with care OR Service utilisation OR Survival OR Survivorship OR Uptake 
OR Well-being. 
The following sources were searched: electronic databases; key websites; grey literature 
sources; hand-searches of key journals; review of policy documents and reports; and I also 
made contact with experts in the field (Figure 1) (Ahmed, 2010; Ahmed et al., 2014). 
Figure 1: Literature review methods (overview)
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Electronic databases searched
The following electronic databases were searched (no limits were applied to the years 
searched): Medline, In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R), 
British Nursing Index and Archive, PsycInfo, Allied and Complementary Medicine Database
(AMED), Cochrane Database of Systematic Reviews (CDSR), Cochrane Controlled Clinical 
Trials Register (CCTR), Centre for Reviews and Dissemination Databases: Database of 
Abstracts of Reviews of Effects (DARE), NHS Economic Evaluation Database (NHS EED), 
Health Technology Assessment (HTA) Database, Cumulative Index to Nursing & Allied 
Health Literature (CINAHL), the British Library Database (ZETOC), System for Information 
on Grey Literature in Europe (OpenSIGLE), Scopus, Google Scholar, National Research 
Register, PubMed U.S. National Library of Medicine, National Institutes of Health, Web of 
Knowledge (includes Web of Science-Social Sciences Citation Index), Index to thesis, 
National Institute for Health and Care Excellence (NICE), Department of Health, The 
National Library for Health (www.library.nhs.uk), NHS Evidence - Supportive and Palliative 
care (formerly a Specialist Library of the National Library for Health), American Society of 
Clinical Oncology (ASCO), BIOSIS, NHS Evidence - National Library of Guidelines.  
Hand-searching 
The following 5 key journals were hand-searched in an attempt to identify articles that may 
not have been identified through electronic searches of databases. Hand-searches were limited 
to journals covering the last 18 years (1st Jan 1999- Dec 2016 inclusive). The reference lists of 
relevant articles were also reviewed. 
1. Palliative Medicine 
2. Supportive Care in Cancer  
3. Journal of Pain and Symptom Management 
4. Quality of Life Research 
5. Psychooncology 
Key websites searched  
The following key websites were searched:  
 Centre for Reviews and Dissemination (http://www.york.ac.uk/inst/crd/)  
 Cochrane Collaboration  (http://cochrane.co.uk/en/index.html)  
 Health Information Resources formerly National Library for Health 
(http://www.library.nhs.uk/)  
 Department of Health (http://www.dh.gov.uk/en/index.htm)    
 National Institute for Health and Care Excellence (NICE) (http://www.nice.org.uk/) 
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Contacting experts in the field 
Professor Alison Richardson (Clinical Professor of Cancer Nursing and End of Life Care, 
Kings College, London) and Mr Mathew Fry (Programme Manager Common Assessment 
Framework for Adults, London), both UK-based, were the two experts that were contacted in 
an attempt to identify additional papers and any other major developments in this field.  
1.22 Inclusion/exclusioncriteria
Primary/empirical studies with data, reports, guidelines, systematic reviews, and reviews 
concerning issues relating to holistic needs assessment in the fields of supportive and 
palliative care as well as the issues outlined in the search strategy and inclusion criteria of the 
review were considered.  
No limits or restrictions were applied to the databases for the years searched. Papers were 
included if they met the inclusion criteria. Papers were not restricted to just cancer patients.    
I included papers that made reference to both cancer and non-cancer conditions e.g. Acquired 
Immune Deficiency Syndrome (AIDS); Motor Neurone Disease (MND); Chronic Obstructive 
Pulmonary Disease (COPD); Parkinson’s Disease; Heart Failure; Dementia and Alzheimer's 
disease. A more detailed description of the inclusion and exclusion criteria is presented in 
Table 3.   
Table 3: Literature review inclusion and exclusion criteria  
Inclusion criteria  Exclusion criteria  
Philosophy of palliative care and supportive care 
(concepts and definitions, discussions of 
terminology) 
Non-English 
Development of supportive and palliative care 
services (historical context/accounts) 
Evaluation of palliative care services (unless 
about access, exclusion, referral or holistic needs 
assessment) 
Access and referral to palliative care (access to 
care, problems of access/barriers to timely 
referrals, referral criteria, eligibility for care)  
Trials of surgical treatments 
Prevalence of concerns, problems and issues in 
palliative care patients (e.g. physical symptoms; 
psychological problems; social issues including 
finance; ability to look after self/others; ADL; 
spiritual issues; religious and cultural issues; 
practical issues; medical or care issues; nursing; 
GP issues; aspects of social work etc.; 
communication and information issues) 
Trials of medicines 
Reporting of symptoms (and symptom enquiry) Trials of equipment or technology 
Working definitions of ‘assessment’ and ‘needs’ Euthanasia 
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Holistic assessment of supportive and palliative 
care needs (main features of assessment and core 
content of assessment, ‘medical vs. holistic 
model of care’) 
Economic factors in palliative care (e.g. cost-
effectiveness papers) 
Systematic holistic questioning in palliative care Laboratory/animal studies 
Assessment tools and instruments (questionnaires 
or outcomes currently used or developed for 
identifying supportive and palliative care needs) 
Studies examining the clinical utility of tools  
Abbreviations: ADL: Activities of Daily Living; GP: General Practitioner 
1.23 Assessmentofrelevanceandvalidityofstudies
As mentioned earlier, whilst the search strategy was systematic, this is NOT a systematic 
review. The methodology adopted was comprehensive and focussed as possible, and 
systematic methods employed were designed to improve rigour. This literature review was 
undertaken to develop and inform the background to the thesis. This is distinct from a 
systematic review which traditionally asks specific research questions about the effectiveness 
of health care interventions, and synthesises evidence from the results of randomised 
controlled trials. For the purposes of this background review (which adopted a much more 
inclusive approach), it was more appropriate to undertake a literature review rather than a 
systematic review, because in an area where there is a limited number of RCTs and other 
forms of quantitative studies, as is the case in palliative care research, the evidence originates 
from a variety of different sources.   
Since the studies/papers used different methods, outcome measures and samples, it was not 
appropriate to combine data across studies for meta-analysis. Furthermore, there have already 
been a number of substantial systematic reviews, reviews and guidelines published prior to 
this work (Ahmed et al., 2004; Cancer Plan, 2004; Cancer Action Team 2007; EOLC 
Strategy, 2008; NICE, 2004; Richardson et al., 2005; and Richardson et al., 2007), supporting 
the need for and highlighting the importance of undertaking patient holistic needs assessment.  
In addition to identifying any research gaps, it was important to ensure the work that I was 
proposing as part of my doctoral study had not been previously undertaken.  
Methodological quality of included papers  
It was anticipated that the literature search would identify papers that used several different 
research methods (all-inclusive approach used), and it was therefore decided not to use 
conventional Cochrane study design criteria to weight or assess the quality of the studies, thus 
no formal assessment was undertaken as would be the case in a systematic review, where 
only high quality RCTs or other forms of quantitative investigation would be eligible. 
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While no formal assessment of the quality of the included papers was undertaken because of 
the reasons described above, in order to improve the rigour of the papers/studies included in 
the background literature review, I did review and assess each paper/study for inclusion using 
a previous method developed by Payne et al., 2002 and Hawker et al., 2002, this method is 
particularly suitable for palliative care studies.  
Ten key areas that I considered to assess the methodological rigour of included papers, 
particularly when including papers describing empirical studies were as follows: title and 
abstract; introduction and aims; method and data; sampling; data analysis; ethics and bias; 
results; transferability or generalisability; implications and usefulness. Only studies as judged 
by me to be of moderate-high quality were included in the review, each area was assessed 
against a 4-point scale from 1 (very poor) to 4 (good) as a guide for making a judgement on 
which papers to include. All of the papers that were included in the background review were 
sorted into groups according to the topic reported. 
1.24 Dataextraction
All citations/abstracts were assessed to identify all relevant papers following a number of 
sifts. Full text copies were then requested. Papers which were identified and considered 
relevant after mutual agreement between myself and my supervisors were included in the 
background review, and data was then extracted.  
1.25 Resultsofliteraturesearches
The initial search for literature was undertaken in 2010 and again in 2014. The search strategy 
generated 35,000 hits, after several sifts of published and unpublished abstracts, I obtained 
200 papers and on closer examination included and reviewed 63 papers of which 21 key 
papers are reported and published in an abridged version of the review (Ahmed et al., 2014). 
The search strategy employed to identify additional papers underwent an evolutionary 
process. With guidance from my supervisors and advice sought from advisory group 
members, I had a basic knowledge of most of the relevant papers in this field, and after 
undertaking the initial broad searches my knowledge increased further, I used a process of 
‘snowball sampling’ and ‘systematic funnelling’ approach to focus and narrow the search to 
papers relating largely to the ‘predetermined themes’ and in keeping with the original aims of 
the review. Another more focussed search for literature was undertaken in 2016. After 
applying inclusion and exclusion criteria and eliminating duplicates, in total 175 papers were 
included in the background literature review section. Results of these searches are presented 
in Figure 2.
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Figure 2: Results of literature searches  
Of the 175 included papers, the authors/co-authors (number in brackets referring to number of 
papers) were based in the following countries: UK (n=90); USA (n=44); Australia (n=12); 
from multiple countries/from EU (n=11); Canada (n=5); Netherlands (n=4); Sweden (n=3); 
Switzerland (n=2); India (n=2); Denmark (n=1); Norway (n=1). Included papers were 
published between 1980-2016 inclusive. The majority of included papers were published 
between years 2000-2016 (n=146/174=83.4%).     
It was clear that the studies were heterogeneous in all aspects of design including methods, 
results and the way in which key outcomes were assessed and reported. The studies employed 
a variety of research methods and participants. Most primary/empirical studies used 
qualitative methods predominantly interview, questionnaires and surveys to elicit data. There 
were also several interview studies, focus group papers, retrospective reviews of records, case 
note reviews, position papers, letters to editors and editorials, methodology papers, systematic 
reviews, reviews (including book chapter reviews), audits, national policy documents and 
guidelines, reports, short reports, commentaries and discussion papers. A total of six 
systematic reviews were included in the review covering different themes of interest. Only 
two RCTs were identified and included in this review, however there were no randomised 
controlled trials of holistic needs assessment tools assessing clinical utility. Some studies 
involved only cancer patients, some involved only patients with non-malignant disease, and 
some involved patients from both of these groups (cancer and non-cancer).   
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1.26 Datasynthesis
Thematic analysis is one of the most widely used forms of analysis in qualitative research 
(Braun & Clarke, 2002; Ritchie & Spencer, 2004). The results of this review are presented in 
the form of themes in relation to the research aims. The thematic synthesis of evidence led to 
the emergence of 12 themes, themes were determined largely by the topics of ‘predetermined 
interest’ and guided by the inclusion criteria. Prominent themes were identified as: 
1. Holistic assessment of supportive and palliative care needs: the evidence for routine 
systematic questioning; 
2. Philosophy of palliative care and supportive care (concepts and definitions); 
3. Basic/general palliative care versus specialised palliative care; 
4. Access and referral to palliative care (barriers and timely referrals); 
5. Prevalence of concerns, problems and issues in palliative care patients; 
6. The need for systematic holistic questioning in palliative care; 
7. Working definitions of ‘assessment’, ‘needs’ and ‘holistic needs assessment’; 
8. Models of nursing that contain holistic assessment; 
9. Concept of holistic assessment (‘medical vs. holistic model of care’); 
10. Main features of assessment and core content of assessment; 
11. Assessment tools and instruments; 
12. Studies examining the clinical utility of tools (presented in Chapter 8: Results in the 
context of other studies). 
(Ahmed, 2010; Ahmed et al., 2014). 
Development of themes (how these related to the aims of literature review)
Key documents in the field  
There have been a number of substantial systematic reviews, reviews, guidelines/national 
policy documents undertaken and published supporting the need for holistic assessment of 
patients’ needs (Ahmed et al., 2004; Ahmed et al., 2014; Holistic Common Assessment of 
Supportive and Palliative Care Needs for Adults with Cancer-Assessment Guidance, 2007; 
NICE, 2004; Report to the National Cancer Action Team, 2007; Richardson et al., 2005; and 
Richardson et., 2007).  
The following eighteen papers, key documents and national policy documents that emphasise 
the importance and priority of undertaking a comprehensive patient holistic needs assessment, 
that is tailored to meet patients’ needs, were used to guide the development of the themes, i.e. 
themes of pre-determined interest. These are presented in Table 4.  
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Table 4: Key papers, documents, and national policy documents used to guide the 
development of themes (i.e. themes of pre-determined interest)  
1. Ahmed, N., Bestall, J.C., Ahmedzai, S.H., Payne, S.A., Clark, D., & Noble, B. 2004. Systematic 
review of the problems and issues of accessing specialist palliative care by patients, carers and 
health and social care professionals. Palliative Medicine, 18, (6) 525-542.  
2. Ahmedzai SH, Payne SA, Bestall JC, et al. Developing a screening measure to assess the distress 
caused by advanced illness that may require referral to specialist palliative care. Academic 
Palliative Medicine Unit, Sheffield Palliative Care Studies Group, The University of Sheffield. 
Final Report to Elizabeth Clark Charitable Trust, London, UK, 2004.  
3. Bruera E. Routine symptom assessment: good for practice and good for business. Supportive 
Care in Cancer 2008; 16:537–8. 
4. Cancer Action Team. 2007. Holistic common assessment of supportive and palliative care needs 
for adults with cancer: Assessment Guidance. Kings College, University of London.  
5. Cancer Plan (2000)- The NHS  Cancer Plan. A plan for investment. A plan for reform.  
Department of Health. 
6. Dunn, G.P. 2001. Patient assessment in palliative care: How to see the "big picture" and what to 
do when "there is no more we can do". Journal of the American College of Surgeons, 193, (5) 
565-573. 
7. End of Life Care Strategy: promoting high quality care for adults at the end of their life. 2008. 
Department of Health. 
8. Maher, D., & Hemming, L. 2005. Understanding patient and family: holistic assessment in 
palliative care. British Journal of Community Nursing, 10, (7) 318-322. 
9. National Institute for Clinical Excellence. 2004. Guidance on cancer services: improving 
supportive and palliative care for adults with cancer. The manual. London. NICE. 
10. Radbruch, L., & Payne, S. 2009. White paper on standards and norms for hospice and palliative 
care in Europe: Part 1. European Journal of Palliative Care, 16, (6) 278-289. 
11. Radbruch, L., & Payne, S. 2010. White Paper on standards and norms for hospice and palliative 
care in Europe: Part 2. European Journal of Palliative Care, 17, (1) 22-33.  
12. Report to the National Cancer Action Team, 2007- Richardson, A., Tebbit., P., Brown, V., Sitzia, 
J., on behalf of the Cancer Action Team. The holistic common assessment of supportive and 
palliative care needs for adults with cancer- Assessment Guidance (Guidance, work 
commissioned by The Cancer Action Team). 
13. Richardson, A., Medina, J., Brown, V., & Sitzia, J. 2007. Patients' needs assessment in cancer 
care: A review of assessment tools. 2007b. Supportive Care in Cancer, 15, (10) 1125-1144.  
14. Richardson, A., Sitzia, J., Brown, V., Medina, J., Richardson, A. 2005. Patients’ needs 
assessment tools in cancer care: Principles and Practice. London: King’s College London 
(Report).   
15. Shah, M., Quill, T., Norton, S., Sada, Y., Buckley, M., & Fridd, C. 2008. "What bothers you the 
most?" initial responses from patients receiving palliative care consultation. American Journal of 
Hospice and Palliative Medicine, 25, (2) 88-92.  
16. White, C., McMullan, D., & Doyle, J. 2009. "Now that you mention it, doctor... ": Symptom 
reporting and the need for systematic questioning in a specialist palliative care unit. Journal of 
Palliative Medicine, 12, (5) 447-450.  
17. World Health Organization (WHO). 2002. National Cancer Control Programmes: Policies and 
Managerial Guidelines, 2nd ed. Geneva, Switzerland.  
18. WHO Definition of Palliative Care. http://www.who.int/cancer/palliative/definition/en/.2006 
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A summary of the key stages involved during the development of themes and thematic 
synthesis of evidence is summarised in Table 5.
Table 5: Summary of key stages involved during development of themes and thematic 
synthesis of evidence  
Stage  Description of the process involved  
Stage 1: Familiarising myself with 
the existing literature 
 Reading key documents and papers in the area to draw up 
initial ‘predetermined themes’ (key ideas and initial 
themes, any recurrent themes or emerging concepts were 
identified using 18 key papers).   
Stage 2: Development of literature 
search strategy (inclusion and 
exclusion criteria)
 The development of the literature review search strategy 
and inclusion and exclusion criteria was guided by my 
preliminary reading, and further advice was sought from 
the project advisory group, experts in the field, and an 
information specialist (The University of Sheffield) 
(Ahmed et al., 2004; Ahmed et al., 2014). 
 Carried out some initial searches on Medline, reviewed the 
overall aims and objectives of the research and 
updated/revised search strategy accordingly. 
Stage 3: Undertaking literature 
searches   
 An extensive and more comprehensive literature search 
was undertaken. 
 All citations/abstracts were assessed to identify all 
relevant papers (following a number of sifts).  
 Papers included or excluded based on the inclusion and 
exclusion criteria.  
 Full text copies of all relevant papers requested.  
 Papers which were identified and considered relevant after 
mutual agreement between myself and my supervisors 
were included in the review, and data was extracted.  
 Familiarised myself with the range and diversity of the 
literature identified, noting down initial ideas.  
Stage 4: Identifying a thematic 
framework 
 Developed ‘thematic conceptual framework’ or ‘index’, 
which was constructed using the recurrent themes 
identified during the familiarisation stage and after 
undertaking the searches.  
 Themes/concepts identified were further sorted and 
grouped into a smaller number of broader categories 
(‘higher order categories’ or ‘main themes’), some were 
identical to ‘predetermined themes’ and some were newly 
developed from emerging themes and placed within an 
overall thematic framework.   
 Reviewed original aims and objectives (research 
questions) of the review to ensure that they were being 
fully addressed.  
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Stage 5: Generating initial codes and 
searching for themes 
 Papers read and numerically coded by themes according to 
the thematic framework constructed in stage four.    
Stage 6: Reviewing themes, 
defining and naming themes, and 
charting
 Preliminary thematic framework (in stage 4), was 
reviewed and revised (i.e. addition or deletion/collapsing 
of themes and subthemes). 
 Identifying key points/findings on a given theme/subtheme 
from the original paper and rearranging it and placing it in 
a chart according to the appropriate thematic reference, 
and making a note of the first author and year of the paper. 
Stage 7: Mapping and interpretation, 
summarising and synthesising or 
interpreting the literature extracts  
to produce the literature 
review report
 Final analysis of selected extracts. Comparing and 
contrasting information/extracts, highlighting key 
concepts and ideas, and searching for patterns, 
connections, motivations, associations and seeking 
explanations in order to draw the necessary conclusions in 
relation to the original aims of the review.  
 Producing a scholarly report of the analysis (Ahmed et al., 
2014 and background section to the thesis).   
1.3 Holistic assessment of supportive and palliative care needs: the
evidenceforroutinesystematicquestioning
There is evidence to suggest that patients with cancer (Ahmed et al., 2004; Ahmed et al., 
2014; Grunfeld, 2005) and other non-malignant chronic progressive illnesses can experience 
distressing symptoms (such as pain, anxiety, and depression), concerns or issues (such as 
independence and activity issues or family and social issues) (Copp et al., 1998; Potter et al., 
2003; Ryan et al., 2013), which can often remain unrecognised (Ahmed et al., 2004; Ahmed 
et al., 2014). Assessing patients’ holistic needs using routine systematic questioning (‘done or 
acting according to a fixed plan or system; methodical’) is useful in identifying supportive or 
palliative care needs that would otherwise not be identified. There is at present no 
standardised systematic, evidence-based holistic approach to screening patients for supportive 
and palliative care needs (Ahmed et al., 2004; Ahmed et al., 2014). In this introductory 
chapter, I will provide an overview of the concepts and definitions of holistic needs 
assessment in the fields of supportive and palliative care, and present evidence of the value of 
routine systematic questioning. Systematic questioning allows patients’ holistic needs (i.e. 
physical, psychological, religious, spiritual, and information needs etc.) to be identified and 
addressed (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 2015). 
1.4 Philosophy of palliative care and supportive care (concepts and
definitions)
The World Health Organisation (WHO) has defined palliative care as ‘Palliative care is an 
approach that improves the quality of life of patients and their families facing the problem 
associated with life-threatening illness, through the prevention and relief of suffering by 
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means of early identification and impeccable assessment and treatment of pain and other 
problems, physical, psychosocial and spiritual’ (Ahmed, 2010; Ahmed et al., 2014; Doyle, 
2005; Radbruch & Payne, 2009; Sepulveda et al., 2002; WHO Definition of Palliative Care, 
http:www.who.int/cancer/palliative/definition/en/2006). Palliative care is the active holistic 
care of patients with advanced, progressive illness, this new and modified WHO definition 
replaced an older 2002 definition that was restricted to patients’ whose disease is not 
responsive to curative treatment and extended the scope of palliative care to patients and 
families facing problems associated with life limiting illness, with now a much greater 
emphasis on extending provision early on in the course of the illness (Ahmed, 2010; Ahmed 
et al., 2014; Association of Palliative Medicine Strategy, 2008; Bristowe et al., 2015; 
Gardiner et al., 2015; Hughes et al., 2015; Jarrett et al., 1999; Radbruch & Payne, 2009; 
Sepulveda et al., 2002; Skillbeck et al., 1999; Smyth, 2008).  
There are calls for better integration of palliative care into disease management guidelines for 
all significant illnesses (Emanuel et al., 2004). Borgsteede et al., 2006, comment on this 
modified version of the definition, which recognises and promotes the early initiation of 
palliative care. Ahmedzai, 2005, argues that many of the earlier definitions of palliative care 
have mainly been associated with caring for dying patients with ‘incurable and fatal cancer’ 
(Sepulveda et al., 2002; Smyth, 2008), and questions the meanings of the terms ‘active’, 
‘progressive’, ‘far-advanced disease’, and ‘prognosis is limited’, which are terms often used 
to describe palliative care (Ahmed, 2010; Ahmed et al., 2014). 
The United Kingdom (UK) is widely regarded as the birthplace of modern palliative care 
(Clark et al., 2005). The modern hospice movement was introduced by Dame Cicely 
Saunders in 1960’s. The first modern hospice St. Christopher’s opened in 1967 to address the 
neglect of dying patients in general hospitals (Clark, 2002; Clark et al., 2005; Delamothe et 
al., 2010). Palliative medicine is considered to be part of the specialty of palliative care. In 
1987, the UK became the first country in the world to recognise Palliative Medicine as a 
specialty (Ahmed et al., 2010; Doyle, 2005; Gilbert, 1996; Higginson, 2005; Smyth, 2008),
and was ranked first in the European Union for development of supportive, palliative and end 
of life care services (Clark et al., 2010). Palliative care often comes into play when a patients’ 
condition becomes incurable or terminal, and when the focus of care shifts from the curative 
phase to that of improving quality of life and provision of end of life care. Palliative care can 
be provided concurrently alongside other curative or disease modifying treatments as 
illustrated by Figure 3, which illustrates how the involvement of palliative care from the 
point of diagnosis onwards increases as the curative intent decreases. It also demonstrates that 
‘bereavement care’ for patients’ families or carers continues after the patients’ death (WHO, 
2002). 
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Figure 3: Palliative care integration model 
(Adapted from World Health Organization; WHO, 2002)  
1.5 Basic/generalpalliativecareversusspecialisedpalliativecare
The European School of Oncology made an attempt to differentiate between the two different 
levels of palliative care and proposed the following definitions: 
‘Basic/general palliative care is the level of palliative care which should be provided by all 
health care professionals, in primary or secondary care, within their duties to patients with life 
limiting disease’ (Ahmedzai et al., 2004a; Ahmedzai, 2005; Lee, 2005; Radbruch & Payne, 
2009; WHO, 2002). 
‘Specialised palliative care is the standard of palliative care provided at the expert level to 
patients with life threatening or debilitating chronic illness, and their families or carers, by a 
multi-professional and interdisciplinary team, who must continually update their skills and 
knowledge, in order to manage persisting and more complex problems and to provide 
specialised educational and practical resources to other non-specialist members of the primary 
or secondary care teams’ (Ahmedzai et al., 2004a; Ahmedzai, 2005; Radbruch & Payne, 
2009). 
In the past, the terms palliative care and specialist palliative care have been traditionally 
closely associated with care of the dying and linked almost entirely within cancer services 
(Mathew et al., 2003). Palliative care is considered to be part of supportive care, which has a 
much broader definition (Ahmed, 2010; Ahmed et al., 2014; Ahmedzai et al., 2004a; 
Ahmedzai, 2005).  
Supportive care is the care of cancer and chronically ill patients and their families and carers 
from the early stages of illness i.e. from the time of diagnosis, or even pre-diagnosis, 
throughout and alongside both curative and palliative treatments, until the patients’ death, and 
the provision of aftercare (as with palliative care), for the bereaved family members or carers 
continues after the patients’ death. ‘Supportive care is the multi-professional attention to the 
individual’s overall physical, psychosocial, spiritual and cultural needs, and should be 
available at all stages of the illness. Information, communication and bereavement support are 
also part of supportive care’ (Ahmed et al., 2010; Ahmedzai et al., 2004a; Ahmedzai, 2005; 
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NICE, 2004), as illustrated by Figure 4: The Sheffield Model of Comprehensive Supportive 
Care (Ahmedzai, 2005).  
Several authors have suggested that there appears to be considerable overlap and no clear 
distinction between the use of the terms ‘palliative care’ and ‘supportive care’, and there is an 
indication that the terms have been used synonymously in the past. Supportive care was 
originally part of oncological care (Harley et al., 2012), and like palliative care it is extending 
to all patients with life-threatening disease (Ahmedzai, 2005; Radbruch & Payne, 2009). 
Figure 4: The Sheffield Model of Comprehensive Supportive Care  
(Adapted from Ahmedzai, 2005)  
Terminal care is an older term that has been used for comprehensive care of patients with 
advanced cancer and restricted life expectancy (Radbruch & Payne, 2009).  
End of life care has also been used synonymously with palliative care or hospice care, and is 
the care provided to patients who are approaching the last months or years of their life 
(Radbruch & Payne, 2009). 
The White Paper on standards and norms for hospice and palliative care in Europe, has put 
forward some suggestions for a ‘Common European Terminology’ for palliative care. This 
paper argues against using the terms ‘supportive care’ and ‘palliative care’ interchangeably, 
and considers supportive care as part of oncological care (Radbruch & Payne, 2009; 
Radbruch & Payne, 2010). Despite several attempts to define palliative care (Farquhar et al., 
2002) and supportive care (Smyth, 2008), there remains a degree of uncertainty about what 
palliative care and supportive care is, what it offers, and who it’s meant for (Ahmed, 2010; 
Ahmed et al., 2014). Radbruch & Payne, 2009, state that much of the confusion is due to the 
considerable overlap and little or no differentiation between the two terms. The definitions 
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and role of both palliative care and supportive care have evolved and changed over time 
(Epstein & Morrison, 2012). Ahmedzai, 2005, proposed that WHO takes responsibility for a 
universal statement on palliative care which should be updated on a regular basis (Ahmed, 
2010; Ahmed et al., 2014). 
There is at present no widely used systematic, evidence-based holistic approach to screening 
patients for supportive and palliative care needs (Ahmed et al., 2004; Ahmed, 2010; Ahmed 
et al., 2014; Ahmed et al., 2015). If such a system could be developed and shown to be 
workable in primary care or secondary care, this may be the first step towards reducing the 
distress associated with chronic progressive and life-limiting disease (Ahmed, 2010; Ahmed 
et al., 2014).   
1.6 Accessandreferraltopalliativecare(barriersandtimelyreferrals)
There are calls from the international community for the recognition of palliative care as an 
international human right (Ahmedzai et al., 2004a; Ahmedzai, 2005; Shrivastava et al., 2016), 
Gwyther et al., 2009, argue that some countries do not have palliative care services or policies 
in place, and even in countries that do, provision is considered to be variable across regions 
(Ahmed, 2010; Ahmed et al., 2010; Ahmed et al., 2014; Bruera & Sweeney, 2002; Higginson 
et al., 2000). In some countries palliative care is still not available to patients or considered a 
public health concern or problem, and therefore not even part of the health agenda (Sepulveda 
et al., 2002; Stjernsward et al., 2007a; Stjernsward et al., 2007b). Studies indicate limited 
access to services (Keegan et al., 2001) and high levels of patient distress particularly on 
general hospital wards in the UK (Ryan et al., 2013). The preference is usually to be cared for 
and to die at home (Aabom & Pfeiffer, 2009; Ahmed et al., 2010; Higginson & Sen-Gupta, 
2000; Pollock, 2015), however just over half of deaths in the UK occur in an acute hospital 
setting (Ahmed et al., 2010; Barclay & Arthur, 2008; Barclay & Maher, 2010; Ellershaw et 
al, 2010; EOLC Strategy, 2008; Higginson et al., 1998; Higginson et al., 2010; Murray et al., 
2004), and older people are particularly likely to die in this setting (Gardiner et al., 2011). 
That said preferences for ‘place of care’ and ‘place of death’ can change as illness progresses 
(Agar et al., 2008; Higginson et al., 2010). The future projections by Gomes and Higginson 
(2008) are that fewer than 1 in 10 people will die at home in 2030. There does however 
appear to be a large country variation in place of death. Cohen et al., 2015, cross sectional 
study using death certificate data for all deaths from cancer in 2008, showed a large between 
country differences and variation in home and hospital deaths which were partly attributed to 
differences in the availability of hospitals long-term beds and on the countries health care 
resources. Pollock, 2015, calls for further research, with an emphasis on the importance of 
recognising and accommodating the diversity and patient preferences for place of death 
(particularly in the context of e.g. cultural heterogeneity).    
In 2004, I undertook an extensive systematic review of the literature on access and referral to 
palliative care. Several issues relating to access and referral to palliative care were identified, 
including: variable availability of services; lack of referral criteria to guide professionals 
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(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014); health professional related factors 
(Bradley et al., 2000; Bradley et al., 2002; Daaleman & Frey, 1998; Kirchhoff & Beckstrand, 
2000; Lamont & Christakis, 2002); and lack of guidance on the timing of this referral 
(Ahmed et al., 2004). The resistance and reluctance of healthcare professionals to refer to, and 
for patients and families to be referred for palliative care due to misconceptions about 
palliative care and hospice care, have also been cited as possible reasons for non-referral or 
may account for late referrals to palliative care (Ahmed et al., 2004; Ahmed, 2010; Ahmed et 
al., 2014; Christakis, 1998; Friedman et al., 2002; Hayley et al., 2001; Johnson & Slaninka, 
1999; Ronaldson & Devery, 2001). Various groups such as minority ethnic groups (Fountain, 
1999; Koffman & Higginson, 2001), older people (Addington-Hall et al., 1998; Burge et al., 
2002; Casarett, 2001; Davies & Higginson, 2004; Grande et al., 2002; Hunt & McCaul, 
1998), those with non-malignant progressive conditions (Gadoud et al., 2013; Hanratty et al., 
2002), and the socially disadvantaged groups, were also seen to be failing to receive timely 
referrals and sometimes not referred at all (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 
2014).  
Referral to palliative care and subsequent hospice admission are often governed by chance 
rather than need (Addington-Hall et al., 1998). To overcome these barriers, Lau and 
O’Connor, 2012, emphasise the need to take action on many fronts, because palliative care 
still remains underutilised by certain groups in the community (Ahmed et al., 2004; Ahmed, 
2010; Ahmed et al., 2014).  
The systematic review that I undertook in 2004, concluded that the main barrier to receiving 
palliative care in the UK, was the failure to recognise need and also variable availability of 
services; it called for the development of more comprehensive standardised referral criteria to 
guide referrals, coupled with a need to improve education and knowledge about palliative 
care for health care professionals (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; 
Bradley et al., 2000; Bradley et al., 2002; Dixon et al., 2002; Gott et al., 2001; Heedman & 
Starkhammar, 2002; Hodgson et al., 1997; Kite et al., 1999; Lagman et al., 2007; Miller et al., 
1997; Schim et al., 2000; Wyatt et al., 2000), and for patients and their families or carers 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014). Several other authors have also 
commented on similar issues which have an impact on access and referral to palliative care. 
Several lines of research show that most patients continue to be referred to palliative care late 
in the disease trajectory, often being referred in a ‘far advanced’ or ‘terminal stages’ of illness 
(Ahmed et al., 2004; Casarett, 2001; Costantini et al., 1999; Currow et al., 2008a; Fadul et al., 
2009; Farnon & Hofmann, 1997; Le & Ashby, 2007; Melvin & Oldham, 2009; Myers, 2002; 
Osta et al., 2008; Radbruch & Payne, 2009; Radbruch & Payne, 2010; Raghavan et al., 2005; 
Rickerson et al., 2005).  
Walshe et al., 2009, argue against conducting further studies on access and referral to 
palliative care, and instead focus attention on research which may shed light on reasons for 
the observed differences in access and utilisation patterns. Higginson, 2005, also supports this 
view. Currow et al., 2008b, argue that a lack of service uptake does not always represent 
unmet needs, and call for a prospective follow up study (Ahmed et al., 2004; Ahmed, 2010; 
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Ahmed et al., 2014). Karim et al., 2000, propose that further research should be undertaken to 
establish the levels of awareness, and attitudes towards palliative care and assess the demand 
and utilisation for specific palliative care services (inpatient and day care services) within 
various black and minority ethnic communities.   
Several authors emphasise the importance of incorporating basic palliative care education in 
all medical, nursing, and allied health care professional courses (Ahmed et al., 2004; Ahmed, 
2010; Ahmed et al., 2014; Kenen, 2010; Radbruch & Payne, 2009; Radbruch & Payne, 2010). 
Palliative care education has become a priority in many European Union (EU) countries. It 
has been argued that palliative care specialists must do more to reach out to those patients in 
need. At the same time other health care professionals (e.g. generalists) must work with the 
specialists by adopting a ‘shared care’ and more integrated (Ahmed et al., 2004; Ahmed, 
2010; Ahmed et al., 2014; Hasselaar & Payne, 2016) care model approach (e.g. fuller 
integration of specialist palliative services) (Dharmasena & Forbes, 2001; Gadoud & 
Johnson, 2011; Gibbs et al., 1997; Hanratty et al., 2002; Kayashima & Braun, 2001; Kenen, 
2010; Kite et al., 1999; Le & Ashby, 2007; Mitchell  et al., 2008; Ogle et al., 2003; Skilbeck 
et al., 1999), which is often described in the literature as being ‘patient-centred’ and ‘active’ 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Wijnia & Corstiaensen, 2008).  
Several lines of research support the view that earlier referrals to palliative care are better 
(Temel et al., 2010), and may allow; 1) more time for professionals to undertake assessments 
and identify patients and their families or carers needs; and 2) more time for patients and their 
families or carers to benefit from the services they subsequently receive if needs are identified 
(Casarett et al., 2008; Currow et al., 2008a; Rickerson et al., 2005). However, Mitchell, 2005, 
argues against putting too many support systems in place at the wrong time, but this argument 
is based on one case study.  
The transition from the curative or disease modifying to the palliative phase is often a very 
complex and difficult one to make (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; 
Gardiner et al., 2011) for both healthcare professionals, patients and their families or carers 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Boyd & Murray, 2010; Fallowfield et 
al., 2002; Hayley et al., 2001; Higginson, 2005; Ronaldson & Devery, 2001; Schofield et al., 
2006). Lofmark et al., 2005 and Lofmark et al., 2007, attribute this partly to the traditional 
‘medical model of care’ which focuses primarily on curative or life prolonging measures 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Griffie et al., 1999). 
The unpredictable course of some chronic progressive illnesses (e.g. cardiac/heart failure) 
with varying illness trajectories (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; 
Barclay & Maher, 2010; Gadoud et al., 2013; Murray et al., 2002; Murray et al., 2007), and 
the difficulties in establishing a prognosis also add to these problems (Boyd & Murray, 2010; 
Hanratty et al., 2002; Murray et al., 2005; Quaglietti et al., 2000; Sigurdardottir & Haugen, 
2008). Therefore, getting the ‘timing right’ is difficult without a comprehensive holistic 
assessment of the needs of patients and their families or carers (Ahmed et al., 2004; Ahmed, 
2010; Ahmed et al., 2014; Currow et al., 2008a; Melvin & Oldham, 2009; Osta et al., 2008; 
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Radbruch & Payne, 2009; Radbruch & Payne, 2010; Rickerson et al., 2005). Murray et al., 
2007, identify a need to undertake more research in order to gain a better understanding and 
insight into the different illness trajectories and how best to cater for the needs of patients 
with varying illnesses. The implications of earlier referrals and expanding the provision of 
palliative care services to patients with non-malignant conditions are yet to be established 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014).  
In the UK, many specialist palliative care teams have developed locally-based guidelines on 
referral; the Leeds Eligibility Criteria for specialist palliative care services, developed by 
Bennett and colleagues is one such example (Ahmed et al., 2004; Ahmed, 2010; Ahmed et 
al., 2014; Bennett et al., 2000).  
1.7 Prevalenceofconcerns,problemsandissuesinpalliativecarepatients
There is evidence to suggest that patients with both cancer (Ahmed et al., 2004; Ahmed, 
2010; Ahmed et al., 2014; Lidstone et al., 2003; Potter et al., 2003), and other non-malignant 
chronic progressive illnesses (Ganzini et al., 2002; Higginson et al., 2000; Kite et al., 1999; 
Potter et al., 2003; Solano et al., 2006) can experience distressing symptoms and concerns 
such as physical, psychological, religious and spiritual needs etc., which can often remain 
unrecognised (Ahmed et al., 2004; Ryan et al., 2013; Salt et al., 1998). For this reason, the 
extension of supportive and palliative care, which are well established in cancer, to patients 
with other non-malignant progressive chronic illnesses is pressing (Bristowe et al., 2015; 
Murray et al., 2004), and there are calls for provision to be needs-based, irrespective of 
diagnosis or prognosis (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Ahmedzai, 
2005).  
Previous research has highlighted that distressing symptoms and concerns can be managed 
and treated, provided they are identified in a timely manner and systems are in place for a 
prompt referral to appropriate specialist teams (Ahmed et al., 2015; Fitzsimons et al., 2007; 
Homsi et al., 2006; Lagman et al., 2007; Shah et al., 2008; Sigurdardottir & Haugen, 2008; 
White et al., 2009). Ahmedzai et al., 2004a, argues that ‘many studies from different parts of 
the world have consistently shown that patients are referred for palliative care in an advanced 
and terminal stage of their illness’ (Ahmedzai et al., 2004a; Raghavan et al., 2005), often for 
symptom control. The timely identification of these symptoms and prompt referral to 
appropriate specialist teams for their management could potentially not only reduce the 
burden of individual patient suffering, but also lead to earlier discharge from expensive 
secondary and tertiary specialist care and thus save revenue for the National Health Service 
(NHS). Similarly, earlier detection of these problems in out-patients could prevent 
unnecessary admissions and their attendant costs. The potential gains to patients and the NHS 
are large, for a relatively small investment in screening. This may also have implications for 
the configuration and funding of services. 
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1.8 Theneedforsystematicholisticquestioninginpalliativecare
There is agreement amongst the research community that assessing patients’ holistic needs 
using routine systematic questioning (‘done or acting according to a fixed plan or system; 
methodical’) is useful in identifying symptoms, problems and issues, which would otherwise 
not be identified by routine medical and nursing assessment, or by using open-ended 
questions (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Bruera, 2008; Homsi et al., 
2006; Shah et al., 2008; White et al., 2009). For example, Shah et al, 2008, describe how a 
study using single open-ended questions that asked palliative care patients what bothers you 
most during the initial consultation, generated a variety of patient concerns. The authors 
propose the use of ‘single open-ended’ questions to identify ‘most pressing needs’. However, 
this has the potential to exclude less urgent concerns that are nevertheless important for health 
professionals’ understanding of a clinical case. This is illustrated by their finding that 
‘physical distress (44%) was reported more often than emotional, spiritual, existential or non-
specific distress (16%)’ (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014).  
For this reason, the ‘total symptom experience’ is best captured using a more systematic 
holistic assessment i.e. systematic questioning together with 'what bothers you most' 
questions so that health care professionals can gauge items to focus on which are most 
pressing to patients. A study that examined symptom evaluation in palliative medicine found 
that the frequency of symptoms identified during a systematic assessment (using 48-item 
symptom checklist) were ten-fold higher (p<0.001) than those that were volunteered during 
open-ended questioning (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Homsi et al., 
2006). Arguments against using systematic questioning are usually based on the time it takes 
to complete an assessment, which can be burdensome for this group of poorly and fatigued 
patients (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Homsi et al., 2006).
White et al., 2009, described a retrospective chart review study of 50 patients admitted to a 
specialist palliative care unit. They found that on average 8 further symptoms were detected 
per patient by systematic questioning than self-report (approximately 66% of symptoms were 
detected by systematic questioning). Pain was the most commonly self-reported symptom in 
this study. The authors propose a number of reasons which may account for this. Shorthose & 
Davies, 2003, also cite several reasons for under-reporting of symptoms. The main reasons as 
to why patients may under-report symptoms are presented below (Ahmed et al., 2004; 
Ahmed, 2010; Ahmed et al., 2014):  
Symptom is not considered severe, considered unimportant, and reporting or under-
reporting is influenced by reason for referral, or referrer (i.e. patients perception of the 
reason for admission may have been in¯uenced by the referrer) have been cited (Ahmed et 
al., 2004; Ahmed, 2010; Ahmed et al., 2014; White et al., 2009). 
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Symptom is inevitable, no treatment is available, perception that health care professional 
will see it as unimportant, and presence of other more important symptoms have been cited 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Shorthose & Davies, 2003). 
And the main reasons as to why health care professionals may not enquire about some 
symptoms are presented below:   
Perception that symptom is uncommon, considered unimportant, no treatment is available 
and time constraints have been cited (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; 
Shorthose & Davies, 2003). 
The precise reasons why health care professionals do not enquire about some symptoms 
remains unclear and requires further investigation (Ahmed et al., 2004; Ahmed, 2010; Ahmed 
et al., 2014).  
Hoekstra et al., 2007, argue that the most ‘severe’ symptom is not necessarily the same as the 
‘most troublesome’, and stress the importance of assessing both for an individual patient. 
Kirkova et al., 2010, report some complexities and challenges of symptom assessment in 
palliative medicine, and highlight the importance of supplementing the clinical interview with 
validated multi-symptom instruments and giving priority to ‘total symptom experience’ 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014).  
Bruera, 2008, stresses that early identification of and monitoring of symptoms is only useful if 
effective treatment programmes are in place. He argued that continued repeated assessments 
of patients’ needs, when no systems or treatments are in place to meet those identified needs 
could be considered ‘unethical’ (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014).  
1.9 Working definitions of assessment, needs and holistic needs
assessment
The following working definitions of ‘assessment’ and ‘needs’ were part of a Report to the 
National Cancer Action Team on Holistic Common Assessment of Supportive and Palliative 
Care Needs for Adults with Cancer (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; 
Report to the National Cancer Action Team, 2007).  
Assessment is the overall process for identifying and recording the health and social care 
needs of an individual and for evaluating their impact on daily living and quality of life so 
that appropriate action can be agreed and planned with the individual (Ahmed et al., 2004; 
Ahmed, 2010; Ahmed et al., 2014).  
Needs are what an individual requires to be met in order to maintain or improve current 
states of well-being or to anticipate and manage their deterioration. Areas of supportive and 
palliative care needs include physical, emotional, spiritual, environmental, social, sexual, 
financial and cultural needs (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014). 
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1.10 Modelsofnursingthatcontainholisticassessment
The concept of holistic assessment is not a new concept, and several authors would argue that 
it has been around for many decades. Nurses have undertaken holistic assessments, often 
referred to as ‘nursing assessment’ as an established part of their practice. The ‘Roper, Logan 
and Tierney model of nursing’ (Roper’s activity of daily living, published 1980) (Ahmed et 
al., 2004; Ahmed, 2010; Ahmed et al., 2014; Roper et al., 1980; Roper et al., 2000), and the 
‘Orem model of nursing’ (Orem’s model of self-care, developed between 1959 and 2001) 
(Cavanagh, 1991; Orem, 1991; Orem, 1995; Orem, 2001), are examples of models of nursing 
that contain holistic assessments. The change with other health needs assessment tools is the 
systematic, standardised, evidence-based approach to questioning and terminology (Ahmed et 
al., 2004; Ahmed, 2010; Ahmed et al., 2014).  
1.11 Conceptofholisticassessment(medicalvs.holisticmodelofcare)
The holistic model of care is often described as ‘patient-centred’, ‘whole-person’ and ‘whole-
situation’; mind, body and spirit approach to care where each domain assessed is given equal 
importance (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014). The persons entire well-
being is taken into account (i.e. physical, emotional, spiritual, mental, social and 
environmental) (Calman, 1984), and the assessment results are used to inform a care plan 
(NCSI, 2013). This ‘holistic’, ‘whole-person’ and ‘whole-situation’ approach to care 
challenges the traditional ‘medical model of care’ which is primarily ‘disease-focussed’ 
(National Cancer Survivorship Initiative: NCSI, 2013). The ‘holistic model of care’ 
recognises that any changes or disturbances to either the mind, body, or spirit, can have an 
effect on the overall health and quality of life of an individual and the family (Ahmed et al., 
2004; Ahmed, 2010; Ahmed et al., 2014). These concepts are closely allied to Cicely 
Saunders’ concept of ‘total pain’ that underpins palliative care practice and comprises of the 
notions of physical, emotional, social and spiritual pain (Finlay, 2006; Locker, 2008). 
Therefore, multidisciplinary teams must assess patients holistically (Ahmed et al., 2004; 
Ahmed, 2010; Ahmed et al., 2014; Locker, 2008; Maher & Hemming, 2005). 
The National Institute for Clinical Excellence (now renamed as National Institute for Health 
and Care Excellence but with the same acronym NICE) issued guidance on improving 
supportive and palliative care for adults with cancer, setting out a series of recommendations 
based on research evidence, which became a major policy document in England and Wales. 
Service users, professionals and policy-makers were consulted during the development phase 
(NICE Guidance, 2004). The NICE guidance recognises the need for patients and their 
families to have their needs assessed on a regular basis and throughout the course of their 
illness by a multidisciplinary team (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014).  
Maher & Hemming, 2005, present the ‘tangled web of cause and effect’ theory which 
proposes that without a comprehensive holistic assessment of an individual, the root cause of 
a problem is unlikely to be identified. In order to ‘unpack’ the complex nature of problems in 
patients, it is important to undertake a thorough holistic assessment. A poor or inadequate 
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assessment can result in unnecessary distress and suffering. A good assessment would inform 
others providing care from that moment forward thereby improving continuity of care 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Maher & Hemming, 2005).  
In response to the NICE guidance recommendation 2, the Cancer Action Team commissioned 
the Holistic Common Assessment of Supportive and Palliative Care Needs for Adults with 
Cancer- Assessment Guidance (2007). A report by Kings College London accompanied this 
guidance which called for a more unified approach to the assessment and recording of 
patients’ needs (setting out the main features of holistic assessment and providing the core 
content of the assessment) (Report to the National Cancer Action Team, 2007).  
1.12 Mainfeaturesofassessmentandcorecontentofassessment
Dunn, 2001, describes assessment as a staging procedure for the dimensions of distress. 
This paper discusses nine dimensions of whole patient assessment for palliative care; these 
are: ‘1) illness/treatment summary; 2) physical; 3) psychological; 4) decision-making;          
5) communication; 6) social; 7) spiritual; 8) practical; and 9) anticipatory planning for death’. 
This paper also addresses the duration of the assessment (20-30 minutes), who should be 
present at the assessment, and discusses the nine dimensions in considerable detail. Although 
this was developed by the authors of the American Medical Association’s Education for 
Physicians on End-of-Life Care Curriculum, and is aimed primarily for surgeons to aid 
comprehensive assessment, this model could easily be applied to patients earlier on in the 
disease trajectory (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014). It is debatable 
whether the full assessment as described by Dunn, 2001, could be successfully completed in 
20-30 minutes, but this very much depends on the patient and the skills of the assessor. It 
could be argued that this form of assessment is best done over 20-30 minute slots per domain; 
otherwise trying to perform the entire assessment in 20-30 minutes, may be too 
overwhelming for the patient. Roberts et al., 2005, argued that there is no one single 
assessment that covers all domains that are necessary for a comprehensive holistic 
assessment. Ellis, 1999, have recommended the use of a patient-centred care model that is 
holistic/multi-professional/reflective, which essentially is a model of care that allows patients 
to determine their own needs, and is holistic in nature, multi-professional, and reflective 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014).  
The Holistic Common Assessment of Supportive and Palliative Care Needs for Adults with 
Cancer-Assessment Guidance (2007), (Cancer Action Team, 2007, Guidance, work 
commissioned by The Cancer Action Team) was developed by a team led by Professor 
Alison Richardson (Kings College, London, UK). The initial stages of development, involved 
a scoping exercise that comprised of: ‘1) a literature review to identify tools for holistic 
assessment; 2) a survey of current practice in cancer networks; and 3) an appraisal of the 
Single Assessment Process for older people’. This work led to the development of a 
specification for assessment and a report that set out the main features of an assessment and 
core content of the assessment. The recommendations are presented in Table 6. Although the 
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guidance was written for the assessment of cancer patients, the principles of assessment could 
easily be applied to other chronic progressive illnesses, such as heart failure (Ahmed et al., 
2004; Ahmed, 2010; Ahmed et al., 2014; Hanratty et al., 2002; Salt et al., 1998).  
These recommendations carry implications for resources required to achieve adequate 
assessment. The recommendation that physical issues be addressed first should be acceptable 
to the majority of patients since it is in accordance with the finding that physical symptoms, 
notably pain and fatigue are the most frequently identified as the most important problems
(Shah et al., 2008). Other recommendations include the proposal that the assessment can 
continue over many sessions and should supplement the routine clinical review. 
Table 6: Holistic Common Assessment of Supportive and Palliative Care Needs for Adults 
with Cancer- Assessment Guidance (2007)  
Recommendations from The Holistic Common Assessment of Supportive and Palliative Care 
Needs for Adults with Cancer- Assessment Guidance (2007) (Cancer Action Team, 2007 
Guidance, work commissioned by The Cancer Action Team).  
1. ‘Makes reference to five domains of assessment: background information and assessment 
preferences, physical well-being, social and occupational well-being, psychological well-being, and 
spiritual well-being. The guidance recommends that physical issues are addressed first, and 
spiritual and psychological issues towards the end’. 
2. ‘Holistic assessment is a process that should ideally capture full range of needs, the use of more 
than one tool is recommended for this purpose, since research suggests that no one tool is capable 
of capturing full range of needs’.   
3. ‘Holistic assessment should take place throughout the course of the illness (from time of diagnosis, 
before and after treatments, and during follow-up)’. 
4. ‘Unnecessary repeated assessments should be avoided’. 
5. ‘Assessment should be done over several sessions’. 
6. ‘Appropriately trained professionals, who have knowledge about the illness, and local services 
available, should undertake the assessment/s’.   
7. ‘Assessment of needs should be seen as patient-led, patient-centred, continuous, and supplement 
but not replace day-day assessment’.   
8. ‘The guidance recommends that summary records of assessments should be first agreed with 
patients. This process must take place prior to any further actions being undertaken’. 
9. ‘The guidance recommends that records of assessment should be well documented, and easily 
accessible to other professionals within and across settings (though patient consent may be 
required)’.
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014) 
1.13 Assessmenttoolsandinstruments
Richardson et al., 2005, and Richardson et al., 2007, undertook a review of the tools for 
patient assessment in cancer care; they found and critiqued 15 tools. Table 1 of Appendix 3,
provides a summary of some of these assessment tools used in supportive and palliative care 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014). Their findings indicate that of the 15 
tools identified, only 6 tools were considered to be comprehensive with respect to health 
status. These included: 1) Problems and Needs in Palliative Care Instrument (PNPC), 
designed for advanced cancer patients, and developed in The Netherlands (Osse et al., 2004; 
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Richardson et al., 2007); 2) Oncology Clinic Patient Checklist (OCPC), designed for cancer 
patients, and developed in the USA (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; 
Richardson et al., 2007; Romsaas et al., 1983); 3) Symptoms and Concerns Checklist 
designed for advanced cancer patients, and developed in the UK (Lidstone et al., 2003; 
Richardson et al., 2007); 4) Supportive Care Needs Survey (SCNS), designed for cancer 
patients, and developed in Australia (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; 
Bonevski et al., 2000; Richardson et al., 2007); 5) Sheffield Profile for Assessment and 
Referral for Care (SPARC), a generic tool designed for patients with an advanced illness, and 
developed in the UK (Ahmed et al., 2015; Ahmedzai et al., 2004b; Hughes et al., 2015); and 
6) the Distress Management Tool designed for cancer patients and developed in the USA 
(Richardson et al., 2007). SPARC and the Distress Management Tool were considered to be 
the most comprehensive tools identified, according to the author’s classification, covering all 
dimensions of need and in relation to health status (Ahmed et al., 2004; Ahmed, 2010; 
Ahmed et al., 2014; Richardson et al., 2007).  
1.14 SheffieldProfileforAssessmentandReferralforCare(SPARC)
The Sheffield Profile for Assessment and Referral for Care (SPARC) is a holistic screening 
tool for identifying supportive and palliative care needs. As part of a team of researchers 
based at the Academic Unit of Supportive Care, The University of Sheffield, I assisted in the 
development of the SPARC tool (Figure 5), and SPARC guidance over a period of 5 years. 
The work was initially commissioned by the Elizabeth Clark Charitable Trust. A final report 
was submitted to the funders in December 2004. SPARC has been subjected to rigorous 
psychometric development, preliminary field-testing, and validation (Ahmed et al., 2004; 
Ahmed et al., 2009; Ahmed, 2010; Ahmed et al., 2014; Ahmedzai et al., 2004b; Bestall et al., 
2004). The acceptability of SPARC to patients in a variety of settings as well as support 
groups (Hughes et al., 2015), and at diagnosis (Wilcock et al., 2010), have also been 
successfully demonstrated (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014).  
SPARC is a multidimensional screening tool which gives a profile of needs to identify 
patients who may benefit from additional supportive or palliative care, regardless of diagnosis 
or stage of disease. SPARC is intended for use by primary care, hospital teams or other 
services to improve patient management, either by current professional carers or by referral to 
a specialist team. 
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Figure 5: SPARC Tool  
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The patient-rated (self-complete) 45-item tool reflects nine dimensions of need and as such 
represents a comprehensive early needs assessment or holistic tool (Table 7) (Ahmed et al., 
2004; Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 2015).  
Table 7: SPARC domains, number of items and response types 
SPARC Guidance, 2004 recommends that ‘SPARC is capable of being completed by patients 
with or without the help of their informal carers or professional carers. It does not point to a 
diagnosis or define a sum total of distress, but rather it describes a profile of the patient’s 
situation, in the way that clinicians and other health and social care professionals can relate to 
and act on. It may be a useful indicator to professionals that a patient could benefit from 
additional care in previously unrecognised areas’ (Ahmed, 2010; Ahmed et al., 2014; SPARC 
Guidance, 2004).  
Domains in SPARC include – 
Communication and information issues 
Physical symptoms 
Psychological issues 
Religious and spiritual issues 
Independence and activity 
Family and social issues 
Treatment issues  
Personal issues 
(Ahmed, 2010; Ahmed et al., 2014; Hughes et al., 2015)  
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SPARC Guidance, 2004
SPARC Guidance, 2004, provides guidance about how SPARC should be used, this is 
summarised below.   
SPARC is designed for use as a comprehensive and holistic self-assessment tool and gives a 
profile of needs to identify patients who could benefit from additional supportive or palliative 
care. It is designed to complement and not to replace the face-to-face clinical assessment by 
healthcare professionals (Hughes et al., 2015).  
SPARC is intended to highlight need, in order to improve patient management, either by the 
current professional carers or by referral to specialist supportive and palliative care services, 
and is found to be acceptable and relevant to patients with a wide range of diagnoses (Hughes 
et al., 2015; Richardson et al., 2005).  
SPARC is designed to give a clinical profile and NOT a single index score. Each item should 
be regarded on its own merit. Currently we do not recommend attaching any clinical 
significance to the total score or sum of scores in any category. 
SPARC does not generate a clinical diagnosis. For example, it cannot indicate if a patient has 
clinical depression or a specific pain syndrome. It should not be used as the structure for a 
clinical interview unless 60 to 90 minutes are available for the task.  
It may be helpful to direct the clinician to another screening tool. For example, a high pain 
score could trigger the use of the Brief Pain Inventory (BPI) and/or Leeds Assessment of 
Neuropathic Symptoms and Signs (LANSS). A high score within the psychological section 
could trigger the use of Hospital Anxiety and Depression Scale (HADS). 
SPARC may be used at any time for patients with any diagnosis or combination of medical 
problems that indicate need for supportive or palliative care. Clinicians whose patients use the 
scale should be made aware of any individual score of 1 or above. Items scoring 2 on the 
scale require early attention. An appropriate course of action may be discussing the issue at a 
meeting of the multidisciplinary team or at the next consultation with the patient. Items 
scoring 3 would usually merit immediate attention by the attending clinician. The speed of 
response and the specific actions taken will depend on the clinical context, how long the issue 
has been a problem and the level of supportive care or palliative care already in place. 
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1.15 Summary
The gap in knowledge: Implications for future research and practice  
Many of the symptoms and problems associated with cancer or advanced progressive 
illnesses are potentially treatable, but often remain unrecognised and may cause significant 
impairment of quality of life or loss of independent functioning (Ahmed et al., 2004; Ahmed, 
2010; Ahmed et al., 2014).  
This review has presented a strong argument in favour of the need for a comprehensive 
holistic assessment of supportive and palliative care needs, and recommendations for 
conducting a HNA have also been presented (Ahmed et al., 2004; Ahmed, 2010; Ahmed et 
al., 2014). There is evidence to indicate a lack of studies on the clinical utility of tools 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Richardson et al., 2007).  
There is at present no standardised systematic, evidence-based holistic approach to screening 
patients for supportive and palliative care needs (Ahmed et al., 2004; Ahmed, 2010; Ahmed 
et al., 2014). Systems and services must be in place in order to address any identified needs in 
a timely manner, and we must consider and evaluate new methods to achieve practice change. 
Further research is also needed on the effective integration of these tools into routine clinical 
care. Future work must therefore address these issues (Ahmed et al., 2004; Ahmed, 2010; 
Ahmed et al., 2014). 
SPARC has been developed by the Academic Unit of Supportive Care, The University of 
Sheffield over a period of 5 years. SPARC has undergone rigorous psychometric 
development, preliminary field-testing, and extensive validation. SPARC has been shown to 
be acceptable to patients in various settings (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 
2014). Despite rigorous psychometric development, preliminary field-testing, and validation, 
the clinical utility of SPARC has yet to be established (Ahmed et al., 2015). 
This review provides the evidence base and the justification for a prospective randomised 
controlled trial of the clinical utility of SPARC as an early holistic needs assessment (Ahmed 
et al., 2004; Ahmed, 2010; Ahmed et al., 2014). Palliative care trials are complex, and in light 
of this, the SPARC intervention study was developed, piloted, evaluated, reported and 
implemented in accordance with the MRC framework for developing and evaluating complex 
interventions (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014; Craig et al., 2008a; 
Craig et al., 2008b). Data generated from this pilot study will guide the development of a 
further, larger definitive multicentre study (Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 
2014). This trial is the first step in a process that would define the clinical utility of SPARC 
(Ahmed et al., 2004; Ahmed, 2010; Ahmed et al., 2014).  
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Chapter2
Hypothesis,aimsandobjectives2
2.1 Hypothesis
The hypothesis was that the use of a validated multidimensional holistic screening tool for 
supportive and palliative care needs; the Sheffield Profile for Assessment and Referral for 
Care (SPARC) would lead to improved recognition of supportive and palliative care needs, 
and improved health care outcomes for patients (Ahmed, 2010). 
2.2 Aims
 To determine whether the use of a validated multidimensional holistic screening tool 
for supportive and palliative care needs; SPARC, will lead to improved recognition of 
supportive and palliative care needs and improved health care outcomes for patients 
(Ahmed, 2010).
2.3 Objectives
 To design and undertake a pilot study to evaluate clinical outcomes associated with 
the use of SPARC in a supportive and palliative care service using a randomised, 
waiting-list controlled trial in order to test its clinical utility.  
 To undertake a detailed process evaluation of the SPARC pilot trial, in order to gain a 
better understanding of ‘whether and how the SPARC intervention works (or does not 
work) and inform the design of subsequent studies’ (Farquhar et al., 2011). 
 To elicit the views of supportive and palliative care professionals concerning the use 
of SPARC in Sheffield (UK), particularly with regards to ‘the effective integration’ of 
SPARC into routine care and standard operating systems (Ahmed, 2010). 
2.4 Potentialimpactofthiswork
This study provides an opportunity to ‘test-drive’ SPARC with patients that have supportive 
and palliative care needs. It will contribute to recognising the best methods for identifying 
patients’ needs, and determine the extent to which these needs are addressed by following 
patients prospectively. This study represents a development of the SPARC tool for use as an 
early holistic needs assessment tool, within the MRC framework for evaluation of complex 
interventions (Ahmed, 2010; Craig et al., 2008a; Craig et al., 2008b).  
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Chapter3
Methodologicalapproach3
3.1 Methodologicalandtheoreticalunderpinningsofthestudy
This study was conducted within the context of a pragmatic randomised controlled trial and 
nested within the MRC framework for evaluating complex interventions (Boon et al., 2007; 
Craig et al., 2008a; Craig et al., 2008b; Craig et al., 2013a; Craig et al., 2013b). This chapter 
focuses on the methodological and theoretical framework that was used to inform the 
methods and the design of this study. Palliative care researchers employ a variety of methods, 
the choice and selection of an appropriate design is an important aspect of the research 
process (Noble, 2014). An embedded (or nested) concurrent mixed methods design was 
considered the most appropriate design for this study. The rationale for this design being 
discussed further within this chapter. 
3.2 Philosophyinmixedmethodsresearch
Creswell, 2009, defines a worldview as a basic set of beliefs that guide action. Mixed 
methods researchers may hold different philosophical positions (dialectical stances), this can 
be particularly challenging when undertaking mixed methods research, due to tensions 
created by the different beliefs; leading to so called ‘paradigm wars’ (Albright et al., 2013; 
Alise & Teddlie, 2010; Bazeley, 2009; Creswell, 2009; Creswell & Clark, 2010; Creswell & 
Tasshakkorri, 2008; Kelle, 2006). The mixed methods literature makes reference to 4 major 
worldviews, namely: 1) postpositivism; 2) constructivism; 3) advocacy/participatory; and     
4) pragmatism (Creswell, 2009; Creswell & Clark, 2010). Creswell, 2009, provides a 
summary (breakdown) of the four worldviews of research (Table 8); and summarises the 
interconnection of worldviews, strategies of inquiry, and research methods and designs 
commonly used in mixed methods research (Figure 6).  
This doctoral study adopted pragmatism as the underpinning philosophical framework to 
inform the choice of methodology and methods.  
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Table 8: Summary (breakdown) of four world views of research (adopted from Creswell, 
2009; and Creswell & Clark, 2010) 
Postpositivism Constructivism 
 Determination
 Reductionism
 Empirical observation and 
measurement
 Theory verification
 Understanding
 Multiple participant meaning
 Social and historical construction
 Theory generation
Advocacy/Participatory Pragmatism 
 Political
 Empowerment issue-oriented
 Collaborative
 Change-orientated
 Consequences of actions
 Problem-centered
 Pluralistic
 Real world practice oriented
Figure 6: The Interconnection of worldviews, strategies of inquiry, and research methods:    
A Framework for Design (adopted from Creswell, 2009; Creswell & Clark, 2010)   
The pragmatic approach is a philosophical movement that has its origins in the United States 
around 1870 (late 19th and early 20th century) (Hookway, 2016), and originated as a result of 
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the ongoing debates between qualitative and quantitative researchers (Creswell, 2009; 
Creswell & Clark, 2010).  
Mixed methods researchers advocate the use of this approach, which is widely regarded as the 
best paradigm in mixed methods research (Patton, 1999; Protheroe et al., 2007; Tashakkori & 
Teddlie, 2010), where the focus is primarily on the importance on answering the research 
questions i.e. drawing on the principles of what works as an ideology, and using diverse or 
multiple approaches (i.e. quantitative and qualitative) to reach a practical solution (Feilzer, 
2010; Miller et al., 2013; Onwuegbuzie & Leech, 2005). This approach does not align itself to 
any one particular approach, or philosophical assumption. Creswell, 2009, state that ‘multiple 
methods and procedures, different worldviews or paradigms, different assumptions as well as 
different forms of data collection and analysis that best fit the research question/s’ can be 
used in a mixed methods research study to address research problems (Creswell, 2009; 
Creswell & Clark, 2010;  Feilzer, 2010).  
3.3 Methodologicalandethicalissuesofconductingresearchinpalliative
care
Methodological and ethical considerations are important aspects for all types of research 
involving patients and are a fundamental part of palliative care research. Keeley, (2008), cites 
the need to improve the evidence base in palliative medicine, however the difficulties of 
conducting research in patients with chronic and advanced progressive diseases, cancer, 
serious illnesses and those at the end of life, who are often regarded as a ‘vulnerable group of 
patients’ are well documented, and much of the ethical debate is based on the issue of 
‘vulnerability’, treatment allocation, respect, confidentiality, burden and gaining informed 
consent (Ahmed, 2010; Addington-Hall, 2002; Ross & Cornbleet, 2003).  
A number of authors have commented on the methodological and ethical difficulties of 
conducting research in palliative care, particularly when self-report methods are used to 
investigate experiences of patients (Entwistle et al., 2002). Challenges include: recruitment 
difficulties; defining the patient population; retention; follow up difficulties; gate keeping; 
high patient attrition rates; patients often regarded as vulnerable; frail; weak; and with 
cognitive impairments; small sample sizes; compliance; dropouts and withdrawals; missing 
data; as well as difficulties with obtaining informed consent have all been cited (Ahmed, 
2010; Addington-Hall., 2002; Borgsteede et al., 2006; Diehr & Johnson, 2005; Dobratz, 
2003; Entwistle et al., 2002; Ewing et al., 2004; Flemming et al., 2008; Grande & Todd, 
2000; Jordhoy et al., 1999; Ly et al., 2002; Mazzocato et al., 2001; McGrath & Phillips, 2007; 
O’Mara et al., 2009; Palmer, 2004; Plu et al., 2007; Ross & Cornbleet, 2003; Seymour et al., 
2005; Steinhauser et al., 2006; Stevens et al., 2003; van der Krieke et al., 2013).  
In light of such challenges within palliative care research, Flemming et al., 2008, present a 
strong case for using a multi-method research design, and supplementing the RCT with 
additional mixed methods research (i.e. with qualitative research), as a way forward. 
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Flemming et al., 2008, cite ‘lack of experience in a research team of using mixed method 
research’ as one factor which could account for few studies employing this approach. Some 
strategies to improve recruitment for palliative care studies, include reducing healthcare 
professional workload, recruiting patients from a variety of settings including inpatient, 
outpatient and from hospital admissions (Jordhoy et al., 1999), and employing research nurses 
(Ross & Cornbleet, 2003). Stevens et al., 2003, argue against using restrictive inclusion and 
exclusion criteria, which often restricts opportunities for some patients to participate. 
Borgsteede et al., 2006, propose using the ‘broadest possible inclusion criteria’ (Ahmed, 
2010). All of these approaches were incorporated into the design of this study, and I ensured 
that health care professional input and workload was kept to minimal. However, research 
nurses were not employed, as I was the main researcher working on this project.  
Despite these challenges, there appears to be a general consensus that palliative care research 
is acceptable and possible in this group of patients (Steinhauser et al., 2006), provided 
patients are treated with ‘empathy’, regularly assessed and monitored, offered support and 
given choice (Ahmed, 2010; Dobratz., 2003; Ross & Cornbleet, 2003).  
How methodological and ethical considerations informed the actual design of the PhD 
study components? 
Randomised controlled trials, particularly in the fields of supportive and palliative care can 
place additional methodological and ethical demands on research design, and there are special 
considerations in this patient population that one must consider. I will discuss how 
methodological and ethical issues (e.g. patient vulnerability, respect, informed consent, 
confidentiality, burden etc.) informed the actual design of the PhD study components.   
Intervention (SPARC) allocation  
The idea of allocating ‘vulnerable patients’ to less than optimal care is contentious. The 
waiting-list control design was appropriate here for ethical and practical reasons. Recruitment 
is facilitated in studies where an intervention (e.g. SPARC) perceived as potentially beneficial 
is made available at some point to all who agree to participate in a study. The two-week 
waiting period was chosen to allow for maximum data to be obtained at the follow-up stage, 
while not unduly delaying offering the SPARC to the waiting–list controls (described in more 
detail in Chapter 4 outcome evaluation). The 2-week point was selected as the crucial follow 
up measure following baseline in order to minimise attrition in a service where we know that 
the median survival is 13 days. Instead of an estimated 75% attrition rate limiting the data 
returned at two weeks, a 32.4% attrition rate was observed from consent to two-week follow 
up in a population largely made up of home care and out-patient clinic patients.  
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3.31 Participantvulnerability
The vulnerability of patients taking part in this study was protected at all times. This study 
only included adult patients (18 years old or above) who had the capacity to give informed 
consent. Patients incapable of giving informed consent or incapable of completing SPARC 
even with the help of a relative or informal carer were excluded. All members of the research 
team applied for an honorary contract and Criminal Records Bureau (CRB) checks were 
undertaken. A Criminal Record check at an Enhanced Disclosure level was undertaken, this is 
the highest level required for undertaking research with ‘vulnerable adults’. Patients were 
recruited from a variety of settings (including inpatients, outpatients, day care and community 
settings), and the study used the broadest possible inclusion and exclusion criteria, this 
enabled the study team to include a representative sample of patients that are seen by the 
supportive and palliative care service (i.e. not restricted to only inpatients on general hospital 
wards who are acutely unwell). Study invitation packs were initially sent out to all patients 
referred to the supportive and palliative care service. However some health care professionals 
caring for the patients expressed concerns and had reservations about sending study 
invitations out to all patients, because they felt that some of their patients were too ill to 
participate (especially inpatients), and some preferred seeing the patients first and getting to 
know them better before inviting them to take part in the study. In some instances, patients 
received the study invitation packs before they had seen anyone from the palliative care team. 
For this reason, the study methodology was changed to allow the clinical team to screen all 
eligible patients from their lists of patients they were seeing prior to sending out the study 
invitation packs. A recruitment guidance sheet was developed for the medical and nursing 
staff (Appendix 9) to help identify potentially suitable patients. This change in methodology 
worked well in identifying suitable patients, and at the same time protected patient 
vulnerability.   
3.32 Participantrespect
Patients were given the option to withdraw from the study at any time without giving a 
reason, the patient information sheet stated that a decision to not to take part or withdraw 
from the study will not affect their future medical care. The patient information sheet also 
stated that there were no specific risks associated with this study, and it was highly unlikely 
that patients will be harmed, however if patients did have any concerns/complaints or were 
unhappy about any aspect of the study, they were advised to contact in the first instance, the 
principal investigator (Professor Bill Noble), and if they remained unhappy, or wanted to 
complain formally, they had the option go through the NHS complaints procedure by 
contacting the Medical Director at STH NHS FT (study sponsor; address and telephone 
details were provided in the patient information sheet). If patients wanted any further 
information about the study, they could contact the research team, principal investigator, 
myself (Project Manager), or my colleague MW (telephone and address provided in the 
patient information sheet). No formal complaints were registered.  
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3.33 Participantconfidentiality
The patient information sheet made it clear that taking part in the trial would be kept strictly 
confidential, and that completed SPARC questionnaires and information (e.g. thoughts about 
death and dying or having suicidal thoughts) would be given to doctors and nurses or other 
health care professionals caring for the patients. Patients were also advised that information 
from research questionnaires (MYCAW, EQ-5D, and PEI), their clinical records and from the 
interviews would be kept strictly confidential and it will be securely stored. All research data 
collected in this study was treated in accordance with the ‘EU Directive on the protection of 
individuals with regard to the processing of personal data’ and UK regulations.  
In order to preserve anonymity, I took out details of characteristics of individuals (patients 
and HCPs), the analysis was described as a group rather than at an individual level. 
Furthermore clinical and research data collected was kept separate from personal data e.g.
postcodes/address/date of birth or other directly related personal identifiers were not present 
in datasets containing clinical data or research data. Identification numbers (ID) were 
assigned to each participant, thus allowing the research team to link the different datasets.  
3.34 Participantburden
The outcome measures (research questionnaires) selected were all short and easy to complete, 
and as per recommended guidance (Finlay & Dunlop, 1994), responses are more likely when 
short questionnaires are used (Boynton, 2004; Edwards et al., 2002; Nakash et al., 2006) on 
quality of life instruments/outcome measures for palliative care (Hearn & Higginson, 1999), 
and place minimal burden on the patient and capture items of most importance (Brasel, 2007). 
The three measures were compiled into a booklet (Appendix 10). Out of 225 patients that 
consented, only 7 withdrew for reasons of burden of research assessments.  
Pre-paid envelopes (freepost) were provided to all participants for returning completed 
consent forms, research questionnaires, SPARC and opt-in forms for semi-structured 
interviews. Patients were given the option to complete the SPARC questionnaire and the 
research questionnaires with or without the help of their informal carers/professional carers or 
family members. Semi-structured interviews with patients were undertaken, which are 
potentially less demanding and less-time consuming than in-depth interviews which can place 
extra burden on participants with an advanced or progressive illness, who may be too ill and 
emotionally upset to participate. Strengths/advantages and limitations of semi-structured 
interviews are presented in more detail in Chapter 5; process evaluation.   
Formal and informal discussions with staff at various sites ensured that they were familiar 
with and comfortable with the study taking place. The patient information sheet outlined the 
benefits, risks and disadvantages of taking part. All potential participants were advised that 
occasionally people (in this field) may feel upset by being reminded of illness or difficulties, 
and that specialist help and support was available should any part of the study upset or affect 
them in anyway, and that the research would be undertaken by experienced researchers. If 
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they wanted to obtain general advice in participating in research studies, participants could 
contact INVOLVE: a national advisory group that supports greater public involvement in the 
NHS, public health and social care research (funded by National Institute for Health 
Research), a link to the website and a telephone contact were provided in the patient 
information sheet. 
Prior to sending out follow-up questionnaires, it was important to ensure that the patient was 
still alive and not deceased, appropriate checks were made with administration teams at the 
different settings at the time of sending out additional questionnaires. This was very 
important for continuity purposes as patients may be referred to a number of different 
settings. As patients may move from one setting to another, careful monitoring was necessary 
to establish whether patients had been admitted to, or discharged from, hospital, and also to 
ensure that continuing contact was appropriate.  
With the methodological and ethical considerations of undertaking palliative care research in 
mind, this study adopted an embedded (or nested) concurrent mixed methods design. ‘A 
concurrent design is where quantitative data and qualitative data are collected concurrently or 
roughly at the same time, thus allowing researchers to maximise the amount of data collected 
in a given time’ (Creswell & Clark, 2010; Tashakkori & Teddlie, 2010). The strategy of 
stratification for baseline quality of life was added to the design to ensure equivalence 
between trial arms.  
There was close cooperation between the research team and the staff at the different study 
sites. 
3.35 Ethicsandresearchgovernanceapprovalsandconsiderations
Ethical approval was required for the main trial, and an ethics application was submitted to 
the appropriate committee. A Research Governance application was made to the Sheffield 
Teaching Hospitals NHS Foundation Trust (STH NHS FT) body which deals with access to 
the study sites. I had the overall responsibility for completing the protocol, ethics submission, 
logistics of the study and analysis. Along with other members of the research team, I applied 
for an Honorary Contract (Appendix 11) and obtained necessary permissions to undertake 
the study at the different study sites. A Criminal Records Bureau (CRB) check was 
undertaken as part of this procedure.  
Informed consent  
Ethics committee requirements for patients losing capacity to consent during the study 
Only patients who are mentally competent to make a decision, as judged by the health care 
professionals caring for them can give informed consent. This is particularly challenging in 
palliative care research due to issues around ‘cognitive failure, fatigue and depression’. Thus,
the study excluded participants that were unable to consent for themselves at the point of  
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recruitment. In this area of care (i.e. palliative care), many patients initially able to provide 
informed consent lose the capacity to do so as the disease progresses. Information about 
patients from family members, carers, their health care professionals, case notes and records 
was an important part of this study. Any participant that lost the capacity to consent during 
the study was not approached again for further questionnaire data, but information from their 
case notes was gathered as part of the study. However, one of the requirements of the ethics 
committee was that under these circumstances an appropriate personal consultee (a named 
next of kin or person to consult) should be identified and supplied with written information 
about the study, and then be required to complete a consent form to agree to patients’ notes 
and records continuing to be used in this study.  
Another requirement of the ethics committee was that if the capacity to consent had been lost, 
but subsequently regained (as established by the clinicians) at some point during the study, 
continuing consent to the study would have to be explored and if necessary formally re-
confirmed. This required careful consideration on how to re-introduce questionnaires for 
patients, and the opportunity to participate in the semi-structured interviews that followed.  
Substantial period for set up required  
The study took place over 35 months (the recruitment period was 22 months). A substantial 
period for setup was necessary for the study. Some factors contributing to the complexity in 
this case were as follows: the use of several different settings; hospital; community; out-
patient and hospice; the need to fulfil procedures for governance in non-NHS settings; and 
addressing procedures for a study in which we might expect that many participants who 
initially had capacity to consent would lose this capacity during the course of the study.  
Obtaining research ethics committee approval and research governance approval proved 
challenging due to the complexity of the trial. The recruitment start date was delayed by 
around 6 weeks. The Bradford Research Ethics Committee received our application on        
3rd November 2010, and subsequently reviewed it at the ethics committee meeting on        
16th November 2010. The committee raised several points of discussion about the study. 
Plans were also agreed for using data given by patients who initially had capacity to consent 
to the study, but then lost capacity.  
The committee required further clarification on minor issues and following review of our 
amendments, approval was given on 9th December 2010 (Appendix 12). Given that I was 
undertaking a PhD, we were also asked to notify and make changes to some study 
documentation to reflect this in a substantial amendment which was submitted on 16th
December 2010. The committee reviewed the documents and a final favourable ethical 
opinion was granted on 14th January 2011 (Appendix 13).
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Applications to NHS and non-NHS sites  
The favourable ethical opinion applied only to conducting the study in NHS sites, therefore a 
similar application to undertake the study at St Luke’s Hospice (non NHS site) was submitted 
to Sheffield REC (based in Leeds) on 13th January 2011, and approved (Appendix 14). Non-
NHS sites have separate research governance arrangements and I submitted all the study 
documents to St. Luke’s Hospice, Sheffield, for review by their committee. All Research 
Passport applications were approved for researchers undertaking the study.
Reminder/follow-up letters  
Another amendment involved developing a reminder letter/follow up contact to patients who 
had not returned the baseline or 2 week questionnaires, as per recommended guidance, 
reminders have the potential to improve response rates (Edwards et al., 2002; Nakash et al., 
2006). Burns et al., 2008, suggest that ‘for postal surveys, each additional mailed reminder 
yields about 30-50% of the initial responses’. The ethics Committee approved this reminder 
letter. We decided to use a reminder letter that did not include another copy of a questionnaire 
that had already been sent. Some patients completed and returned the original questionnaire 
and also completed the one sent with the reminder letter, thus causing confusion for some 
patients. Furthermore, one patient wrote a letter of complaint saying that she had received too 
many questionnaires and reminders in the post, and declined further participation. This 
prompted us to change the procedure, so that the reminder letter (edited) (Appendix 15), was 
only sent one week after baseline and one week after the two-week questionnaires were sent. 
For the analysis it was critical that we received the completed two-week questionnaires. 
Reminder letters were not sent after sending out the four or six week questionnaires.  
Research Governance applications were made to the relevant organisations (Trust R&D 
approval letter presented in Appendix 16). It was necessary to wait until the ethical 
submission was underway before proceeding with parts of this process. Negotiation for use of 
facilities and staff time was also delayed somewhat. Liaison with clinical colleagues and 
detailed preparation of materials was crucial to the success of this study as it involved 
working in clinical areas. The process of setting up the study had taken the project team 
longer than anticipated, and as a result the project was slightly behind schedule.  
The original intention was to have started data collection in January 2011; this was amended 
to start data collection in February/March 2011. Furthermore, recruitment slowed down 
towards the end of the recruitment period and for this reason the team applied for a no-cost 
extension to extend the recruitment period in order to recruit the required number of patients 
to power the study. This was approved by Macmillan Cancer Support in June 2012, and a   
no-cost extension to 30th November 2012 was officially granted. There were no significant 
changes to the project in its aims or methodology (Macmillan Cancer Report Final Report, 
January 2013).  
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General ethical and research governance issues 
If a hospital patient was identified through the survey as having a significant problem, i.e. a 
score of 2 or 3 on SPARC for any of the symptoms or psychological distress scores, then they 
were offered a referral to the appropriate specialist care nurse/team for their disease site. This 
information was relayed back to their own team, with the patient’s permission. For patients 
who may become distressed when answering the questionnaires, specialist help and support 
was initially available from the study team. If the situation was outside of the team members’ 
experience then the principal investigator was advised of the situation and the patient offered 
appropriate help and support. Patients who were resident or attending the Macmillan 
Palliative Care Unit (MPCU) (Sheffield) or St. Luke’s Hospice (Sheffield) were offered to 
have their problems communicated to the senior nurse in charge on the day, with the patient’s 
permission. 
3.36 Timescale
Phase 1: Outcome evaluation  
The first year of the research project was devoted to setting up the project: which involved 
undertaking a literature review; study design and protocol writing; making necessary research 
governance and ethics applications; service user consultation; familiarisation with the service 
and liaison with clinical personnel (Ahmed, 2010; Ahmed et al., 2014). A long set-up period 
was allowed. This was based on our previous experience of the time needed to gain the 
relevant permissions for a study to go ahead. In particular, new procedures for approving 
research field-workers to carry out the research with patients were proving lengthy at our 
institution and at others in the country. Applications for approval in the Sheffield Teaching 
Hospitals, was at that time taking in excess of six months to process. The set-up part of the 
study was also important for informing and liaising with clinical staff, and the time given to 
this area was crucial in ensuring the proper functioning and successful carrying out of the 
study. This was followed by a data collection period of 15 months. A no-cost extension was 
approved by the funding body to allow data collection to continue. In the end the recruitment 
period was 22 months in duration. The final 12 months of the project were allocated to 
analysis, report writing and dissemination (SPARC study timescale is presented in Appendix 
17).  
Phase 2: Process evaluation  
A process evaluation of the trial was undertaken from 1st February 2013-14th July 2014.  
Regular monitoring of recruitment was necessary to identify any accrual problems, and to 
identify the amount of missing data. Early identification of these problems enabled the 
research team to make any necessary changes to the protocol and design of the study early on, 
as missing data can present significant challenges to researchers at the data analysis stage 
(Diehr & Johnson, 2005; Palmer, 2004). Considerable groundwork was undertaken to ensure 
that clinicians/health care professionals and patients perceived the pilot RCT to be fair, 
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justified and useful, and it was essential to gain their full support for the successful 
completion of the study.   
3.4 Randomisedcontrolledtrials
In this section, I will explain why RCTs are considered the Gold Standard, and discuss the 
underlying principles and rationale behind choosing an RCT design for this study in order to 
establish the effectiveness of the SPARC intervention. 
Clinical trials are essentially scientific experiments that are undertaken to establish the 
benefits and harms of a particular treatment or intervention (e.g. professional assessment and 
advice, medicines, medical/surgical procedures or devices). In palliative care the primary 
focus is often on improving quality of life of patients with an advanced progressive or 
incurable disease (Addington-Hall., 2007a; Addington-Hall., 2007b; Bausewein et al., 2016).  
Sir Austin Brad-Hill, is widely regarded as one of the pioneers of the Randomised Controlled 
Trial (RCT). With growing emphasis on evidence based medicine, the RCT is traditionally 
regarded as the ‘gold standard’ and most scientifically robust method for evaluating new 
treatments, interventions, or services. This is largely attributed to features such as random 
allocation of participants to treatment/interventions, the use of control groups and blinding of 
participants and researchers, thus minimising bias and improving rigour and the strength of 
evidence that is generated (Bennett, 2007). RCTs are undertaken to establish a causal 
connection between an intervention or treatment and an outcome. In other words, to 
determine whether a ‘cause-effect’ relation exists between the intervention/treatment and 
outcome of interest (Bennett, 2007; Hanley et al., 2016; Midgley et al., 2014; O’Cathain et 
al., 2009b). The prospective RCT allows comparisons to be made between interventions and 
standard (control) groups (Flemming et al., 2008; Grande & Todd, 2000; Hudson et al., 2001; 
Mazzocato et al., 2001).  
However, designing and conducting prospective RCTs with potentially ‘vulnerable patients’ 
with an advanced progressive illness who often have many symptoms and limited survival 
times is challenging (Bennett, 2007). Furthermore, patients may have a preference of one 
treatment to another, and the concept of allocating vulnerable patients ‘less than optimal care’ 
(control group) is contentious (Bennett, 2007; Relton et al., 2010; Reyna et al., 2007). For 
these reasons a very limited number of RCTs have been undertaken and reported in this field 
(Addington-Hall, 2007a; Addington-Hall, 2007b; Bennett, 2007). In the previous section,       
I have addressed some of the ethical and practical challenges involved in designing and 
conducting clinical trials in palliative care.  
Evidence based medicine is the systematic approach to clinical problem solving and involves 
making use of best available research evidence (i.e. research that is well designed and 
conducted to the highest standards), to optimise the decision-making process, particularly 
when it comes to making important decisions about the care of individual patients. Some 
research designs such as RCTs, are considered to be more ‘superior’ and more ‘powerful’ 
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compared to other research designs (e.g. surveys or service evaluations) in answering research 
questions, such as determining the effectiveness of interventions, hence giving rise to the 
concept of ‘hierarchy of evidence’. For these reasons RCTs (along with systematic reviews of 
these trials) are well positioned in the hierarchy of evidence (Figure 7) compared to other 
methods employed by researchers (Sackett et al., 2000). 
Figure 7: Hierarchy of evidence diagram (position of RCTs in the hierarchy of evidence in 
relation to other methods used) (adapted from Sackett et al., 2000)  
The characteristic pyramid shape is used to represent the inherent risk of bias in study design, 
which increases as one goes down the pyramid, with more ‘scientifically rigorous’ 
methodologies, such as RCTs and systematic reviews situated at the top of the pyramid and  
methodologically ‘simpler/weaker’ methods placed towards the bottom of the pyramid (e.g. 
case reports, expert opinion etc.). The rigorous processes undertaken during the design and 
conduct of a properly conducted and executed RCT are considered to be of paramount 
importance in minimising the risk of confounding factors that could potentially influence the 
results and damage the internal validity of the study. It is widely acknowledged that the 
findings generated by well-designed and well-conducted RCTs, are closer to the true effect 
than findings generated by other forms of research methods used lower down the pyramid, 
hence providing a more powerful and reliable form of evidence (Bennett, 2007).   
RCTs as the name suggests, involves the random allocation of patients (population of 
interest) to one or another intervention/treatment (in this case SPARC). The waiting-list 
control design used in this study is discussed further in Chapter 4 (outcome evaluation). This 
approach ensures that each participant has an equal probability of being assigned to any given 
group (intervention or control), and they are followed up for a specified period of time.  
However, it must be stressed that this strict process of randomisation does not eliminate 
confounding variables (i.e. both known and unknown); such as age, sex, disease activity, and 
duration of disease etc., but rather it distributes them equally between the two groups. Thus, 
the characteristics of patients or any other confounding variables that could potentially 
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influence the outcome of the trial result are randomly distributed equally between the two 
groups, so that any effects cancel out and any difference in outcome can only be attributed to 
the intervention or treatment administered (i.e. randomisation cancels out the impact of 
everything but the intervention), thereby, reducing the overall bias in the trial.  
Random allocation or assignment of an intervention or treatment is typically undertaken after 
potential participants have been assessed for eligibility against study inclusion and exclusion 
criteria and recruited to the trial, but prior to administering the intervention or treatment.  
The presumption of causality cannot be achieved in other research designs e.g. retrospective 
designs where confounding variables may create associations with causal relationships which 
do not arise out of intervention.  
Apart from receiving the intervention (or timing of receiving the SPARC intervention, as was 
the case in this study), the intervention and control groups were treated and observed in an 
identical manner, and at the end of the study, the two groups were analysed in terms of 
outcomes defined at the outset/start of the study. This approach ensured that any differences 
in outcomes are attributed to the trial intervention (SPARC in this case).   
Methods employed to randomly assign participants to either the intervention or control group, 
include the use of a table of random numbers and a computer program that generates random 
numbers. This study used a computer to generate random numbers. There is no other robust 
and reliable method of controlling a trial which will allow presumption of absence of 
systematic bias.  
Block randomisation and stratification are strategies that can add to the credibility of a trial 
and are often used to help ensure balance between groups in size and patient characteristics. 
In this study stratification for baseline quality of life ensured comparability between study 
arms in terms of severity of symptoms and level of quality of life. In terms of 
implementation, the trial statistician (Professor Peter Bath and others involved with the trial) 
generated the randomistaion sequence.  
It was important to document that random allocation of intervention or treatment was 
successfully achieved. The CONSORT statement suggests that sequence generation, 
allocation concealment and implementation should be reported. These are reported further in 
Chapter 4 (outcome evaluation).  
Allocation concealment underpins successful randomisation strategies, and is the term used to 
describe the process by which those running the trial and responsible for recruiting patients 
who have agreed to take part in the trial, remain unaware of the group to which group 
participants will be allocated, thus avoiding both conscious and unconscious selection of 
patients into the study. Concealment of allocation, clarification of who generated the 
sequence, the method used, and how concealment was achieved and monitored is discussed 
further in Chapter 4 (outcome evaluation). 
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Blinding is used to reduce bias and usually refers to keeping patients, investigators and those 
collecting and analysing clinical data unaware of assigned treatment (single blind, double 
blind, or open blind), so that they are not influenced by that knowledge and any expectations 
do not bias the results of the trial. Blinding can be difficult to achieve or sometimes 
impossible. The rationale behind using an open blind approach in this study is discussed 
further in Chapter 4 (outcome evaluation). 
3.5 Feasibilityvs.pilotstudies
The UK MRC guidance for designing and evaluating complex interventions to improve 
health was updated in 2008 (Craig et al., 2008a; Craig et al., 2008b), making specific 
reference for the need to undertake feasibility and pilot studies prior to embarking on costly 
and large scale definitive trials of complex interventions (De-Silva et al., 2014; Sampson et 
al., 2008; Simmons et al., 2013). However, there appears to be still a lack of agreement and 
clarity in the research community about the use of the terms ‘feasibility’ and ‘pilot’ study. 
The literature suggests differences of opinion, and inconsistent use of these terms, with some 
researchers using the two terms interchangeably and consider them to be synonymous, others 
argue that they are different, thus leading to conflicting approaches to interpretation of the 
two terms (Eldridge et al., 2016). Whitehead et al., 2014, state that the different terms are 
often used to define stages of development of a study. However, while there appears to be no 
formal guidance as to what constitutes a pilot study and what constitutes a feasibility study, 
some authors have called for a more consistent usage of these terms and attempted to reach a 
consensus over the conceptual framework for definitions, but this still remains a grey area 
(O’Cathain et al., 2015). There is a difference between feasibility and pilot studies, and I will 
outline the main distinguishing features of a pilot study (i.e. descriptions not usually applied 
to feasibility studies) from a feasibility study (Table 9). 
Eldridge et al., 2016, and the National Institute for Health Research (Close et al., 2015; 
NIHR); define ‘feasibility as an overarching concept for studies assessing whether a future 
study or project development can be done’, ‘whereas pilot studies, are viewed as the 
miniature version of the RCT that resembles the main study in many respects, and are a 
subset of feasibility studies with a specific design’ (O’Cathain et al., 2015). Most researchers 
agree that feasibility/pilot studies should not test treatment comparisons nor estimate feasible 
effect sizes (Eldridge et al., 2016; Whitehead et al., 2014). The primary focus of these studies 
is to ensure that there is an accurate assessment of processes such as: recruitment; 
randomisation; treatment and follow-up assessments; that all ‘run smoothly to plan’; prior to 
commencing much larger definitive trials (Arain et al., 2010; Eldridge et al., 2016; Olstad et 
al 2016).  
In 2015, and following on from the work undertaken as part of my doctoral study, I published 
an article in Journal of Pain and Symptom Management entitled ‘A Pilot Randomised 
Controlled Trial of a Holistic Needs Assessment Questionnaire in a Supportive and Palliative 
Care Service’, this is an example of a pragmatic pilot RCT (Ahmed et al., 2015, Appendix 1). 
The aim of this pragmatic pilot RCT was to determine whether the use of SPARC leads to 
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improved health care outcomes (health-related quality of life and self-identified concerns) for 
patients referred to a palliative care service. This was an effectiveness trial that would guide 
the development of a definitive multicentre study designed as a definitive assessment of 
clinical effectiveness of SPARC in triggering clinical interventions, a description usually 
applied to a pilot and none of the outcomes usually related to feasibility (e.g. time to 
completion, missing items) were assessed. The term ‘pragmatic’ was used in this context as 
the study was focussing on what works in a clinical service. SPARC could either be used as 
an aid to specialist clinical assessment or as a screening tool. In this study, SPARC was used 
primarily to assess need. Thus, this pilot trial is the first step in a process to define the clinical 
utility of SPARC in a specialist service (not as a screening tool for referral to specialist 
palliative care services).  
A feasibility study on the other hand might typically involve undertaking interviews with 
patients and health care professionals and other users of services; to ascertain the 
acceptability and implementation of an intervention; or questionnaires; to assess the types of 
outcomes participants might think are important; the willingness of patients to be randomised; 
or the willingness of clinicians to recruit participants; and the number of people eligible to 
take part etc. Elbridge et al., 2016, provide an example of a feasibility study that is not a pilot 
study. They describe a study undertaken by Palmer et al., 2013. In this study, questionnaires 
were sent to surgeons to determine their opinion about whether it would be feasible to 
conduct an RCT that compared operative with non-operative treatment for femoroacetabular 
impingement surgery. The aims of this feasibility study are consistent with the consensus 
view of what constitutes a feasibility study.  
The randomised pilot study undertaken during this doctoral study can be considered as a 
miniature version of the main RCT (i.e. regarded as the first phase of a substantive study), 
that mimics the definitive trial design, and was conducted on a smaller scale with a specific 
design feature. It resembled the main proposed trial in many ways, e.g. having an intervention 
and a control group as well as randomisation (Whitehead et al., 2014). The use of the term 
‘pilot’ in this context implies an intention for further definitive work in the future. In other 
words, it was conducted in preparation for a future definitive RCT to assess the effect of an 
intervention; namely SPARC (Eldridge et al., 2016). Furthermore there was an assessment of 
processes e.g. recruitment, randomisation, treatment and follow-up assessments, retention, 
assessment procedures, to determine whether they all run smoothly and to plan and to 
determine if the intervention SPARC can be delivered as intended to highlight any problems 
so that they may be corrected prior to proceeding to the main trial and prior to any scaling up 
projects (Eldridge et al., 2016). The main distinguishing features of a pilot study                  
(i.e. descriptions not usually applied to feasibility studies) from a feasibility study are 
presented in Table 9.   
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Table 9: The main distinguishing features of a pilot study (i.e. descriptions not usually 
applied to feasibility studies) from a feasibility study  
Pilot studies  Feasibility studies  
 ‘Subset of feasibility studies’ 
 ‘All pilot studies are feasibility studies but not all 
feasibility studies are pilot studies’  
 ‘Studies labelled ‘pilot’ should have different aims 
and objectives to main trials’  
 ‘More likely to mimic design of main study’ 
 ‘Smaller version of the main study (e.g. use of a 
control group and randomisation)-and results 
should be interpreted with caution’  
 ‘Stricter study methodology-with more rigorous 
methodological components (e.g. a justification of 
the sample size in a subsequent main study, which 
should be adequate to estimate critical parameters, 
such as recruitment rate)’   
 ‘Focus on trial processes (1. testing procedures,    
2. estimating recruitment/retention, 3. determining 
sample size) to identify problems prior to 
undertaking main trial’ 
 ‘An intention for further work’ 
 ‘A catch-all/ all-encompassing term for preliminary 
work- overarching concept/term for preliminary 
studies to assess whether a future 
study/project/development can be done, and if so 
how to proceed with a full-scale study’  
 ‘May or may not include a pilot RCT/randomised 
design/an evaluation of outcome of interest and 
power calculations are not normally undertaken’ 
 ‘Umbrella term for three distinct types of study      
1) randomised pilot studies, 2) non-randomised pilot 
studies, or 3) feasibility studies that are not pilot 
studies’ 
 ‘Occur slightly earlier in the research process’  
 ‘Studies labelled feasibility are often conducted 
with more flexible methodology compared to those 
labelled pilot' 
 ‘May have no plan for further work and no part of 
the future RCT is being conducted on a smaller 
scale’  
Key references  
 Arain et al., 2010; Eldridge et al., 2016; O’Cathain et al., 2015; Olstad et al., 2016; Whitehead et al., 2014 
Strengths of pilot study  
The strengths and weaknesses of this pilot study are discussed further in the discussion 
section (Chapter 8). This pilot study defined clear circumstances in which the intervention, 
namely; SPARC, could be potentially harmful i.e. in which the outcomes were adversely 
affected. The trial was sufficiently powered to detect the adverse effect, and provided a 
framework within which a process evaluation was possible. Furthermore, the design and 
methods used for the pilot study were appropriate to the study population. A recruitment rate 
of 26.5% (225/850), and with only a few consenting patients (7/225) withdrawing for reasons 
of burden due to completion of research assessments, as well as the lack of differences 
between the study arms for either demographic factors or baseline research assessment values 
are all indicators of good data quality and a successful randomisation. The strategy of 
stratification for baseline quality of life which was added to the design to ensure equivalence 
between trial arms, also proved successful. Instead of an estimated 75% attrition rate limiting 
the data returned at two-weeks, a 32.4% attrition rate was observed from consent to two-week 
follow up in a population that was largely made up of home care and out-patient clinic 
patients.  
Weaknesses/limitations of pilot study 
This pilot did not take account of unforeseen factors that would damage feasibility. The study 
failed to recruit patients from the inpatient units and the hospital support service. This meant 
that the study sample had fewer patients with conditions other than cancer and a smaller 
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proportion of patients acutely ill than the whole population of patients referred to the 
palliative care service, and because of this attrition was rather less than expected. Thus, the 
findings from this pilot study are particularly relevant to cancer patients in the community. 
This was not designed as a feasibility study (which is seen as more of an earlier stage), 
because of clinicians previous experience of using SPARC during earlier development work. 
The weaknesses of the pilot study would have been accounted for in a formal feasibility 
examination of how SPARC would have been integrated into clinical practice, however this 
was not undertaken. The design of the study erroneously thought that this was not necessary 
because clinicians and other health care professionals taking part in the study had previously 
used SPARC in a clinical context and this was another reason why a pilot design was chosen. 
An earlier feasibility study could have helped to ‘iron-out’ some of the weaknesses of the 
pilot study. O’Cathain et al., 2015, outline the possible questions that qualitative research can 
address in a feasibility study (Table 10).   
Table 10: Range of issues and questions including category of question, sub-category, and 
examples of possible questions that qualitative research can address in a feasibility study 
(Reproduced from O’Cathain et al., 2015)   
Category of 
question Sub-category Examples of possible questions 
Intervention 
content and 
delivery 
Intervention development To what extent does the planned intervention need to be refined or adapted to make it more acceptable to users or more relevant or useful to the specific context in which it is delivered? 
Intervention components 
Consider the different aspects of the intervention and which are fixed and flexible. The 
intervention may be different in practice from the planned intervention and may need to be 
documented so it can be delivered consistently in the full trial. 
Mechanisms of action 
How might the intervention be working? How might it produce the outcomes important to 
the trial? Data collected to address these questions may be interpreted in relation to the 
theory upon which the intervention is based or may help to develop new theory. 
Perceived value, benefits, 
harms or unintended 
consequences of the 
intervention 
What value do service providers and intervention users place on the intervention and the 
outcomes it plans to deliver? What benefits and harms do they feel they have experienced 
from the intervention so that these can be measured in the full trial? 
Acceptability of 
intervention in principle 
Are service users or health care providers unhappy with any aspect of the content or delivery 
of the intervention? 
Feasibility and 
acceptability of 
intervention in practice 
What are service users or health care providers’ views of the implementation of the 
intervention? Has implementation varied by setting? Are there any important intervention-
context interactions? Should implementation be tailored by setting? 
Fidelity, reach and dose of 
intervention 
Is the right amount of the intervention getting to the right recipients in the right way? Do 
those delivering the intervention and/or receiving it adhere to the planned intervention? If 
not, what are the reasons for this? What are the limits of acceptable tailoring of the 
intervention? 
Trial design, 
conduct and 
processes 
Recruitment and retention 
How do the planned recruitment practices work in the field? Do recruitment practices need to 
be improved to increase recruitment rates and levels of informed consent? If so, how? Are 
the trial participants willing to be randomised? Are clinicians willing to recruit patients, or 
are they uncomfortable? Are there ways in which trial procedures could be improved to 
increase retention rates? 
Diversity of participants Are the planned recruitment practices likely to result in recruitment of the desired range of participants for the trial? If not, how might recruitment practices be improved? 
Trial participation 
How is the planned trial communication implemented by recruiters and received by 
participants? How can trial communication be improved to ensure recruiters understand 
patients’ views about participating in the trial? 
Acceptability of the trial in 
principle Is the trial design acceptable to patients, recruiters and service providers in principle? 
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Category of 
question Sub-category Examples of possible questions 
Acceptability of the trial in 
practice 
Is the trial design acceptable to patients, recruiters and service providers in practice, or are 
there ways in which participants try to alter the procedures? 
Ethical conduct Are the informed consent procedures appropriate and acceptable to likely trial participants? 
Adaptation of trial conduct 
to local context 
Will the planned trial procedures allow the trial to operate effectively in the proposed 
context? Do any changes need to be made to these procedures? 
Impact of trial on staff, 
researchers, participants 
and the health system 
Does this trial have any unanticipated negative impacts on recruiters, participants, other 
stakeholders and the health system? How can these impacts be minimised (e.g. workload 
involved in recruitment, numbers of measures undertaken)? 
Patient and public 
involvement How is patient and public involvement best achieved in the trial? 
Outcomes Breadth and selection of outcomes 
Are outcomes important to service users selected for measurement in the full trial—both 
primary and secondary? Do some trial participants feel that they have experienced or noticed 
improvements in some outcomes that need to be included in the full trial? 
Measures 
Accuracy of measures Are the process and outcome measures valid for this participant group? 
Completion of measures Can completion rates of measures be improved? 
Development of measures If validated measures do not exist for all the outcomes to be measured in the full trial, can they be developed in preparation for the trial? 
The weaknesses identified during the pilot study have important consequences on the study 
design, the intervention, the timing of assessments, and on outcomes and these are discussed 
further in the discussion section (Chapter 8).  
3.6 MRCcomplexinterventionsframework
The MRC complex interventions framework, provides a framework for conducting and 
reporting complex interventions and process evaluations. A complex intervention is described 
as having ‘several interacting components’ any of which could have an impact on the 
outcome (MRC framework for developing and evaluating complex interventions, new 
guidance, 2008 www.mrc.ac.uk/complexinterventionsguidance), (Ahmed, 2010; Boon et al., 
2007; Campbell et al., 2000; Craig et al., 2008a; Craig et al., 2008b; Craig et al., 2013a; Craig 
et al., 2013b; Higginson, 2005; Paterson et al., 2009; Redfern et al., 2006; Richards & 
Hamers, 2009; Webb et al., 2016). 
The development and evaluation of complex interventions of RCTs, particularly in 
palliative care remains a challenging area in health services research (Bradley et al., 1999; 
Brady et al., 2011; Burr et al., 2011).  
Palliative care patients’ needs and interventions required to address them, as well as the trials 
themselves are complex (Farquhar et al., 2011; Farquhar et al., 2013; Higginson et al., 2013), 
complexity can be at an individual level, system level or at an organisational level (complex 
interventions versus complex systems) (Hawe et al., 2004; Shiell et al., 2008), and in light of 
this, the SPARC intervention study was developed, piloted, evaluated, reported and 
implemented in accordance with the Medical Research Council framework for developing 
and evaluating complex interventions to improve health (Ahmed, 2010; Craig et al., 2008a; 
Craig et al., 2008b) (Figure 8). The framework is regarded as one of the most widely used 
guidelines reported for developing complex interventions (Ahmed, 2010; Boon et al., 2007; 
Campbell et al., 2007; Corry et al., 2013; Curry et al., 2013; Craig et al., 2008a; Craig et al., 
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2008b; Craig et al., 2013a; Craig et al., 2013b; Paul et al., 2007). The mixed methods inquiry 
is advocated by MRC (Craig et al., 2008a; Craig et al., 2008b; Moore et al., 2015; NICE 
Guidance, 2004). A multi-method research methodology was therefore employed using both 
qualitative and quantitative techniques. 
This study represents a development of the SPARC tool for use as an early holistic needs 
assessment tool, within the MRC framework for evaluation of complex interventions 
(Ahmed, 2010; Craig et al., 2008a; Craig et al., 2008b). 
Figure 8: MRC framework for developing and evaluating complex interventions
Key elements of the development and evaluation process. ‘Different stages do not 
necessarily follow a linear or a cyclical sequence’ Palliative care trials are complex, and in 
light of this, the SPARC intervention study was developed, piloted, evaluated, reported and 
implemented in accordance with the Medical Research Council framework for developing 
and evaluating complex interventions (Ahmed, 2010; Craig et al., 2008a; Craig et al., 
2008b; Craig et al., 2013a; Craig et al., 2013b; Higginson, 2005; new MRC Guidance, 
2008; www.mrc.ac.uk/complexinterventionsguidance).  
Feasibility/piloting [Undertaken]
Testing procedures
Estimating recruitment/retention
Determining sample size
Evaluation [Some parts undertaken]
Assessing effectiveness
Understanding change process
Assessing cost-effectiveness
Development [Undertaken]
Identifying the evidence base
Identifying/developing theory
Modelling process and outcomes
Implementation [Some parts undertaken]
Dissemination
Surveillance and monitoring
Long-term follow-up
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3.7 PhasesofMRCframeworkcompleted
SPARC has already been developed and undergone rigorous psychometric development, 
preliminary field-testing and validation (Ahmed et al., 2004; Ahmed et al., 2009; Ahmed, 
2010; Ahmed et al., 2014; Ahmedzai et al., 2004b; Ahmedzai et al., 2010; Bestall et al., 
2004; Burton et al., 2010; Leppert et al., 2012). I was involved in all stages of SPARC 
development including the study design, ethics application submissions, recruitment of 
participants, writing up the report and publications, and presenting the work at local, 
national and international conferences. 
I identified the evidence-base by undertaking a review of the literature (Ahmed et al., 2014). 
I also identified the hypothesis, and undertook the modelling process with outcomes being 
identified for the doctoral study. The prospective randomised controlled pilot study tested 
procedures, estimated recruitment/retention, and outcomes. Patients with selected chronic 
progressive diseases were recruited from a range of settings including the community, day 
care, in-patient and outpatient settings. The implementation of SPARC (stages which come 
later) are outside the scope of this doctoral study. However, the evaluation (process 
evaluation) of the SPARC tool was undertaken as part of this doctoral study and is reported 
in Phase II (process evaluation; Chapters 5-7).   
3.8 Quantitative,qualitativeandmixedmethodsresearchapproaches
At a very simple level, a quantitative study such as an RCT, involves gathering and analysing 
numbers (expressed in terms of ‘quantity’ or measured in numbers rather than its quality), in 
an attempt to answer ‘how many/how much/how often’ questions, focussing primarily on 
prevalence, trends and relationships amongst two or more variables.  
A qualitative study deals with the ‘what, who, when, why, and how’ questions in an attempt 
to capture participants’ experiences and views (Elliottt et al., 1999; Jansen et al., 2010; Payne, 
2007; Stapleton et al., 2002; Yardley, 2000). Qualitative research has its origins in Sociology 
and Anthropology, and the approach has been widely adopted by researchers from other 
disciplines (Daly & Lumley, 2007).   
A mixed methods approach combines both quantitative and qualitative approaches into a 
single study, providing multiple perspectives and comprehensiveness to addressing research 
questions and is particularly useful in dealing with complex and multifaceted research 
questions (Craig et al., 2008a; Craig et al., 2008b; Creswell, 2003; Creswell & Clark, 2010; 
Creswell & Tassahkkori, 2008; Curry et al., 2013; Farquhar et al., 2011; Freshwater, 2013; 
Ingleton & Davies, 2007; NICE, 2004; O’Cathain et al., 2004; O’Cathain et al., 2007a; 
O’Cathain et al., 2007b; O’Cathain et al., 2008a; Pope & Mays, 1993; Seymour, 2012; Small, 
2011; Tariq & Woodman, 2013; Tashakkori & Teddlie, 1998; Teddlie & Tashakkori, 2009). 
Tashakkori & Teddlie, 2010, describe mixed methods as the ‘third methodological 
movement’ (Collins et al., 2012; Denzin, 2010; Tashakkori, 2009).  
A mixed methods study draws on the strengths of each method to counterbalance their 
weaknesses (Creswell & Clark, 2010; Tashakkori & Teddlie, 2010).   
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3.9 Mixedmethodsdefinition
Tashakkori & Creswell, 2007a, 2007b, definition of mixed methods is as follows: ‘mixed 
methods is a procedure for collecting, analysing, and ‘mixing’ or integrating both quantitative 
and qualitative data at some stage of the research process within a single study for the 
purpose of gaining a better understanding of the research problem’ (Collins & O’Cathian, 
2009; Creswell, 2009; Creswell & Clark, 2010; Tashakkori & Creswell, 2007a; Tashakkori & 
Creswell, 2007b; Tashakkori & Teddlie, 2003). All approaches (quantitative, qualitative and 
mixed methods) have advantages/strengths and weaknesses/limitations (Creswell & Clark, 
2010), these are summarised in Table 11.
When undertaking a mixed methods study it is important to consider whether a mixed 
methods study is feasible and that there is sufficient time and resources available to collect 
and analyse both quantitative and qualitative data. The research team must have the 
appropriate levels of skills and experience for the successful completion of the study 
(Creswell & Clark, 2010).  
Creswell & Clark, 2010, argue that ‘the use of quantitative and qualitative approaches, 
provides a much more comprehensive and complete account of both intended and unintended 
outcomes of the intervention than either approach used alone’. The qualitative data that is 
derived from this study, serves to enhance the inferences and interpretations from the RCT.   
Table 11: Quantitative, qualitative and MMR approaches (strengths/advantages and 
limitations). Summary of strengths/advantages and limitations/weaknesses of quantitative, 
qualitative and MMR approaches
 Strengths/advantages Weaknesses/challenges/disadvantages/limitations   
Quantitative   ‘Often involve large sample sizes (vs. 
qualitative research): conclusions 
generalisable to target population’  
 ‘Statistical validation’  
 ‘More efficient data analysis’  
 ‘Bias control/limitation 
(minimisation)’  
 ‘Gathers and analyses numbers: 
examine and explore prevalence, 
trends and relationships- (cause and 
effect/confirmatory)’ 
 ‘Limited/weak understanding of context/setting 
of participants’  
 ‘Limitations of statistical analysis (does not 
reveal participants complex lives and subjective 
experiences)’  
 ‘Words/voices/experiences of participants not 
directly heard (limited understanding of 
participants’ thoughts and feelings)’   
 ‘Researcher personal biases in interpretations of 
results seldom discussed or reported- qualitative 
research makes up for those weaknesses’  
 ‘Mainly researcher driven’ 
Qualitative   ‘Examining perspectives and views of 
a smaller sample of participants in 
more detail’  
 ‘Voices of participants heard 
(stories/narratives) in an attempt to 
capture/understand participants’ 
views, behaviours and experiences 
within a certain context’ 
 ‘Not researcher driven’ 
 ‘Increased recognition that qualitative 
 ‘Most studies use small sample sizes, too 
small to detect statistically significant 
differences’  
 ‘Generates a large amount of detailed 
information about a small number of 
participants/settings’ 
 ‘Lacking scientific rigour, generalisability, 
reproducibility, and labelled unscientific’ 
(compared to quantitative research, which 
does not have those weaknesses) 
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methods have potential to reach parts 
that other methods cannot reach’ 
 ‘Assembly of anecdote and personal 
impressions’ (most common)  
 ‘Highly interpretative: strongly subject to 
researcher bias’  
 ‘Often resource-intensive, requiring more time 
and resources than quantitative research 
procedures for data collection and analysis’  
Mixed 
methods  
 ‘Evidence-derived from a variety of 
sources to study a research problem, to 
provide a comprehensive picture 
(multiple views and perspectives) than 
either approach alone’  
 ‘Utilisation of a variety of tools and 
methods for data collection: not 
restricted to using those tools typically 
associated with quantitative or 
qualitative research’  
 ‘Useful in answering research 
questions that cannot be answered by 
either approach alone (e.g. the use of 
qualitative research to explain 
quantitative findings)’  
 ‘Provides a bridge across the 
divide/divisions/disciplines between 
quantitative and qualitative 
researchers’  
 ‘Encourages use of multiple 
worldviews/paradigms (i.e. beliefs and 
values)- not restricted to any one 
particular paradigm associated with 
quantitative or qualitative research’  
 ‘Strengths of one method may offset 
weaknesses of the other’  
 ‘Encourages pragmatism’  
 ‘Considered practical and intuitive’  
 ‘Use of both numbers and words, 
combines inductive and deductive 
thinking’ 
 ‘Well suited for ‘interdisciplinary and 
multidisciplinary’ research- brings 
together scholars from different fields’  
 ‘Complex, difficult and challenging’ 
 ‘Extensive time, resources and effort required for 
data collection and analysis’- gathering both 
quantitative and qualitative data (sometimes over 
a much longer period of time)’  
 ‘May not be appropriate for all research 
questions/problems’ 
 ‘A need to educate and convince others of the 
value of using MMR’   
 ‘Minimum skills set: basic quantitative and 
qualitative skills required-need a solid grounding 
in MMR’  
 ‘Variety of terms used to describe MMR, so 
difficult to locate in literature’  
 ‘Practical challenges- team members from 
diverse professional backgrounds, managing 
power differentials and roles within team 
challenging, and lack of shared language, 
different values and beliefs, sometimes 
conflicting views, leading to philosophical 
discordance’ (O’Cathain et al., 2008b) 
 ‘Dissemination: difficulty in publication of MMR 
findings- due to strict word count restrictions in 
many journals’ 
 ‘MMR challenges in relation to data collection, 
representation, integration, analysis, 
dissemination, legitimation and politics- 
quantitative and qualitative components bring to 
the study their own unique challenges’ (Farquhar 
et al., 2011)  
Adapted from  
(Creswell & Clark, 2010)  
&  
(Bowers et al., 2013; Bradley et al., 1999; Clark, 1997; Curry et al., 2012; Daly & Lumley, 2007; Elliottt et al., 1999; 
Farquhar et al., 2011; Kelle, 2006; Mays & Pope, 1995; Schwartz & Revicki, 2012; Small, 2011; Steckler et al., 1992) 
3.10  Rigourofmixedmethods,quantitativeandqualitativeresearch
The strategies available for quantitative, qualitative and mixed methods researchers to protect 
against bias, and enhance the rigour, reliability and trustworthiness of findings are described 
in methodological checklists that assess the quality of the research. In this Chapter, I will 
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discuss why the principles of rigour and trustworthiness were relevant to my study, the 
strategies that I used to ensure rigour and trustworthiness and the implications of these on the 
design of my study. 
Creswell & Colleagues (2004), outline five criteria to consider when evaluating the rigour of 
mixed methods research, these are as follows: 1) the reasons for mixing; 2) types of data that 
will be collected and analysed; 3) the priority assigned to quantitative and qualitative 
components (emphasis on either quantitative or the qualitative component, or assigned equal 
priority); 4) implementation sequence (e.g. concurrent or sequential); and 5) the point of 
interface, or the point where mixing occurs (Creswell et al., 2004).  
The main purpose of combining methods within this doctoral study was to bring 
complementary datasets using methods to address different aspects of the intervention; and 
also for comprehensiveness, to ensure that views of both patients and health care 
professionals are taken into account, thus increasing confidence in interpretation of findings 
of the RCT (Moffatt et al., 2006; O’Cathain et al., 2007a; O’Cathain et al., 2007b). The mixed 
methodology design adopted was practical, and strengthened the credibility and 
trustworthiness of findings (advantages/disadvantages of this approach have been presented). 
The process evaluation required a mixed methods design in order to consider all the data that 
might point to causes of the result of the trial. Consideration of both quantitative and 
qualitative data enabled a coherent explanation of the effects of clinical intervention.  
The principles of rigour and trustworthiness were the principle reasons for using a pilot RCT 
to assess the clinical utility of SPARC. The RCT is considered to provide the most reliable 
evidence on the effectiveness of interventions and the processes undertaken during the 
conduct of this trial minimised the risk of confounding factors influencing the results. 
Palliative care trials are complex, and in light of this, the SPARC intervention study was 
developed, piloted, evaluated, reported and implemented in accordance with the Medical 
Research Council framework for developing and evaluating complex interventions     
(Ahmed, 2010; Craig et al., 2008a; Craig et al., 2008b; Craig et al., 2013a; 
Craig et al., 2013b; Higginson, 2005; new guidance, MRC Guidance, 2008; 
www.mrc.ac.uk/complexinterventionsguidance). 
The quantitative component (pilot RCT) is reported in accordance with the Consolidated 
Standards of Reporting Trials (CONSORT) 2010 statement, which is a checklist of 
information to include when reporting a randomised trial (Altman et al., 2012; CONSORT, 
2010; Hopewell et al., 2008a; Hopewell et al., 2008b; Turner et al., 2012; Zwarenstein et al., 
2008).  
The reliability and validity (or trustworthiness) of qualitative research cannot be assessed 
using the same criteria used to assess quantitative research, due to the different philosophical, 
methodological, and theoretical positions and origins of the two components. Various 
strategies and checklists are available to assess the quality and rigour of qualitative research 
(Barbour, 2001; Campbell & Machado, 2013; Noble & Smith, 2015; Pope & Mays, 1995; 
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Pope & Mays, 2000; Tracy, 2010). Barbour, 2001, argues that checklists should be viewed as 
being ‘reflective’, of good research, there is evidence to suggest that sometimes they are used 
‘prescriptively’ which can be counter-productive. The qualitative interviews (with patients 
and health care professionals) components of this study followed the generic criteria included 
in COREQ, a 32-item checklist developed for the ‘explicit and comprehensive reporting of 
qualitative studies’ (Tong et al., 2007).  
Analysis of qualitative data was designed in accordance with framework analysis approach 
(Ritchie & Spencer, 2004; Chapter 6), considered to be sufficiently rigorous for purposes of 
this study. The rigour of the analysis and the validity of the categories that I developed could 
be questioned if only a small part of the dataset that I coded was covered by the coding 
categories, however this was not the case because only a relatively small part of the coded 
text from the transcriptions of the semi-structured interviews had to be assigned to the 
‘miscellaneous’ category, and my comprehensive classifications and coding of the data were 
able to account for most of the dataset. In order to ensure the retest reliability of my analyses, 
I kept and maintained meticulous records of interviews and observations/field notes and 
documented the process of analysis in considerable detail. Transcriptions were undertaken by 
an experienced research administrator (PH), and I checked each transcript against each of the 
interview audio-recordings to ensure accuracy and identify any ambiguities. I then made 
changes to the electronic versions. In order to minimise any bias, and improve the reliability 
of the analysis, 20% (7 out of 33) of the patient interview transcripts, and 20% (4 out of 20) 
of the health care professional interview transcripts were independently coded and charted by 
two experienced qualitative researchers (NA and KC). Subsequent detailed discussions of the 
analysis optimised consistency and agreement within interpretation and the development of 
themes, as an on-going process throughout the data analysis. Thus, the integrity of the 
qualitative component was protected throughout the research process, by using this 
systematic approach to research design, data collection, analysis, reporting and the 
communication of results.  
The audio-recording of all the semi-structured interviews undertaken provides an opportunity 
for independent observers to analyse, scrutinise and check the study findings against the 
original audio-recordings at a later data if the need arises, and for comparing oral testimony 
with written records and case notes. 
In the interest of safeguarding validity and trustworthiness of findings, the approach that I 
adopted was called ‘triangulation’, which involves using at least two different data collection 
methods and techniques and information sources to obtain the information about the same 
phenomenon with the aim of reducing inherent bias associated with a single source, or 
method. This approach was used to good effect, the qualitative study running alongside the 
pilot RCT concerning the views of patients about their experiences of completing SPARC and 
the views of health care professionals, conducted within the context of a pragmatic 
randomised controlled trial and nested within the MRC framework for developing and 
evaluating complex interventions, helped in the interpretation of the trial outcome results 
(quantitative component). Eliciting the views of patients and health care professionals 
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represented an important phase in the development of SPARC. The accounts of patients and 
health care professionals, were compared with field notes and case notes in order to undertake 
a comparative analysis of views (i.e. for similarities and differences and for comparing oral 
testimony with written records and case notes).  
In order to describe the rigour, reliability, validity and the quality of the research undertaken
during this doctoral study, I have explicitly outlined the theoretical framework and methods, 
and data collection techniques used at every stage of the research process. Both quantitative 
and qualitative approaches describe the context (settings), as well as the sampling strategy 
used. I have provided a detailed description of how the trial and qualitative fieldwork was 
undertaken (fieldwork notes, interview transcripts, recordings, case note reviews), and how 
these were inspected independently by others to ensure reliability. I have also outlined the 
procedures for data analysis and the methodological checklists used to assess the quality of 
the research and how this related to the original research questions e.g. how the themes and 
concepts were identified from the data. This was presented systematically in the written 
account to improve rigour, transparency, justification of data collection and analysis methods 
being used, and hence the integrity of findings.  
3.11  Embedded(ornested)designs
For the purposes of this study the embedded (or nested) design was considered most 
appropriate. The embedded or nested design is increasingly used in health services research, 
and is particularly useful when collecting supplemental qualitative data that informs how 
participants (patients and HCP’s) are experiencing an intervention. In this form of integration, 
it is common to have a dataset of secondary priority (i.e. participants’ experience of using 
SPARC), that is embedded within a larger primary design (i.e. pilot RCT) (Fairbrother et al., 
2013).  
Quantitative and qualitative approaches in this study were used in tandem (i.e. one dataset 
was embedded in the other). In the case of this study, the SPARC intervention study was 
undertaken (pilot RCT), and the qualitative data (patient and health care professional 
interviews) was embedded within the intervention procedures in order to better understand 
the quantitative outcomes. The intervention was followed by individual semi-structured 
qualitative interviews with the trial participants in order to get a better understanding of why 
the intervention worked or did not work. The results provide evaluation of both outcomes and 
process of intervention (Creswell & Clark, 2010; Tashakkori & Teddlie, 2010). 
3.12  Concurrentorsequentialdatacollection
Embedded (or nested) designs may be either convergent or sequential designs. ‘A concurrent 
design is where quantitative data and qualitative data are collected concurrently or roughly at 
the same time, thus allowing researchers to maximise the amount of data collected in a given 
time’ (Creswell & Clark, 2010; Tashakkori & Teddlie, 2010). 
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‘The sequential design is where the researcher collects quantitative and qualitative data in a 
sequence, with one phase of data collection followed by another’. However, this approach 
requires data to be collected over a longer time period, and is particularly useful when the 
results of one phase of the study are required to inform a subsequent phase (Creswell & 
Clark, 2010; Curry et al., 2013; Tashakkori & Teddlie, 2010). This study adopted an 
embedded (or nested) concurrent mixed methods design.  
3.13  Priority
In some mixed methods studies equal priority is assigned to the quantitative and qualitative 
components. An unequal priority occurs for example when a secondary dataset (e.g. from a 
qualitative study) as is the case in this study, is embedded within a larger primary design 
(quantitative study) (Creswell et al., 2004; Creswell & Clark, 2010; Tashakkori & Teddlie, 
2010). 
3.14  Pointofinterface(integrationphase)
The ‘point of interface’ also known as triangulation or the point at which the mixing occurs is 
dependent upon the design of the mixed methods study (Bazeley, 2009; Farmer et al, 2006; 
Fetters et al., 2016; Moran-Ellis et al., 2006; O’Cathain et al., 2010; Ostlund et al., 2011; 
Tashakkori & Creswell, 2007a; Tashakkori & Creswell, 2007b; Tashakkori & Creswell, 
2008; Thurmond, 2001). Teddlie & Tashakkori, 2009, outline the different time points when 
mixing can take place. Quantitative and qualitative data can be integrated during the data 
collection stage (e.g. collecting both quantitative items and qualitative open-ended questions 
on the same survey/questionnaire), at the analysis stage (e.g. converting qualitative data into 
quantitative scores to then compare with the quantitative dataset), or alternatively findings 
may be integrated at the stage of interpretation and conclusion (e.g. comparing results of 
quantitative data analysis with the emergent themes from the qualitative data analysis) 
(Bazeley, 2009; Creswell et al., 2004; Creswell & Tashakkori, 2007; Curry et al., 2013; 
Fetters et al., 2013; Johnson et al., 2007; O’Cathain et al., 2010; Teddlie & Tashakkori, 2009; 
Zhang & Creswell, 2013). In this study, findings were integrated at the stage of interpretation 
and conclusion.    
3.15  Reportingofdata-approachusedinthisthesis
This is an embedded concurrent mixed methods study. This thesis will report the outcome 
evaluation in the following steps: data collection and analysis (pilot RCT) first followed by a 
process evaluation: data collection and analysis (supplemental qualitative data from 
interviews) separately, and will then discuss the results of both analysis, from both phases of 
the study in the discussion and conclusions section (Chapter 8; thesis summary and 
discussion) (Creswell et al., 2004).  
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3.16  Instrumentsanddatacollection
A variety of different types of instruments are available for data collection, with different 
methods employing different types of instruments. This study makes use of quantitative 
questionnaires for data collection during the trial, data extraction templates for case note 
reviews (Appendix 18), and qualitative semi-structured interviews with patients and health 
care professionals to gain further insights into why the intervention namely; SPARC, did or 
did not work (Yin, 2006).   
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Chapter4
RESEARCHPHASEI:Outcomeevaluation
Apilotrandomisedcontrolledtrialofaholisticneedsassessment4
questionnaireinasupportiveandpalliativecareservice
Professor Peter Bath is a health informatics specialist/statistician (Information School, The 
University of Sheffield) working on the project. He undertook the quantitative statistical 
analysis component of this study, which is reported in this section.  
4.1 Abstract
Context: At present, there is no widely used systematic evidence-based holistic approach to 
assessment of patients’ supportive and palliative care needs. 
Objectives: To determine whether the use of a holistic needs assessment questionnaire; 
Sheffield Profile for Assessment and Referral for Care (SPARC), will lead to improved health 
care outcomes for patients referred to a palliative care service. 
Methods: This was an open, pragmatic, randomised controlled trial. Patients (n=182) referred 
to the palliative care service were randomised to receive SPARC at baseline (n=87) or after a 
period of two weeks (waiting-list control n=95). Primary outcome measure is the difference 
in score between Measure Yourself Concerns and Wellbeing (MYCAW) patient-nominated 
Concern 1 on the patient self-scoring visual analogue scale at baseline and the two-week 
follow-up. Secondary outcomes include difference in scores in the MYCAW, EuroQoL (EQ-
5D), and Patient Enablement Instrument (PEI) scores at Weeks 2, 4, and 6. 
Results: There was a significant association between change in MYCAW score and whether 
the patients were in the intervention or control group trend = 5.51; degrees of freedom = 
1; P = 0.019). A higher proportion of patients in the control group had an improvement in 
MYCAW score from baseline to Week 2: control (34 of 70 [48.6%]) vs. intervention (19 
of 66 [28.8%]). There were no significant differences (no detectable effect) between the 
control and intervention groups in the scores for EQ-5D and Patient Enablement Instrument at 
2-, 4-, or 6-week follow-up. 
Conclusion: This trial result identifies a potential negative effect of SPARC in specialist 
palliative care services, raising questions that standardised holistic needs assessment 
questionnaires may be counterproductive if not integrated with a clinical assessment that 
informs the care plan (Ahmed et al., 2015).  
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4.2 Introduction
A pilot study of a pragmatic randomised controlled trial was undertaken to determine whether 
the use of SPARC leads to improved health care outcomes (health-related quality of life and 
self-identified concerns) for patients (Ahmed et al., 2015), and to guide the development of a 
further, and larger definitive multicentre study. This trial was the first step in a process that 
would define the clinical utility of SPARC (Ahmed, 2010; Ahmed et al., 2015).  
This study represents a development of SPARC for use as an early holistic needs assessment 
questionnaire within a specialist palliative care service in accordance with the MRC 
framework for developing and evaluating complex interventions (Craig et al., 2008a; Craig et 
al., 2008b). This study does not test the utility of SPARC as a screening questionnaire for 
specialist palliative care (Ahmed, 2010; Ahmed et al., 2015).  
4.3 Methods
4.3.1 Trialdesignandrecruitment
The trial is reported in accordance with the Consolidated Standards of Reporting Trials 
(CONSORT) 2010 statement, which is checklist of information to include when reporting a 
randomised trial (Ahmed et al., 2015; Altman et al., 2012; CONSORT 2010; Hopewell et al., 
2008a; Hopewell et al., 2008b; Turner et al., 2012; Zwarenstein et al., 2008), and was 
registered with the International Standard Randomised Controlled Trials Register (ISRCTN 
Number: 25758268) (Appendix 5). ‘The ISRCTN is a simple numeric system for the 
identification of randomised controlled clinical trials worldwide’. This open randomised 
controlled trial used a waiting-list control design. All patients referred to the supportive and 
palliative care service who met the study inclusion criteria were invited to take part in the 
study. Invitations to participate were sent by post (outpatients and those in the community) or 
given face to face (inpatients and day care patients). Patients who consented to taking part in 
the study were randomised to receive the SPARC questionnaire at baseline (intervention 
group) or after a two-week period (control group). The study received approval from the 
Bradford Research Ethics Committee, UK Multicentre Research Ethics Committee (MREC) 
reference number: 10/ H1302/88 on 14th January 2011, and received Research and 
Development (R&D) permission from local trusts (Ahmed et al., 2015).  
As part of a process evaluation, case notes were reviewed at week 8 (findings reported in this 
Chapter), and semi-structured interviews were undertaken with a sub-group of patients 
(Chapter 6) and health care professionals (Chapter 7). The waiting-list control design was 
appropriate here for ethical and practical reasons. Recruitment is facilitated in studies where 
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an intervention perceived as potentially beneficial is made available at some point to all who 
agree to participate in a study. The two-week waiting period was chosen to allow for 
maximum data to be obtained at the follow-up stage, while not unduly delaying offering the 
SPARC to the waiting–list controls. In this group of patients, usual care is different in the 
different settings, and has not therefore been closely defined here (in the context of the trial, 
‘usual care’ concerns clinical encounters in the first 2 weeks of the trial, these are in the 
nature of ongoing assessment by clinical staff, specialist palliative care, clinical nurse 
specialists and physicians working in outpatients who routinely assess physical, social, 
spiritual, and psychological features of a patients’ condition and progress. This is routinely 
done in a structured clinical interview such as medical clerking or nursing assessment or as a 
cue-based intervention where patient concerns are elicited). The key feature of the study was 
to introduce the SPARC structured questionnaire in addition to the clinical interview (which 
takes place in all settings), either at baseline (Intervention Group), or at 2 weeks (Control 
Group). Data relating to demographic variables were collected at baseline.  
4.3.2 Participants
4.3.3 Inclusioncriteria
1. Any diagnosis (cancer and non-cancer). 
2. Any referral to the palliative care service in any care setting. 
3. Patients 18 years old or above. 
4. Patients able to give informed consent. 
4.3.4 Exclusioncriteria
1. Patients incapable of giving informed consent.  
2. Patients incapable of completing SPARC even with the help of a relative or informal carer. 
3. Patients under 18 years old. 
4.3.5 Stratification
Baseline quality of life may confound response to an intervention by reversion to the mean, 
so patients were stratified for baseline EQ-5D (standardised outcome measure of health-
related quality of life) thermometer score. Thus, patients completing the consent form were 
also asked to complete the EQ-5D thermometer score before randomisation. Based on 
previous work (Brooks, 1996), the research team set the EQ-5D thermometer score at 40. 
Patients scoring 40 or above at baseline were placed in the median and above group (MA), 
and those scoring less than 40 were placed in the below median group (BM) (Ahmed et al., 
2015).  
4.3.6 Collectionofbaselinedatarelatingtodemographicvariables
At baseline, I collected data relating to demographic variables, and whether the diagnosis was 
cancer or non-cancer, and whether the patient was a cancer survivor or a cancer patient 
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needing end of life care. Descriptive analyses of these data helped to characterise the samples 
across the care settings, and for control purposes in the analyses (Burgess et al., 2003).  
4.3.7 Sheffieldpalliativecareservicecontextandsettings
Study population, settings and locations where the data were collected
Patients were recruited from the whole range of settings (in-patients, outpatients, day care and 
from the community), and were recruited from the following sites in Sheffield: Central site: 
Royal Hallamshire Hospital (RHH); Northern site: Northern General Hospital (NGH); 
Sheffield Macmillan Unit for Palliative Care (SMUPC, NGH); and from the Community via a 
team of community specialist nurses based at St. Luke’s Hospice (Sheffield) (Ahmed et al., 
2015).    
Over 2000 patients a year are referred to these services, which deal with a much wider range 
of patients than might be assumed from the name of the service. They include those with 
long-term conditions and cancer survivors as well as those needing end of life care. There is a 
wide range of survival within the population referred to the palliative care service (Ahmed et 
al., 2015). In Sheffield, about one third of patients die within a week of referral, two thirds 
within a month, while a sixth survive beyond three months. Patients seen by the service are a 
very varied group. In the year 2008-9, 342 patients were admitted to the Macmillan Palliative 
Care Unit. Of these, 40% went home, while 10% were transferred to other care. 2,150 
patients were seen as in the hospital support part of the service at the two sites. The 65 and 
over age group were in a majority, but at the Central site over 40% were younger than this, 
while at the Northern site over a third had diagnoses other than cancer.   
At the Central site; 44% of patients were discharged home vs. 30% at the Northern site, and     
32% were discharged to other care at the Central site vs. 35% at the Northern site. A further 
921 patients were seen in out-patient clinics. The out-patient group seen is very varied, and 
includes a greater proportion of patients with long-term conditions, and cancer survivors who 
are reviewed regularly.  
Sheffield Teaching Hospitals  
The Palliative Care Team at Sheffield Teaching Hospitals NHS Foundation Trust (STH NHS 
FT) provides a specialist palliative care service, including symptom control and support, to 
patients admitted to the Royal Hallamshire Hospital (RHH), Weston Park Hospital (WPH) & 
Northern General Hospital (NGH) with supportive or palliative care needs, irrespective of 
diagnosis, in order to help them achieve the best possible quality of life. Working alongside 
colleagues in other services, the team aims to extend this support to families, carers and 
professionals involved with the patient, and to provide an educational resource to 
professionals involved in palliative care. The STH Team provides a hospital support service, 
an outpatient service and the Sheffield Macmillan Unit for Palliative Care (MPCU) with 18 
specialist palliative care beds at the NGH site. Some medical staff undertake home visits and 
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the Macmillan Unit Therapy Team also provide an outreach service to selected patients as 
part of their treatment plan. A more detailed description of the STH Sheffield Palliative Care 
Service (Context and Settings) is presented in Appendix 19 (Adapted from Palliative Care 
Annual Report Summary, Sheffield Teaching Hospitals; STH) (Ahmed et al., 2015).  
St. Luke’s - The Sheffield Hospice  
St. Luke’s Sheffield Hospice, offers specialist palliative care in 3 settings, the in-patient unit 
with its 20 beds, the Therapies and Rehabilitation Centre, which looks after the needs of day 
patients, and has a team of 10 St. Luke’s Community Palliative Care Nurses, caring for 
people in their own homes covering the whole of Sheffield. Patients in the community seen 
by the St. Luke’s Community Palliative Care Nurses were invited to participate. Recruitment 
was extended to patients attending the Therapies and Rehabilitation Centre (day care).          
A more detailed description of the St. Luke’s Hospice Palliative Care Service (Context and 
Settings) is presented in Appendix 20 (Adapted from St Luke’s Sheffield Hospice Corporate 
Brochure, 2011/2012) (Ahmed et al., 2015).   
ENROLMENT, RANDOMISATION AND INTERVENTION ALLOCATION, 
FOLLOW-UP PROCEDURE AND DATA ANALYSIS
4.38 Enrolment/recruitment
Patients who met the study inclusion criteria were recruited to the trial using purposive 
sampling (i.e. patients who had already been referred to the palliative care service in any care 
setting irrespective of diagnosis were recruited). As part of the recruitment procedure for the 
main trial, all patients received a study invitation pack (full study pack), which consisted of a 
patient invitation letter (Appendix 21), patient information sheet (Appendix 22), patient 
consent form and EQ5D (thermometer) (Appendix 23), and a freepost envelope. A 
recruitment guidance sheet was developed for the medical and nursing staff (Appendix 9) 
(Ahmed et al., 2015).   
For inpatients and day care patients, I had prepared study invitation packs for health care 
professionals to give to patients. A health care professional, who was caring for the patient 
informed suitable and eligible patients about the study and asked whether they were willing to 
participate. Health care professionals, then hand-delivered invitation study packs to those 
patients expressing an interest in the study. Patients were given an opportunity to ask any 
questions that they may have prior to taking part. Those patients wishing to participate were 
asked to sign and complete the consent form and the EQ-5D thermometer which could either 
be handed to the health care professional or sent back to the research team via post in the pre-
paid envelope. Patients were informed that their participation was completely voluntary and 
that they would receive the same care whether or not they chose to participate.   
Community patients and outpatients were sent study invitation packs via medical secretaries. 
The list of patients was first agreed with the health care professional with responsibility for 
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the care of these patients, who first screened suitable patients who would be suitable and 
eligible (Ahmed et al., 2015).  
When patients (inpatients and day care patients) were provided with or sent study invitation 
packs via post (community patients and outpatients), the administration staff at the different 
settings (in-patients, outpatients, day care and community), were asked to make a note of this 
on infoflex (electronic clinical record), to avoid any duplication and any patient being sent an 
invitation more than once. They also ensured that patients were alive, and deemed suitable by 
the health care professional caring for the patient, and that the patient was not an in-patient 
prior to sending invitations out by post.  
Semi-structured interviews were then conducted with a sub-group of trial participants as well 
as with health care professionals caring for these participants. All participants were 
interviewed after they had completed the study (i.e. 8 weeks from the date baseline 
questionnaires were received) (Ahmed et al., 2015; EAPC abstract, 2015). The method that I 
used to recruit patients and health care professionals for the follow-up semi-structured 
interviews (i.e. how participants were identified and who was invited to participate) is 
described in more detail in Chapter 6 (patient interviews) and in Chapter 7 (health care 
professional interviews). All patients had the option of withdrawing from the study at any 
time without giving any reason, and without their medical care or legal rights being affected.  
4.39 Randomisationandinterventionallocation
Randomisation 
A set of sequentially numbered, opaque, sealed, A4 envelopes containing all study documents 
were set up (henceforth called the study pack). The randomisation process was undertaken by 
a member of the study team (M.W.), who then identified which study packs were for the 
intervention arm and which were for the control arm. MW and PM were the only members of 
the research team who knew which envelopes were for which arms of the study. A copy of 
the SPARC tool (Figure 5) was added to the study packs for the intervention arm, and an 
equivalent number of blank sheets were added to the study packs for the control arm of the 
study. All of the study packs were placed into separate boxes in the numbered sequence, and 
182 patients were randomised with computer-generated random numbers in prepaid sealed 
envelopes to receive SPARC at baseline (n=87) or after a period of two weeks (waiting-list 
control n=95) (Ahmed et al., 2015).   
Upon receiving consent, I was blinded to the study and so did not know to which arm of the 
study patients belonged, and I collected the next sequentially-numbered, opaque, sealed 
envelope (SNOSE, containing the questionnaires) from the appropriate box (labelled MA: 
median and above group; or BM: below median group), and hand-delivered it to the patient 
(for inpatients/day care patients), or sent it via post (for community care patients/those seen in 
95 
outpatients) for recruitment purposes (Ahmed et al., 2015). The number of patients recruited 
during follow up is described in the results section. 
Intervention (SPARC) allocation (details of how the intervention actually worked) 
Patients returned the completed forms (i.e. signed and completed consent form and the      
EQ-5D thermometer questionnaire; Appendix 23) to the research team (University of 
Sheffield postal address) in freepost envelopes. Patients were stratified according to baseline 
quality of life (details of stratification presented earlier).   
Those patients who consented were randomised to receive the SPARC questionnaire at 
baseline (intervention group) or after a two-week waiting-list period (control group) (Table 
12). All patients received ongoing care as usual.  
Upon receiving the completed SPARC questionnaire, I immediately hand-delivered it to the 
administration team at each site and asked that it be immediately given to the health care 
professional caring for the patient. The administration staff at each site were also asked to 
keep a completed SPARC questionnaire (paper copy) and file it in the patients’ notes, and to 
scan a copy of it and upload it onto the electronic clinical record (Infoflex). The original copy 
of SPARC was filed with other completed research questionnaires and retained by the 
research team. Constant and careful monitoring and supervision of administration staff 
ensured that this procedure was strictly adhered to in all care settings.  
Prior to sending out follow-up questionnaires it was important to ensure that the patient was 
still alive and not deceased, appropriate checks were made with administration teams at the 
different sites and settings at the time of sending out additional questionnaires. This was very 
important for continuity purposes as patients may be referred to a number of different 
settings.  
Patients were made aware that information from SPARC would be sent to the health care 
professional/s caring for them. If participants returned a completed SPARC form (or raised 
concerns in a follow up interview) which indicated that they were very much distressed by 
thoughts of death or dying or if they were having suicidal thoughts, then I would immediately 
convey this concern to the health care professional caring for the patient. Only on one 
occasion did this occur. As a health services researcher, I could not provide any medical 
advice, but when concerns were raised, I did suggest to the patient that they could contact 
their GP or a health care professional caring for them for help or further advice.  
4.3.10 Follow-upprocedure
Follow up questionnaires were administered either face to face (inpatients, and day care 
patients), or by post (community and home care patients), according to the following table 
(Table 12). The 2-week point was selected as the crucial follow up measure following 
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baseline in order to minimise attrition in a service where we know that the median survival is 
13 days (Ahmed et al., 2015).   
Table 12: Study follow up procedure (questionnaire completion at 2-week intervals) (Ahmed 
et al., 2015)   
Baseline 
Randomisation
Group A 
intervention group 
MYCAW; EQ-5D; PEI 
SPARC 
Group B 
waiting–list control 
MYCAW; EQ-5D; PEI 
Two 
weeks 
MYCAW; EQ-5D; PEI 
[Invitation for patient interview] 
MYCAW; EQ-5D; PEI 
SPARC 
Four  
weeks 
MYCAW; EQ-5D; PEI 
plus supplementary question on 
experience of completing SPARC 
MYCAW; EQ-5D; PEI 
[Invitation for patient interview] 
Six weeks MYCAW; EQ-5D; PEI MYCAW; EQ-5D; PEI 
plus supplementary question on experience 
of completing SPARC 
Eight  
weeks 
Case Note Reviews 
Semi-Structured Interviews with Patients  
Semi-Structured Interviews with Health Care Professionals  
SPARC: Sheffield Profile for Assessment and Referral for Care 
MYCAW: Measure Yourself Concerns and Wellbeing 
EuroQoL (EQ-5D): Standardised outcome measure of Health Related Quality of Life  
PEI: Patient Enablement Instrument 
(Ahmed et al., 2015)   
Those patients who consented were randomised to receive the SPARC questionnaire at 
baseline (intervention group) or after a two-week waiting-list period (control group). Follow-
up for patients was conducted by post as far as this was possible (Ahmed et al., 2015). As 
patients may move from one setting to another, careful monitoring was necessary to establish 
whether patients had been admitted to, or discharged from, hospital, and also to ensure that 
continuing contact was appropriate.  
4.3.11Researchquestionnaires(outcomemeasures)
An outcome has been defined by the Working Party on Clinical Guidelines in Palliative Care 
as ‘any end result that is attributable to health services intervention’, and chosen outcome 
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measures must measure the effects of a service or intervention, that is a change in a patient’s 
health status (Higginson, 1995; O Boyle & Waldron, 1997).  
Study participants were required to complete three validated brief self-complete research outcome 
measures: the Measure Yourself Concerns and Wellbeing (MYCAW), the EuroQoL (EQ-5D) 
(measure of health-related quality of life), and the Patient Enablement Instrument (PEI), at 
Baseline, Week 2, Week 4, and Week 6 (Ahmed et al., 2015). The measures selected were all short 
and easy to complete, and as per recommended guidance (Finlay & Dunlop, 1994), responses are 
more likely when short questionnaires are used (Boynton, 2004; Edwards et al., 2002; Nakash et 
al., 2006) on quality of life instruments/outcome measures for palliative care (Hearn & Higginson, 
1999), that place minimal burden on the patient and capture items of most importance (Brasel, 
2007). The three measures were compiled into a booklet (Appendix 10). The rationale for the 
choice of outcome measures is presented in Table 13 (Ahmed et al., 2015; EuroQoL Group, 1990; 
Guyatt et al., 1998; Howie et al., 1999; Paterson, 1996; Paterson et al., 2007; Peace & Manasse, 
2002; Thompson et al., 2008).  
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Table 13: Research questionnaires: Rationale for choice of outcome measures (Ahmed et al., 2015)   
MYMOP
(Measure Yourself Medical Outcomes Profile) 
MYCAW  
(Measure Yourself Concerns and Wellbeing) 
EuroQoL (EQ-5D)  
(Health-related quality of life outcome measure) 
PEI 
(Patient Enablement Instrument)
 A precursor of MYCAW. 
 Demonstrated sensitivity to change.  
 Used in a range of contexts.  
 Patient self-complete, outcome questionnaire, 
problem-specific (includes general wellbeing).
 Applicable to all symptomatic patients.
 Brief and simple questionnaire to administer. 
 MYCAW used in preference to MYMOP 
because concerns raised could be of any kind, 
and not restricted to symptoms or activity (may 
be of significance when comparing the 
information from the three groups: cancer 
survivors, people with long term conditions and 
people needing end-of-life care). 
 For the purposes of this study it was important to 
use an outcome measure which covered the 
diversity in the patient group.
 A slightly modified version of MYCAW was 
used (the sentence “Please write down one or 
two concerns or problems which you would most 
like us to help you with” was replaced with 
“Please write down one or two concerns or 
problems that bother you most”).
(Adapted from Paterson, 1996; Paterson et al., 
2007; Peace & Manasse, 2002) 
 Developed from a validated tool MYMOP, 
simple to use and sensitive enough to show any 
changes with time.  
 Patients nominate concerns, which may or may 
not be medical (MYCAW) or symptoms 
(MYMOP) of importance to them (two 
concerns/symptoms can be identified). 
 They then score these on a scale of 0 (not 
bothering me at all) - 6 (bothers me greatly).  
 Patients are also asked to rate their general 
feeling of wellbeing on a scale of 0 (as good as it 
could be) - 6 (as bad as it could be).  
 The follow-up form asks patients to re-score the 
concerns/symptoms, and rate their general feeling 
of wellbeing they previously nominated, thus 
capturing any changes over time that are 
important to the patient.  
 However, HRQoL may not be sensitive enough to 
changes in the short term, possibly because 
people adjust their expectations.  
 Work by Guyatt et al., 1998, indicates that in 
seven-point scales of this kind, a shift of one 
point corresponds to a moderately important 
change for a patient.  
 Is an additional element of needs assessment, 
stated concerns, are truly patient generated, 
reflecting an accurate expression of need at that 
time. 
(Adapted from Guyatt et al., 1998; Paterson et al., 
2007; Peace & Manasse, 2002) 
 Outcome measure of health-related quality of life. 
 Patient self-complete. 
 Five questions (3 varying response categories): 
on mobility, self-care, usual activities (e.g. work, 
study, housework, family, or leisure activities), 
pain/discomfort and anxiety/depression.  
 A further question (EQ-5D thermometer scale) 
asks people to mark their current health status on 
a scale of 0 (worst imaginable health state)-100 
(best imaginable health state). 
 Used extensively in studies where quality of life 
is compared between patient groups.  
(Adapted from Brooks, 1996; EuroQol Group, 
1990)  
 Outcome measure of a patient’s ability to cope 
with life and their illness and the confidence 
and ability to help themselves (as a result of 
visiting a doctor or health care professional). 
 Patient self-complete. 
 One main question “thinking about the last 
time you saw a doctor or nurse from palliative 
care, do you feel you are:...?” (6 sub-questions 
with 4 varying response categories).  
 Studies in general practice to assess quality of 
consultations using PEI, have shown it to be a 
crucial outcome measure, with enablement 
correlating best with the length of consultation 
and how well the patient knew the doctor. 
 PEI scores consultations in cancer clinics, 
independently of quality of life and 
scores higher when sufficient time is allocated 
or when staff have communication skills 
training (our own unpublished work).  
 PEI may detect an effect of SPARC (if any) on 
the quality of subsequent consultations with the 
clinical team.
 A measure of consultation quality was included 
in order to detect an effect on communication 
between patients and professionals. However, 
we overestimated the intensity of contact 
between patients and professionals and 
palliative care services in the duration of this 
trial. 
(Adapted from Howie et al., 1999; Thompson et 
al., 2008) 
Abbreviations 
MYMOP: Measure Yourself Medical Outcomes Profile; MYCAW: Measure Yourself Concerns and Wellbeing; EuroQoL (EQ-5D): Standardised outcome measure of 
health-related quality of life; PEI: Patient Enablement Instrument; HRQoL: Health-related quality of life (Ahmed et al., 2015).
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4.3.12Outcomes
Primary outcome 
 The change in MYCAW score between the first MYCAW patient nominated concern 
(MYCAW Concern 1) at baseline and the two-week follow up. This is the nominated 
first concern (Ahmed et al., 2015).   
Secondary outcomes 
 The change in scores in the EQ-5D at the two time points. 
 Changes in the enablement scores (PEI) at the two time points. 
 Comparisons of MYCAW patient nominated concerns, EQ-5D, and the PEI at 
baseline, 2 weeks, 4 weeks and 6 weeks between patient groups. 
 The pattern of actions taken and referrals made as a result of administering the 
SPARC screening tool were examined, by analysis of the clinical record (reported in
Chapter 4) (Ahmed et al., 2015).   
DATA ANALYSIS  
4.3.13Statisticalmethodsandanalysis
Sample size calculation  
Calculation of the number of patients needed to recruit was based on the sample size required 
to power the study, which had taken into account the likely attrition, also considering that a 
proportion of patients that will be too ill to be approached to participate. Patients attending as 
outpatients for review were included as well as new referrals, and this group included cancer 
survivors and those with long-term conditions (Ahmed et al., 2015).    
Primary endpoint analysis 
The primary outcome measure was the difference in score between the patient-nominated 
concern (MYCAW; Concern 1) on the self-scored visual analogue scale at baseline and at the 
two-week follow-up. Assuming the changes in the score (baseline to Week 2) would be 
normally distributed, we had planned to carry out a t-test to test the null hypothesis that the 
difference between the intervention and control groups in the mean score on the first 
symptom nominated on the scale at baseline and two weeks is 0. However, because the data 
were not normally distributed, the Mann-Whitney test was used to test for difference in the 
two groups in the rankings of Weeks 2, 4, and 6 scores and the rankings of the change in 
scores from baseline to Weeks 2, 4, and 6 (Ahmed et al., 2015).   
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Statistical power 
To detect a medium-sized difference between two independent sample means at alpha=0.05 
and beta=0.80, required a minimum of 64 individuals in each group with scores at baseline 
and two weeks (Cohen, 1992). Therefore, a total of 128 patients would need to be recruited. 
The power of the study was based on the randomised controlled trial with the group of 
patients from whom it would be possible to obtain follow-up data. Differences between the 
control and intervention groups were tested using t-tests to compare the mean scores at 
Weeks 2, 4, 6, and the mean change in scores from baseline to Weeks 2, 4, and 6 (Ahmed et 
al., 2015).   
4.3.14Secondaryandexploratoryanalyses
Statistical analysis of the comparisons between patient groups for the secondary outcomes 
involved both descriptive analyses and statistical tests. A qualitative content analysis (Ahmed 
et al., 2015; Graneheim & Lundman, 2004; Hsieh & Shannon, 2005) of the nominated first 
concern and the nominated second concern was undertaken at baseline. Stated concerns were 
examined for key words and themes, with the context taken into account for the final 
interpretation. Analysis of the data from patient semi-structured interviews, health care 
professional semi-structured interviews (Ritchie & Spencer, 1994), and from the 
supplementary question about patients’ experience of completing the SPARC (Ahmed et al., 
2015) are presented in Chapters 6 and 7 respectively.  
4.4 Results
4.4.1 Recruitmentandattritionrates
A total of 850 patients were invited to take part in the study, of which: 225 consented to take 
part (225/850=26.5% response rate); 182 patients completed baseline questionnaires; 152 
completed the 2 week questionnaires; 126 completed the 4 week questionnaires; and 120 
completed the 6 week questionnaires. The critical point in the analysis was the 2-week point, 
the point at which patients in Group A (intervention arm) had already received the SPARC 
intervention, and patients in Group B (control arm) had not yet received the SPARC 
intervention. A few patients (n=7) dropped out and did not complete the trial, citing 
questionnaire completion and taking part in the trial as being too burdensome as reasons for 
not continuing to take part. Two patients expressed concern around issues of data collection, 
and had anticipated more face to face contact visits as opposed to receiving postal 
questionnaires (Ahmed et al., 2015).    
At the end of the trial (eight weeks after completion of baseline questionnaires), 23 patients 
had died, and 159 patients were alive. There was no significant difference in the number of 
deaths between the intervention and control groups. In Group A (Intervention), nine people 
(10.3%) died within the 8-week study period and in Group B (Control), 14 people (14.7%) 
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died within the 8-week study period   0.445;   1;   0.504	. A summary of the 
recruitment for the SPARC intervention trial is presented in Figure 9 (Ahmed et al., 2015).  
4.4.2 SummaryofrecruitmentfortheSPARCtrial
There was fluctuation in the recruitment rate, with recruitment rate increasing steadily, and 
then tailing off and reaching a plateau towards the end of the study (Figure 10).  
The medical secretaries and staff at the recruitment centres were updated on the study 
progress on a regular basis, and methods to achieve a better response rate were discussed. 
Careful monitoring of recruitment and several requests for medical secretaries to increase the 
number of invitations sent out, enabled the successful completion of the study (Ahmed et al., 
2015).   
Figure 9: Summary of recruitment for the SPARC trial (Ahmed et al., 2015) 
850 invitations
225 patients (26.5% patients) consented 
randomly allocated to receiving SPARC at baseline or 
SPARC at Week 2 
Intervention
N=87 (baseline)
Control
N=95 (baseline)
At Follow up
2 week: n= 73
4 week: n= 62
6 week: n= 57
Died n=9 (10.3%) 
At Follow up
2 week: n=79
4 week: n=64
6 week: n=63
Died n=14 (14.7%) 
 43 patients lost to follow up 
after consenting to study and 
prior to completion of baseline 
questionnaires, either due to 
illness/poor prognosis, being 
discharged from 
service/setting or declined to 
take any further part in the 
trial. 
 7 patients dropped out during 
the study (found 
questionnaires too 
burdensome). 
 23 patients died (159/182 
patients alive at the end of the 
study).
Summary of recruitment for the SPARC trial
182 patients were randomised 
Recruitment period: 22 months
6
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Figure 10: SPARC study recruitment 
Update 31st March 2011 to 1st December 2012 
Shows the fluctuation in the recruitment rate. Recruitment rate increases steadily, tailing off 
and reaching a plateau towards the end of the study (Ahmed et al., 2015).   
4.4.3 Baselinedata
Of the 182 study participants, 84 were males (46.2%) and 98 were females (53.8%). The 
mean age of the participants on trial registration was 64.47 years (median 66.00 years; SD 
12.57; minimum age 27 years; and maximum age 90 years). There were 87 (47.8%) 
participants in the intervention arm (Group A) and 95 (52.2%) participants in the control arm 
(Group B); there was no significant difference in the partnership status of patients in Group A 
vs. Group B. Most patients were married (n = 118; 64.8%) and of White-British ethnicity     
(n = 173; 95.1%). No significant differences were observed between the intervention and 
control groups with respect to age distribution, gender distribution, in the baseline scores for 
MYCAW, EQ-5D, and PEI, or in any other study parameters (Ahmed et al., 2015).   
Study participants were categorised on the basis of care received, the four categories of care 
participants received were as follows: end of life cancer (93); end of life care for non-cancer 
conditions (4); care as cancer survivors (71); or care as people with a long-term condition 
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(14). Demographic characteristics of participants are summarised in Table 14. No significant 
differences were observed between the intervention and control groups with respect to age 
distribution, gender distribution, partnership status/marital status, ethnicity, living 
arrangements, religion or in any other study parameters (Ahmed et al., 2015).   
Table 14: Baseline demographic characteristics of participants (Ahmed et al., 2015) 
The most frequently occurring primary diagnosis in Group A (Intervention) was malignant 
neoplasm of the breast (unspecified) (n=11; 12.5%) and in Group B (Control) was malignant 
neoplasm of the bronchus or lung (unspecified) (n=10; 10.5%). The most common National 
Diagnosis Code was Cancer/Malignant Disease (n=77; 88.5%) in Group A (Intervention) and 
10 patients had a Other Non-Cancer Diagnosis (11.5%). In Group B (Control), 87 patients 
(92.6%) had a National Diagnosis Code of Cancer/Malignant Disease and 7 patients had a 
Other Non-Cancer Diagnosis (7.4%)  0.459;   1;   0.498	. There was no 
significant difference in the National Diagnosis Code between the intervention and control 
groups. The majority of patients (n=153; 84.1%) were referred for pain/ symptom control. 
The most common additional reason for referral was emotional/psychological support          
(n = 46; 57.5%) (Ahmed et al., 2015). There was no significant difference in the urgency of 
referral between the intervention and control groups   0.018;   1;   0.894	. 
There was no significant difference in care received upon referral across the two groups   6.498;   3;   0.090	. There was no difference between Groups A 
(Intervention) and B (Control) as to where patients were recruited from   0.160;  
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2;   0.923	. In Group A (Intervention), 60 patients were recruited from SLH Community 
(69.0%), 26 patients were recruited from STH outpatients (29.9%) and one patient was 
recruited from STH inpatients (1.1%). In Group B (Control), 63 patients were recruited from 
SLH Community (66.3%), 31 patients were recruited from STH outpatients (32.6%) and one 
patient was recruited from STH inpatients (1.1%) (Ahmed et al., 2015).   
Information relating to referral of patients and care received upon referral in the intervention 
and control groups is presented in Table 15. 
Table 15: Referral of patients and care received upon referral in the intervention and control 
groups (Ahmed et al., 2015)
Characteristic  Intervention 
Group A 
n (%) 
Control Group B 
n (%) 
All patients  
n (%)
Notes  
p 
Location before 
service
No significant difference   4.561;  2;   0.102	. Most patients (n=141; 77.9%) 
were at home before service, followed by those 
in hospital (acute) (n=38; 21.0). 
Home 62 (72.1) 79 (83.2) 141 (77.9) 
Hospital (acute) 22 (25.6) 16 (16.8) 38 (21.0) 
Care Home/Nursing 
Home 
2 (2.3) 0 (-) 2 (1.1) 
Total 86 (100) 95 (100) Unknown: 1 
181 (100) 
Location referred 
to (before trial 
entry)
No significant difference   2.012;  3;   0.570	.The majority of patients were 
referred to St. Lukes Hospice (n= 108; 
59.3%).  Northern General 
Hospital 
9 (10.3) 13 (13.7) 22 (12.1) 
Royal Hallamshire 
Hospital 
21 (24.1) 17 (17.9) 38 (20.9) 
St. Lukes Hospice 49 (56.3) 59 (62.1) 108 (59.3) 
Weston Park 
Hospital 
8 (9.2) 6 (6.3) 14 (7.7) 
Total 87 (100) 95 (100) 182 (100) 
Services requested 
(before trial entry)
 The majority of patients (n=98; 53.8%) had the 
St. Lukes Hospice Community team 
requested. Northern General 
Hospital HST 
6 (6.9) 6 (6.3) 12 (6.6) 
Royal Hallamshire 
Hospital HST 
9 (10.3) 7 (7.4) 16 (8.8) 
SLH  Community 
Team 
45 (51.7) 53 (55.8) 98 (53.8) 
WPH HST 8 (9.2) 6 (6.3) 14 (7.7) 
NGH Outpatients 2 (2.3) 6 (6.3) 8 (4.4) 
RHH Outpatients 12 (13.8) 10 (10.5) 22 (12.1) 
SLH Therapies and 
Rehab 
4 (4.6) 5 (5.3) 9 (4.9) 
St. Lukes Hospice 
Inpatients 
0 (-) 1 (1.1) 1 (0.5) 
NGH Inpatients 0 (-) 1 (1.1) 1 (0.5) 
Other 1 (1.1) 0 (-) 1 (0.5) 
Total 87 (100) 95 (100) 182 (100) 
Referral sources The largest source of referrals in both groups 
was the Ward Nurse/Other (n=57; 31.3%). Hospital  
doctor/Consultant 
21 (24.1) 18 (18.9) 39 (21.4) 
GP 11 (12.6) 14 (14.7) 25 (13.7) 
Ward nurse/Other 31 (35.6) 26 (27.4) 57 (31.3) 
District Nurse 6 (6.9) 9 (9.5) 15 (8.2) 
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CNS/Other 15 (17.2) 24 (25.3) 39 (21.4) 
Care/Nursing Home 0 (-) 1 (1.1) 1 (0.5) 
Community Liaison 
Nurse 
0 (-) 1 (1.1) 1 (0.5) 
Self-referral 0 (-) 1 (1.1) 1 (0.5) 
Day Unit 1 (1.1) 0 (-) 1 (0.5) 
Other 1 (1.1) 1 (1.1) 2 (1.1) 
Unknown 1 (1.1) 0 (-) 1 (0.5) 
Total 87 (100) 95 (100) 182 (100) 
Primary reason 
for referral
The majority of patients (n=153; 84.1%) were 
referred for pain/ symptom control. 
Pain/symptom 
control 
70 (80.5) 83 (87.4) 153 (84.1) 
Social/financial 
support 
2 (2.3) 1 (1.1) 3 (1.6) 
Emotional/psycholo
gical support 
15 (17.2) 9 (9.5) 24 (13.2) 
Other 0 (-) 2 (2.1) 2 (1.1) 
Total 87 (100) 95 (100) 182 (100) 
Additional reasons 
for referral
 The most common additional reason for 
referral was emotional/psychological support 
(n = 46; 57.5%). Pain/symptom 
control 
1 (2.4) 0 (-) 1 (1.3) 
Social/financial 
support 
7 (16.7) 3 (7.9) 10 (12.5) 
Emotional/psycholo
gical support 
23 (54.8) 23 (60.5) 46 (57.5) 
Other Other: 4 (9.5) Other: 5 (13.2) Other: 9 (11.3) 
Emotional/psycholo
gical support and 
Social/financial 
support 
7 (16.7) 7 (18.4) 14 (17.5) 
Total 42 (100) 38 (100) 80 (100) 
Urgency of 
referral
No significant difference   0.018;  1;   0.894	. 
Urgent 32 (38.1) 37 (40.2) 69 (39.2) 
Routine 52 (61.9) 55 (59.8) 107 (60.8) 
Total 84 (100) 92 (100) 176 (100)
Care received 
upon referral
No significant difference   6.498;  3;   0.090	. The condition of the people in 
the study sample was categorised under four 
categories, according to whether they were 
considered to require care for end of life cancer 
(93); end of life care for non-cancer conditions 
(4); care as cancer survivors (71); or care as 
people with a long-term condition (14).   
EOLC cancer 48 (55.2) 45 (47.4) 93 (51.1) 
EOLC non-cancer 1 (1.1) 3 (3.2) 4 (2.2) 
Cancer survivor 28 (32.2) 43 (45.3) 71 (39.0) 
Long-term 
condition 
10 (11.5) 4 (4.2) 14 (7.7) 
Total 87 (100) 95 (100) 182 (100) 
Comparisons at baseline between people receiving EOLC for cancer and cancer 
survivors 
There were no significant differences in baseline data between participants receiving EOLC 
for cancer and cancer survivors for any of the following parameters; MYCAW concern 1 
score, the total EQ5D score, the EQ5D responses or in the PEI responses. However, it is 
worth noting that there was a significant difference between the two groups in baseline EQ5D 
thermometer score, with the mean EQ5D thermometer score at baseline for people receiving 
end of life care for cancer being lower than that for cancer survivors (Ahmed et al., 2015).    
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4.4.4 MYCAWdataanalysis:ComparisonofGroupsfromBaselinetoWeeks
2,4,and6
The mean MYCAW Concern 1 score for both groups improved over six weeks (Table 16). 
The overall mean change in score from baseline to Week 2 was 0.368 (median 0; SD 1.39); 
from baseline to Week 4 was 0.430 (median 0; SD 1.66); and from baseline to Week 6 was 
0.462 (median 0; SD 1.59). There were no significant differences (no detectable effect) 
between the control and intervention groups in the change in mean MYCAW Concern 1 
scores at two, four-, or six-week follow-up (Ahmed et al., 2015).   
Table 16: Distribution of scores for MYCAW Concern 1 at baseline, 2, 4, and 6 week follow 
up in the intervention and control groups (Ahmed et al., 2015)  
4.4.5 MYCAW:ComparisonofGroupsfromBaselinetoWeek2
There was a significant difference in the rankings for the change in MYCAW Concern 1 
score [Baseline to Week 2] of patients in Groups A (Intervention: mean rank of patients: 
61.21) and B (Control: mean rank of patients: 75.37) (Mann Whitney Z = -2.192; p = 0.028;  
n = 136). Overall patients in Group B (Control) showed greater improvement or less 
deterioration in the MYCAW score than patients in Group A (Intervention). The mean 
change in MYCAW Concern 1 score [baseline to Week 2] in Group A (Intervention) was 
0.15 (SD = 1.32; median = 0) [a small improvement] vs. Group B (Control) was 0.57 (SD = 
1.44; median = 0). When the scores for changes in MYCAW Concern 1 score for the patients 
were re-coded [baseline to week 2] into groups for deterioration/ no change / improvement, 
there was a statistically significant association between the change in MYCAW Concern 1 
score and study arm (2trend = 5.51; df = 1; p = 0.019). A higher proportion of patients in 
Group B (Control: 34/70 [48.6%]) had an improvement in the MYCAW Concern 1 score 
[baseline to Week 2] compared with patients in Group A (Intervention: 19/66 [28.8%]). A 
higher proportion of patients in Group A (Intervention: 16/66; [24.2%]) showed a 
deterioration in the MYCAW Concern 1 score [baseline to Week 2], compared with patients 
in Group B (Control: 10/70 [14.3%]) (Table 17) (Ahmed et al., 2015).  
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From Baseline to Week 2 
Table 17: Distribution of level of change in MYCAW scores from Baseline to Week 2 in the 
intervention and control groups (Ahmed et al., 2015)    
 N (%) Total (%) 
Change in 
MYCAW 
score 
Group A 
(Intervention) 
Group B (Control) Total Sample 
(A plus B)
Deterioration 16 (24.2) 10 (14.3) 26 (19.1) 
No change 31 (47.0) 26 (37.1) 57 (41.9) 
Improvement 19 (28.8) 34 (48.6) 53 (39.0) 
Total 66 (100) 70 (100) 136 (100) 
4.4.6 MYCAW:ComparisonofGroupsfromBaselinetoWeek4
There was no significant difference in the rankings for the change in MYCAW Concern 1 
score [Baseline to Week 4] of patients in Groups A (Intervention: mean rank of patients: 
55.41) and B (Control: mean rank of patients: 59.45) (Mann Whitney Z = -0.679; p = 0.497; n 
= 114). The mean change in MYCAW Concern 1 score [baseline to Week 4] in Group A 
(Intervention) was 0.31 (SD = 1.44; median = 0) [a small improvement] vs. Group B 
(Control) was 0.54 (SD = 1.85; median = 0). When the scores for changes in MYCAW 
Concern 1 score [baseline to Week 4] for the patients were re-coded into groups for 
deterioration/ no change / improvement, a higher proportion of patients in Group B (Control: 
25/59 [42.4%]) had an improvement in the MYCAW Concern 1 score [baseline to Week 4] 
vs. patients in Group A (Intervention: (19/55; [34.5%]); however, this association was not 
statistically significant (2trend = 0.026; df = 1; p = 0.872). A higher proportion of patients in 
Group B (Intervention: 14/59; [23.7%]) showed a deterioration in the MYCAW Concern 1 
score [baseline to Week 4], vs. patients in Group A (Control: 10/55 [18.2%]) (Table 18) 
(Ahmed et al., 2015).  
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From Baseline to Week 4 
Table 18: Distribution of level of change in MYCAW scores from Baseline to Week 4 in the 
intervention and control groups (Ahmed et al., 2015)  
  N (%) Total (%) 
Change in 
MYCAW 
score 
Group A 
(Intervention) 
Group B (Control) Total Sample 
(A plus B)
Deterioration 10 (18.2) 14 (23.7) 24 (21.1) 
No change 26 (47.3) 20 (33.9) 46 (40.4) 
Improvement 19 (34.5) 25 (42.4) 44 (38.6) 
Total 55 (100) 59 (100) 114 (100) 
4.4.7 MYCAW:ComparisonofGroupsfromBaselinetoWeek6
There was no significant difference in the rankings for the change in MYCAW Concern 1 
score [Baseline to Week 6] of patients in Groups A (Intervention: mean rank of patients: 
48.28) and B (Control: mean rank of patients: 56.56) (Mann Whitney Z = -1.439; p = 0.150; n 
= 104). The mean change in MYCAW score [baseline to Week 6] in Group A (Intervention) 
was 0.27 (SD = 1.34; median = 0; n=51) vs. mean change in Group B (Control) was 0.64 (SD 
= 1.78; median = 0; n=53). When the scores for changes in MYCAW Concern 1 score 
[baseline to Week 6] for the patients were re-coded into groups for deterioration/ no change / 
improvement, a higher proportion of patients in Group B (Control: 26/53 [49.1%]) had an 
improvement in the MYCAW Concern 1 score [baseline to Week 6] compared with patients 
in Group A (Intervention: (18/51; [35.3%]); however, this association was not statistically 
significant (2trend = 1.428; df = 1; p = 0.232). A slightly higher proportion of patients in 
Group A (Intervention: 13/51; [25.5%]) showed a deterioration in the MYCAW Concern 1 
score [baseline to Week 6], vs. patients in Group B (Control: 11/53 [20.8%]) (Table 19) 
(Ahmed et al., 2015).  
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From Baseline to Week 6 
Table 19: Distribution of level of change in MYCAW scores from Baseline to Week 6 in the 
intervention and control groups (Ahmed et al., 2015) 
 N (%) Total (%)  
Change in 
MYCAW 
score 
Group A 
(Intervention) 
Group B (Control) Total Sample 
(A plus B)
Deterioration 13 (25.5) 11 (20.8) 24 (23.1) 
No change 20 (39.2) 16 (30.2) 36 (34.6) 
Improvement 18 (35.3) 26 (49.1) 44 (42.3) 
Total 51 (100) 53 (100) 104 (100) 
4.4.8 MYCAW:Qualitativeanalysisofpatients/respondentsstated
concerns
The MYCAW questionnaire invites patients to nominate concerns, which may or may not be 
medical (MYCAW) or symptoms (MYMOP) of importance to them (two concerns/symptoms 
can be identified). They then score these on a scale of 0 (not bothering me at all)  to 6 
(bothers me greatly). Patients are also asked to rate their general feeling of wellbeing on a 
scale of 0 (as good as it could be)  to 6 (as bad as it could be). The follow-up form asks 
patients to re-score the concerns/symptoms, and rate their general feeling of wellbeing they 
previously nominated, thus capturing any changes over time that are important to the patient. 
The primary outcome measure was the change in score between the first MYCAW patient 
nominated concern at baseline and the two-week follow up. This is the nominated first 
concern (Ahmed et al., 2015; Guyatt et al., 1998; Paterson et al., 2007; Peace & Manasse, 
2002). Three respondents gave scores on concern one, but without stating the concern; one 
respondent did this for concern two. 
MYCAW concerns at Baseline  
Of the 182 patients completing baseline questionnaires, 173 (95.1%) respondents nominated 
and scored a primary concern (MYCAW Concern 1) and 125 (68.7%) nominated and scored 
a secondary concern (MYCAW Concern 2) (Ahmed et al., 2015).   
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First concerns nominated 
A thematic analysis revealed that several areas of concern were nominated as a first concern. 
These are summarised below.  
Nominated concerns relating to (number of patients in brackets):  
1. Physical symptoms (66); 
2. Apprehension for themselves (24) or for others (10); 
3. Disease progression (18); 
4. Current condition or state of health (16); 
5. Disability, either from their symptoms or from other causes (14); 
6. Loss of faculties, function or role (12);  
7. Needing help from family/services (11); 
8. Effects of treatment (9); 
9. Worrying thoughts about death and dying (6); 
10. Loneliness, loss of meaning of their place in the world, existential concerns (6); 
11. Psychological concerns e.g. depression (4); 
12. Effects on social life (3); 
13. Information on their disease (2); 
14. Hope of improvement (2); 
15. Work and finance (1); 
16. No concerns voiced (6), suggesting that things were fine at present. 
Some respondents nominated more than one concern. One respondent made a specific 
comment about the forms themselves.  
Second concerns nominated  
A thematic analysis revealed that several areas of concern were nominated as a second 
concern. These are summarised below.  
Nominated concerns relating to (number of patients in brackets):  
1. Physical symptoms (51); 
2. Apprehension for themselves (10) or for others (10); 
3. Loss of faculties, function or role and existential concerns (15); 
4. Current condition or state of health (13); 
5. Disease progression (12); 
6. Effects of treatment and treatment plans (12); 
7. Disability, either from their symptoms or from other causes (11); 
8. Needing help from family/services (7); 
9. Effects on social life (6); 
10. Worrying thoughts about death and dying (3); 
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11. Psychological concerns (3); 
12. Work (2) and finance (2); 
13. Loneliness, loss of meaning of their place in the world, existential concerns (1);  
14. No concerns voiced (4), suggesting that things were fine at present. 
Some respondents named concerns in more than one area.  
Summary of MYCAW Concern 1  
For MYCAW concern 1, physical symptoms, condition and disability predominate in the first 
stated concern, but other concerns such as apprehension for themselves or others, concerns 
about disease progression and dying, feelings of loss of function or purpose, and on help 
needed are also prominent. There were a minority of respondents that appear to be without 
any problems, issues or concerns (Ahmed et al., 2015).   
Summary of MYCAW Concern 2  
The pattern of concerns closely follows that stated in the first concerns, although a smaller 
number named a second concern. Individuals second concerns may not be of the same nature 
as their first ones. Physical symptoms predominate, but other concerns such as apprehension 
for themselves or others, concerns about disease progression and dying, and on feelings of 
loss of function or purpose, are also prominent. There were a minority without issues that are 
currently causing them concern (Ahmed et al., 2015).   
Summary of MYCAW Concerns 1 and 2 according to clinical groups  
The condition of the people in the study sample was categorised under four categories, 
according to whether they were considered to require care for end of life cancer; end of life 
care for non-cancer conditions; care as cancer survivors; or care as people with a long-term 
condition. Several points are raised by viewing the data for the analysis of MYCAW 
concerns 1 and 2 according to the clinical groups. Similarities are marked, in that for all 
groups, symptoms, condition and disability feature most strongly. For cancer survivors, and 
those receiving end of life cancer care, all concerns are named: apprehension for themselves 
or others; concerns related to the progression of disease; psychological concerns; concerns 
related to loss or existential issues; concerns about needing help; the effect on their social 
life; work or financial issues; and treatment effects (Table 20) (Ahmed et al., 2015). Any 
possible differences in emphasis in concerns between these two groups could be explored by 
further analysis of SPARC and other data.  
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Table 20: Summary of MYCAW Concerns 1 and 2 according to clinical groups  
ANALYSIS ACCORDING TO CLINICAL GROUP  
Clinical group  
(number of patients) 
Summary  
End of life care in cancer 
conditions (93)
 87 named a first concern 
 66 named a second concern 
 Some respondents named 
concerns in more than one 
area 
Physical symptoms predominate in the first stated concern, closely 
followed by feelings of apprehension, and concerns about disease 
progression. Other concerns, such as feelings of loss; concerns about 
needing help and the effects of treatment are also present. There are a 
minority without issues that are currently causing them concern. The 
pattern of second concerns closely follows that stated in the first concerns, 
although individuals second concerns are not necessarily of the same 
nature as their first ones. 
End of life care in non-cancer 
conditions (4)
In this small group, respondents concerns were about dying; their illness; 
the effect on their families; wanting to do more; the restrictions caused by 
pain; adjusting to a new house; and fear of falls.  
Cancer survivors 
Care for people who are cancer 
survivors (71)
 69 named a first concern 
 56 named a second concern 
 Some respondents named 
concerns in more than one 
area 
Physical symptoms predominate in the first stated concern, closely 
followed by feelings of apprehension and concerns about disease 
progression. Other concerns, such as feelings of loss, are present; with 
concerns about needing help, wanting to be independent, and the effects of 
treatment are also present. There are a minority without issues that are 
currently causing them concern. The pattern of concerns closely follows 
that stated in the first concerns in the sample overall, although individuals 
second concerns may not be of the same nature as their first ones. 
Long-term conditions  
Care for people with long-term 
conditions (14) 
All 14 named a first concern
 8 named a second concern
 Some respondents named 
concerns in more than one 
area
Physical symptoms, condition and disability predominate in the first stated 
concern, with apprehension, help needed, and loss being other stated 
concerns. The second concern reflects the predominance of concerns 
related to physical symptoms, with emotional concerns also present. 
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4.4.9 EQ5D:ComparisonofGroupsfromBaselinetoWeeks2,4,and6
There were no meaningful or significant associations between any of the EQ-5D domains for 
Groups A (intervention) and B (control) at baseline, Weeks 2, 4, or 6. Table 21 shows the 
frequency of responses for the EQ-5D domains at all of the time points. It is also worth 
noting that, in this analysis, the mean EQ-5D scores did not change in any significant or 
meaningful way (Ahmed et al., 2015).   
Table 21: Frequency of EQ5D responses at Baseline, Weeks 2, 4 and 6 in the intervention 
and control groups (Ahmed et al., 2015)  
4.4.10 EQ5Dthermometerscores
There was no significant difference in the rankings of the EQ5D thermometer scores for 
Groups A (Intervention) and B (Control) at baseline (Mann Whitney Z = -0.311; p = 0.756), 
Week 2 (Mann Whitney Z = -0.125; p = 0.900), Week 4 (Mann Whitney Z = -0.694;              
p = 0.487) or Week 6 (Mann Whitney Z = -1.260; p = 0.208). There was no significant 
difference in the rankings of the changes in EQ5D thermometer scores for Groups A 
(Intervention) and B (Control) from baseline to Week 2 (Mann Whitney Z = -1.227;              
p = 0.220), baseline to Week 4 (Mann Whitney Z = -1.425; p = 0.154) or baseline to Week 6 
(Mann Whitney Z = -1.199; p = 0.231) (Ahmed et al., 2015).   
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4.4.11 TotalEQ5Dscores
There was no significant difference in the rankings of the total EQ5D scores for Groups A 
(Intervention) and B (Control) at baseline (Mann Whitney Z = -1.043; p = 0.297), Week 2 
(Mann Whitney Z = -0.930; p = 0.353), Week 4 (Mann Whitney Z = -0.559; p = 0.576) or 
Week 6 (Mann Whitney Z = -0.324; p = 0.746). There was no significant difference in the 
rankings of the changes in total EQ5D scores for Groups A (Intervention) and B (Control) 
from baseline to Week 2 (Mann Whitney Z = -0.838; p = 0.402), baseline to Week 4 (Mann 
Whitney Z = -0.125; p = 0.900) or baseline to Week 6 (Mann Whitney Z = -1.035; p = 0.301) 
(Ahmed et al., 2015).   
4.4.12 EQ5D:ComparisonofGroupsfromBaselinetoWeek2
When the scores for changes in the total EQ5D score for the patients were re-coded into 
groups for deterioration/ no change / improvement, the association between change in total 
EQ5D score from Baseline to Week 2 and study arm was not statistically significant (2trend = 
0.43; df = 1; p = 0.511). The distribution across the two groups is shown in Table 22 (Ahmed 
et al., 2015).     
From Baseline to Week 2 
Table 22: Distribution of level of change in total EQ5D scores from Baseline to Week 2 in 
the intervention and control groups (Ahmed et al., 2015) 
N (%) Total (%) 
Change in total EQ5D score Group A 
(Intervention)
Group B 
(Control) 
Group A plus 
Group B 
Deterioration 17 (6.2) 24 (33.8) 41 (30.1) 
No change 32 (49.2) 30 (42.3) 62 (45.6) 
Improvement 16 (24.6) 17 (23.9) 33 (24.3) 
Total 65 (100) 71 (100) 136 (100) 
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4.4.13 EQ5D:ComparisonofGroupsfromBaselinetoWeek4
When the scores for changes in the total EQ5D score for the patients were re-coded into 
groups for deterioration/ no change / improvement, the association between change in total 
EQ5D score from Baseline to Week 4 and study arm was not statistically significant (2trend = 
0.025; df = 1; p = 0.876). The distribution across the two groups is shown in Table 23 
(Ahmed et al., 2015).  
From Baseline to Week 4 
Table 23: Distribution of level of change in total EQ5D scores from Baseline to Week 4 in 
the intervention and control groups (Ahmed et al., 2015)  
 N (%) Total (%)  
Change in total EQ5D score Group A 
(Intervention)
Group B 
(Control) 
Group A plus 
Group B 
Deterioration 18 (36.7) 19 (33.3) 37 (34.9) 
No change 17 (34.7) 25 (43.9) 42 (39.6) 
Improvement 14 (28.6) 13 (22.8) 27 (25.5) 
Total 49 (100) 57 (100) 106 (100) 
4.4.14 EQ5D:ComparisonofGroupsfromBaselinetoWeek6
When the scores for changes in the total EQ5D score for the patients were re-coded into 
groups for deterioration/ no change / improvement, the association between change in total 
EQ5D score from Baseline to Week 6 and study arm was not statistically significant (2trend = 
0.746; df = 1; p = 0.388). The distribution across the two groups is shown in Table 24 
(Ahmed et al., 2015).  
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From Baseline to Week 6 
Table 24: Distribution of level of change in total EQ5D scores from Baseline to Week 6 
(Ahmed et al., 2015) 
 N (%) Total (%)  
Change in total EQ5D score Group A 
(Intervention)
Group B 
(Control) 
Group A plus 
Group B 
Deterioration 15 (32.6) 23 (39.7) 18 (36.5) 
No change 16 (34.8) 20 (34.5) 36 (34.6) 
Improvement 15 (32.6) 15 (25.9) 30 (28.8) 
Total 46 (100) 58 (100) 104 (100) 
4.4.15 PEI:ComparisonofGroupsfromBaselinetoWeeks2,4,and6
Table 25 shows the distribution of responses for the PEI questions at Baseline and Weeks 2, 
4, and 6, respectively, in Groups A (intervention) and B (control) and in the total sample (A 
plus B). There were no meaningful or significant associations between the PEI responses to 
the questions for either group or in the total sample at any of the time points (Ahmed et al., 
2015).   
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Table 25: Distribution of responses for the PEI questions at Baseline and Weeks 2, 4, and 6 in the intervention and control groups (Ahmed et al., 
2015)   
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4.4.16 Retrospectivecasenotereviews
Hospital admissions and outpatient visits  
There was no significant difference between the intervention and control groups in the 
number of hospital admissions and outpatient visits during the 12 months prior to receiving 
baseline questionnaires or during the study period (Table 26).
Table 26: Hospital admissions and outpatient visits 
Characteristic Intervention Group A Control Group B All patients, n Notes  
p 
Number of hospital admissions during 12 months prior to receiving baseline questionnaires No significant difference 
(Mann-Whitney Z = -1.593; 
p = 0.111) 
The mean number of 
hospital admissions 
during the 12 months 
prior to baseline data 
received 
6.30 (median = 4; SD = 
6.60) 
4.45 (median = 3; SD = 
5.67) 
5.34 (median = 3; SD = 6.19) 
Number of hospital admissions during study (period is 8 weeks from baseline questionnaires received) No significant difference 
(Mann-Whitney Z = -0.298; 
p = 0.766) 
The mean number of 
hospital admissions 
during the study 
period (period is 8 
weeks from baseline 
data received) 
0.94 (median = 0; SD = 
1.42; n= 87) 
0.91 (median = 0; SD = 
1.34; n= 95) 
0.92 (median = 0; SD = 1.37; 
n=182) 
Number of outpatient visits during 12 months prior to baseline questionnaires received No significant difference 
(Mann-Whitney Z = -0.334; 
p = 0.738) 
The mean number of 
outpatient visits 
during the 12months 
before the baseline 
data were received 
14.17 (median = 11; SD = 
10.51) 
13.44 (median = 11; SD = 
9.12) 
13.79 (median = 11; SD = 
9.79) 
Number of outpatient visits during study (period is 8 weeks from baseline questionnaires received) No significant difference 
(Mann-Whitney Z = -0.912; 
p = 0.362) 
The mean number of 
outpatient visits 
during the 8-week 
study period 
1.70 (median = 1; SD = 
1.98) 
1.87 (median = 1; SD = 
1.80) 
1.79 (median = 1; SD = 1.89) 
Number of days in hospital during 12 months prior to baseline questionnaires received No significant difference 
(Mann-Whitney Z = -1.795; 
p = 0.073) 
The mean number of 
days in hospital 
during the 12 months 
prior to receiving 
baseline data  
22.15 (median = 14; SD = 
26.27) 
15.51 (median = 9; SD = 
21.05) 
18.68 (median = 10; SD = 
23.86) 
Number of days in hospital during study duration (period is 8 weeks from baseline questionnaires  received) No significant difference 
(Mann-Whitney Z = -0.233; 
p = 0.816)
The mean number of 
days in hospital 
during the 8-week 
study period from 
when the baseline 
data were received 
4.21 (median = 0; SD = 
9.81) 
4.03 (median = 0; SD = 
8.38) 
4.12 (median = 0; SD = 9.07) 
Summary of key findings from retrospective case note reviews  
 164/182 patients (90.1%) completed a SPARC questionnaire.  
 107/164 (65.2%) patient-completed SPARC forms were filed in the notes (when 
reviewed at the 8-week point).  
 123/182 (67.6%) patients had progress notes for the duration of study.  
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 43/182 (23.6%) patients had no progress notes for the entire duration of the study, a 
further 16/182 (8.8%) patients did not complete SPARC. 
 30/182 (16.4%) trial participants were discharged during the trial period.  
 In 12/182 (6.59%); the prospect of pending discharge was discussed during the trial 
period. 
SPARC referenced in notes: What actions were taken? 
Only 5/164=3.0% of patient notes made any direct reference to SPARC. The following 
actions were taken as a result of participants completing SPARC (as documented in the 
participants notes).  
BM001 (trial duration period 15.3.11-10.5.11) 
This participant was not seen by a palliative care health care professional during the trial 
duration, in fact the notes suggest that this participant was last seen by the palliative care 
team in August 2010, and has not been seen since. The notes indicate that the participant has 
a long-term condition, and has had multiple admissions to the hospital. The notes have 
documented that the consultant was currently trying to make another appointment to see the 
participant in the outpatient clinic following high level scoring of SPARC on some issues. In 
this case the completion of SPARC resulted in the Palliative Medicine Consultant recalling 
the participant back to the outpatient clinic for further review, who had not been seen in clinic 
for over 6 months, and for whom appointments seemed to have slipped through the net. 
MA006 (trial duration period 24.3.11-19.5.11) 
The completion of SPARC by this participant who was seen during the trial duration period, 
identified various psychological concerns that needed addressing, loneliness was a major 
cause of unhappiness in this participant, caused by the death of her husband, depression was 
therefore due to the bereavement. The completion of SPARC by this participant when 
attending the outpatient clinic resulted in the consultant seeking a referral to a clinical 
psychologist based in the hospice. In this case the completion of SPARC initiated a referral to 
a clinical psychologist to address any underlying psychological concerns/issues.  
MA015 (trial duration period 12.4.11-7.6.11) 
In this case the participant completed SPARC, and informed the clinical nurse specialist that 
she had been concerned that she may alarm someone when she ticked thoughts of suicide. 
She said that she often thought of suicide when questioned, and said that it had gone through 
her mind on a number of occasions. The participant was aware that this was not an easy way 
out and only contemplates it, and has never developed her thoughts on it. This prompted the 
health care professional to inform the participants GP, so that the GP was made aware of this. 
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The health care professional said that she never got the impression that the participant had 
any intention of following through with these thoughts. When the participant was asked if she 
would like a referral to psychological support (as done in past), the participant felt that this 
was not necessary (was open and honest), but will do if she needs more psychological support 
in future. In this case the completion of SPARC by the participant who had high-level scoring 
for the thoughts of suicide question, prompted the health care professional to immediately 
contact the participant to see what help if any could be offered.  
MA046 (trial duration period 7.6.11-2.8.11) 
In this particular case the participant completing SPARC had already been discharged (prior 
to trial entry). The SPARC questionnaire was returned following patient discharge, and one 
area highlighted 3 (very much distressed by), however the participant had already been 
discharged and the health care professional then made a plan to establish contact with the 
participant. The health care professional made contact with the patient by telephone 
following receipt of the completed SPARC tool, and checked with the participant if she had 
been provided support in the area that had been highlighted as 3. The participant stated that 
she had the opportunity to talk with the health care professional (since completing SPARC) 
and had been provided with literature (during a subsequent consultation with the health care 
professional), which had been helpful but she did not feel the need for further support at this 
time, and said that her illness still had an impact on her sexual life. However, she did not feel 
that this would change. 
MA110 (trial duration period 18.1.12-14.3.12) 
The health care professional spoke to the participant about a copy of SPARC form received, 
the participant informed the health care professional that the information he had required was 
covered by the last visit (completed SPARC before that visit), he had also asked at that time 
when he would be able to try his new catheter out, and was advised he should ask Dr E at 
his next outpatient appointment. The participant said that he still has some questions for       
Dr E at his next outpatient appointment. The health care professional encouraged the 
participant to ask questions.  
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4.5 Summary
The unexpected negative finding that a higher proportion of patients in the control group    
(34 of 70; 48.6%) showed a relative improvement in their MYCAW score from Baseline to 
Week 2 compared with the intervention group (19 of 66; 28.8%) (P = 0.019) raises questions 
about the application of SPARC and possibly other holistic needs assessment questionnaires 
in the context of a specialist palliative care service. No positive effect of the intervention on 
either the primary or secondary outcome measures was observed at two, four, or six weeks, 
suggesting that the intervention did not have a detectable beneficial effect at any point and 
the difference between arms was obliterated when the control arm received SPARC (Ahmed 
et al., 2015).   
Data which indicate that most patients felt that no particular action or benefit followed from 
completion of SPARC will be reported in Chapter 6. There were no meaningful or 
significant differences between the control and intervention groups in the scores for health 
related quality of life as recorded in the general measure EQ-5D. This measure did not 
significantly change over the six weeks, as would be expected of patients attending a 
palliative care service. However, in contrast, there appears to be improvement in the most 
important concern as recorded in the MYCAW; this suggests that usual palliative care is 
having a beneficial effect in this respect (Ahmed et al., 2015).   
This trial result identifies a potential negative effect of SPARC in specialist palliative care 
services, raising questions that standardised holistic needs assessment questionnaires may be 
counterproductive if not integrated with a clinical assessment that informs the care plan 
(Ahmed et al., 2015). This is supported by review of case notes, and the interview data from 
patients which indicate that most patients felt that no particular action or benefit followed 
from the completion of SPARC (Ahmed et al., 2015). 
The SPARC pilot trial focused primarily on outcomes, not on the processes involved in 
implementing the intervention. The Medical Research Council framework requires an 
evaluation of the pilot study, a process evaluation was undertaken and is reported in 
Chapters 5, 6, and 7, to elucidate the precise mechanism by which this result came about 
(Ahmed et al., 2015).   
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Chapter5
RESEARCHPHASEII:Processevaluation
Processevaluation5
Evaluating interventions or health care services is an important component of health services 
research. The new MRC guidance, 2008 provides a framework for conducting and reporting 
process evaluation studies. A process evaluation is a means by which researchers attempt to 
better understand why an intervention/program/strategy was or was not successful and how 
any effects were achieved (Escoffery et al., 2016; Francis et al., 2013; Hanley et al., 2016; 
Moore et al., 2013a; Moore et al., 2013b; Moore et al., 2015; Munro & Bloor, 2010; Murphy 
et al., 1998; Norman et al., 2016; OCathain et al., 2002; OCathain et al., 2009a; Rudolf et 
al., 2006; Volpe et al., 2013; Wilkinson, 2011). Huis et al., 2013, emphasise the importance 
of undertaking process evaluations as a means of looking inside the black box to ascertain 
which components of an intervention work well and which work less well (Grant et al., 
2013; Pope & Mays, 1993; Riley et al., 2005). That said, there appears to be limited guidance 
on how to undertake a process evaluation, much of the guidance is on the use of qualitative 
methods alongside RCTs, rather than on the processes to evaluate (De Silva et al., 2014; 
Grant et al., 2013; Grimshaw et al., 2007; Moore et al., 2012).  
A process evaluation should be an integral element of RCTs (Craig et al., 2008a; Craig et al., 
2008b; Ellard et al., 2011; Ezendam et al., 2013; Flottorp et al., 2003; Francis et al., 2013; 
Grant et al., 2013; Hind et al., 2010; May et al., 2007a; May et al., 2007b; Moore et al., 2015; 
Toroyan et al., 2004; White, 2013). However, Huis et al., 2013, argue that researchers are 
more likely to publish RCTs that mainly focus on outcomes data (answering the question 
does it work?), and rarely publish process evaluation data answering why or how an 
intervention/program/strategy was successful or why it failed (OCathain et al., 2013; Ellard 
et al., 2011).    
The SPARC pilot trial funded by Macmillan Cancer Support focussed primarily on outcomes, 
not on the processes involved in implementing the intervention (Ahmed et al., 2015).   
Macmillan Cancer Support agreed to further fund this process evaluation. 
An important part of the MRC framework requires an evaluation of the pilot study (Ahmed et 
al., 2015; Craig et al., 2008a; Craig et al., 2008b; Grant et al., 2013) and a process evaluation 
of the trial was undertaken during the period 1st February 2013-14th July 2014, in order to 
elucidate the precise mechanism by which this result came about in this pilot randomised 
controlled trial (Ahmed et al., 2015).  
Process evaluations of trials are particularly appropriate for complex interventions to examine 
content, implementation and receipt of intervention in depth and how it was conducted and 
received (Baranowski & Stables, 2000; Brady et al., 2011; Burr et al., 2011; Chandler et al., 
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2013; Craig et al., 2013), and are useful in multi-centre trials where the same intervention 
may be implemented and received in different ways (Oakley et al., 2006; Verwey et al., 
2016).  
An outcome evaluation does not provide any information about the causal mechanisms and 
contextual factors associated with variation in outcomes (Moore et al., 2013a). It is therefore 
now common practice for process evaluations to utilise qualitative methods alongside RCTs 
to explore participants attitudes towards, and experiences of, study interventions (Grimshaw 
et al., 2007). For this reason, a small scale process evaluation was undertaken to elucidate the 
underlying mechanisms through which the intervention (SPARC) influences outcomes, for 
whom, why, and under what circumstances (Hartman et al., 2013).
5.1 TheuseofaqualitativestudyrunningalongsideanRCT
The UK MRC updated guidance of complex interventions (2008) recommends undertaking 
qualitative research in the early stages and alongside trials to develop an understanding of the 
intervention under study, and at a later stage to explore why an intervention did or did not 
work and to enhance the inferences and interpretations from the RCT (Craig et al., 2000; 
Craig et al., 2008a; Craig et al., 2008b). Research in this area has gained momentum, and 
process evaluations of this nature are now common (Blackwood et al., 2010; Bradley et al., 
1999; Campbell et al., 2003; Campbell et al., 2007; Dyson, 2010; Lewin et al., 2009; Oakley 
et al., 2006; OCathain, 2009; Riley et al., 2005; Weaver et al., 1996; Wilkinson, 2011; 
Young et al., 2013). OCathain, 2009, argues that the use of qualitative methods alongside 
an RCT allows researchers to highlight the discrepancies arising between the two methods.
The value of combining qualitative research with RCTs in health services research is now 
widely acknowledged, researchers often cite helping to interpret the results of RCT as a 
rationale for using qualitative research with RCTs, this is one of the important contributions 
of qualitative research (OCathain et al., 2013). OCathain et al., 2015, explores and report          
8 rationales for using qualitative research with RCTs based on findings from the QUART 
study. There is now growing recognition that qualitative research methods can reach the 
parts other methods cannot reach (Bradley et al., 1999). In the context of this doctoral study, 
a mixed methods study was considered appropriate and undertaken for reasons of:                
1) triangulation (convergence or corroboration); 2) complementary (qualitative method 
elaborates, enhances or clarifies results of RCT); 3) offsetting (strengths of one method offset 
weaknesses of the other method); 4) development/expansion (extends breadth and range of 
inquiry); 5) development of SPARC (as a HNA tool); and 6) comprehensiveness (issue is 
addressed more fully than either approach alone) (Creswell, 2009; Creswell & Clark, 2010; 
Tashakkori & Creswell, 2007a; Tashakkori & Creswell, 2007b).  
5.2 Theuseofqualitativeinterviewsinhealthservicesresearch
There are three main types of qualitative interviews used in health services/medical research, 
namely: 1) structured interviews; 2) semi-structured interviews; and 3) in-depth interviews. 
Structured interviews, as the name suggests elicit participants views using a structured 
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questionnaire; semi-structured interviews make use of open-ended questions (questions/topics 
for discussion are drawn up in advance); and in-depth interviews usually involve covering 
one or two issues in much greater detail (Britten, 1995). Qualitative interviews provide useful 
insights into the lives, experiences and understandings of research participants. However, as 
with other methods of research, they may be limited to providing only partial understandings 
of situations (Cheek et al., 2004).  
5.3 Semi-structuredinterviews
The qualitative component of this mixed methods study comprised of semi-structured 
interviews with patients and health and social care professionals about their experiences of 
completing SPARC during the trial. The aim was to determine the reasons why the SPARC 
intervention did not appear to work. A retrospective case note review was also undertaken 
(presented in Chapter 4). The questions/topic guides were used to guide the research process 
and ensure that key areas are covered using prompts (probes). Semi-structured interviews do 
have some degree of structure and the use of open-ended questions allows some flexibility for 
participants to tell their stories (i.e. their understandings and experiences) spontaneously in 
their own words. During the interview the researcher is able to pursue topics that are relevant 
to the research question and are of interest to participants, and can delve deeper by asking 
further questions (Britten, 2006). Interviews are normally audio-recorded and then 
transcribed (with participants consent), a one-hour interview can take up to six hours for a 
simple transcription, and longer if there are interruptions or long pauses during the interview. 
Field notes are often taken by the researcher (Ritchie & Spencer, 1994).   
Payne, 2007, emphasises the importance of the researchers skills and experience in making 
sense of not only what is said but how it is said, paying particular attention to both the 
narrative and the non-verbal communication. Participants must be encouraged to talk freely, 
in a comfortable and relaxed way. Therefore, it is essential to develop a good rapport, gain 
trust and co-operation between the researcher and the researched. The strengths (advantages) 
and the limitations/weaknesses of semi-structured interviews are summarised in Table 27.
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Table 27: Semi-structured interviews (strengths/advantages and limitations) 
Strengths/advantages limitations/challenges/weaknesses 
 Face-face interviews: higher response rate 
vs. postal questionnaires/postal surveys  
 Loose structure/some degree of structure- 
open-ended questions allow participants to 
tell their stories spontaneously and in their 
own words  
 Can deal with confusing questions and 
address any misunderstandings during 
interview  
 Interviews can be conducted in participants 
own language (for those with language 
difficulties but this has resource 
implications)   
 Less missing data vs. postal 
questionnaires/postal surveys 
 May be less demanding than postal 
questionnaires (some participants may have 
difficulty writing/reading)   
 Mainly participant-led  
 Can place extra burden on participants with an 
advanced or progressive illness who may be 
too ill and emotionally upset to participate  
 Relationship between researcher and 
participant may have an impact 
 Distressed/sensitive patients may decline, and 
some may not wish to be interviewed  
 Open to selection bias and interviewer bias, 
may influence interview   
 Sex, race, religion, class and educational 
experiences of researcher may affect 
interviews   
 Lack of rapport between researcher and 
interviewer can hinder research process 
 Good listening skills essential, and researcher 
must facilitate interview in a non-judgemental 
and non-directive manner   
 Transcription process: involves some element 
of interpretation 
 Miss non-verbal communication and non-
verbal behaviour omitted in audio-recordings  
 Extensive skill and training required   
 Skill and experience of researchers- 
determines data quality 
Adapted from Bennett, 2007; Britten, 1995; Edwards et al., 2002; Payne, 2007  
5.3.1 Samplesizeandtheconceptofsaturation
A number of issues can affect sample size in qualitative research, and this is dependent upon 
researchers methodological and epistemological perspective. Many experts agree that the 
concept of saturation is central to qualitative sampling, i.e. the point at which no further 
information or themes emerge or are observed in the data and collecting more data does not 
necessarily generate more information (Baker & Edwards, 2012; Guest et al., 2006; Mason, 
2010). Guest et al., 2006, argue that while the concept of saturation is useful and helpful at a 
conceptual level, it provides no indication or guidance on how to estimate sample sizes. The 
sample sizes of qualitative studies are typically much smaller than those used in quantitative 
studies (Guest et al., 2006). Some authors have attempted to estimate sample sizes in 
qualitative studies. Mason, 2010, study looked at a sample of PhD studies using qualitative 
approaches, they found that the study mean sample size was 31, some suggest a range 
between 12-16 interviews. A mean sample of 30 interviews required for saturation has also 
been cited (Baker & Edwards, 2012).  
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Chapter6
A qualitative study to elicit the views of patients about their6
experienceofcompletingSPARC
6.1 Abstract
Background
The findings of a pilot randomised controlled trial of a holistic needs assessment 
questionnaire in a supportive and palliative care service appear to defy the conventional 
assumption that the use of a validated multidimensional holistic screening tool for supportive 
and palliative care needs such as SPARC, will lead to improved health care outcomes for 
patients (Ahmed, 2010; Ahmed et al., 2015). The results of this trial were counter-intuitive 
and the trial result identified a potential negative effect of SPARC in specialist palliative care 
services (Ahmed et al., 2015).   
This is a qualitative study embedded and running alongside a randomised controlled trial, to 
elicit the views of trial participants (patients) about their experience of completing SPARC, to 
help in the interpretation of the trial result (EAPC abstract, 2015).   
Methods 
As part of a process evaluation, semi-structured interviews were undertaken with a sub-group 
of trial participants (n=33) referred to the palliative care service in Sheffield (UK). All 
patients were interviewed after they had completed the study (i.e. 8 weeks from the date 
baseline questionnaires were received). The interview schedule was designed to provide a 
description of patients experience of completing the SPARC questionnaire during the trial, 
in particular: how they found completing SPARC; what they thought about the SPARC 
questions; whether anything changed because of completing SPARC; and whether or not they
felt that completing SPARC resulted in any actions being taken. Interviews were digitally 
recorded and transcribed verbatim and analysed using the framework analysis approach 
(EAPC abstract, 2015).    
Findings  
Seven prominent themes emerged from the patient interviews, themes were determined 
largely by the topics of predetermined interest and guided by the interview schedule, these 
provided useful insights into why the intervention (SPARC) did not work, and highlighted 
potential areas for improvement. Prominent themes were identified as: Theme 1: Ease of 
SPARC completion; Theme 2: Suitability, relevance and sensitivity of SPARC questions; 
Theme 3: Impact of completing SPARC on clinical practice; Theme 4: Usefulness and 
comprehensiveness of SPARC; Theme 5: Follow up and monitoring of patients (timing of 
administering SPARC); Theme 6: Information and communication issues; Theme 7: 
Satisfaction with services or care received. Most patients interviewed [30/33], found SPARC 
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either quite easy to complete, fairly straightforward, simple or had no problems in completing 
it. Only a small number of participants found questions on SPARC too sensitive or 
upsetting. A crucial finding in the context of the trial was the large proportion of patients 
interviewed [30/33] who did not experience or report any noticeable change, or beneficial 
effects after completing SPARC (EAPC abstract, 2015).    
Conclusions  
Overall, participants considered SPARC to be an acceptable and relevant tool for the clinical 
assessment of supportive and palliative care needs (EAPC abstract, 2015). However, patients 
reports of a failure to act on identified needs would support the conclusion that holistic needs 
assessment may be potentially harmful if not integrated with a clinical assessment that 
informs the care plan.  
The potential negative effect of SPARC in a specialist palliative care service could be due to 
the failure of health care professionals to act on identified needs in a timely manner, or 
related to the raising of patients expectations that are not subsequently met (Ahmed et al., 
2015). This qualitative study helps in the interpretation of the outcome results, and provides 
useful insights into how SPARC might be used in practice (EAPC abstract, 2015).    
Key Words: Palliative care, holistic needs assessment, SPARC, process evaluation, semi-
structured patient interviews, qualitative study.  
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6.2 Introduction
In the previous Phase of the study (Chapter 4: outcome evaluation), I presented the findings 
of a pilot study of a pragmatic randomised controlled trial to determine whether the use of 
SPARC leads to improved health care outcomes (health-related quality of life and self-
identified concerns) for patients referred to a supportive and palliative care service (Ahmed et 
al., 2015).   
In this Phase 2 (process evaluation), I will present the findings from semi-structured 
interviews undertaken as part of the wider RCT.  
This Chapter explores trial participants (patients) (n=33) views of completing SPARC, as a 
further important aspect of the development of the tool and provides useful insights on the 
implementation, receipt and setting of the SPARC intervention that would help in the 
interpretation of the outcome results, and guide the development of a definitive multicentre 
study (Hughes et al., 2015). This is a qualitative study embedded and running alongside a 
randomised controlled trial, to elicit the views of trial participants (patients) about their 
experience of completing SPARC.
This Chapter will also review the feedback from the supplementary question about patients 
experience of completing SPARC during the trial (Ahmed et al., 2015).   
6.3 Methods
Study design 
As part of a process evaluation, semi-structured interviews were undertaken with a sub-group 
of trial participants (n=33) referred to the palliative care service in Sheffield (UK). All 
patients were interviewed after they had completed the study (i.e. 8 weeks from the date 
baseline questionnaires were received). The interview schedule was designed to provide a 
description of patients experience of completing the SPARC questionnaire during the trial, 
in particular: how they found completing SPARC; what they thought about the SPARC 
questions; whether anything changed because of completing SPARC; and whether or not they
felt that completing SPARC resulted in any actions being taken. Interviews were digitally 
recorded and transcribed verbatim and analysed using the framework analysis approach 
(EAPC abstract, 2015).    
This qualitative methodology is particularly useful in identifying themes on topics of 
predetermined interest and has the flexibility to capture themes in other related areas of 
interest.  
I developed the patient interview schedule (Appendix 24) with help from other members of 
the research team that comprised of experienced qualitative researchers, a palliative medicine 
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consultant, and two consumers. The interview schedule was piloted with a member of the 
research team.  
Supplementary question on patient experiences of completing the SPARC questionnaire 
As part of the follow up procedure, all patients were asked to complete a supplementary 
question on their experience of completing the SPARC questionnaire; Please tell us about 
your experience of completing the SPARC questionnaire The supplementary question on 
experience of completing SPARC was part of the questionnaire booklet that was sent out four 
weeks after completed SPARC questionnaires were received. For the intervention group this 
was at week 4, and for the control group this was at week 6 (Table 12) (Ahmed et al., 2015).  
6.3.1 Patientrecruitmentanddemographics
How participants were identified and who was invited to participate 
Semi-structured interviews were conducted with a sub-group of trial participants using 
purposive sampling (i.e. patients who had taken part in the main trial who had been referred 
to the palliative care service and those that met the study inclusion criteria). The inclusion 
and exclusion criteria for recruiting patients to this study, is presented below (also presented 
in Chapter 4).   
Trialparticipants
Inclusioncriteria
1) Any diagnosis (cancer and non-cancer). 
2) Any referral to the palliative care service in any care setting. 
3) Patients 18 years old or above. 
4) Patients able to give informed consent. 
Exclusioncriteria
1) Patients incapable of giving informed consent.  
2) Patients incapable of completing SPARC even with the help of a relative or informal 
carer. 
3) Patients under 18 years old. 
The method that I used to identify patients for semi-structured interviews (i.e. how 
participants were identified and who was invited to participate is described in more detail 
below).   
Patients taking part in the main trial were also invited to take part in a follow-up interview 
about their experiences of completing SPARC, and reference to this was made in the initial 
patient information sheet sent out in the study invitation pack (as described in Chapter 4).  
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An invitation letter (Appendix 25), a patient opt-in form (Appendix 26) for taking part in 
semi-structured interviews and a consent form (Appendix 27) was initially sent to all patients 
(two weeks after they had completed the SPARC questionnaire) and placed inside the 
questionnaire pack which contained MYCAW, EQ5D and PEI (2 week questionnaires). For 
the intervention group this was at week two, and for the control group this was at week four, 
as shown in Table 12.
Table 12: Study follow-up procedure (questionnaire completion at 2-week intervals) (Ahmed 
et al., 2015, also presented in Chapter 4)   
Baseline 
Randomisation
Group A 
intervention group 
MYCAW; EQ-5D; PEI 
SPARC 
Group B 
waiting–list control 
MYCAW; EQ-5D; PEI 
Two 
weeks 
MYCAW; EQ-5D; PEI 
[Invitation for patient interview] 
MYCAW; EQ-5D; PEI 
SPARC 
Four  
weeks 
MYCAW; EQ-5D; PEI 
plus supplementary question on 
experience of completing SPARC 
MYCAW; EQ-5D; PEI 
[Invitation for patient interview] 
Six weeks MYCAW; EQ-5D; PEI MYCAW; EQ-5D; PEI 
plus supplementary question on experience 
of completing SPARC 
Eight  
weeks 
Case Note Reviews 
Semi-Structured Interviews with Patients  
Semi-Structured Interviews with Health Care Professionals  
SPARC: Sheffield Profile for Assessment and Referral for Care 
MYCAW: Measure Yourself Concerns and Wellbeing 
EuroQoL (EQ-5D): Standardised outcome measure of Health Related Quality of Life  
PEI: Patient Enablement Instrument  
(Ahmed et al., 2015)  
The completion of the opt-in form indicted that the participant would be willing to be 
contacted by a researcher about taking part in an interview, and participants were asked to 
provide contact details (name, address, phone number, email address) and a good time to 
contact them. Those patients (inpatients, outpatients and community care patients) expressing 
an interest in taking part completed the enclosed opt-in form, signed the consent form, and 
returned them in a freepost envelope provided (addressed to the research team). The consent 
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form was completed when I went out to interview; for those patients that had not returned the 
signed and completed consent form in the freepost envelope. Inpatients also had the option of 
returning the reply form and opt in form to any health care professional that was caring for 
them, and a procedure was in place so that health care professionals would inform researchers 
of all completed reply forms and for researchers to collect these forms from the health care 
professionals. Upon receiving the completed opt-in form, I contacted the participant by phone 
to arrange a suitable date, time and place that was convenient to the participant to conduct the 
interview. Recruitment of patients for the purposes of the interview continued until saturation 
was achieved, and also when sufficient numbers of patients representing the different groups 
of patients were recruited (i.e. cancer, non-cancer, long-term conditions, and end of life care), 
at which point no further invitations for interview were sent out. There were no patient drop-
outs during this stage. All interviews were audio-recorded with permission of the participants 
and field notes were kept. All participants had the option of withdrawing from the interviews 
at any time without giving any reason, and without their medical care or legal rights being 
affected. Participants were also made aware that researchers would be accessing their 
clinical/medical records.  
Characteristics of patients and their interviews (n=33) are described below.  
6.3.2 Settingandsample
Characteristics of patients and their interviews (n=33) 
Thirty-three patient interviews were undertaken between May 2011 and February 2012 
(Interviews took place between 16/5/2011 and 16/2/2012).  
Response saturation was achieved with the interview of thirty-three patients. Interviews were 
undertaken at a location that was convenient to the participants; all 33 interviews were 
undertaken at patients homes (EAPC abstract, 2015). 
Nineteen of thirty-three participants were female, and 14/33 participants were male. The 
mean age of participants was 63 years old (range 34-83 years), the majority of patients had a 
diagnosis of cancer, with 29/33 participants with a cancer/malignant diagnosis, and 4/33 
participants with a other non-cancer diagnosis (EAPC abstract, 2015). The year of diagnosis 
ranged from 1984-2011. I undertook 26/33 of the patient interviews, and my colleague MW 
undertook 7/33 of the patient interviews. The mean interview duration was 12.95 minutes 
(range 3.18-46.18 minutes). The majority of participants interviewed were cancer survivors; 
(19/33); some were categorised as having end of life care cancer; (9/33); and some as having 
a long-term condition; (5/33). The characteristics of participants and their interviews are 
summarised in Table 28.  
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Table 28: Characteristics of patients and their interviews (n=33) 
Patient ID 
Number 
Gender National Diagnosis Code Interviewer’s name Length of interview 
(minutes) 
Care received upon 
referral: 
1. EOLC cancer 
2. EOLC non-cancer 
3. Cancer survivor 
4. Long-term condition 
BM001 F Other Non-Cancer Diagnosis NA 7.27 minutes  4 
BM002 F Cancer/Malignant Diagnosis NA 27.33 minutes  3 
BM009 F Cancer/Malignant Diagnosis NA 6.43 minutes 1 
BM021 M Cancer/Malignant Diagnosis MW 14.15 minutes 3 
BM028 M Cancer/Malignant Diagnosis MW 5.05 minutes  1 
BM033 F Other Non-Cancer Diagnosis NA 12.00 minutes  4 
MA001 F Cancer/Malignant Diagnosis NA 14.21 minutes 3 
MA006 F Other Non-Cancer Diagnosis NA 5.48 minutes 4 
MA012 F Cancer/Malignant Diagnosis NA 15.05 minutes 1 
MA014 F Cancer/Malignant Diagnosis NA 23.50 minutes 3 
MA015 F Cancer/Malignant Diagnosis NA 10.57 minutes  3 
MA024 F Cancer/Malignant Diagnosis NA 18.16 minutes 3 
MA025 F Cancer/Malignant Diagnosis NA 10.18 minutes 4 
MA026 M Cancer/Malignant Diagnosis NA 11.36 minutes 3 
MA029 F Cancer/Malignant Diagnosis NA 10.00 minutes  1 
MA033  M Cancer/Malignant Diagnosis NA 10.41 minutes 1 
MA039 M Cancer/Malignant Diagnosis NA 46.18 minutes 3 
MA046 F Cancer/Malignant Diagnosis MW 13.16 minutes 3 
MA047 F Cancer Malignant Diagnosis MW 8.38 minutes 1 
MA057 F Cancer/Malignant Diagnosis NA 13.02 minutes 3 
MA058 M Cancer/Malignant Diagnosis NA 9.08 minutes 3 
MA060 M Cancer/Malignant Diagnosis NA 12.30 minutes 3 
MA061 M Cancer/Malignant Diagnosis NA 3.18 minutes 3 
MA064 F Cancer/Malignant Diagnosis NA 10.09 minutes 3 
MA065 M Cancer/Malignant Diagnosis NA 30.42 minutes 1 
MA070 M Cancer/Malignant Diagnosis NA 14.40 minutes 3 
MA071 M Cancer/Malignant Diagnosis NA 6.58 minutes  1 
MA090 M Cancer/Malignant Diagnosis NA 3.53 minutes 3 
MA091 F Cancer/Malignant Diagnosis NA 8.58 minutes 3 
MA093 M Other Non-Cancer Diagnosis MW 12.55 minutes 4 
MA098 F Cancer/Malignant Diagnosis MW 12.24 minutes 1 
MA100 F Cancer/Malignant Diagnosis NA 6.15 minutes 3 
MA102 M Cancer/Malignant Diagnosis MW 16.21 minutes 3 
NA: Nisar Ahmed, MW: Michelle Winslow 
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Interview data was examined qualitatively using a Framework Analysis approach (Ritchie & 
Spencer, 1994), and a summative content analysis was used to analyse feedback from the 
supplementary question on patients experience of completing SPARC (Ahmed et al., 2015; 
Graneheim & Lundman, 2004; Hsieh & Shannon, 2005).   
6.4 Dataanalysis(theframeworkapproach)
The interview schedule was designed to provide a description of patients views about their 
experiences of completing the SPARC questionnaire, in particular: how they found 
completing the SPARC questionnaire; what they thought about the SPARC questions and 
whether or not they felt that completing the SPARC questionnaire resulted in any change or 
actions being taken by the clinical staff; as well as any other comments they had about 
SPARC or in general. Interviews were digitally recorded and transcribed verbatim and 
analysed using the framework analysis approach (EAPC abstract, 2015). A full description of 
the framework approach is presented below. An example of a coded verbatim patient 
interview transcript is presented in Appendix 28, the coding framework (theme headings, 
subheadings and code numbers) is presented in Table 30, and an example of a patient 
thematic Chart is presented in Appendix 29. Field notes were also kept. 
Some authors support the use and reporting of numbers in qualitative research as these can 
complement and enhance narratives in order to generate significance and meaning (Olson, 
2000; Sandelowski, 2001). The use of numbers is particularly useful in the context of this 
study (process evaluation).  
6.5 Frameworkanalysis
Framework analysis is a method for analysing qualitative data that was developed during 
the 1980s by social policy researchers at the National Centre for Social Research (UKs 
largest independent not-for-profit research institute) (Ritchie & Spencer, 1994; Smith & 
Firth, 2011; Ward et al., 2013). This pragmatic analytical approach allows researchers to 
organise and manage large volumes of qualitative data in a rigorous, transparent and 
systematic manner, and is used by researchers in a wide range of disciplines, such as health 
related research, policy development and program evaluation. The systematic process of data 
sifting, charting and sorting, and the subsequent categorisation of data according to key 
issues, themes and sub-themes are the key features of this method of analysis, hence giving 
rise to the term framework, which is derived from the term thematic framework. The 
analytical process comprises of five distinct, but highly interconnected stages of data 
analysis, leading to the development of a robust and flexible grid structure or matrix, 
constructed by data that is summarised and presented in the form of themes, sub-themes (in 
columns), against participants (in rows). Thus, facilitating exploration of complex relational 
data at many different levels (both within and between comparisons), and allowing research 
questions to be answered. The framework approach has undergone refinement and further 
development over the years, but the general underlying principles remain the same (Ritchie & 
Spencer, 1994). For these reasons, the framework analysis approach was considered the 
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most appropriate choice for the analysis of the qualitative data generated from the transcripts 
of the semi-structured interviews of patients and health care professionals, interviewed during 
the study. The strengths and weaknesses of the framework approach are presented in Table 
29.
Table 29: The strengths and weaknesses of the framework approach 
Strengths Weaknesses
Relatively straightforward form of 
qualitative analysis (Braun & Clarke, 
2006).  
Flexible approach in dealing with large 
volumes of complex data. 
Follows a systematic and well defined 
procedure, following a particular order and 
with logic steps, analytical process is 
documented, accessible, retaining links to 
original data set (Ritchie & Spencer, 1994). 
Flexibility and good documentation of the 
procedure offers analyst to revisit, and 
reconsider or rework earlier or initial ideas.  
(Adapted from Gale et al., 2013; Ritchie & 
Spencer, 1994; Ward et al., 2013). 
There is a certain degree of subjective 
judgement required by the analyst about 
meanings, the importance or prominence and 
connections that need to be made.  
Despite the systematic, rigorous, and 
disciplined nature, the process does not provide 
a fool-proof method with a guaranteed 
outcome.  
Time-consuming and resource-intensive  
(Adapted from Gale et al., 2013; Pope et al., 
2000; Ritchie & Spencer, 1994). 
A description of each stage in the framework analytical process that I followed is described 
below (Gale et al., 2013; Ritchie & Spencer, 1994; Ward et al., 2013).  
6.5.1 Stage1:Familiarisation
The familiarisation stage is an important first stage which takes place prior to the process of 
sifting and sorting data. This stage requires the analyst to listen to the interviews and read 
through the material (transcripts) collected in order to become familiar with the range and 
diversity of the data collected, hence the name familiarisation stage. During this stage key 
ideas and initial themes as well as any recurrent themes or emerging concepts are identified 
(such as attitudes, behaviours, motivations, views etc.). It is not compulsory at this stage to 
review the entire dataset, however a sufficient examination of the material gives the analyst a 
more thorough overview and a feel for the material collected as a whole. It is advisable to 
review the overall aims and objectives of the research at this point (Ritchie & Spencer, 1994). 
6.5.2 Stage2:Identifyingathematicframework
Stage two involves the development of a thematic conceptual framework or index, which 
is constructed using the recurrent themes identified during the familiarisation stage and/or 
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issues introduced into the interview using the topic guide/questionnaire. During this stage 
themes/concepts identified are further sorted and grouped into a smaller number of broader 
categories (higher order categories or main themes), which may be identical to the 
interview questioning or newly developed from emerging themes and placed within an 
overall thematic framework. Thus this stage, compared to stage one involves a more careful 
and detailed examination and arrangement of data by themes/concepts identified. The process 
of devising and refining a thematic framework typically involves the analyst to draw 
inferences from the dataset, and making certain level of judgements about the meaning of the 
data, its relevance and importance, as well as establishing any connections between 
emerging themes/concepts and ideas. It is important at this stage to go back to the original 
research questions, and ensure that they are being fully addressed (Gale et al., 2013; Ritchie 
& Spencer, 1994; Ward et al., 2013). The final coding framework (theme headings, 
subheadings and code numbers) that I developed from the patient interviews is presented in 
Table 30.
6.5.3 Stage3:Indexing(labellingortaggingthedata)
The next stage is called indexing and involves labelling or tagging the data on margins of 
each transcript against each paragraph/sentence using a numerical system, which should link 
back to the index (similar to an index found at the back of text books). During this stage the 
transcripts are re-read and numerically coded by themes and the thematic framework 
constructed in stage two is systematically applied to the entire dataset. This stage, as with 
stage two is regarded as a highly subjective process and once again the analyst is required to 
draw conclusions about meaning, importance and significance of material collected prior to 
applying an index which can be applied either manually or electronically. At this stage it is 
advisable to review the preliminary thematic framework, which may need further refinement 
(i.e. addition or deletion/collapsing of categories and subcategories) following initial 
application to the data. It is advisable to record any revisions made to the index during this 
stage for consideration during the latter stages of analysis (Ritchie & Spencer, 1994). An 
example of a patient interview transcript that I coded is presented in Appendix 28.
6.5.4 Stage4:Charting(thematiccharting)
Having applied a thematic framework, indexed, labelled and tagged the entire dataset, this 
stage requires the analyst to explore and review the pattern and range of responses for each 
issue or theme identified across the whole dataset. Charting or thematic charting involves 
lifting the data from the original transcript and rearranging it and placing it in a chart 
according to the appropriate thematic reference. Charts are constructed using the headings 
and subheadings of the thematic framework or from a priori set of questions which are 
presented in the columns of the matrix, against each respondent presented in rows in the 
matrix. This is another critical stage in the analysis, again requiring a certain level of 
judgement about the amount and content of the material to chart, without losing content, 
context and importance of the material being charted, and retaining language of the 
respondent. The content and context of the charted data should be sufficient enough to allow 
136 
understanding of the point being made without having to go back to the original 
transcriptions. At this point it is advisable to make a note of the page number of the transcript 
against all the data that is lifted from the original transcripts, thus allowing the analyst to go 
back, and so retaining the link to the original dataset should the need arise (Gale et al., 2013; 
Ritchie & Spencer, 1994; Ward et al., 2013). An example of a patient charting/thematic 
charting table that I developed during this stage is presented in Appendix 29.
6.5.5 Stage 5: Mapping and interpretation (mapping, linking and
interpretingthewholedataset)
The final stage of the analysis regarded as perhaps the most difficult stage of the analytical 
process, involves summarising and synthesising or interpreting the whole dataset, this being 
the stage at which the key objectives of qualitative analysis are addressed. During this key 
stage the analyst is comparing and contrasting data, highlighting key concepts and ideas, and 
searching for patterns, connections, motivations, associations and seeking explanations, and 
taking a step back and looking at the dataset in its entirety in order to draw the necessary 
conclusions (Ritchie & Spencer, 1994). 
The familiarisation phase and the initial thematic analysis, development of themes and sub-
themes was conducted by myself, and then examined by another experienced qualitative 
researcher (KC). I listened to each patient interview audio-recording, checking for any errors 
in the verbatim transcript; listening to an interview audio-recording also facilitated the 
analysis. 
In order to minimise any bias, and improve the reliability of the analysis, 20% (7 out of 33) of 
the patient interview transcripts were independently coded and charted by two experienced 
qualitative researchers (NA and KC). Subsequent detailed discussions of the analysis 
optimised consistency and agreement within interpretation and the development of themes, as 
an on-going process throughout the data analysis. 
6.6 Transcriptionconventions
Any words appearing between two square [ ] brackets indicate where I have added notes of 
clarification. Ellipsis points [  ] indicate where I have abridged a quotation or omitted some 
words. All quotations presented in the findings section have been indented. Following each 
quotation, the trial participants identification number is reported. This is followed by the 
page number (s) of the original interview transcript from which the extract/quotation has been 
lifted.
6.7 Emergenceofsevenprominentthemes
Initially the coding framework (Table 30) identified five main themes and 18 sub-themes 
headings (determined largely by the topics of predetermined interest). These included: ease of 
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SPARC completion; suitability, relevance and sensitivity of the SPARC questions; changes 
or any actions taken as a result of completing SPARC; usefulness of completing SPARC; 
timing of administering SPARC, and issues relating to follow-up and monitoring of patients 
and other general comments.  
However, upon closer examination the themes and subthemes that were determined largely 
by the topics of predetermined interest were collapsed into seven prominent themes, which 
provided useful insights into why the intervention (SPARC) did not work, and other potential 
areas for improvement.  
Theme 1: Ease of SPARC completion; 
Theme 2: Suitability, relevance and sensitivity of SPARC questions; 
Theme 3: Impact of completing SPARC on clinical practice;  
Theme 4: Usefulness and comprehensiveness of SPARC;  
Theme 5: Follow-up and monitoring of patients (timing of administering SPARC);  
Theme 6: Information and communication issues;
Theme 7: Satisfaction with services or care received.  
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Table 30: Coding framework (patient interviews): Theme headings, sub-headings and code numbers 
PATIENT ID  
EASE OF SPARC 
COMPLETION 
1)
Quite easy/fairly straightforward/no problems completing 
How patients found completing the SPARC questionnaire: easy, straightforward/no 
problems completing, answered truthfully/dishonestly. 
2) Quite difficult/difficult 
How patients found completing the SPARC questionnaire: Quite difficult/difficult, hard to fill in. 
SUITABILITY, 
RELEVANCE AND 
SENSITIVITY OF SPARC 
QUESTIONS  
3) 
Suitable/appropriate/relevant  
What patients thought about the questions: questions 
were suitable/appropriate/relevant.  
4) 
Not relevant/not applicable    
Felt questions on SPARC/SPARC questionnaire not 
relevant/not applicable.   
5) 
Inappropriate/too personal/sensitive  
What patients thought about the questions: questions were 
inappropriate/too personal/ 
sensitive/invasive/offensive/upsetting/bothering
CHANGES OR ANY 
ACTIONS TAKEN AS A 
RESULT OF 
COMPLETING SPARC 
6) 
Actions: referrals/consultations  
Did completing SPARC result in any actions taken (for 
the better/for the worse): resulting in referrals being 
made/consultations being undertaken?
7) 
Actions: interventions (treatment/care) 
Did completing SPARC result in any actions taken (for the 
better/for the worse): in relation to changes in 
intervention/s, treatment/care?
8)  
Nothing changed/no action/no beneficial effect  
Completing SPARC resulted in no noticeable changes in actions 
taken (for the better/for the worse) in relation to referrals, 
consultations, changes in intervention/s, treatment/care?, no 
beneficial effect/s observed (possible reasons).  
USEFULNESS OF 
COMPLETING SPARC 
9)  
Helpful/worthwhile completing/good idea 
Reasons why completing SPARC was or could be useful: 
helpful/worthwhile completing/good idea. 
10) 
Unhelpful/not worthwhile completing/not so good idea 
Reasons why completing SPARC wasn’t or could not be 
useful: unhelpful/not worthwhile completing/not so good 
idea.
11) 
Impact of completing SPARC on others (e.g. family/carer/s) 
The impact of completing SPARC on other people (e.g. 
family/carer/s). 
TIMING OF SPARC, 
IMPORTANCE OF 
FOLLOW UP AND 
MONITORING OF 
PATIENTS  
12) 
Timing of SPARC/who should get it  
Timing of SPARC: when, how, and to whom SPARC should be given?  
13) 
Importance of follow up and monitoring of patients 
The importance of follow up and monitoring of patients. 
OTHER GENERAL 
COMMENTS  
14) 
Comments on missing questions/depth 
of questioning/ ambiguous/confusing 
questions/ SPARC format, 
categories/scales/layout  
SPARC missed important 
things/questions, comment on depth of 
questioning (too simple/too lengthy), 
any ambiguous/confusing questions, 
comments on SPARC format, 
categories/scales/layout.
15) 
Information and 
communication issues 
General information and 
communication issues 
arising. 
16) 
Comments about service/care 
received/availability of 
services 
General comments about 
service/care 
received/availability of 
services. 
17) 
Participated to help 
others/advance research  
Motivations/reasons for taking part 
in the research: to help 
others/advance research. 
18) 
Unsure why patients were asked to take 
part in the study/what was required/how 
SPARC would be useful 
Confusion as to why patients were asked to 
take part in the study/what was 
required/how SPARC would be useful. 
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6.8 Findings
6.8.1 Theme1:EaseofSPARCcompletion
Most patients interviewed [30/33] said that SPARC was either quite easy to complete, fairly 
straightforward, simple, or they had no problems in completing it. 
‘…Perfectly straightforward,…only took about a minute to complete, …was a case of 
tick, tick, tick, scribble that’s it, …tick the boxes it was very, very straightforward, far 
more straightforward than I anticipated’ [Patient ma100, p114].  
Several patients [3/33] said that they found the questions quite difficult or emotionally 
difficult. 
 ‘…Very emotionally hard makes you focus on the things that you are concerned 
about, can't do whatever it is you are finding problematic. So there’s two different 
levels to that so is it difficult?; no, as a task?, it's difficult emotionally?; yes. …I never 
thought about that I'm going to lose my independence, what they are saying now?, 
…if you are already frightened’ [Patient bm033, p19, p20].  
Some patients [2/33] in this group indicated that it was difficult to score the questions. 
‘Sometimes bit hard to fill in the questions, …how do you feel?, I don’t know?, shall I 
put three or shall I put two cos you are thinking do I really feel like this or that is very 
much?, quite a bit?’ [Patient ma029, p52].  
One patient said that although she wasnt troubled by SPARC, there was always the option of 
not completing it. 
‘…I wasn’t fazed by it, It didn’t trouble me…If I found my mind wandering I used to 
put it in a drawer and close it’ [Patient ma024, p42].  
6.8.2 Theme2:Suitability,relevanceandsensitivityoftheSPARCquestions
Over a third of patients [13/33] interviewed regarded the questions on SPARC to be either, 
suitable, appropriate, or relevant and applicable. 
‘Yes…it seemed to mention anything anybody might be feeling…you should get a 
good an all-round picture..’ [Patient bm009, p11]. 
Several patients [5/33] felt that the SPARC questionnaire or questions on it were either not 
relevant, not applicable, or becoming less relevant.  
‘Did me head in to be honest, …some of them don’t seem relevant, …I answered best I 
can…’ [Patient ma064, p88].  
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Several patients [5/33] found some of the questions (e.g. religious and spiritual issues, 
worrying thoughts about death and dying) on SPARC too personal, inappropriate or sensitive.  
‘…I couldn’t relate to the one about, religion, religious and spiritual issues; worrying 
thoughts about death. I suppose there would be some people because they had cancer 
that’s right yes, would think about death’ [Patient ma024, p42]. 
‘…I don’t like the ones about the dying and they stressed me a little bit, I like to try 
and keep positive of course and feel that I can beat this hopefully, and not look at that 
part really. I try not to talk about that much. It was mainly that…, yes you are always 
thinking about that (death and dying) all the time of course and then you go off the 
subject and you think no I'm not going to die, I'm going to look positive and I'm going 
to be okay, to carry on and try to forget it again and keep busy…’ [Patient ma029, 
p52]. 
Some patients said that they had answered other questionnaires that were a lot more personal 
than SPARC.  
‘…I have answered other questionnaires that have been a lot more personal than this, 
I don’t really find this personal in comparison with other things I have done’ [Patient 
bm001, p1, p2]. 
Those patients that did have thoughts about death and dying talked about the various coping 
mechanisms or strategies for dealing with those thoughts.  
‘No (sensitive/personal)…, I don’t mind at all…, yes I'm okay (with being asked about 
questions on psychological issues).…I have people around me that give me moral 
support…’ [Patient ma098, p112]. 
‘…had I had any thoughts about death or dying?,…I was a Chaplain at the hospice 
for fifteen years, so I've seen plenty of death and dying and as you can gather by that 
I'm a very religious man…, well I've had thoughts but it hasn’t bothered me. I'm a 
believer and, I believe that sooner or later whichever one of us goes first we will meet 
again, and that's why I've written it here not at all, but that doesn’t mean I've had no 
thoughts whatsoever, it just means that I'm happy with my thoughts’ [Patient ma102, 
p116].  
In contrast, other patients in this group felt that although some questions might be sensitive 
and upsetting, this doesnt mean its wrong to ask them. 
‘…they might be sensitive and they might be upsetting, that doesn’t mean it’s wrong 
to ask them’ [Patient bm033, p19].  
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The consensus view was that these questions do need to be asked in order to learn and to help 
other people in the future. 
‘No, no, no (sensitive/personal)…if they don’t learn they don’t know things do they?, 
so you know that's alright’ [Patient ma014, p32].  
‘No not really (sensitive), well you need to know them things to help people in future 
that's why I did it, people must have done things in past to help me, so I just help 
other people’ [Patient ma061, p86].  
6.8.3 Theme3:ImpactofcompletingSPARConclinicalpractice
Most patients interviewed as part of the main trial [30/33] felt that nothing had changed as a 
result of completing SPARC, i.e. patients did not experience any noticeable, beneficial effects 
after completing SPARC (EAPC abstract, 2015).  
‘…and for me they don’t seem to be doing anything, but if they do I don’t know…they 
don’t tell us anything’ [Patient bm021, p13].  
‘Well at the moment I don’t really feel anything has changed…I’ve still got problems 
(in the arm) which, hasn’t been sorted, getting me down a lot…because it won’t go 
down the swelling’ [Patient ma029, p53].  
Various reasons were given for the perception that nothing had changed or no action had 
been taken as a result of completing SPARC, these together with illustrated comments are 
presented in Table 31.
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Table 31: Possible reasons why no beneficial effect was seen as a result of completing 
SPARC (patients views)  
Possible reasons why nothing changed, 
no action taken, or no beneficial effect 
seen as a result of completing SPARC 
Illustrative Comments  
Not seen by a palliative care health 
professional, not heard from anyone, or had 
no follow-up appointment throughout the 
duration of the study  
‘I've not heard anything since I've completed the last form, not 
heard anything from anybody, no’ [Patient ma012, p29]. 
Didnt want to bother the health 
professionals (there were more deserving 
patients than them, or that they didnt 
consider themselves to be terminal)  
‘…I wasn’t thankfully terminal last year…, must be more 
deserving patients: who are needing this time than me, I’ve been 
through the whole system before’ [Patient ma026, p50, p51].  
Saw this as a research study  ‘Really good idea, … if it does get followed up,…a lot of 
questionnaires…, you fill it out and that’s it, it’s used for research 
and there’s nothing that sort of comes from it…, and people to get 
help that need help…’ [Patient bm001, p3, p4].  
‘…as far as I know these go to the University, so such as Dr S 
wouldn’t have seen this, so there wouldn’t be any changes…’ 
[Patient ma058, p81].  
Study follow-up period (6 weeks) is too 
short  
‘… perhaps six weeks is too short’ [Patient ma065, p93].  
Discharged from the palliative care service  ‘… I’m not seeing him anymore now, he’s discharged me cos… 
nothing else, I can have done’ [Patient ma061, p86].  
‘… LP (health professional), signed me off, … she said if we need 
her at all then she will be there’ [Patient ma033, p56, p57].  
Open appointment system (although 
patients were discharged from the service, 
they could still contact the health care 
professional via the open appointment 
system)  
‘…I might go nine months now without seeing him…, I can go 
whenever I want to see him’ [Patient ma057, p78]. 
‘... as long as I make an appointment,… having the same 
conversation every time I go and nothing really is happening, so I 
did say to him [health professional] we’ve tried everything, would 
it be alright if we left things until they may have got an idea of a 
different avenue to explore and rather than me just go back and 
have the same old, same old, … he said just leave the appointment 
open’ [Patient ma057, p78].  
Nothing more could be done  ‘…he basically said there is nothing he could do and he’s now 
passed me back to Dr J...., Dr J.... is ganna pass me down to 
Nottingham… I have sort of come to terms with the fact that I’m 
not ganna be how I was…’ [Patient bm001, p2, p3].  
‘… he ses there was nothing more they could do just yet…’   
[Patient bm021, p15]. 
Tried everything  ‘…It was about December, referred to by the haematologist but 
tried me on all different things nothing didn’t work but prior to 
that I had been to (hospital name) with NP (health professional), 
… so he tried first and tried all things even acupuncture, but then 
I went and saw A (health professional) and told him everything 
and he tried virtually everything but nothing you know from  
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creams to different tablets,… the anti-depressant… didn’t work…’ 
[Patient ma060, p83].  
‘…he tried a number of things most of which made me iller than I 
already was…’ [Patient bm033, p19].  
Any improvements had plateaued  ‘… I've gradually improved but I've got to a limit,…but it's 
plateaued…’ [Patient ma039, p60].  
Problems untreatable or treatment not 
available  
‘The biggest…problem I've got which finally stopped me going to 
work about ten days ago is this chronic peranial pain…, the pain 
problem it seems to be untreatable…I don’t think anything helped 
apart from the whole half a day of being cared for…’  [Patient 
ma026, p50]. 
‘… I don’t think they can do chemotherapy at the moment because 
there isn’t one available,… maybe some treatment was available 
or some trials in the future then maybe I would be able to go on a 
trial otherwise, there is nothing much they can do really…’ 
[Patient ma029, p53].  
Got to a ‘dead-end’  ‘…we’ve got to dead end… we’ve tried things that’s going round 
and round in a circle…’ [Patient ma029, p54].  
Learned to live with it, accepted it, or  
adapted to illness due to long-standing  
issues  
‘… I've had fifteen years of learning of in depth looking at myself, 
learning how to pick myself up and how to kick myself up the 
backside and make myself shift from the position of, oh woe is me 
because oh woe is me is for emergency situations, you can’t live 
your life oh woe is me, cos you end up ill, I mean really ill…you 
have to live with disabilities, and with the on-going side effects…’ 
[Patient bm002, p10]. 
‘I have sort of come to terms with the fact that I’m not ganna be 
how I was’ [Patient bm001, p3].  
Not been that ill, not had any problems,  
not needing anything, managing illness  
quite well, or had stable disease  
‘I haven’t had a lot of problems (stable disease), perhaps 
somebody with more problems than me, they might sit up and 
think, but of course you have got to go across the board when you 
doing something like this, and of course not everybody will fill it 
in’ [Patient ma024, p43].  
‘…my GP who I'm seeing tomorrow, about two months ago said 
he didn’t think I needed to see the palliative care nurse as I was, 
as he said managing a chronic illness perfectly well…’ [Patient 
ma015, p40].  
Health professionals unable to find out 
what was wrong 
‘I was going at one stage to about seven or eight different 
clinics… I was going and a lot of this pain… they couldn’t find 
anything wrong with me, it was just was numb…’ [Patient ma025, 
p47].   
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Several patients [3/33] said that the completion of SPARC resulted in either, referrals being 
made or consultations being undertaken in the form of a follow-up call.  
For two of the patients in this group, completing SPARC initiated a follow-up call from a 
Macmillan Nurse or a health care professional following high level scoring of SPARC, which 
in turn initiated a discussion about the issues raised.  
‘I said to the palliative care nurse, I told them, I'm thinking about how I'm going to 
die, I said are they going to be rushing round and get me sectioned for self- harm?’ 
[Patient ma015, p38]. 
‘… I did get a follow-up call from…the Macmillan Nurse contact (for one of the 
concerns), to discuss some of the aspects on the form,…cos, it raised a red flag 
because I had marked a number three on the form, so we had a frank discussion about 
it,…proved to be really helpful,…I probably wouldn’t have raised it with a GP but by 
raising it on the form it did enable me to get some additional help you know which 
was good. …yes so something did change, and it made me reflect on what I’d written, 
enabled me to have some help…’ [Patient ma046, p69].  
And for one patient in this group this resulted in a request for a referral being made for 
bereavement support even though the patient didn’t think that it would be beneficial. 
‘Dr N referred me (for bereavement support), Dr N seems to think I should be feeling 
better than I am, but I don’t know what the answer is,…Dr N who is lovely, seems to 
think it's all from bereavement of my husband, I'm not in agreement with him, I think 
it's because I’m lonely, that’s top and bottom of it. See it's just a flat and no one 
comes, well I've got family, neighbours, everybody keeps themselves to themselves, 
you just close the door and it's…but what can they do about it?’ [Patient ma006, 
p27].  
Others said that they did not feel neglected, and felt reassured that help would be available if 
things deteriorated.   
‘…I'm sure I'm not being neglected’ [Patient ma001, p25].  
‘Well I do believe if your health deteriorates or if I ring them up and say I feel really 
shocking they may let me go in for respite for a week…’ [Patient ma039, p62].  
None of the thirty-three patients felt that anything had changed in relation to changes in 
intervention, treatment or the care that they received following completion of SPARC.  
6.8.4 Theme4:UsefulnessandcomprehensivenessofSPARC
Just over a half of the sample of patients interviewed [18/33] gave reasons as to why they felt 
that SPARC was either helpful, worthwhile completing, or a good idea. These are presented 
below under relevant headings with illustrative quotations.  
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Adequate questionnaire that covers most things: Most patients within this group talked about 
SPARC being an adequate and comprehensive needs assessment questionnaire that identifies 
needs or concerns which perhaps would otherwise not be picked up. 
 ‘…I think its brilliant…a professional get to know what the patient needs, there are 
so many little bits and pieces, personal issues your care your treatment, these 
depending on the individual, they might need quite a lot of these sort of 
things…nobody would pick these things up, perhaps things aren’t picked up…, 
perhaps not picked up full stop…’ [Patient ma065, p94]. 
Someone decided to listen, felt like I had been forgotten, and neglected: Some patients within 
this group who previously felt neglected were pleased that someone was keeping an eye on 
them, and was listening. 
 ‘I couldn’t believe somebody is listening to me…I've had my body battered and I'm 
just left…now and somebody’s decided to listen’ [Patient ma057, p75].  
Time for reflection: For some patients the completion of SPARC was a time for reflection, 
and made them think more about the illness, or about palliative care and complementary 
therapy. 
 ‘…Made me think more about my illness, and more about palliative care and 
complementary therapy…’ [Patient ma012, p28]. 
Makes you more interactive/proactive: Several patients among this group said that 
completing SPARC made them more interactive or proactive, and they were now more likely 
to get in touch with somebody for help.  
 ‘…main thing that's changed is I'm more likely to ring up more if I think I need some 
help, whereas I've been prone to forget it…I've always been a bit like don’t bother 
anybody…it's made me look at that more but not to leave things, and get you know get 
in touch with somebody…’ [Patient ma012, p29]. 
Writing things down versus verbal communication: Several respondents talked very 
positively about being given the opportunity to write things down on paper. 
 ‘…I've always been positive and to actually see things like this, and where it's all 
worded down you know feeling weak, feeling tired you know,…anxious, low mood, 
confused all these psychological issues, I've got no problems with them at all and it 
was nice, it was good to see that because I could put down in writing,…it doesn’t 
worry me that side of it…’ [Patient ma060, p84]. 
Some patients among this group said that they found it easier to put down their thoughts 
(especially about personal issues) and express their concerns on paper rather than speaking to 
someone.  
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‘…I found it easier to sort of put my thoughts down on paper, rather than speaking to 
someone about it to be honest with you’ [Patient ma046, p69]. 
‘…it just felt easier…to put concerns down, that were quite personal…’[Patient 
ma046, p69]. 
While other patients among this group talked about SPARC being a useful prompt or aide-
mémoire that was particularly useful for those patients that have undergone intensive 
treatment.  
‘Some of the questions you see on here, you kind of forget, my treatment was so 
intense,…it actually causes memory loss,…it prompts to remind you about things that 
you have got, pain, loss of memory, dry mouth, sore mouth and all these sort of 
things…it jogs your memory about things…you might get a truer picture by somebody 
filling a form in like this than just a one to one consultation’, WIFE ‘well I think that 
will encourage people to be more frank…and paint a truer an overall picture of how 
their life is, whatever their condition might be’ [Patient ma065, p94, p95].  
Several patients [2/33] talked about the reasons why SPARC was either unhelpful, not 
worthwhile completing or not so good idea. 
‘…sometimes they do bring it home to you actually how you do feel, but because you 
start thinking about it then, cos I tend not to’ [Patient ma064, p88]. 
‘… it makes you think about things don’t get me wrong, it’s like do you worry about 
death or dying?, and then well yes I do because, its summat that's ganna affect me…’   
[Patient ma064, p90]. 
Some patients [2/33] talked about the impact (negative) of completing SPARC on other 
people (e.g. family or carer/s).  
‘…People can get someone else to help them fill that in,…they could but a family 
member might be even more upset about it’ [Patient bm033, p21]. 
Almost a third of patients interviewed [9/33] made specific references to either missing 
questions on SPARC, depth of questioning, ambiguous or confusing questions, or made 
comments on SPARC questionnaire format, categories, scales, or about the general layout.  
One patient felt that SPARC didn’t ask a question about family history. 
‘I am amazed you don’t ask a little bit more about family history, whether that would 
be an issue or not I don’t know. I did think…oh you don’t ask about any other 
conditions or any family histories, obviously not important and passed it off’ [Patient 
ma024, p42]. 
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Several patients felt that the questions on SPARC were ‘too simple’ and ‘too general’, and 
were expecting a more specific and detailed level of questioning.  
‘…I thought it could have asked deeper questions (more in depth),…a lot more 
invasive questions and it still wouldn’t have been an issue,…wouldn’t be appropriate 
for somebody who is…yes could have asked an awful lot more, you could have gained 
a lot more knowledge about what was appropriate for me. But… you have to ask 
questions which everybody is okay…answering. When I was first referred in, I had my 
head so far under the quilt, that if you had asked me,… simple question how are you?,  
I couldn’t answer…’ [Patient bm002, p7].  
‘No it was far easier than I expected, I expected some more detailed questions,… 
possible too simple for my liking, questions perhaps a bit too general,… could have 
been perhaps a little more specific…’ [Patient ma100, p 114]. 
6.8.5 Theme 5: Follow-up and monitoring of patients (timing of
administeringSPARC)
Timing of administering SPARC to patients: Almost a third of patients interviewed [10/33],  
made some comments about follow-up and monitoring of patients in relation to the timing of 
administering SPARC; in terms of when, how, and to whom SPARC should be given. Some 
patients were of the view that SPARC may not be appropriate for newly referred patients, 
who needed time to accept the diagnosis or those patients going through the very early stages 
of the illness.  
 ‘…suppose you know you were going to see a consultant for the first time and you 
were sent this with your letter,…I just wonder if it would be a bit much, at that 
point…’ [Patient bm033, p20].   
‘I think… early on perhaps a couple of months after diagnosis....people, once that you 
know they have been able to accept the diagnosis themselves and they know what 
their feelings are around it and then they would be able to put their feelings down on 
paper. I think if you did it any earlier it might be a little bit too soon and just aren’t 
interested,…you know be quite reluctant to fill in forms, if it was done much earlier…’ 
[Patient ma046, p71]. 
Conversely, other patients felt that it would be most appropriate to administer SPARC either 
before or after the patient goes to see the consultant, and then again at the 6-month interval.  
‘…it would have been better…perhaps if the questionnaires had been done either just 
before or just after seeing him (health professional) and spread it out perhaps just 
that little bit longer…’ [Patient ma065, p91].  
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‘Well I think you put this into operation for all the patients you get and six months 
down the line, same thing again and I think you would find a change…’ [Patient 
ma065, p96]. 
Several respondents touched on the sensitivity around the timing of SPARC and about how 
patients should be approached, in terms of who should or shouldn’t be given SPARC.  
‘…I think there are some judgement calls in who you give it to, and where they are 
at,… and I feel a bit strongly about that because it talks about some quite frightening 
things in here…’ [Patient bm033, p20].  
 ‘…only certain kinds of patients can do it because I think people say with mental 
illness, or a lot of depression they will just go sling it in the corner…’ [Patient 
ma039, p67]. 
Some respondents within this group talked about the time constraints and the limited amount 
of time available when patients go to see the doctor in clinic.  
‘…in all fairness when you go into a clinic or anywhere to talk to anybody you have 
got five minutes, now how can you get to the bottom of, what most people have 
suffered is a shock, to start with…’ [Patient ma024, p44].  
‘…I think oh I didn’t ask this, I didn’t ask that, and what did she say and 
sometimes…they are so busy the nurses and the doctors that you don’t really get a 
chance to say how you feel so much that way’ [Patient ma029, p53]. 
Almost a third of patients interviewed [9/33] stressed the importance of follow-up and for 
better monitoring of patients, particularly after completion of questionnaires. 
‘…really good idea, if it does get followed up, a lot of questionnaires,…you fill it out 
and that’s it, it’s used for research and there’s nothing that sort of comes from it. And 
people to get help that need help…’ [Patient bm001, p3, p4].  
There was however, some degree of scepticism about just how much of this information     
(on SPARC) will actually be taken on board. 
‘I would like to think so (when asked if patients would benefit from receiving SPARC), 
but I'm a bit sceptical. …I wonder just how much the powers that be will take this on 
board…’ [Patient ma024, p43].   
Several patients felt like they had been forgotten or lost in the system, and had not been seen 
by a health professional for a considerable period of time.  
‘…the way that I was feeling before this landed on my door step was that I was just 
stuck, I had nowhere to go, …it just felt like I had been forgotten, and it was just like 
I’m ganna be like this forever’ [Patient bm001, p2, p3].  
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Others talked about the need for patients to be seen by a health professional at least once a 
year. 
‘It would be nicer to see him (referring to the health professional), once a year or 
something like that just to keep in touch cos he was very nice, weren’t he? (‘oh yes 
smashing’…)’ [Patient bm021, p15, p16].  
One patient stressed the importance and the need for better monitoring of patients, as soon as 
a diagnosis is made, and having a follow-up with shorter time-frames. 
‘…It could if it came earlier and then perhaps do a follow-up…as soon as the 
diagnosis was made…the disappointing thing for me, and I try not to dwell on it is the 
fact that it took a long time from me to actually feeling ill to a diagnosis being made, 
because I was going to the doctors for about four months in severe pain, I could 
barely walk and being treated for back pain…’ [Patient ma046, p70, p71].  
6.8.6 Theme6:Informationandcommunicationissues
Almost a third of patients interviewed [10/33] talked about information and communication 
issues arising. Many of these patients talked about the general lack of information from 
health care professionals about their illness.  
‘…can't always find, get as much information from them (referring to health 
professionals) as you would like…’ [Patient ma033, p57].  
‘…concerns me I don’t know what the next stage of my illness will be. And it's very 
difficult to get the professionals to tell you, they don’t want to talk about it. They all 
say absolutely depends on the individual, but I'm sure there are some generalities…’  
[Patient ma015, p39].  
With some patients even suggesting that they felt like being ‘cheated’ 
‘…they don’t tell us anything…I mean we are just being fobbed off all the time,… no 
never said anything what they are going to do or anything whatsoever,… I would like 
to know what’s going off…there’s a lack of information for you’ [Patient bm021,  
p13, p14).  
‘…doctors are very bad at telling you these things,…I am going to become you know 
unable to work?, unable to walk?, well we don’t know. And sometimes that's in 
brackets but we are not wanting to tell you, so there is another side to this which 
could open the dialogue…’ [Patient bm033, p21].  
One patient expressed concern over the lack of information and support from health care 
professionals, particularly after surgery and at the point of discharge.
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‘…you are brought out of hospital major surgery, they give you a huge bag of 
medication they don’t know anything about it, some of the stuff I've had, I couldn’t 
read them and they say here you are, tara, best of luck, and we will see you again...’  
[Patient ma039, p66].  
For those patients that did receive information, concerns were expressed about the approach 
that was used to convey the information to the patient. 
‘WIFE…Well it was the wrong approach to go into a consultation unaware of 
anything to come out having been given that information and you know off you go. 
Have this done and that done and we will see you on Thursday for a bone marrow’ 
[Patient ma065, p96]. 
Some patients felt that communication issues were a real problem that seemed to be getting 
worse. 
‘…the communication stuff which is a real problem,…it’s a problem that's getting 
worse for me…’ [Patient bm033, p20].  
In contrast some patients in this group said that they didn’t know much about their illness, 
and preferred it that way.  
‘…he said to me then how long have you got S? and I said I don’t know and I don’t 
want to know, I really didn’t know much about illness except I knew it were 
terminal…’ [Patient ma064, p88, 89].  
Others said that they would have benefited from more explanation from health care 
professionals.  
‘…I would have benefited from that being explained to me,… and then I think you 
accept it more,…if you find out at the beginning you find it easier to accept…’ 
[Patient ma046, p71].  
6.8.7 Theme7:Satisfactionwithservicesorcarereceived
Just over half of the patients interviewed [17/33] made comments about the service, care 
received, or about the availability of services. Fifteen of the seventeen respondents praised 
the service, care, or treatment that they received, with many pleased with the level of care 
that they received, particularly at the hospice.  
Praise for Macmillan Nurses 
Several patients specifically praised the Macmillan Nurses for the excellent care that they 
provided.  
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‘…we had a Macmillan Nurse, didn’t we?, and you know they were smashing, 
whereas here you are just a number at… (hospital name)…’ [Patient bm021, p14].  
‘…they’ve been fantastic to me and my Mrs, they are like family, I mean the 
Macmillan Nurse, she is bringing my medication here on…because they don’t want 
me going in with big groups of people so you can't ask for better than that’ [Patient 
ma058, p81]. 
Some patients in this group went on to praise the availability of services at the hospice.  
‘…if my pains not very good I can go there for the day or the night (hospice), and I 
can have my pain sorted,…and I know that I can ring them for that…’ [Patient 
ma014, p33].  
Most patients praised the hospice and all the staff.  
‘…I think that service from the…(hospice name) has made this whole experience 
immeasurably more satisfactory than it might have been…(comparing it to without 
the visits of the palliative care nurse)’ [Patient ma015, p40].  
‘…It's a great pity that more people can't go to (hospice name)…had I not gone to… 
(hospice name), I would have really been left in the lurch…’ [Patient ma024, p43, 
p44].  
There was also praise for the palliative care nurses. 
‘…and I feel that the palliative care nurse understands me, and is sympathetic to the 
problems of my life…’ [Patient ma015, p40].  
‘…L (health professional’s name) who is extremely helpful, very good indeed, she is 
the only sort of professional that I have seen isn’t she?’ [Patient ma033, p57].  
Some patients within this group praised the doctor or their GP, and the care received 
particularly after discharge. 
‘…my doctor is absolutely fantastic,…I've got a marvellous GP,…I’ve had absolutely 
fantastic treatment in all the different departments…’ [Patient ma025, p48].  
‘…do you know I worship him he’s my god (referring to the hospital doctor), and I'm 
not saying that because you are here,…I do feel proud of them…’ [Patient ma057, 
p76, p78].   
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‘…my doctor is very good, he’s excellent, but I don’t think he knows a lot about this 
sort of situation…and they don’t just stop there, when the patients discharged a lot of 
these things are on-going’ [Patient ma024, p43, p44]. 
Others went on to praise the NHS service, and all the departments. 
‘…I'm a hundred percent in I think the National Health is absolutely brilliant, I’ve 
had fantastic treatment wherever I've been in (two hospital names). …I’ve had 
absolutely fantastic treatment in all the different departments…’ [Patient ma025, 
p48].  
On the whole there was all round praise for the palliative care service provision in Sheffield, 
with some describing the service and care received as excellent, compared to other towns.   
‘…the hospice Macmillan Nurse,…everybody is so helpful there, absolutely 
marvellous, no complaints with anyone, even the food was good…so I'm very grateful, 
fantastic service in Sheffield, It really is because I know other towns aren’t so good’ 
[Patient ma047, p73,74]. 
In contrast, some patients in this group made some negative comments about their National 
Health Service (NHS) experience, making reference to a lack of empathy in hospitals, and 
expressing concerns over a deteriorating NHS system.  
‘…I think this would have all been very, very much more difficult for me,…when you 
go to the hospital however good they are, you are just a person with cancer, you are 
not a person per se…’ [Patient ma015, p40]. 
‘…I would say it’s a reflection on how the NHS is currently working (laughing), it’s 
just rubbish at the moment,…there is nobody at all who has a grasp of you as a 
person, and I think that's an increasing problem, I don’t think its necessarily me,        
I think...the system is deteriorating’ [Patient bm033, p20].  
Several patients commented on the lack of out of hours, evening and weekend availability of 
services and were unsure about who to contact at evenings and at the weekend.  
‘…If anything goes wrong it's evening and weekend, and then you sort of left with who 
can talk?, who do I ring up?,…who do I get in touch with at evening and weekend?…’ 
[Patient ma012, p30]. 
One patient was unsure about how someone would get hold of a Macmillan Nurse and also 
commented on the lack of general information for the public about the availability of services 
in hospitals.   
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‘…until you are poorly like this you don’t realise anything that's out there,…or who 
can help you or anything,… we were at the hospital and then my daughters talked and 
said, how do you get a Macmillan Nurse,…so we wouldn’t know which phone 
number…’ [Patient ma014, p35].  
6.8.8 Supplementaryquestiononpatientsexperienceofcompletingthe
SPARCquestionnaire
As part of the follow up procedure, all patients were asked to complete a supplementary 
question on their experience of completing the SPARC questionnaire; ‘Please tell us about 
your experience of completing the SPARC questionnaire’. Patients in both groups completed 
this supplementary question 4 weeks, after receiving the SPARC intervention (for patients in 
Group A; intervention arm, this was at Week 4, and for patients in Group B; control arm, this 
was at Week 6). Patients of all ages responded. The age range of respondents to this question 
was 34-87 years old, thirty of the seventy-one respondents were male and forty-one female. 
Sixty-three respondents had a cancer/malignant diagnosis, seven with other non-cancer 
diagnosis, and in one patient the diagnosis was unknown. Thirty-three respondents were in 
the intervention arm, and thirty-eight respondents were in the control arm of the study 
(Ahmed et al., 2015). The question generated a variety of responses, some relating to SPARC 
and some general comments. A thematic content analysis was undertaken (summative content 
analysis) (Ahmed et al., 2015; Graneheim & Lundman, 2004; Hsieh & Shannon, 2005).  
Several ‘prominent themes’ were identified, and illustrative quotations are presented under 
the relevant themes, both negative and positive feedback on the use of SPARC in this trial is 
presented in Table 32.  
Overall most respondents [53/71] considered SPARC to be acceptable, easy to complete and 
understand, relevant and useful tool for the holistic assessment of supportive and palliative 
care needs. Several patients [9/71] reported some negative feedback, or did not find 
completing SPARC useful or beneficial. 
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Table 32: Supplementary question on patients’ experience of completing SPARC questionnaire
Theme Illustrative Quotation 
Explicit, easy to understand and complete, 
fairly straightforward or very clear and 
straightforward  [6/71]
‘Have found questionnaire explicit and easy to complete’ (bm009, 
Intervention) 
‘I found the questionnaire easy to understand and complete. Very clear 
and straightforward. Generally my situation has not altered much but 
there has been an improvement in my mood’  (ma095, Intervention)  
No problem or no trouble completing the 
SPARC questionnaire [4/71] 
One patient commenting on how basic the 
questions were and was expecting more in-depth 
questions  
‘No problems at all although the questions seemed very basic. I was 
expecting more in-depth details to be requested’ (ma100, Intervention)  
Someone was interested in problems, issues or 
concerns, and felt like being listened to [3/71]
‘Made me feel appreciative that someone was interested in how I was 
feeling/coping. It also gave me a kick to try and fight back against my 
illness’ (bm001, Intervention) 
‘Although things at the moment remain 'the same'. In some ways I do feel 
that the current 'problems' are being listened to. Whether anything can be 
gained from this only time will tell’ (ma057, Control) 
Brings home reality of illness, and brings 
issues to the fore to address realities of coping, 
accepted what the future holds [4/71]   
‘It has made me aware that my health has to come first. Not feeling great 
keeps you feeling low. Slowly but surely things will get better and your 
questionnaire has helped bring the issues to the fore’ (ma108, Control)
‘Completing may have helped me understand what has happened to me. 
Writing things down makes things more real. I am just hoping that 
treatment has worked and that I can get to get on with life as I was before. 
I am not very good at explaining myself so I hope this will be alright’  
(ma092, Intervention) 
‘I have found it satisfying that such a study is taking place. I have tried to 
be accurate in my answers. I have been very happy with the palliative care 
I have been given and have with the help of….accepted the future I face’ 
(ma102, Control) 
Good diary of condition, state of current 
health, or a useful MOT [4/71]  
‘A useful MOT’ (bm014, Intervention)  
‘The questionnaire is a good diary of my condition. Unfortunately, this 
condition has deteriorated since the start of it’ (ma071, Intervention)   
Helpful in allowing to focus and reflect on 
issues [7/71]
‘It was a useful way at looking at my situation and, as such, somewhat 
depressing’ (bm033, Control)
‘I found completing the SPARC questionnaire quite useful in that it made 
me think more deeply about my personal condition and how it would/is 
affecting my family’ (bm046, Control) 
‘Some of the questions made me think of before all my problems began. 
Mainly trying to remember what it was like to be 'normal', not in pain    
24-7’ (ma060, Control)  
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Useful actions resulted from completing 
SPARC: helped patient communicate with 
doctor, prompted patient to visit their GP, enquire 
about palliative care services, realise the 
importance of family and religion, adopt a 
healthy lifestyle and to think more positively 
[6/71]  
‘Helped me to communicate with Dr about pain and medication and to 
accept physical limitations due to illness. Treatment has been excellent. 
Thank you’ (bm032, Control)   
‘The questionnaire was easy enough to complete but it made me realise I 
ought to visit my GP. She is sending me for tests’ (ma062, Intervention) 
 ‘Completing the questionnaire has made me think more about my illness 
and find out more about palliative care and any complementary therapy 
that may help. My way of dealing with my illness was to try and ignore it 
and not talk about it’ (ma012, Control)  
‘It has made me more aware of how much my family and my religion mean 
to me. How patient and understanding my palliative care doctors are. And 
how important it is for me to work harder in looking after my own health 
by trying to exercise more and eat more healthy’ (ma067, Control)  
‘My experience in completing the questionnaire is to look at myself 
generally, both physically and mentally, realise my condition generally 
and make a more determined effort, to be if possible to maintain a more 
positive attitude and avoid thinking negatively’ ( ma005, Control) 
Negative aspects relating to SPARC 
completion: Opened up certain issues, problems, 
or concerns best left, better to block out/didn’t 
want to talk about, increased awareness of issues, 
problems or concerns and how awful life is, 
initiated a physical/emotional response, 
highlighted patients limited control over illness or 
disease progression and a comment on SPARC 
box categories [9/71]  
‘Completing the questionnaire made me think more about my health and 
mental state as usually I find it better to block it all out otherwise I get 
depressed and I can't talk about my health or illness to anyone. I just tell 
everyone I'm ok. So people don't go on about it. It’s easy for people who 
have not had cancer to talk about it, wait till it gets them, then they play a 
different tune on the fiddle’ (ma061, Control)  
‘My wife has completed the form indicating my views/feelings etc. 
otherwise I would not have bothered. it has however opened up certain 
issues best left’ (ma075, Intervention) 
‘The questionnaire in some ways made me feel worse because putting the 
problems down in writing makes them look more real, but also shows one 
that over time they can bother you a bit less just by the passage of time. 
I've had no treatment during this study but some issues, like anxiety and 
guilt, they're still there but less all 'consuming' (bm002, Control)  
‘Completing the SPARC questionnaire made me even more aware of how 
awful my life is at the moment due to my health’ (bm001, Intervention)
Felt like writing about someone else: someone 
they didn’t know [2/71]  
‘I have found it hard completing this questionnaire. It’s as though I’m 
writing about someone else’ (ma013, Intervention) 
‘Writing down how I feel about problems seemed to me someone I don't 
know, helped me get my feelings out into open. Thank you for this chance 
to voice my feelings. My family and husband are fantastic, but can all do 
without my worries, especially my husband. This week he was diagnosed 
with angina. He hasn't got to have any more stress’ (ma084, Control)  
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General/other comments 
Theme Illustrative Quotation 
Study-timeframe: too short of a time frame to 
detect a difference [2/71] 
Study questions (SPARC and other study 
questionnaires) were either too close together 
with appointments less frequent than the 
questionnaire, not seen anyone from the palliative 
care team, study duration simply too short of a 
timeframe to detect any change or difference in 
health status or quality of life  
‘Too short of time to let you know about the difference in the change of 
medication’ (bm038, Intervention)  
‘But I do think that they were too close together as appointments were less 
frequent than the questionnaire. The problems still exist and I am making 
a slow recovery’ (ma065, Control)  
Not seen anyone from palliative care team 
[2/71]  
‘I don’t mind helping out if it has some benefits. I don’t mind telling you 
how I feel but some of the questions seem a bit odd, especially when it’s so 
long since I’ve seen anyone from the Palliative Care Team. Keep sending 
'em though' cos I really don't mind helping out’ (ma064, Intervention) 
Timing of questionnaires: Problems, concerns, 
and issues change over time: the need to 
capture these changes [3/71]
‘Some worries can vary during the day e.g. pain is worse at night and 
evening and less in the day time. Limitation of function is there all the 
time but reduced further by pain. Therefore, answers may vary according 
to the time of day or night!’ (ma091, Intervention) 
‘Did not realise that the first 2 issues would continue in this survey. 
Things change-issues/concerns come and go. I have suggested before that 
concerns change over time, but you do not change your questionnaire. 
Your research might be better if you took changes into account’ (ma099,
Intervention)
Confused as to how this will help/not relevant 
or of any benefit/can’t remember [5/71] 
Expressed confusion as to how their 
participation will help, one patient didn’t feel 
SPARC was of any particular benefit to them at 
that particular moment in time, and one patient 
didn’t remember much of the SPARC 
questionnaire   
‘Didn't mind completing the questionnaires but I'm puzzled as to how this 
can help’ ( ma124, Control) 
‘I’m dying of cancer, am virtually blind and very deaf. I don’t see where I 
fit in with your questionnaire’ (bm017, Intervention)    
‘I don’t feel that it is of particular benefit to me. As at the moment I am 
quite well. My only concern being that I am unable to see how things are 
progressing’ (ma082, Intervention)   
‘Can’t remember much of SPARC questionnaire. However, I feel about 
the same as a few months ago’ (bm006, Intervention) 
Participated in study to help research and 
other people, or others in the future in a 
similar situation [9/71]
Hope participation would help research and other 
people, or others in the future in a similar 
situation 
‘I just hope by completing these questionnaires it will help others in the 
future’ (ma070, Control) 
‘I am very pleased to help you in your study. If it helps other people to get 
more support in the beginning’ (ma118, Intervention) 
‘If completing these questionnaires has helped some way to understanding 
patients’ needs and understanding of living with cancer then I am happy 
to have taken part’ (ma074, Control)  
Physical symptoms are often well catered for, 
but not the psychological symptoms [1/71]
‘I am finding that physical symptoms are well catered for, care, pain relief 
etc. but little exists for the psychological effects. Support groups are in 
place, but they are a two edged word’ (ma022, Intervention)    
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6.9 Summaryanddiscussion
This qualitative study concerning the views of patients about their experiences of completing 
SPARC was conducted within the context of a pragmatic randomised controlled trial and 
nested within the MRC framework for developing and evaluating complex interventions, it 
may help in the interpretation of the trial outcome results (EAPC abstract, 2015). Eliciting the 
views of patients represents an important phase in the development of SPARC (Hughes et al., 
2015).   
Seven prominent themes emerged from the patient interviews. Most patients interviewed 
[30/33], found SPARC either quite easy to complete, fairly straightforward, simple or had no 
problems in completing it. Only a small number of participants found questions on SPARC 
‘too sensitive or upsetting’. A crucial finding in the context of the trial was that almost all of 
the patients interviewed [30/33] did not experience or report any noticeable change, or 
beneficial effects after completing SPARC (EAPC abstract, 2015).   
Overall, most participants found SPARC quite easy to complete, simple, and fairly 
straightforward and most participants did not have problems completing it. In fact it was 
considered to be more straightforward than some participants had originally anticipated. That 
said, some participants found it difficult and emotionally challenging, because it made them 
focus on things that were problematic in their lives. This could be due to the fact that 
participants were recruited from a wide range of settings, patients seen by the supportive and 
palliative care service are a very varied group and are at various stages of illness, they include 
those with long-term conditions and cancer survivors as well as those needing end of life 
care, as a result some of these patients may still be coming to terms with the illness, losing 
their independence or already frightened about what will happen to them. Hence, the process 
and the prospect of completing SPARC for these patients can be quite daunting. Participants 
felt consoled that they had the option of not completing or finishing SPARC on the off 
chance that it turned out to be excessively disquieting or troubling, making it impossible to 
finish. 
Overall most patients also regarded the questions on SPARC to be either suitable, 
appropriate, or relevant and applicable, and the questions seemed to mention anything 
anybody might be feeling, thus providing a good all round picture of the patients current state 
of health and well-being. For some patients, again as one would expect in this type of service, 
that deals with a varied group of patients, the SPARC questionnaire or questions on it were 
either not relevant, not applicable, or becoming less relevant. This does raise important 
questions about who should receive SPARC, and more importantly when patients should be 
asked to complete it. The supplementary question on SPARC, endorsed the overall view that 
the questions were clear, well written, easy to understand and complete, and appropriate and 
relevant.  
158 
It is inevitable, as we found in this study that holistic needs assessment questionnaires of this 
nature, will ask questions about religious and spiritual issues, worrying thoughts about death 
and dying, and other questions related to psychological issues, which are regarded by some 
patients as sensitive, inappropriate or too personal. Some participants said they were reluctant 
to talk about some of these issues, because they felt that patients are always thinking about 
these issues anyway, but try to remain positive, others valued these questions as they 
provided them with an opportunity to talk about them with their health care professionals. 
Some strategies presented by some participants for dealing with these thoughts included 
having good moral support from family and friends and other people around them, being 
religious, keeping busy and generally thinking positive about what the future holds. It was 
however, reassuring to hear that overall most patients didn’t really find SPARC too personal 
or sensitive in comparison with other questionnaires that they had completed. The consensus 
view appears to be that questions of this nature should be included in questionnaires despite 
their sensitive and personal nature.  
It is also important to take note of the way that somebody has scored something on SPARC 
as distressing or bothering them. A low score on any item or question doesn't necessarily 
imply that they don't have that issue, problem or concern. It might imply that they are content 
with it or not bothered by it, so for this reason it is vital to cross check this information during 
a clinical consultation.  
I have presented the reasons why most participants interviewed as part of the main trial felt 
that nothing had changed or no action had been taken as a result of completing SPARC; 
patients did not experience any noticeable, beneficial effects after completing SPARC and 
this is a critical finding in the context of the trial. What is concerning here is that some 
patients felt that health care professionals did not appear to be doing anything, or if they 
were, then the patient wasn’t aware of it, because some of the problems hadn’t been sorted or 
patients still had those same problems. None of the thirty-three patients felt that anything had 
changed in relation to changes in intervention, treatment or care they received following 
completion of SPARC, and a retrospective review of the case notes (Chapter 4), appears to 
support these findings (i.e. only 5/164=3.0% patient notes made any direct reference to 
SPARC, and 43/182; 23.6% patients had no progress notes for the entire duration of the 
study).   
The information derived from both the patient interviews and the case note reviews seem to 
suggest that a large proportion of patients were not seen by a palliative care health 
professional, not heard from anyone, or did not have a follow-up appointment throughout the 
duration of the study. Many of these patients were scoring high (i.e. high levels of distress) 
on many of the items on SPARC. The precise reasons, as to why this may be the case requires 
attention, and further investigation.   
There is an urgent need to review how often and when patients are followed-up by reviewing 
the follow-up period. Participants described how they were having the same conversations 
each time with their health care professionals, and that nothing more could be done because 
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they had tried virtually everything, sometimes this was detrimental to their health, resulting in 
some participants being discharged. Others reported that improvements had either plateaued, 
the problems were untreatable or treatment was not available, they got to a dead end or were 
going round in circles.  
While some patients said that they had learned to live with the illness, accepted or adapted to 
the illness due to long standing issues, patient perceptions from the sample of participants 
interviewed is a true reflection of their clinical situation. The information derived from 
patient interviews was verified and cross checked with clinical information from a note 
review of the whole patient sample, and we can conclude with some degree of confidence 
that the findings are generalisable to the whole study sample.    
There is a strong case here of the need for more adequate assessment of patients’ holistic 
needs in a timely manner, not only when a patient enters the service, but also at regular 
intervals, at different stages of the illness or treatment and at the point of discharge. What is 
of great concern, is that some participants were being discharged from the service and placed 
on an ‘open appointment system’, many of these patients reported high levels of distress in 
many areas, but failed to contact their health care professionals, and the health care 
professionals failed to re-engage with these patients. Others said that they did not feel 
neglected, and felt reassured that help would be available if things deteriorated.  
Some patients viewed this as a research study and therefore didn’t expect to see any 
improvements in their health and well-being, but rather saw this as an opportunity to help the 
research study and others in the future. However these patients felt that this was a really good 
idea/concept, provided it does get followed up, and others felt that the study period (6 weeks) 
was simply too short to notice any changes in improvement. Only a small number of patients 
that scored high on some of the SPARC items were contacted and recalled by the service and 
reassessed.  
For the small number of patients where completion of SPARC resulted in either referrals 
being made or consultations being undertaken in the form of a follow-up call, these took 
place after the study duration period, so one would not expect to see any changes in health 
outcomes during the first six weeks of the study. These are very important considerations that 
one must consider when designing any future study of the clinical utility of SPARC.  
The Sheffield Palliative Care service is well established in Sheffield, and it was reassuring to 
hear about the high levels of patient satisfaction with services or care patients received, 
particularly at the hospice. Further work must focus attention on improving out of hours 
access i.e. improving evening and weekend availability of services, and on improving 
information and communication issues.     
In summary the results of this study, and our earlier work (Hughes et al., 2015), indicate that 
SPARC is a suitable, relevant, applicable, comprehensive and useful tool for the holistic 
assessment of supportive and palliative care needs, with the potential to improve health 
professionals’ understanding of patients’ needs (Hughes et al., 2015). Participants’ reports of 
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a failure to act on identified needs, in other words the raising of patients’ expectations that are 
not subsequently met, would lend support to the conclusion that holistic needs assessment 
may be counterproductive if not integrated with a clinical assessment that informs the care 
plan (Ahmed et al., 2015). This qualitative study helps in the interpretation of the trial 
outcome results and provides useful insights into how SPARC might be used in practice 
(EAPC abstract, 2015).  
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Chapter7
Aqualitativestudytoelicittheviewsofsupportiveandpalliative7
carehealthcareprofessionalsabouttheuseofSPARC
7.1 Abstract
Background
This is a qualitative study embedded in a randomised controlled trial, to elicit the views of 
supportive and palliative care health care professionals about their experiences of using 
SPARC during the trial, to help in the interpretation of the trial result (EAPC abstract, 2015).  
Methods
As part of a process evaluation, semi-structured interviews were undertaken during a 
randomised controlled trial with supportive and palliative care health care professionals 
[n=20]. All participants were interviewed after they had some experience of using SPARC. 
The interview schedule was designed to provide a description of health care professionals’ 
views about their experience of using the SPARC questionnaire during the trial. Interviews 
were digitally recorded and transcribed verbatim and analysed using the framework analysis 
approach (Burnard, 1991; EAPC abstract, 2015; Ritchie & Spencer, 1994; Smith & Firth, 
2011; Ward et al., 2013).  
Results  
Ten prominent themes emerged from the health care professional interviews, themes were 
largely determined by topics of predetermined interest and guided by the interview schedule. 
These provided useful insights into why the intervention (SPARC) did not work and 
highlighted potential areas for improvement. Prominent themes were identified as: Theme 1: 
Holistic assessment of patients’ needs (methods and tools used); Theme 2: Awareness and 
previous experience of using SPARC; Theme 3: Patient feedback on SPARC; Theme 4: 
Impact of completing SPARC on clinical practice; Theme 5: Usefulness of completing 
SPARC; Theme 6: Sensitive, inappropriate or personal questions; Theme 7: Barriers to the 
relief of distress; Theme 8: Timing of administering SPARC; Theme 9: Education, training 
and skills issues around the use of SPARC; Theme 10: Future utilisation of SPARC. Most 
health care professionals had something positive to say about SPARC and had previous 
experience of using SPARC, and most professionals were considering using SPARC at some 
point in the future. A number of barriers were identified to the relief of distress highlighted 
by SPARC. Lack of professional action and the numerous barriers identified following high 
level scoring of SPARC has revealed useful insights into how SPARC might be used in 
practice (EAPC abstract, 2015).  
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Conclusions 
Overall, supportive and palliative care health care professionals considered SPARC to be an 
acceptable and relevant tool for the clinical assessment of supportive and palliative care 
needs (EAPC abstract, 2015). However, the intervention was not sufficiently integrated 
within existing holistic needs assessment practice to impact on health care professionals’ 
perceptions of their patients’ needs, and therefore would not in itself prompt action. The 
effective integration of SPARC into routine care and standard operating systems requires 
further investigation. 
7.2 Introduction
In this Chapter, I will present the findings from semi-structured interviews that I conducted 
with supportive and palliative care health care professionals. This is component two of the 
process evaluation, and follows on from the semi-structured interviews that I conducted with 
a subgroup of trial participants (patients) in Chapter 6.  
Chapter 7 explores the views of supportive and palliative care health care professionals 
(n=20) about the use SPARC during the trial, and is a qualitative study embedded in an RCT. 
This component, as with component one (patients’ semi-structured interviews) is a further 
important aspect of the development of the tool (Hughes et al., 2015), and provides useful 
insights on the implementation, receipt and setting of the SPARC intervention, that would 
help in the interpretation of the outcome results (Oakley et al., 2006). To my knowledge, this 
is the first study of its kind to elicit the views of supportive and palliative care health care 
professionals about the use of SPARC since development of the tool (Hughes et al., 2015).   
7.3 Methods
Study design 
Semi-structured interviews were undertaken to elicit the views of supportive and palliative 
care health care professionals (n=20) concerning the use SPARC during the trial. 
I developed the interview schedule (see Appendix 30), with the help of other members of the 
research team; including experienced qualitative researchers; a palliative medicine 
consultant; and two consumers. The interview schedule was piloted with one health care 
professional.   
7.3.1 Healthcareprofessionalrecruitmentanddemographics
A purposive sample of health care professionals was selected for interviews because they 
were working in the supportive or palliative care service, and were caring for the patients that 
had participated in this study. The purpose of the semi-structured interview was for health 
care professionals to talk about their experience of using SPARC, and to give the research 
team a better understanding of the current methods of assessing patients’ holistic needs in a 
supportive and palliative care service. 
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Health care professionals were interviewed at the end of the study (i.e. 8 weeks after baseline 
questionnaires were received), and only after they had some experience of working with 
SPARC. Health care professionals received an invitation pack consisting of the following: 
invitation letter (Appendix 31); information sheet (Appendix 32); an opt-in form (Appendix 
33) inviting them to take part in the study; a consent form (Appendix 34); and a freepost 
envelope. Those health care professionals expressing an interest in taking part in the 
interview completed the opt-in form with their contact details and suggested a suitable time to 
contact them. All completed consent forms were returned to the research team in the freepost 
envelope. I then contacted the health care professional who had expressed an interest in 
taking part in the interview by telephone to arrange a suitable date, time and location for the 
interview that was convenient to the health care professional.  
I ensured that the consent form was completed when I went out to interview; for those health 
care professionals that had not returned the signed consent form in the freepost envelope. All 
interviews were audio-recorded with permission of the participants and field notes were kept. 
Health care professionals were given the option to have their interview either face-face or 
over the telephone, however all agreed to have face-face interviews. The characteristics of 
participants (HCPs) and their interviews are presented below.  
7.3.2 Settingandsample
Characteristics of health care professionals and their interviews [n=20]  
A total of 20 supportive and palliative care health care professionals, working in the service 
that hosted the study, were invited to take part in semi-structured interviews and all 20 agreed 
to participate. Purposive sampling technique ensured that I interviewed Clinicians 
(Consultants in Palliative Medicine), Clinical Specialist Palliative Care Nurses, Macmillan 
Palliative Care Nurses, Specialist Registrars, Lead Nurse and a Senior Sister. This group 
comprised mostly of females [15/20], with fewer males [5/20]. Of the 20 health care 
professionals interviewed, eleven were Clinical Specialist Palliative Care Nurses [nine from 
hospice, and two from Sheffield Teaching Hospitals, STH]; one lead nurse [hospice]; one 
senior sister [therapies and rehabilitation at hospice]; two Macmillan Palliative Care Nurses 
[hospital support team]; four consultants in Palliative Medicine [two from hospice, and two 
from STH]; and one Specialist Registrar in Palliative Medicine [STH].  
Nineteen participants were part of the original main trial, and one participant was already 
using SPARC, and wasn’t included in the main trial but included in this part of the study for 
comparative purposes. I undertook all twenty interviews. Interviews took place between 
7/12/2011 and 21/2/2012, and were conducted in locations that were convenient to the health 
care professionals. The mean interview duration was 13.75 minutes (range 7.59 minutes-
26.14 minutes). Most of the interviews were undertaken at the offices of the research team 
[Sykes House/Centre] and only a few were undertaken at the health care professionals’ 
workplace/office. Response saturation was achieved with the interview of 20 health care 
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professionals. There were no drop-outs or withdrawals. The characteristics of participants 
(HCPs) and their interviews are summarised in Table 33.
Table 33: Characteristics of health care professionals and their interviews [n=20]
Health care 
professional  
ID Number 
Gender Health care professional occupation  Length of 
interview 
(minutes) 
 HCP 1 F Clinical Specialist Palliative Care Nurse  12.20 
 HCP 2 F Lead Nurse  11.41 
 HCP 3 F Clinical Specialist Palliative Care Nurse  26.14  
 HCP 4 F Clinical Specialist Palliative Care Nurse  20.04  
 HCP 5 F Clinical Specialist Palliative Care Nurse  9.33  
 HCP 6 F Clinical Specialist Palliative Care Nurse  16.20  
 HCP 7 F Clinical Specialist Palliative Care Nurse  15.14  
 HCP 8 F Clinical Specialist Palliative Care Nurse  10.32  
 HCP 9 F Clinical Specialist Palliative Care Nurse  19.27  
 HCP 10 F Clinical Specialist Palliative Care Nurse  11.29  
 HCP 11 M Macmillan Nurse Part of Hospital Support Team  19.45  
 HCP 12 M Consultant in Palliative Medicine  14.01  
 HCP 13 F Macmillan Palliative Care Nurse  11.26  
 HCP 14 F Clinical Specialist Palliative Care Nurse  7.59 
 HCP 15 M Consultant in Palliative Medicine  13.35  
 HCP 16 F Clinical Specialist Palliative Care Nurse  12.09  
 HCP 17 M Specialist Registrar in Palliative Medicine  15.37  
 HCP 18 F Senior Sister, Therapies and Rehabilitation Centre 12.46  
 HCP 19 F Consultant in Palliative Medicine 17.26  
 HCP 20 M Consultant in Palliative Medicine and Professor  13.09  
7.4 Dataanalysis(theframeworkapproach)
Interview data was examined qualitatively using a Framework Analysis approach (Ritchie & 
Spencer, 1994). A full description of the Framework approach is presented in Chapter 6.   
The interview schedule (Appendix 30) was designed to provide a description of supportive 
and palliative care health care professionals’ views about the use of SPARC during the trial, 
in particular; the current method of assessing patients’/families’ holistic needs; awareness and 
previous experience of using SPARC; whether anything changed because of patients filling in 
the SPARC questionnaire; and whether or not they felt this resulted in any actions being 
taken; as well as any other comments they had about SPARC or in general.  
Interviews were digitally recorded and transcribed verbatim and analysed using the 
Framework analysis approach (EAPC abstract, 2015). Field notes were also kept. Twenty 
health care professional interviews were undertaken. An example of a coded verbatim health 
care professional interview transcript is presented in Appendix 35, the coding framework 
(theme headings, sub-headings and code numbers) is presented in Table 34, and an example 
of a health care professional thematic chart with illustrative quotations is presented in 
Appendix 36.
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The familiarisation phase and the initial thematic analysis, development of themes and sub-
themes was conducted by myself, and then examined by another experienced qualitative 
researcher (KC). I listened to each health care professional interview audio-recording, 
checking for any errors in the verbatim transcript, listening to an interview audio recording 
also facilitated the analysis.  
In order to minimise any bias, and improve the reliability of the analysis, 20% (4 out of 20) of 
the health care professional interview transcripts were independently coded and charted by 
two experienced qualitative researchers (one clinical and one non-clinical). Subsequent 
detailed discussions of the analysis optimised consistency and agreement within 
interpretation and the development of themes, as an on-going process throughout the data 
analysis.  
7.5 Emergenceoftenprominentthemes
Initially the coding framework (Table 34) identified five main themes and fourteen 
subthemes that were determined by topics of predetermined interest. These included the 
following: current method of assessing patients’/families’ holistic needs; awareness and 
previous experience of using SPARC; whether anything changed/any actions taken as a result 
of completing SPARC; usefulness of completing SPARC; and other comments.  
However, upon closer examination these themes and subthemes were collapsed into ten 
prominent themes, which provided useful insights into why the intervention; SPARC did not 
work and highlighted other potential areas for improvement.  
Prominent themes are presented below.  
Theme 1: Holistic assessment of patients’ needs (methods and tools used);
Theme 2: Awareness and previous experience of using SPARC;  
Theme 3: Patient feedback on SPARC;  
Theme 4: Impact of completing SPARC on clinical practice;  
Theme 5: Usefulness of completing SPARC;
Theme 6: Sensitive, inappropriate or personal questions;
Theme 7: Barriers to the relief of distress;
Theme 8: Timing of administering SPARC;
Theme 9: Education, training and skills issues around the use of SPARC;
Theme 10: Future utilisation of SPARC. 
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Table 34: Coding framework (HCP interviews): Theme headings, sub headings and code numbers 
HCP ID  
CURRENT METHOD 
OF ASSESSING 
PATIENTS/FAMILIES 
HOLISTIC NEEDS 
1) 
Description of current method of assessing patients’/families’ holistic needs  
A description of the current method of assessing patients’/families’ holistic needs
2) 
Tools used  
Any tools used when assessing patients’ needs? (value/usefulness, benefits/ barriers)
AWARENESS AND 
PREVIOUS 
EXPERIENCE OF 
USING SPARC 
3) 
Awareness  
Awareness of what SPARC questionnaire is used for 
(before, during or after the study?, any expectations?)
4) 
Previous experience of using SPARC 
Do you have any previous experience of using SPARC?
5) 
How SPARC results are fedback or discussed with 
patients 
How SPARC results are fedback or discussed with patients 
(by telephone, letter, face to face), what feedback have they 
had?
HAS ANYTHING 
CHANGED/ANY 
ACTIONS TAKEN AS 
A RESULT OF 
COMPLETING SPARC 
6) 
Yes: Actions (or considering taking action): referrals/consultations/interventions   
Did completing SPARC result in any actions taken (for the better/for the worse): resulting 
in referrals being made/consultations, intervention/s, treatment/care, being undertaken?
7) 
No: Nothing changed/no action 
Completing SPARC resulted in no changes in actions taken for the better/for the worse 
(possible reasons). Nothing new/no surprises. 
USEFULNESS OF 
COMPLETING SPARC  
8) 
Helpful for patients to have completed SPARC 
Reasons why completing SPARC was or could be useful: 
helpful/worthwhile completing/good idea. 
9)  
Unhelpful/not worthwhile for patients to have completed 
SPARC 
Reasons why completing SPARC was or could not be 
useful: unhelpful/not worthwhile completing/not so good 
idea.
10)  
Inappropriate/ too personal/ 
sensitive/invasive/offensive/upsetting/bothering? 
Any questions considered to be 
inappropriate/sensitive/upsetting/personal?
OTHER COMMENTS  11) 
Barriers to the relief of distress 
highlighted by SPARC 
Were there any barriers to the relief of 
distress highlighted by SPARC? 
12) 
Timing of SPARC/who should get it  
Timing of SPARC: when, where, how 
often, and who should receive it?, follow 
up? 
13) 
Education, training and skills issues 
around the use of SPARC  
General comments about education and 
training and skills issues around the use of 
SPARC?  
14) 
Do you plan to use SPARC in the future? 
Do you think using SPARC will help you in 
your work, and do you plan to use it in the 
future? 
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7.6 Findings
7.6.1 Theme1:Holisticassessmentofpatientsneeds(methodsandtools
used)
All health care professionals provided some form of description about their current method of 
assessment. Analysis of the descriptions of the current method of assessing patients’ needs 
revealed some similarities, particularly amongst the staff working at the hospice.  
There appears to be no definitive method, or any particular model or tool used for doing a 
holistic needs assessment.  
‘The current methods that I use for assessing patients holistically is not a definitive, 
it's not a particular model as such. It's a tool that we’ve used as specialist palliative 
care nurses, so it covers every aspect of the patient. So it tends to be an assessment 
…for looking at diagnosis and physical needs, psychological elements, and social 
circumstances’ [Health care professional 9, p38].  
Most participants interviewed [13/20], mostly the hospice staff said that they were using the 
holistic needs assessment format developed by senior members of the team (hospice 
document, covers all systems).  
‘When I first started in the team, I was shown…a brief outline of all the things that you 
needed to cover when assessing patients…and used that as guide really. It was put 
together by…senior members in the team…and…you make sure when you go to see a 
patient that you cover all aspects of what’s there, physical, psychological, social, 
spiritual…just a holistic needs assessment’ [Health care professional 5, p22].  
Health care professionals described the assessment as ‘fairly structured’, with some degree of 
structure (but not entirely structured).  
‘…But it's as I say it's something that isn’t done in a very structured way…you go to see 
the patients introduce yourself. I normally just ask how they have ended up coming into 
hospital, and then the conversation takes off from there and whatever the patient 
focuses on…’ [Health care professional 16, p67]. 
Several health care professionals within this group talked about how the interviews would start 
off with introductions and roles being explained as well as obtaining patient consent in order to 
do the assessment and for sharing of information, which was followed by a general question 
about the impact of the illness on the patient.  
 ‘Well I start off by saying you have been referred to me…tell them who I was and why I 
was going to be coming, what my role is.……and then say would they tell me a little bit 
about what’s happened to them and…why we are where we are now, and then 
sometimes they go right back to the beginning of diagnosis. And that’s a good way of, 
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cos I often say to them you know I've got some medical information about you but that 
doesn’t tell me about how it's impacting on your, how you are feeling?’ [Health care 
professional 3, p9].  
Participants said that the assessment process often involved undertaking a routine clinical or 
medical interview (referring to the assessments undertaken in outpatient clinics, and on the 
wards). The use of informal interviews with the patient in a conversational style using open 
questions as well as closed questions appears to be the preferred method of assessing 
patients’ and families’ needs.  
‘I suppose my assessment style has been for a long time, has been a conversation style 
which is course is all the latest guidance anyway, we shouldn’t be just going for a 
proforma…as a student nurse I remember you just sort of went through the tick box list 
really. But rather because your assessment is not just … finding out information but is 
also getting to know the person. It's the support that we are giving people so you want 
that to be a conversational style and supportive style as well’ [Health care professional 
11, p47].  
‘It is primarily through informal interviews with the patient, through open questions 
as well as closed questions about the patients’, psychosocial background and other 
needs, physical aspects, family backgrounds, financial issues, any other psychosocial 
concerns with the family as well as with the patient’ [Health care professional 17, 
p71].  
The use of more structured interviews with an examination (medical clerking) appears to be 
the common approach used for assessing patients on the wards.  
  ‘…Apart from well of course the…medical clerking which we designed for palliative 
 care, is really also a category of holistic assessment as well, and I would do that if I'm 
 filling in for the juniors when I assess a patient on the ward, and that's a more 
 structured interview with…examination in it’ [Health care professional 15, p63]. 
Most health care professionals said that they took a very systematic approach to assessing 
patients’ needs and described the assessment process as having a professional agenda as a 
structure, but one which was mainly patient-led and patient focussed. Health care professionals 
said that during their assessment they would prioritise what was important to the patient. Most 
health care professionals within this group described the assessment process as being holistic, 
and having a whole person focus. Referral forms or discharge summaries from the wards were 
often used to initiate further discussions. 
‘My current way of assessing somebody would be to take a very systematic approach, to 
assessing their physical needs, psychological needs, social and spiritual needs, and with 
physical needs I think there’s always a tendency for that to dominate … but I would take 
a very systematic approach sort of to the systems. So although it’s kind of a professional 
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agenda as a structure, I would only focus on the things that the patient identified as 
being problematic’ [Health care professional 2, p5]. 
Health care professionals said that the ‘full holistic needs assessment’ was undertaken mainly 
on the first contact or appointment with the patient, and patients were reviewed during    
follow- up appointments.   
‘…Well when I first get a referral, when I first meet a patient for the first time I do a full 
holistic needs assessment, and then at each follow-up appointment I will go over certain 
areas. I probably won’t cover every single area every time I see the patient, so the main 
holistic assessment is done on the first contact’ [Health care professional 13, p56].  
Several health care professionals stated that many patients were too ill to do a complete holistic 
needs assessment, therefore sometimes much of the work they do is with the family rather than 
the patient, but in some instances families do not wish to be contacted by the health care 
professionals.    
‘…A lot of the patients we see, we can’t complete a holistic assessment because they are 
too unwell, and although we do try to make contact with families, some families don’t 
want to be contacted directly by us, or don’t want to meet with us…so in some 
circumstances we don’t meet the family, in other circumstances a lot of the work we do 
is more with the family than with the patient them-self’ [Health care professional 14, 
p60].  
The responses varied about the types of tools used when assessing patients’ needs. Most 
health care professionals [13/20], particularly at the hospice were using an aide-mémoire/ 
model/template developed by the team (hospice staff), that was developed from the holistic 
needs assessment document, and most were guided by or followed the holistic needs 
assessment [HNA] framework/document produced by Richardson and colleagues 
(Richardson et al, 2007). 
Aide-mémoires
‘I use an aide-mémoire that I’ve taken from the holistic needs assessment document. 
[referring to the holistic needs assessment document developed by Alison Richardson 
and colleagues]…myself and one of my colleagues…hopefully cover all the bases, but   
I usually start off by saying, I suppose a bit like Maguire and Faulkner; can you tell me 
about what’s been going on?, and then let them tell me… story, very open question. Let 
them tell their story and then if something key comes up that I think is an issue, then      
I might stop them there and focus on that and then hopefully go back, so I do have some 
degree of structure, but quite open’ [Health care professional 3, p9].  
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Other tools and methods cited included SPARC, a Proforma, and some HCP’s were guided by 
other nursing models (e.g. Roper Logan Model).  
SPARC
‘The only sort of formal way I have is of using SPARC, if I'm ganna use it, if I'm going 
to do it at all, I would use SPARC. I have to say to be honest I don’t use SPARC for 
every one of my patients, by no means, but if I wanted to do what I would call a 
holistic needs assessment then I have to use SPARC…well I'm aware obviously the 
distress thermometer, concerns checklist, and other variations of those, people have 
used but clearly I would only use SPARC’ [Health care professional 20, p85].  
However, health care professionals expressed some reservations about using SPARC with 
certain types of patients (i.e. with those lacking mental capacity, those with dementia, elderly 
frail patients, and those who are imminently dying).  
‘It depends on their mental capacity, if they have got dementia then it’s totally 
different, you can't work with SPARC,…I will if the patient’s got full mental capacity 
and they are able to talk and they have got the ability to answer the questions…Again 
it will depend on the patients. It literally is depending and if they are elderly frail, 
sometimes it’s too much to ask them, and you actually go in and prioritise what’s 
important at that particular moment in time. And if they are in a nursing home 
sometimes they are imminently dying, so again some of the things aren’t always 
appropriate’ [Health care professional 6, p25].  
Proforma, or guided by other nursing models [e.g. Roper Logan model] 
‘I think this is probably based on many years of different nursing really. I have done 
numerous nursing training and specialist training and each of those you come across 
new ways of assessing, I think my background in nursing focused on a sort of nursing 
process model based on nursing models of alleged holistic assessment, there’s very 
well-known models Roper Logan model, and so all these models that nursing which 
over twenty-six years I've been a nurse have kind of been embedded, so, those are all 
things that give you I suppose a framework to hang your assessment on really’ 
[Health care professional 11, p47].  
Some health care professionals stated that they would use tools or methods that they felt most 
comfortable with using (i.e. no set thing or particular tool used for assessment).  
‘I wouldn’t say that they were sort of you know a set thing but it's kind of what I guess 
I'm comfortable with having done the same…way for a long time’ [Health care 
professional 2, p5].  
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7.6.2 Theme2:AwarenessandpreviousexperienceofusingSPARC
Awareness: Almost all of the health care professionals interviewed [18/20] said that they 
were aware of SPARC before the study. 
‘Yes, although I have had little use of it, I am aware that it is about looking at 
people’s concerns, and then ways of addressing, looking, find ways of addressing 
those concerns’ [Health care professional 14, p60].  
‘…When I first started as a consultant…I attended [health professionals name] clinic 
… I sat in for a few times with him and he was using it at that point with all of his… 
although the way he used it was he would ask an SpR to go and give the patient the 
questionnaire while they were waiting, so just my experience of observing how useful 
that was with [health professionals name], I’ve used it ever since in my clinic but I 
decided I wouldn’t get the patients to fill it out when they came, I would send it out 
with the clinic letter. So I’ve used it since 2006’ [Health care professional 19, p81]. 
Some health care professionals [2/20] said that they were not aware of SPARC before the 
study.  
‘…I wasn’t really aware of it until [Health Professionals name] spoke to us which 
will be quite a long time ago now’ [Health care professional 13, p56].  
There was some variation in health care professionals’ views and expectations on what 
SPARC was used for, these are listed below.  
1) as a holistic needs assessment tool/screening tool; 
2) as a guide for health care professionals/as a trigger/flagging up referrals; 
3) for administering outside the specialty; 
4) to be used during initial assessment, and as a discharge tool; 
5) not used as an outcome measure.  
One health care professional talked about the limitations of using SPARC in relation to the 
difficulties in trying to triangulate the assessment between the patients, their families and 
health care professionals.    
‘…And I guess…that's where I perceive the limitations with it, it’s when I’m trying to 
triangulate the assessment between the patient and the perception of what the issues 
are, their own issues and then the nurses or the professional team’s issue, the 
perception of what the person and all the problems are and their own problems. It's 
kind of…a useful, it would be useful there, but…I think how you triangulate those’ 
[Health care professional 11, p49]. 
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Only one health care professional was unsure about what SPARC was originally developed 
for.  
‘…Although I knew it [referring to SPARC] was a tool, I didn’t actually know what it 
was originally developed for no. I wasn’t aware of that originally’ [Health care 
professional 9, p38]. 
A half of the sample of the respondents interviewed [10/20], said that they had some previous 
experience (sometimes limited) of using SPARC, three health care professionals [3/20] said 
that their colleagues had experience of using SPARC, and only two health care professionals 
[2/20] said that they had no previous experience of using SPARC. Most health care 
professionals went on to describe some of their positive experiences of using SPARC.  
‘...I'm quite interested in SPARC because we have as a service used…and found it 
quite beneficial as…a structured tool to do assessments with, and it gave us a far 
more patients’ centred assessment, which was quite surprising, because people felt 
that they already did patient centred assessments, but actually it brought up things 
that were unexpected’…And…as a professional you can become very, almost kind of 
over confident that you know what the patient's problems are going to be…I think for 
me it showed that various professionals had not been asking the right questions 
perhaps. …We had a sense that we knew, we know all about it, but actually, it did 
throw up some surprises…’ [Health care professional 2, p5, p6, p8].  
At least three health care professionals [n=3/20] talked about their positive experiences of 
using SPARC as part of a service evaluation done at the hospice with ten hospice community 
patients, and described how SPARC helped patients talk about issues (sensitive) that would 
otherwise not have come up until the second or third visit. 
‘…We did ten patients here…and one of the things that was quite obvious was that it 
brought up the more sensitive or the more important issues to the patient…we would 
give it to the patient to do here, we’d then in the afternoon do the assessment 
interview…but what did happen was that some of these issues that came up would be 
issues that perhaps wouldn’t have come up to the second or third visit…so I think 
what it did, was to raise surface issues that would otherwise not have come’ [Health 
care professional 18, p77].  
Several health care professionals within this group [3/20], based on their previous 
experiences of using SPARC, stated the reasons as to why they were reluctant to use SPARC 
with inpatients (with acute problems).  
‘…we know that we have got a cohort of quite a lot of older patients on this site than 
there are at the Central site. We have got patients with dementia here, and you know 
those kind of issues, as well so that’s a problem. A lot of patients come in the initial 
point aren’t probably well enough…sometimes we do have patients that would be well 
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enough probably to sit and fill one of these questionnaires in, but they are coming in 
with quite acute problems initially…’ [Health care professional 16, p68].  
7.6.3 Theme3:PatientfeedbackonSPARC
Just over a half of the sample of health care professionals interviewed [13/20] said that they 
had limited or no feedback from patients about using SPARC or had not discussed it with 
them; with some even suggesting that because the research study was done ‘remotely’, 
patients didn’t necessarily connect with it.   
‘For the SPARC tools, didn’t do it…no-ones mentioned it and I've not mentioned it to 
them either, discussed it with them’ [Health care professional 8, p36].    
‘I don’t think many of the patients who’ve actually filled in questionnaires in the study 
have actually mentioned them to us, we have seen them…I haven’t had anybody say to 
me, oh I’ve sent that questionnaire or anything, now I don’t know if it was because 
that was done remotely, so they didn’t connect with it necessarily, because a lot of the 
patients who have done questionnaires from here have done them via the community 
visit…so I think they may have associated it with the community, and didn’t mention it 
to us…’ [Health care professional 18, p77]. 
From the very limited feedback received by health care professionals from patients [4/20], 
generally the feedback was positive, and patients found it very useful to have completed 
SPARC, and weren’t put off by it, as it brings their problems, issues and concerns to the fore, 
but for some completion can be quite a challenge.  
‘I think on the whole the patients that I known, that have filled it in have found it very 
useful and found although it can be quite a challenge for them, It focuses the interest 
on their problems. So although it's not an easy thing for somebody to fill in, it's 
actually very productive in that it shows them as well what they’re worried about’ 
[Health care professional 2, p6].  
Sometimes the feedback received [4/20] from patients was more about the research study 
than about the process of using SPARC.  
‘…I've had a few patients that said they have received this in the post [not sure about 
it, the word research]…and I've had patients that have said…do I have to go 
somewhere to be interviewed?…because I don’t feel I can do that…so I’ve had those 
sort of comments…’ [Health care professional 1, p2, p3].   
‘…The letters yes, patients often shown me and say this has come from you and well 
it's actually from me but it's part of a research project that’s happening…’ [Health 
care professional 4, p17].    
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Interestingly, two health care professionals stated that they didn’t really expect to have 
received any feedback as they didn’t specifically invite it.  
‘…patients just see it as a normal thing to do. So they don’t make a big deal out of 
it…I don’t specifically invite feedback, because I don’t want to make it look as if it's 
something special we’re doing, it's just a part of our assessment…’ [Health care 
professional 20, p86].  
Health care professionals said that they used a combination of methods (by telephone, letter, 
or face to face) depending on the circumstances to discuss SPARC results with patients, 
however the preferred method appears to be a face to face consultation rather than a phone 
discussion with patients.  
‘…That might have been a combination of those things [by telephone, letter, or face to 
face] and depending on what…the plans were for them in terms of being seen again, 
or being referred to other people, or you know it became part of their sort of 
management plan’ [Health care professional 2, p6].  
‘My personal preference is to actually bring the patient back to clinic and discuss it 
face to face, that’s my preference, there is a particular patient…I'm thinking about 
bringing back where the patient has been discharged from the clinic, and in order to 
re-engage with them, I am going to have to call them and so the SPARC tool that they 
sent plus other letters, I may…need to raise those as an issue. So I might end up 
having a telephone consultation although I would rather see him and speak to him 
face to face’ [Health care professional 12, p53].  
7.6.4 Theme4:ImpactofcompletingSPARConclinicalpractice
Almost half of the respondents interviewed [9/20] stated the following things happened as a 
result of patients completing SPARC; on most occasions [7/10] this initiated another 
discussion with the patient.  
1)  SPARC highlighted issues/areas: plan to phone patient and discuss further;  
2)  Phoned a lady to discuss issues she raised with another health care professional;  
3) Initiated a discussion around thoughts about ending it all, and about the future of her 
 disease (highlighted on SPARC); 
4)  Encouraged HCP to re-ask question later on but didn’t feature as something that required 
 attention; 
5) Nothing really that needed action apart from involving another discussion around  
 psychological issues;  
6) Patient was called back to the clinic for further discussion.  
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Some HCP’s felt that SPARC has an important role in monitoring patients, particularly those 
patients that they were not seeing.   
‘…Well I called them into clinic, and that’s been the pattern with about half the 
patients that I've had SPARC information back on…but because the process is 
relatively slow, I don’t know whether that will actually you know change the patients 
position for some time. I think it's useful because it does show you things that you 
weren’t aware of…but I think its common enough now for me to get a SPARC form 
from somebody back particularly from clinic who are more distressed than I thought 
they would be by this stage. I conclude…it has got a role in maybe sort of monitoring 
patients who I’m not seeing…well only the opportunity to see them. I don’t think 
SPARC tells you what to do at all, all it does is, it says look there is an issue here that 
you haven’t addressed. And you need to get on to it. I don’t think actually SPARC 
replaces anything that I do in clinic, it merely adds a sort of warning, it sort of 
highlights an issue, so I think it’s a trigger to sort of going back to my usual 
assessment methods, this time focus on what we’ve found on SPARC’ [Health care 
professional 15, p64].  
Most health care professionals [16/20] stated possible reasons as to why no action had been 
taken (for the better or for the worse) during the study, and why no beneficial effect was seen 
as a result of patients completing SPARC. The main reasons are presented in Table 35 
together with illustrative quotations.  
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Table 35: Possible reasons why no beneficial effect was seen as a result of completing 
SPARC (HCP views) 
Possible reasons why nothing 
changed, no action taken i.e. no 
beneficial effect seen as a result of 
completing SPARC 
Illustrative Comments  
Treated SPARC like any other 
correspondence [correspondence that 
wasn’t requested] [n=1] 
 ‘…I think I was led to believe for this research purposes that we were to regard the 
SPARC tools that we got back like any other kind of correspondence that we hadn’t 
requested…’ [Health care professional 8, p36].  
Didn’t expect anything to change 
[n=7]  
‘The last patient I used it on, he very much answered the questions in the way that, 
there was no surprises on it…everything that he answered was what I already 
knew, so there were no surprises…just reinforced the assessment I had done. On a 
couple of occasions, I have been surprised by what the patients have actually
scored, maybe there was more distress for the patient than I actually thought there 
was. It was more about psychological….’ [Health care professional 5, p22, 23].   
Tried everything; long-standing 
problems; nothing more could be 
done/got to a dead end [n=1] 
‘… the SPARC’s I've had back, there has been a number which I have kind of 
already discharged. So what it's doing it's come after a point where we have either 
recognised the limitations of our intervention and we’ve discussed that with the 
patients. So even though a patient might score relatively highly on some of the 
features, we have kind of got to point that we have agreed that we haven’t been 
able to make progress beyond that…, and the patient has had the opportunity to 
decide whether they want more intervention or not. At that point elected not to 
receive anything else…’ [Health care professional 12, p52, p53].  
Patient had moved on to another 
setting (no follow-up) [n=3] 
‘Have to say, that the SPARC patients that I carried out SPARC with, when the 
results actually came back to me, they were in another part of the service. So…like 
the last gentleman’s now an inpatient, so I've taken the SPARC tool up there…when 
they go to another area of care then they have another primary nurse looking after 
them so…politically correct is that they follow that through …’ [Health care 
professional 5, p23].  
Health care professionals wanted more 
ownership of the study in order to be 
more pro-active, seen as a third party 
[n=1] 
‘I think that’s the nature of how the study has been set out because it's not us that 
are generating SPARC. And actually if I was a patient filling that out, I would 
expect somebody to be engaging with me…because it's been done as the third 
party…I don’t think we have been engaging with it in the same way because we 
haven’t been proactive in saying have you filled your SPARC form in and because 
that’s not in the nature of the thing to do that…I think we have been like a third 
party’ [Health care professional 3, p14].  
Some problems/issues cannot be 
completely resolved/patient has 
adjusted to live with it  [n=4] 
‘…I think sometimes its, people, you know you have dealt with the problem but 
there may still be some degree of pain that they have adjusted to live with if you 
like’ [Health care professional 1, p2]. 
‘…We can’t always resolve all symptoms or all problems, but what we want to do is 
resolve the ones that are important to the patient’ [Health care professional 12, 
p54].  
Patient previously discharged from 
service/referred elsewhere /open 
appointment (no follow-up call), or 
even died [n=7]  
‘…As I say they’ve been, I've discharged them. You know when we discharge 
people we usually leave it for them to… contact us if they feel they need us…’ 
[Health care professional 1, p3]. 
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Limited number of completed SPARC 
forms received/only recently received 
completed SPARC forms [n=6]  
‘I've some sent back but not very many… I've not had many back…I think I've only 
seen about four returned on my desk’ [Health care professional 1, p2].  
‘…And I've only received them fairly recently. I do feel I want to make contact with 
them to see if they are okay’ [Health care professional 1, p3]. 
Saw this as a research study run by the 
research team, done as a third party, 
not in the loop, been happening in 
isolation, or wasn’t aware of 
consenting patients [n=5]  
‘… In terms of it impacting on our assessment, because it's not done in conjunction, 
by ourselves, in other words we are not leading it, we are not in control of it, you 
haven’t been able to engage with the patient about it, particularly either, you can’t 
sort it, unless they chosen to talk to us about it...’ [Health care professional 3, p11]. 
‘I'm not in the loop… I would say that yes. It's like, it's been happening in 
isolation…’ [Health care professional 3, p14].  
‘Well to be honest I haven’t been looking at those forms formally because they not 
necessarily all patients who are coming back to me…so I have tended to regard 
those as separate, as a research exercise, I've not been using those clinically, if I 
have been wanting to use SPARC clinically with my patients I have used it 
anyway…no the ones that come back I mostly keep to myself, I mean I might share 
it with someone else a member of the team. But I keep them myself…’ [Health care 
professional 20, p85].  
‘I can see the benefits, and I think I’m a little bit confused…because it's almost as 
though we should have been incorporating this into our practice and really using it 
more. My understanding of the trial was that we would just identify patients who 
might be able or willing to fill it out and it was more like your study and…we 
weren’t… incorporating it into the feedback, and it was more for our interest to 
look at the SPARC tools, so maybe that’s a lack of understanding on my part…I 
don’t think I probably engaged with it as much as…’ [Health care professional 8, 
p37]. 
Originally thought HCPs weren’t to 
address any highlighted issues only if 
something jumped out that needed 
addressing [n=1]  
‘I thought originally we weren’t there to address some of the issues, but also I think 
if something jumped out then obviously it needed addressing. I'm not sure because 
there is a confidentiality…does the patient know that they are coming back to 
us?...’ [Health care professional 6, p28].  
Not timely enough to have an impact 
on HCP assessment, feedback needed 
much quicker (time delay/time-lag) 
[n=4]  
‘…I think it's helpful but it would be helpful if you had the feedback much quicker, 
in relation to your contact with the patient, in other words because it's been done 
as a research and you have only been given SPARC two or three weeks into your 
contact with them… I think it may be the delay in the patients returning it to 
you…yes, so it's not timely…in terms of it impacting on our assessment…’ [Health 
care professional 3, p11].  
‘…I think sometimes when we looked at it, because there would be a time-lag,          
I think that’s the issue that when the questionnaires came back to us there would be 
time-lag between the patients starting here and probably doing that questionnaire 
and us seeing the questionnaire’ [Health care professional 18, p77].  
Not sure whether HCP was meant to 
be re-engaging with patients, unsure 
about the extent of involvement [n=2]  
‘…If patients had consented to being part of the study, maybe if we had known 
about that…but then I'm not sure we're meant to be re-engaging with them about it, 
so in other words I don’t think we, I don’t think that’s been clear’ [Health care 
professional 3, p14].  
‘…I know that patients have received it. It's very difficult because it's been 
addressed to them directly…I didn’t want to sort of have an influence on the study 
if you like really…you are obviously the ones who are doing the study. I don’t know 
how much you wanted us to be part of that, or if it was supposed to be them’ 
[Health care professional 4, p17].  
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Notes may have gone somewhere else 
(for discharged patients and those in 
other settings)  
‘…The only ones that I've had back they have both been discharged and then, do 
you phone them, do you not?, you know, how do you manage that?…But the notes 
have already gone somewhere else by the time…yes, so when you discharge a 
patient then notes go….well I wonder if that’s because we get them back so late…’ 
[Health care professional 3, p14].  
Not seen patient for a while/during 
study/no discussion with patients  
‘The last two that I've seen within the study, one-and it reflects the pattern, I think 
one ticked concerns which I was aware of in the severity that were indicated. And it 
didn’t give me any extra information. The other one, however, ticked a couple of 
concerns that were outside what I expected, and it reflected the fact that the patient 
was in distress that I wasn’t aware of and that’s probably because I hadn’t seen 
them for a little while. So from that I concluded that the review period that I had 
put into that outpatient was too long’ [Health care professional 15, p64].  
Can’t sort it unless patient choses to 
talk about it 
‘…You haven’t been able to engage with the patient about it, particularly either, 
you can’t sort it, unless they chosen to talk to us about it…’ [Health care 
professional 3, p11]. 
Concerns on SPARC forms have been 
taken seriously but not sure if they 
have been referenced back to SPARC: 
loop needs closing 
‘I think when the SPARC’s have come back their concerns have been taken 
seriously. But I’m not sure that has been referenced back to SPARC, I think that’s 
probably just a loop that needs closing really’ [Health care professional 2, p7].  
Patient had died. Institution wasn’t 
able to meet patient’s needs at the time 
‘I've had one and unfortunately by the time I had it returned to me, the patient had 
died. But, it was actually quite interesting, his response to some of the questions 
and I'm not quite sure how I would have dealt with them, Because of his character 
as well. And it was actually quite sad seeing it in a way. It was emotional, which I 
think identified the type of people we are seeing is that we don’t do enough on the 
psychological support…the physical is easy…A lot of the issues I have are not the 
physical which you can probably treat easily it’s the psychological side, the loss of 
independence, the loss of having been taken out of your own home, and some of 
them maybe acceptance of dying, but it’s the stages that they go through, through 
losing their independence, of dying. And that’s …where it, sometimes it’s quite 
difficult. He [referring to the patient] wanted to be respected and wanted to be 
independent and do things, which the institution at that time, wasn’t meeting those 
needs. He felt he was being treated like a child as well. Unfortunately, as I said, it 
would have been interesting to have gone back and discussed it with him but he had 
died’ [Health care professional 6, p26].  
Correspondence that HCP had not 
requested, didn’t tend to respond too 
much to the SPARC tools 
‘…And…that’s the way I kind of looked at it really and it was interesting to look at 
it but I perhaps went by my own assessment more than, I didn’t tend to respond too 
much to the SPARC tools’ [Health care professional 8, p36].  
It’s not incorporated into HCP role yet. 
SPARC was not seen as part of routine 
clinical practice  
Just viewed it as another piece of 
information, like getting a letter from a 
GP/clinic 
‘For the SPARC tools, didn’t do it…no because I didn’t feel that was…no because 
it’s not incorporated into my role yet. I just viewed it as another piece of 
information. Like if I got a letter from the GP or a letter, clinic letter, I wouldn’t 
ring the patient up and discuss the results. I wouldn’t discuss…and I viewed the 
SPARC tool in that same, in this instance, if we were using it day to day as part of 
our culture if you like then I perhaps then I might yes’ [Health care professional 8, 
p36]. 
HCP not mentioned/discussed it with 
the patient  
‘No-ones mentioned it and I've not mentioned it to them either, discussed it with 
them…no nothing that, no action that I've taken is as a result of SPARC’ [Health 
care professional 8, p36]. 
Assessor may have felt it’s not the 
right time to address 
unresolved/outstanding issues or 
problems but these could be addressed 
‘The only thing that I would like to think if there are issues that aren’t addressed 
it’s because the person that's done the assessment doesn’t believe it's been the right 
time at that time, and it might be something that might have been picked up later 
down the line or, when there is a bit more of a relationship formed…I would like to 
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later down the line when a better 
relationship is formed with the patient 
think in my experience that’s…what might have happened, some patients 
deteriorate quite rapidly’ [Health care professional 10, p45].  
‘…I suppose I found it really interesting actually…I think two of the patients 
particular things that had come up that I hadn’t addressed at all, there was one 
there was a sexuality one, and I hadn’t addressed that at all with the patient, 
having said…on that one, I had only seen the patient once. And unless that patient 
had probably brought the sexuality issue up, that wouldn’t have been necessarily 
something I would have gone straight into on my first assessment, so it was sort of 
interesting things that were brought up’ [Health care professional 9, p38, p39].  
Nothing that needed action/addressing 
something that’s not addressable 
‘…I don’t think, anything sort of came to mind that it was really something that I 
needed to sort out, or if it did it might have been things that I thought well you 
know if somebody like circled feeling very weak. And yet they were very poorly and 
there was not perhaps a lot that I could do about that, so how do you address 
something that’s not addressable, those kind of issues’ [Health care professional 8, 
p36].   
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7.6.5 Theme5:UsefulnessofcompletingSPARC
All health care professionals interviewed [20/20] had something positive to say about the 
usefulness of SPARC, comments on the usefulness of SPARC are summarised in Table 36
together with illustrative quotations, these were in the majority. 
Table 36: Usefulness of completing SPARC (HCP views)  
Usefulness of completing SPARC  Illustrative comment  
1) Writing things down: allows 
patients to communicate (sometimes 
uncomfortable/difficult things) in a 
different way, without having to say 
something out aloud [n= 6]  
‘…I think it allows a patient to communicate in a different way. So to be 
able to communicate without having to say something out loud. So if 
something feels a bit uncomfortable to say they can let you know they want 
to talk about it’ [Health care professional 2, p7]. 
2) Very helpful tool to use where time 
and interaction with patient is very 
limited e.g. in outpatients [n= 3] 
‘…I think probably in areas where there is probably limited contact 
especially in an outpatients setting, It is probably where SPARC is very 
helpful where, because your time is limited and because the interaction with 
the patient is limited, SPARC is where you can actually use it as something 
to prioritise your consultation, maybe not in the first interview but 
subsequent consultations…’ [Health care professional 17, p72].  
3) Sometimes SPARC confirms and 
reinforces what we had done in the 
initial assessment. Sometimes gives 
new information that health care 
professionals were not aware of [n= 4] 
‘…Seeing it in writing and hearing it just reinforces it’ [Health care 
professional 6, p26].  
‘…There are times obviously when it gives new information I didn’t know 
about before then it's very helpful. Sometimes it just confirms the 
information I had or thought I had…It's often been very useful…when it 
gives some new information which I wasn’t aware of cos it clearly asks 
about a lot of areas which I don’t normally do in my clinical assessments’ 
[Health care professional 20, p86].   
4) Cuts to the chase with patients about 
their real problems and their 
perceptions of what their problems are 
in a patient-led way [shift from a very 
medically-driven agenda to a patient 
agenda] [n= 6].  Patients are in control 
‘…I think it's good because I think it sometimes cuts to the chase. Certainly 
have one experience of looking after a young woman who I was doing first 
visit. And …it enabled her to talk about end of life care issues in relation to 
her family and her children and what she wanted for them. Whereas I might 
have been a bit more gentle and not gone there in the initial assessment. So 
in a way it opened up a dialogue really quickly which was really important 
because she didn’t have that much time. So in that sense I've had positive 
outcomes from it…’ [Health care professional 3, p11, p13, p14].  
‘…I guess what it does it gives you the patient’s agenda. And that for me is 
extremely useful because all from my personal view is what we are here for 
is really about trying to ensure that the patients’ major concerns are being 
addressed. We can’t always resolve all symptoms or all problems, but what 
we want to do is resolve the ones that are important to the patient. And this 
is what it does rather than us going from a very medically driven agenda…’ 
[Health care professional 12, p53, p54, p55]. 
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5) Useful guide/prompt, reminder-
helps prioritise, sets the scene, and 
stimulates further discussion [n= 5] 
‘…Looking at SPARC when you look at it, I mean these are exactly the kind 
of things that you know I was saying this is what we’d cover, so I would 
hope you know our role doing a holistic assessment that we would cover 
these things. However, I don’t think it does any harm to have a tool to guide 
you, to remind…to remember to…so it's a guidance…’ [Health care 
professional 4, p18]. 
‘I think it can be a useful tool to stimulate some further discussion, and        
I think people can look at these in their own time…’ [Health care 
professional 11, p49, p50].  
6) Brings up the unexpected, things-
important to the patient you weren’t 
aware of, forgotten to ask, missed, or 
things you don’t ask in clinical 
assessments [n= 8] 
‘…It gave us a far more patients’ centred assessment, which was quite 
surprising, because people felt that they already did patient centred 
assessments, but actually it brought up things that were unexpected…I think 
what’s interesting is that it brings up, the unexpected. And you, as a 
professional you can become very, almost kind of over confident that you 
know what the patient's problems are going to be. And actually…I can recall 
somebody who appeared to be very calm on the outside and had been seen 
by a number of health professionals and assessed. And nothing had been 
raised about anxiety but actually when she completed the SPARC she scored 
very highly on that. And it opened a door to a lot of things that she hadn’t 
discussed before, and I think for me it showed that various professionals had 
not been asking the right questions perhaps’ [Health care professional 2, 
p5, p6]. 
7) Simple, short (not too lengthy), 
useful tool, fairly compact and concise, 
very streamline, structured mental 
checklist [n= 5] 
‘…I do like the set-up of it; I must admit…I think its self-explanatory 
really…quite simple isn’t it. It's not rocket science tool’ [Health care 
professional 4, p18].  
‘… I think the nice thing about it is it's not too lengthy and it's fairly 
compact isn’t it and concise?…I think it's two A4 and that's pretty okay isn’t 
it?...I think it's a useful tool…’ [Health care professional 9, p42]. 
8) Part and parcel of our assessment, 
useful addition to HCP’s normal 
practice [n=1] 
‘…I have quite a clear opinion that I think having something like this as part 
and parcel of our assessment would be helpful’ [Health care professional 4, 
p19].
9) SPARC gives permission to ask 
patients again, message is that health 
care professionals are taking all 
patients’ concerns seriously and want 
to help [n=2] 
‘...What SPARC did was almost give me permission to ask the patient the 
question again, but you think you have covered it, you think patients have 
given you a clear answer, and you think that’s the end of that particular 
discussion or it's reached a negotiated point where that’s where it's been 
left. But the fact that the patient has still identified it as an ongoing problem 
really invites you in a kind of patient-led way to re-challenge that and just 
be sure that you’ve reached an acceptable compromise, or that the problem 
has been resolved…’ [Health care professional 12, p53, p54].  
‘…I think the message that it gives is you know I'm taking all your concerns 
seriously. I want to help so generally very positive…’ [Health care 
professional 19, p82, p54].  
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10) Can home in on highlighted issues, 
problems, concerns (smartly and 
quickly) [n= 2] 
‘Well I mean I suppose we are coloured a bit by previous experience with 
using SPARC. I think I would like to believe that the assessment that we do 
is robust enough that issues come up and that the relationship that develops 
between the key worker and the patient, issues will come up. But I suspect 
we just would not have addressed them as smartly, as quickly without using 
the SPARC’ [Health care professional 18, p78]. 
11) Could be helpful in a limited 
number of patients particularly in 
patients with lots of on-going issues, 
helping them to focus [1] 
‘I think that in a limited number of patients it could be very helpful, the lady 
that I've seen this morning has got a lot of anxieties and I just wonder now, 
with hindsight if giving her something like this may help her to focus on the 
way she’s feeling cos there is so much going on, and it maybe that this helps 
her to focus…’ [Health care professional 14, p61]. 
7.6.6 Theme6:Sensitive,inappropriateorpersonalquestions
Of the 16 health care professionals that responded to this question, just over a half of the 
sample of health care professionals interviewed [12/20] stated reasons as to why SPARC 
could be potentially unhelpful or not worthwhile for patients to have completed. A few health 
care professionals [2/20] said that some patients might be alarmed at receiving SPARC 
because of its association with palliative care, and with the prospect of being defined as a 
‘palliative patient’. There was also the worry expressed by some health care professionals 
[2/20] that patients would have to complete a questionnaire with lots of questions, and the 
perception that this would take a lot of time to complete. There was a concern amongst some 
health care professionals [4/20] that SPARC might be burdensome for some patients, 
particularly those patients who were unwell, or had cognitive impairments, those 
experiencing a change in circumstances due to illness (e.g. profound fatigue, loss of 
independence) and those coming to terms with the illness. Some health care professionals 
[2/20] felt that SPARC could reinforce the situation the patient was in (e.g. losing 
independence), and you then run the risk of reinforcing problems that can’t be solved.
Some health care professionals [n=2/20] felt that the questions that made reference to the 
patient’s sexual problems were considered to be either inappropriate too personal, or too 
sensitive.  
‘…I don’t think I would have used a direct enough question like you know is your 
illness impacting on your sexual life?, I'm not sure I would have gone there. And         
I think as professionals we are not very good at covering, I tend to talk about it in 
terms of sexuality, it will be about body image, rather than about the…’ [Health care 
professional 3, p12]. 
And one health care professional said that as a health care professional you have got to be 
comfortable addressing and talking about sexual issues. 
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‘As a health professional say the sexual issues…you have got to be comfortable 
addressing those issues, and I feel that … in our field we should be able to do that so, 
but perhaps it allows them to put it down…’ [Health care professional 9, p40]. 
In contrast, others felt it was useful to ask about sexual problems as it can be a useful prompt 
to check on things that sometimes are difficult to talk about. 
‘…I think when patients identify…sexual problems for instance, I think that's very 
useful thing about the SPARC tool because I think patients aren’t always very 
comfortable talking about that…other colleagues have said....the return of the SPARC 
tool has identified concerns that maybe they haven’t expressed verbally, so that's 
very, very useful, and I think the fact that they’ve written that on the form hopefully 
will help enable them to maybe you know feel more comfortable about discussing it 
and bringing up concerns. It’s how we then address it you know’ [Health care 
professional 1, p3]. 
Some health care professionals [2/20] found discussing of end of life care issues, dying, death 
and life is not worth living questions distressing and sensitive. The issue around timing of 
asking these questions was considered important.   
‘And you know questions about death or dying, although we do try and touch on them 
in an assessment you get a feel for if somebody wants to talk about it or not, whereas 
if you know, and then we can sort of pursue it or not, back away or leave it. You know 
its timing isn’t it?, but that maybe a question that....people might find distressing to 
answer, yeah it’s a bit different when it’s seen there in black and white. I mean they 
may sort of think oh am I dying [when this may not necessarily be the case]….’ 
[Health care professional 7, p33].  
Several health care professionals reflected on their positive experience of using SPARC in 
relation to asking these questions [i.e. about death and dying].  
‘…I think…as nurses…we’ve just sort of had a more tentative approach to maybe 
discussing death or discussing…peoples’ views about how they wanted things to be, 
we would sort of hold off and wait till we had got to know them a bit better…whereas 
what was interesting was that people wanted to talk about that right away. So we 
would make that assumption quite incorrectly, you know…’ [Health care professional 
2, p6]. 
‘I think it's good because I think it sometimes cuts to the chase. Certainly have one 
experience of looking after a young woman who I was doing first visit. And…I think it 
enabled her to talk about end of life care issues in relation to her family and her 
children and what she wanted for them. Whereas I might have been a bit more gentle, 
… and not gone there, in the initial assessment…so in a way it opened up a dialogue 
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really quickly which was really important because she didn’t have that much time. So 
in that sense I've had positive outcomes from it’ [Health care professional 3, p12, 
p13, p14]. 
Other potentially sensitive/distressing questions include: questions about psychological 
issues, because patients are not always ready to talk about them; loss of independence and 
questions about long-term effects of treatment.  
‘I think the only thing about the tool is … there are going to be some aspects of it that 
the patient might not be ready, able to talk about, you know when it comes to things 
like, some of the psychological issues…’ [Health care professional 9, p40, p41].  
On the whole HCP’s felt that including upsetting questions may be potentially useful because 
patients may feel reassured that someone was looking into addressing their issues or 
problems. 
‘… I suppose quite a lot of the things that we ask patients can be upsetting,…but in 
the long-term of course these may be things that patients may find upsetting but have 
wanted to talk about but never had an opportunity to discuss with, so in a way, it may 
actually become a relief there is someone actually looking into these issues, because 
that's something that can get side-lined in especially hospital environment. So no        
I think on the whole it's very helpful’ [Health care professional 17, p73, p74].
7.6.7 Theme7:Barrierstothereliefofdistress
Several barriers were identified by health care professionals [15/20] to the relief of distress 
highlighted by SPARC, these are presented below with illustrative quotes/comments and 
summarised in Figure 11.   
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Figure 11: Barriers to the relief of distress highlighted by SPARC (HCP views) 
Just over a third of the sample of health care professionals interviewed [7/20] commented on 
the limited resources available and the difficulty with accessing and referring patients to 
psychotherapy services (psychologist, or psychiatrist) as potentially a barrier to addressing 
the psychological issues. Several health care professionals [4/20] commented on the time 
constraints, limited time to discuss, unpack problems, issues and concerns particularly with 
regards to addressing patients’ psychological needs in the clinic context/outpatients setting. 
‘…But the clinic context doesn’t give you a lot of time to unpack those problems. So 
then you need to be confident that you can refer onto a colleague in psychology and if 
a patient doesn’t want to be identified as having a psychological or psychiatric 
problem, that in itself can act as a barrier to addressing the issues, as well as having 
the resource of having a psychologist to refer to…’ [Health care professional 12, 
p54]. 
‘…I suppose timing is an issue for us…I mean it’s not like an outpatients where you 
have got a very specific slot. And if you have created sort of problems that you can’t 
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address, then you are going to go home with those problems…we have got more time’ 
[Health care professional 18, p78].
Health care professionals talked about the difficulties in accessing psychological services 
straight away or in a short period of time for patients with very complex psychological issues 
in comparison with accessing other services like religious, spiritual and social services.  
‘Well psychology not good, you see…we waited quite a long time sometimes for a 
psychologist or psychiatrist, It's easier to refer patients to a physio or a dietician 
that’s quite easy. Chaplain is quite easy yes, so the psychologist is probably one of the 
most difficult ones’ [Health care professional 20, p86].
There were some health care professionals who felt it was not possible to deal with all the 
issues at once, and there was a need to prioritise. However, on the contrary, there were some 
health care professionals [2/20] who felt that completing SPARC may be a more efficient and 
effective way of identifying problems, concerns, or issues and may actually save time in the 
long run, because SPARC helps patients focus on things that matter or bother them most.  
‘I can see that for some professionals they may think, oh my goodness they have 
ticked three for everything, but if they have ticked three for everything actually that 
gives you I suppose a lot of information as to how they are feeling emotionally, I think 
there is a worry that if they do [tick 3 for everything]…given our time limitations how 
are we going to, what ones do you want time to address?. So I wouldn't feel 
threatened by it…I can see that it may be seen as time consuming but actually doing a 
full holistic needs assessment does take time, but I mean the other thing is it does 
allow you to be focused, so in some ways it might save time’ [Health care 
professional 19, p83]. 
Health care professionals expressed concerns about SPARC identifying problems, issues, or 
concerns that other HCP’s couldn’t ‘fix’, but at the same time said that they could refer 
patients to someone who could help.   
‘…I can see having spoken to some of the neurology clinical nurse specialists that 
they worry they are going to identify something that they then can't fix, I suppose        
I don’t personally have any concerns about…. if I've identified there is a problem with 
their sexual life I'm not the right person to help sort that but I know who is…’ [Health 
care professional 19, p83].
Other general barriers identified by a very small number of health care professionals included 
the following: 1) the lack of privacy on the wards; that meant that some patients may be 
reluctant to talk about certain things; 2) language barriers; 3) general noise on the wards;      
4) lack of bereavement support in the general hospitals; 5) difficulties of accessing home 
care/intensive home nursing/ no 24hr nursing service in some cities; 6) the possibility of lots 
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of issues being identified which health care professionals may not be able to deal with on 
their own, and so would require a team approach.  
Several health care professionals [3/20] said that completing SPARC may increase 
workloads, especially in bringing back discharged patients (because not all patients stay 
continually on a caseload).  
 ‘…We are busy, we have limited time with patients and if someone were to complete 
 the form and highlight a lot of issues, I need to have factored that into my visit, that I 
 may go and there be no issues, but I may go and there may be lots of issues and that 
 may then have a knock on effect in terms of how my visits proceed from then on…and 
 it also I guess could create more work in that I may need to make referrals to other 
 teams, …it's not just a paper exercise is it?, It's not just a case of giving it to someone 
 to fill in, its dealing with the fall out’ [Health care professional 14, p61].  
 ‘The only issue that I could see there is that if…perhaps I have discharged a patient 
 then I get a form back and there are lots of issues there, I think crikey they never said 
 that. And then I might think I have got to get back in touch with this patient again…it 
 wouldn’t be a barrier but that might be a clinical issue…it just might make our 
 workloads a bit more’ [Health care professional 8, p37].
At least one health care professional was concerned that she wouldn’t have the skills to deal 
with the issues, problems, concerns identified, and that SPARC may bring up issues, 
concerns, problems that they nor the patient was ready to talk about. Another health care 
professional said off-tape that he was concerned about leaving ward staff who may not have 
the necessary training or skills to deal with the complex issues identified.
‘I worry that if it highlighted lots of issues that I wouldn’t have the skills then to deal 
with those issues, but I also worry that if a patient has lots of issues and is unable to 
decide which ones are the most pressing that they need to deal with first, that then 
may be left to me to decide which I address first, and it may be that I don’t know and 
that I don’t do that in a manner in which they would want me to do’ [Health care 
professional 14, p61].  
‘I think my worry is that I open a can of worms that I then am not equipped to deal 
with or not ready to deal with, or that it opens a can of worms for the patient that they 
weren’t ready to open’ [Health care professional 14, p62].
Several health care professionals said that you would still need to put what is on paper into a 
verbal communication.   
‘I suppose the barrier though is then that you still putting it into a verbal 
communication … they identified it, haven’t they on paper. And I suppose by doing 
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that they are saying this is something I wanted to discuss and is a concern’ [Health 
care professional 9, p40].
7.6.8 Theme8:TimingofadministeringSPARC
Most health care professionals [18/20] commented on the timing of administering SPARC to 
patients, the main time points considered as important by health care professionals varied and 
are presented below with illustrative comments and are summarised in Figure 12.
Several health care professionals [5/20] strongly felt that SPARC should be used as an initial 
assessment or as an early holistic needs assessment tool, early on in the course of the illness, 
and then perhaps again at discharge, or as a reassessment tool. Participants stated that you 
need to be careful when SPARC is sent out because usually when these go out they coincide 
with lots of other things going on. And some health care professionals [n=2] said that SPARC 
should be used judicially, and then repeated or used more routinely, with a particular time-
frame. A small number of health care professionals initially thought of SPARC as something 
that would be particularly useful for health care professionals to use in primary care (outside 
the specialty) and that could help point health care professionals to which patients require 
extra attention or referral to specialist palliative care (for people referring to the palliative 
care service e.g. District Nurses or General Practitioners). Others felt it could be a re-usable 
tool that could be used at different stages in the patient’s illness/journey.  
Health care professionals said that the timing depends on the client that they are dealing with 
(i.e. whether the patient was in a nursing home, at home or in an inpatient unit etc.), and that 
you need to strike a balance between the burden you put someone under and the benefit you 
get out of it, and it was difficult weighing this up, as some patients that are on general 
hospital wards are acutely unwell. And others said that SPARC should be completed when 
you are seeing the patient so that you could ‘capture the moment’.  
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Figure 12: HCP views on the main time points to administer SPARC 
The main time points considered as important by health care professionals varied  
7.6.9 Theme9:Education,trainingandskillsissuesaroundtheuseof
SPARC
Almost a third of health care professionals interviewed [6/20] talked about the need for 
education, training and skills issues around the use of SPARC.  
 ‘…It maybe that we just need more education in its use…it would be good to have that 
 evidence really…’ [Health care professional 11, p51].  
‘…We might need to consider the skills of the people using it…I think as well that you 
have…got to be comfortable to talk about the things that might come up, or know where 
to go with them and I think…there is some work to do around that. And I think around 
a process for using it’ [Health care professional 2, p7].  
For some it was more about receiving education and training around confidence building and 
on introducing and using something like SPARC.  
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‘…I think you have got to have some thought process behind it. And a way of 
introducing it and maybe some you know education and training or you know just 
confidence building about using something’ [Health care professional 2, p8].  
‘…I understand what it’s for, but explaining that to patients and whether they will get 
any benefit from it. I don’t know if I feel confident doing that…’ [Health care 
professional 13, p58].  
Some health care professionals [2/20] expressed concern about how they would deal with and 
address any concerns or issues highlighted by the patient. 
‘I worry that if it highlighted lots of issues that I wouldn’t have the skills then to deal 
with those issues…’ [Health care professional 14, p61].  
 ‘…Yes I think that would help [education and training on using SPARC], yes, cos it's 
not just a paper exercise is it?, It's not just a case of giving to someone to fill in its 
dealing with the fall out…’ [Health care professional 14, p61].  
However, some [2/20] felt that health care professionals should have received sufficient 
training to be able to tackle a lot of these issues anyway. 
‘…I think that's something that we would be expected to learn from our training for 
example things like bowel problems, constipation you would expect a Registrar in 
Palliative Medicine to know about how to deal with….of course…’ [Health care 
professional 17, p74]. 
‘As a health professional say the sexual issues…you have got to be comfortable 
addressing those issues…in our field we should be able to do that…but perhaps it 
allows them to put it down…’ [Health care professional 9, p40].  
One health care professional commented on how SPARC would be beneficial for physicians 
and consultants, especially those who were in the initial stages of their training. 
‘…And probably good thing about SPARC of course, it is very streamline it is kind 
of…..it's a very structured way, so it would be definitely helpful for physicians 
especially those who were in the initial stages of their training, and for 
consultants…even a consultant can make mistakes’ [Health care professional 17, 
p74].  
Another health care professional was very supportive of using SPARC, providing it was not 
too burdensome for the patient.  
‘…I think anything that is ganna help people and really provide a good benefit that's 
not burdensome to the person, I think I would be supportive of that. I just think it's … 
striking this balance between the burden that you perceive you put someone under 
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and the benefit that you get out of it, it is difficult and it's weighing this up [burden vs. 
benefit]’ [Health care professional 11, p51].  
The same health care professional said the following ‘off-tape’ 
Off tape: ‘…Concerned about leaving ward staff to deal with complex issues 
identified, as ward staff may not be skilled or trained to deal with such complex 
issues’ [Health care professional 11, p51].  
Another health care professional said that if they found difficulty dealing with issues, they 
could always get help from one of their colleagues. 
‘…And if we are finding difficulty, we can always get help from our colleagues, so      
I think on the whole it will be helpful. I mean I think yes we would be expected to be 
able to tackle quite a lot of these issues, but if we can't then at least in a way it can be 
also used as an early opportunity…’ [Health care professional 17, p74].  
7.6.10 Theme10:FutureutilisationofSPARC
All health care professionals interviewed said that they would either use SPARC in the future 
or consider using it. It is fair to conclude that the majority of health care professionals 
interviewed in this study support the use of SPARC, and there seems to be a lot of enthusiasm 
amongst teams and individual members of staff about using SPARC in the future, particularly 
amongst staff working at the hospice. 
‘I think it certainly helps in our work with assessing patients. And we are very 
interested in using it in the future…there is a lot of enthusiasm amongst particularly 
the community team to use this…as part of their, as an assessment tool’ [Health care 
professional 2, p7].  
‘I'm a big fan and like I say I've never used anything like this before I came to 
Sheffield and I see it as a really useful addition to our normal practice…we all like to 
think we do a very thorough needs assessment when we assess patients but I know      
I don’t always, there are always things I miss out, so I think what it does is it gives the 
patient’s permission that…all of these are issues that we consider important and it 
just makes sure that we don’t miss anything. I find it very help to prioritise as well as 
to what we are going to concentrate on now and what we can afford to leave till 
perhaps a bit later. So I’m a big fan’ [Health care professional 19, p83, p84].  
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Some health care professionals [2/20] said that they were considering using SPARC, but put 
it on hold due to the ongoing research.  
‘…I would like to start using it … although the research is really important we’ve sort 
of put it on hold…I think that’s a shame. But I understand…it's good to get proper 
evidence behind using something. But I would certainly look to use it in the future, 
myself… as a way of doing holistic needs assessment’ [Health care professional 3, 
p15].  
‘…We did have really positive experience of it when we used it that time. And we 
haven’t used it any further because effectively you are doing the study…didn’t want to 
do sort of the same at the same time. But yes. I think we would use it’ [Health care 
professional 18, p79].  
Other health care professionals stated reasons as to why they considered SPARC to be useful.  
‘…It…compartmentalises things but in a negative way but quite a constructive 
way…rather than a ream of stuff and then you are trying to sort of work out which 
bits you need to address it’s quite simple…I have quite…a clear opinion that I think 
having something like this as part and parcel of our assessment would be helpful’ 
[Health care professional 4, p19].  
‘…It seems to me that if fulfils the assessment, a paper assessment which is awfully 
good a screening for the things that clinicians don’t do naturally…I would certainly 
use it in our service and I think something like it should be used and I think SPARC is 
as good as anything else I've seen…I think it's much more useful than a global 
measure … and the good thing about SPARC is it tells you whether it is the thing you 
know about, whether it's something else’ [Health care professional 15, p65, 66].  
A few health care professionals suggested that the use of SPARC should not become 
obligatory or be seen as an enforcement but instead it should become part and parcel of what 
you are doing.  
‘…I don’t necessarily think they…should be seen as an enforcement you know we 
have to do this. Because if something becomes obligatory people think of it as like oh 
it's extra work, and we have got to start messing about filling this in and doing this. 
Whereas if it becomes part of parcel of what you are doing, or this is just a bit of a 
guidance to help you… I think it works much better…I think it's got a place, …there 
are mixed views in our team but you will get that back when you talked to everybody, 
there are some people who are really keen on its use…’ [Health care professional 4, 
p20, p21].  
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One health care professional said that she would use part of SPARC, but wouldn’t go through 
it all in one go. 
‘I could use part of it. I wouldn’t say I would go through the whole framework or 
maybe I would over a period of time with the patient. But maybe not on one initial 
visit, it maybe something I would use there and pick in on that assessment, so if I had 
it there then yes...I think it’s a good framework…but it’s maybe something that you 
come in and out of because…depending on the mood of the patient at the time’ 
[Health care professional 6, p29].  
Some health care professionals said that they would be happy to use SPARC in the future, but 
for them it was more important to know when it was used.  
‘I would be quite happy to use it in the future…but again for me it's actually about 
when it's used’ [Health care professional 12, p54].  
One health care professional commented on the difficulties of trying to convince other 
colleagues to using SPARC, despite the fact that the hospital Trust had put SPARC on the 
intranet and promoted SPARC as the leading official holistic needs assessment tool.  
‘…I suppose my concern is I am working in a team, where the team itself doesn’t use 
SPARC. They use a different holistic needs assessment, it's not even a formal tool. 
They have just got like a check-list of things, topics and that’s in a sense my biggest 
failure that I haven’t even convinced my own team, that’s the nursing team to use 
SPARC, now that’s more to do with you know politics and the fact that…I don’t run 
the team I work with them, but with nursing team managed by a different 
management. But having said that, I'm very pleased that the Trust has now put 
SPARC on…it’s intranet. It's become established as the leading, the official holistic 
needs assessment tool, so if anyone is going to do it properly they have to use SPARC, 
and the Trust is supporting that, but trouble is some of the individual nursing teams 
are opting not to do it and that is a problem and that is something we have to take up 
with the Trust’ [Health care professional 20, p88].  
The same health care professional quoted a recent study presented at the British Thoracic 
Oncology Group meeting in Dublin that supports the use of SPARC. 
‘…I came across a good piece of research recently, the British Thoracic Oncology 
Group meeting in Dublin in January a nurse from Rotherham, lung cancer nurse from 
Rotherham, had done a study where she’d compared SPARC with I think normal 
assessment. And she had found that patients all liked using SPARC, and the staff that 
have used SPARC also found that it was very helpful as well. So again that was an 
area where people were a bit resistant to using something new, but once they used it 
they found it very good’ [Health care professional 20, p88]. 
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7.7 Summaryanddiscussion
This qualitative study was undertaken to elicit the views of supportive and palliative care 
health and social care professionals about their experiences of using SPARC during the trial. 
The study was conducted within the context of a pragmatic RCT and nested within the MRC 
framework for developing and evaluating complex interventions, in order to help in the 
interpretation of the trial outcome results. Eliciting the views of health and social care 
professionals represents an important phase in the development of SPARC (Ahmed et al., 
2009; Hughes et al., 2015).   
Ten prominent themes emerged from the health care professional interviews. Most health 
care professionals had something positive to say about SPARC and had previous experience 
of using SPARC, and most were considering using it at some point in the future. A number of 
barriers were identified to the relief of distress highlighted by SPARC. Lack of professional 
action and the numerous barriers identified following high level scoring of SPARC has 
revealed useful insights into how SPARC might be used in practice (EAPC, 2015).  
The usefulness of completing SPARC has been discussed in Chapters 6 and 7. Patient and 
health care professional views are very similar on this matter. All health care professionals 
interviewed had something positive to say about the usefulness of SPARC, and patients gave 
reasons as to why they felt that SPARC was either helpful, worthwhile completing, or a good 
idea. 
The findings suggest that health care professionals could benefit from using a more structured 
holistic needs assessment tool like SPARC to assess patients’ holistic needs, alongside their 
normal face to face consultation with the patient on the wards (e.g. at bedside), in the 
outpatient clinic or during home visits. The findings support the use of both open-ended and 
closed questions. SPARC can help to structure and guide a consultation, and clinicians may 
benefit from reviewing a patient completed SPARC form alongside any physical examination 
that they undertake to assess patients’ holistic needs. This approach appears to be the 
preferred method of assessing patients’ needs. 
SPARC was developed by our team of researchers based at The University of Sheffield and 
as one would expect, most health care professionals interviewed were aware of SPARC and 
had some previous experience of using SPARC before the study. This is largely due to the 
fact that much of the earlier development work on SPARC was undertaken in Sheffield at the 
same study sites. I also presented the study to colleagues and widely disseminated the interim 
findings at local meetings and at national and international scientific conferences in the fields 
of supportive care, palliative care, cancer care and end of life care.  
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Some of the more positive experiences of using SPARC, included how SPARC helped 
patients talk about issues, often sensitive and personal issues that would otherwise not have 
come up until the second or third visit.  
Health care professionals’ perceptions and expectations about what SPARC was actually 
used for varied, this was partly due to the fact that SPARC could either be used as a screening 
tool, as a guide for referral of patients to specialist palliative care, or as a holistic needs 
assessment tool. SPARC can also be used at different stages and phases of a patients’ illness 
trajectory and at different time points (i.e. during referral, initial assessment, follow-up, 
discharge, or re-entry to the specialist palliative care service as a reassessment tool). SPARC 
may have some role in helping to triangulate an assessment between patients, their families, 
carers and their health care professionals, but this requires further work.  
Most health care professionals and patients failed to connect with the study and viewed it 
primarily as a research study that was done ‘remotely’ to help the researchers. This became  
apparent from the limited feedback that health care professionals received from patients about 
using SPARC, and health care professionals did not discuss SPARC with them either. This 
points to an implementation failure of the intervention rather than failure of the SPARC 
intervention itself. It is possible that a standardised intervention such as SPARC will never 
supplement the quality of care unless it is properly integrated with the clinical methods and 
routine care planning procedures of the clinical team.  
Due to the nature and sensitivity of some of the questions, it is recommended that completed 
SPARC forms should be discussed during a face to face consultation with the patient rather 
than over the phone. However, a combination of methods could be employed (e.g. letter, 
telephone and face to face consultation), this would largely depend on the type of issues, 
concerns or problems that need to be addressed, as well as the time and resources available.       
With regards to the impact of completing SPARC on clinical practice, the findings suggest 
that there were only a very limited number of occasions when SPARC appears to have had an 
impact on clinical practice, and on most occasions this initiated a further discussion with the 
patient, often resulting in health care professionals having to call patients back to the clinic, 
but this did not take place during the study duration period. Therefore, one would not 
necessarily see any immediate impact on clinical practice or any improvement in patient 
health-related outcomes during the first six weeks of the study. This suggests that SPARC 
does have a role in the long-term monitoring and follow-up of patients. 
There are similarities and parallels in the type of questions that both patients and health care 
professionals perceive to be sensitive, personal and potentially distressing. These include 
questions about: sexual problems; death and dying; end of life care issues; life is not worth 
living; and psychological issues. It is also worth noting that we need to take account of the 
concerns expressed by some practitioners about SPARC being potentially too burdensome for 
some patients, particularly those patients who are unwell and those coming to terms with the 
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illness, and there is also a genuine concern that you run the risk of raising patient 
expectations and reinforcing problems, issues and concerns that can’t be solved. These 
concerns are well founded. Thus, the timing of asking these questions and the type of patients 
approached to complete SPARC is an important consideration. We must also consider how to 
help health care professionals become more comfortable in addressing and talking about 
some of these issues.  
On a more positive note, this study reveals that SPARC can be a useful prompt to check on 
things that sometimes are difficult to talk about, and practitioners reflected on their positive 
experiences of using SPARC in relation to asking these questions. While there was some 
resistance initially to ask these questions, the consensus view was that it was ok to include 
them on a questionnaire, and some patients felt reassured that someone was looking into 
addressing their issues, problems or concerns.  
There is some consensus around using SPARC as an initial assessment or as an early holistic 
needs assessment tool, preferably early on in the course of the illness, and then perhaps again 
at discharge, or as a reassessment tool. SPARC could be used outside the specialty and in 
primary care for referring patients into specialist palliative care. The precise timing of 
SPARC and how often it is administered requires careful consideration, this will no doubt 
depend on the type of patient being asked to complete SPARC, the setting in which they are 
located, and the stage and nature of their illness.   
The findings support the need for health care professionals to receive education, training and 
skills around the use of SPARC, particularly around confidence building and on introducing 
and using SPARC, which were identified as important areas for further development. This is 
further supported by the finding that some practitioners working within specialist palliative 
care expressed concern about how they would deal with and address any concerns or issues 
highlighted by the patient. There were genuine concerns about leaving ward staff to deal with 
complex issues identified, and others who may not be skilled or trained to deal with such 
complex issues. This raises some very important questions. It demonstrates that even those 
practitioners working within specialist palliative care and considered to have expertise in this 
line of work, may need help, support and further guidance on how to use SPARC, and on 
how to deal with the complex issues and problems that are identified. We need to ensure that 
health care professionals receive sufficient education and training, and have the necessary 
skills to be able to tackle these complex issues. Education and training should also extend to 
the generalists and other practitioners who do not have the expertise within specialist 
palliative care, and the adoption of a more shared-care approach to caring for patients is 
recommended. Education, training and skills programmes should perhaps be delivered by 
more senior and experienced members of the supportive and palliative care team.   
Holistic needs assessment methods (e.g. for identifying and addressing supportive and 
palliative care needs) training should also be incorporated further into training and education 
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programmes for future nurses, doctors and other allied health and social care professionals, 
which should continue during the initial stages of their training after they have qualified.   
This study has demonstrated that health care professionals interviewed are very supportive of 
and receptive to the idea of using SPARC in the future, and the enthusiasm amongst teams 
and individual members of staff for using SPARC in the future, particularly amongst staff 
working at the hospice is very encouraging and reassuring. It is also worth noting that for 
SPARC to become widely adopted it must become embedded in health care professional 
roles (i.e. become part and parcel of their role) rather than become ‘obligatory’ or be seen as 
an ‘enforcement’. There will of course be many obstacles and challenges in trying to 
convince all practitioners to use SPARC and this requires further investigation. There is a 
need to undertake further research on the clinical utility of SPARC in order to build a strong 
evidence base.     
What are the underlying issues and reasons for little or no follow-up (patient versus 
practitioner views)?   
In this section, I will present the underlying issues and reasons that attempt to explain why 
nothing appears to have changed, or no action taken i.e. why no beneficial effect was seen as 
a result of completing SPARC, and why there was little or in some instances no patient 
follow-up. I will also be comparing and contrasting patient and practitioner views.   
When we presented the study to health care professionals during our initial site visits we 
asked them to treat completed SPARC questionnaires like any other correspondence          
(i.e. similar to correspondence that they may receive from a general practitioner or any other 
health care professional, that informed them of clinical issues). Unfortunately, this approach 
appears to have backfired and had a detrimental effect on the study design and on the 
outcome. Findings from case note reviews, patient interviews and health care professional 
interviews all confirm that on most occasions SPARC was filed away with no further action 
taken. As a result, practitioners took the view that this was only for research purposes, a view 
that was echoed by some patients. Although most practitioners said that they found SPARC 
interesting to look at, they were more inclined to go with their own assessment. Thus they 
treated SPARC tools that they got back as information they had not requested, and didn’t tend 
to respond to the issues highlighted by SPARC.  
The study suggests that practitioners felt that the research team did not provide clear guidance 
about what they should do once patients had completed the SPARC forms. Others felt that 
they weren’t to address any highlighted issues, unless something jumped out that needed 
addressing, and some were unsure whether a health care professional was meant to be re-
engaging with patients and unsure of the extent of this involvement. Practitioners were 
worried that their involvement may have an influence on the research study.  
At the start of the study we did consider providing health care professionals with a clinical 
guide for SPARC, to help them make decisions about what actions they should take when 
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issues, problems and concerns are identified. However, our clinical colleagues felt that this 
was not necessary, because those working within supportive and palliative care service 
already had previous experience of using SPARC in the clinical service. The clinical teams 
had specialist knowledge, training, skills and the expertise to deal with these complex issues. 
For this reason, we designed the trial with the assumption that practitioners would act on the 
information elicited by SPARC. However, our findings suggest that it would have been 
useful to have developed a clinical guide or manual to accompany SPARC. This is an 
important consideration for the design of any future study of the clinical utility of SPARC, 
and equally important is the need for full cooperation, support and engagement of health care 
professionals with the design of any future study.  
Practitioners wanted more ownership of the study and viewed this as a research study run by 
the research team (a view that was also shared by some patients), and felt that it was done as 
a third party, and they were not in the loop. Lack of engagement with patients and little or no 
follow-up of patients who had completed SPARC, seems to be a direct result of the belief 
held by practitioners that it was not them generating SPARC, and as a result of this, many of 
them did not engage with patients in the same way, and did not pro-actively follow-up 
patients to ask them about SPARC completion. Some patients specifically went on to say that 
they participated in the study to help the research and other people, or help others who might 
be in a similar situation in the future. Thus, both patients and health care professionals failed 
to connect and engage with clinical information generated by the study, and it seems that the 
only time health care professionals talked about SPARC, was when the patient chose to talk 
about it. For these reasons the completion of SPARC by patients may have raised their 
expectations that were not subsequently met. Practitioners nevertheless acknowledged that if 
they were a patient completing SPARC, then they would have expected somebody to have 
engaged with them.  
It is important to point out that in some cases practitioners were receiving completed SPARC 
forms outside of the study period, or had only recently received them when I went out to 
interview them, and so one would not expect to see any immediate impact on clinical practice 
or changes in patient outcomes during the first six weeks of the study. This suggests that, 
despite hand-delivering completed SPARC forms to the health care professionals 
immediately upon receiving them, there is a need to review methods employed of relaying 
this information back to health care professionals much quicker, and we need to put 
appropriate systems and procedures in place that would allow one to track the journey of 
completed SPARC forms (i.e. from the point a researcher receives a completed SPARC form 
to the point where the health care professional has acknowledged receipt and beyond).   
The study also suggests that when patients were discharged or moved from one setting to 
another, there was little or no follow-up during the study i.e. practitioners describe how on a 
number of occasions when SPARC results came back to them, the patient was in another part 
of the service or discharged and was referred back to primary care, and some patients died, so 
they didn’t feel the need to take any action, with some still pondering over whether or not it  
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was ‘politically correct’ to contact the patient because they were under the care of another 
health care professional, a view held by both patients and health care professionals.  
Some practitioners felt that by the time that they had received completed SPARC forms, it 
was simply ‘too late’ to take any action and the patient notes had gone somewhere else 
because as mentioned earlier, the patient was either discharged or had moved to other 
settings. It is true that in some cases, as practitioners pointed out, the process of getting 
SPARC forms back to health care professionals was not timely enough to have had an impact 
on health care professional assessment, and there is clearly a need for feedback much quicker 
(i.e. time delay/time-lag). The lateness of information accessed by SPARC was in part due to 
the timing of recruitment into the study. Participating nursing teams had been reluctant to 
approach or inform patients about the study until their second visit, after their own 
assessment had taken place. 
The delay in patients returning the completed SPARC forms to the research team, and the 
further delay in the research team and site administrators returning them to practitioners 
caring for the patient (i.e. time lag between the patients starting the study and probably doing 
that questionnaire and health care professionals seeing the questionnaire), has meant that in 
some instances there was not enough time for SPARC to have had an impact on health care 
professionals’ assessment. This does raise some very important questions about the continuity 
of care, and follow-up of patients. This whole procedure of relaying information back to 
practitioners needs careful consideration. One option would be to have information i.e. the 
completed SPARC forms and the results relayed back to practitioners in ‘real time’.   
For those patients that were discharged during the study, or previously discharged prior to 
completing SPARC or on an ‘open appointment’, it appears that the onus was on the patient 
to contact the health care professional if they felt the need to do so. This study demonstrates a 
failure of this system, and even patients with high levels of distress for a number of 
symptoms, issues and problems as evident from the completed SPARC forms, failed to 
contact and re-engage with their practitioners. Some patients even citing that they did not 
want to bother their practitioners because they didn’t consider themselves as ‘terminal’ and 
felt there were more deserving patients than them. Others felt that there was nothing more 
that could be done, or that no treatment was available and that they had reached a ‘dead-end’ 
and any improvements in their health had plateaued, or that they had ‘learned to live with the 
condition’ ‘adapted’ or ‘come to terms with the illness’ due to the long-standing issues. This 
view was held by both patients and practitioners. This may well be a true reflection of the 
clinical situation for many patients, particularly in the late advanced or terminal stages of the 
illness, and for some symptoms, problems and concerns there is only so much that could be 
done to help. However, I believe that better methods of assessment, monitoring and earlier 
management of patients may go some way in alleviating some of these problems and the 
distress that they cause, but this has yet to be established.  
It is important to recognise the limitations of any intervention or treatment, and equally 
important is for this to be discussed with patients and their families or carers in a timely 
200 
manner. It is inevitable that even though a patient might score relatively highly on some of 
the items (i.e. for levels of distress), there will come a point when practitioners and patients 
will have to reach a mutual agreement that no further progress is likely beyond that point, as 
was the case in this study, a view shared by both patients and practitioners. It is also worth 
noting that some patients may have elected to receive no further treatment beyond this point 
despite being given the opportunity to continue with the treatment or intervention. We can 
conclude from these findings that there may come a point when it may not always be possible 
to resolve all symptoms, problems or concerns, and it becomes important to try and resolve 
the ones that are important to the patient in order to improve the patients’ overall quality of 
life.  
What also emerges is that some patients taking part in the study were not seen for a 
considerable amount of time, some were recalled back to the clinic as a result of completing 
SPARC, what is alarming is that many of these patients appeared to be in a much more 
distressed state than their health care professionals had originally anticipated. So from that 
one can conclude that the review period especially in an outpatient setting was too long, and 
needs to be reviewed urgently, this of course may have resource implications, for a service 
that is already stretched, and operating on limited resources, and on limited government 
funding.     
Interestingly, some practitioners felt that concerns on the SPARC forms were taken seriously 
but were not sure if they have been referenced back to SPARC. This may well be the case, 
but I was unable to find any evidence of this when I reviewed the case notes, because not all 
symptoms, concerns and problems, treatments and clinical interventions are documented in 
the notes, thus making it difficult to cross check them with what patients identify on SPARC. 
SPARC could be used to improve the documentation of symptoms, issues and problems, and 
it is important to then link SPARC results with a care plan, i.e. holistic needs assessment 
questionnaires should be integrated with a clinical assessment that informs a care plan.  
Some practitioners suggested that they had only recently received a limited number of 
completed SPARC forms, therefore not yet had a chance to follow them up.  
A view that was shared by both patients and practitioners was that the study duration was too 
short of a time frame to detect any changes or differences in health status or quality of life. 
The study questionnaires (SPARC and other study questionnaires) were either too close 
together with appointments less frequent than the administration of the questionnaires i.e. 
they were not timely enough to have had an impact on health care professionals’ assessment, 
and feedback is needed much quicker. From this, it can be concluded that the study follow-up 
period (i.e. 6 weeks) was too short. This could explain why there were no significant 
differences (no detectable effect) between the control and intervention groups in the scores 
for EQ-5D and Patient Enablement Instrument scores at two, four and six weeks follow-up. 
I can draw from at least one example in the study where a nursing home patient scored high 
(‘very much distressed by’) for nearly all of the items on SPARC, and was in an extremely 
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distressed state. However the health care professional caring for the patient said that the 
institution wasn’t able to meet the patients’ needs at that time, and the practitioners and 
nursing staff were aware of this. The patient wanted more independence and didn’t want to be 
in a nursing home in the first place, but for a patient to suffer from this level of distress is of 
great concern. The precise reasons why this may be the case is unknown as the patient died 
during the study, and I was unable to interview him. This finding suggests that SPARC does 
have a role in identifying holistic needs of patients in nursing homes, but how we then 
address these concerns for this group of patients and those in other care homes and 
institutionalised care settings requires urgent attention. Patients in these settings may benefit 
from a timely shared-care model approach to care with a much greater involvement of the 
palliative care team, but this is likely to have resource implications.    
There has been an independent evaluation of SPARC by staff at the Sheffield Hospice prior 
to this study, and the results were positive and encouraging. However at the time of this study 
SPARC was not incorporated into practitioners’ role, and this accounts for one of the main 
underlying reasons as to why there was little or no patient follow-up following completion of 
SPARC. SPARC was not seen as part of routine clinical practice, and practitioners just 
viewed it as another piece of information, like getting a letter from a GP/clinic, thus they 
wouldn’t ring the patient up and discuss the results. There was a suggestion that if SPARC 
was used on a day to day basis as part of the culture, then perhaps practitioners may have 
been more proactive.  
The findings also seem to suggest that some assessors felt that it was not the right time to talk 
about and address unresolved or outstanding issues or problems, and felt more comfortable 
with addressing these later on down the line when a better relationship was formed with the 
patient. I can draw from one specific example in the study where a patient had brought up the 
sexuality issue, but the practitioner caring for this patient said that this wouldn’t necessarily 
have been something that she would have gone straight into talking about on her first 
assessment of the patient. It was interesting and very useful for practitioners that these issues 
were brought up much earlier on than would otherwise have been the case if they hadn’t used 
SPARC.  
Many patients had not seen anyone from the palliative care team for a considerable amount of 
time or not heard from anyone, and did not have any follow-up appointments throughout the 
duration of this study. This study has demonstrated that some of these patients were in a 
distressed state and should have been recalled back to the service. Some patients seem to 
suggest that their practitioners were unable to find out what was wrong with them, and 
therefore it was not much point going back to them. Both patients and practitioners suggested 
that problems, concerns, and issues change over time and that there is a need to periodically 
review patients and capture these changes, this is where SPARC would be a very useful 
safety net, if acted upon in a timely fashion.  
There is a genuine and well-founded concern and belief that SPARC may increase workloads, 
especially in bringing back discharged patients, because not all patients stay continually on 
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the caseload. This has resource implications. That said, there is all round agreement that 
SPARC may be a more efficient and effective way of identifying problems, concerns, or 
issues and may actually save time in the long run, because SPARC helps patients focus on 
everything that distresses them. The cost-effectiveness of using SPARC needs to be 
established.   
There was considerable discussion around barriers to the relief of distress highlighted by 
SPARC. There are concerns over limited resources available, time constraints i.e. limited 
time to discuss, unpack problems, issues and concerns, and difficulties with accessing and 
referring patients to psychotherapy services (e.g. psychologist, or psychiatrist). There are also 
difficulties with accessing home care/intensive home nursing/24hr nursing service, as well as 
other services. This is an accurate reflection of the kind of barriers to the relief of distress in 
the service, and one must be mindful of these when using SPARC. There is more work that 
needs to be done in order to identify these barriers and how best to overcome them.  
Overall, supportive and palliative care health care professionals and patients considered 
SPARC to be an acceptable and relevant tool for the clinical assessment of supportive and 
palliative care needs (Ahmed et al., 2009; EAPC abstract, 2015; Hughes et al., 2015). 
However, the intervention was not sufficiently integrated within existing holistic needs 
assessment practice to impact on health care professionals’ perceptions of their patients’ 
needs, and therefore would not in itself prompt action. There is compelling evidence here to 
suggest an implementation failure, with little disagreement between practitioners and patients 
views on the underlying reasons for the lack of patient follow-up after the completion of 
SPARC. The effective integration of SPARC into routine care and standard operating 
systems requires further investigation, and systems and services must be in place to meet 
those needs in a timely manner.   
A direct comparison of HCPs’ views with patients’ views on: 1) the usefulness of completing 
SPARC is summarised in Figure 13; and 2) the possible reasons why no beneficial effect was 
seen as a result of completing SPARC is summarised in Figure 14.
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Figure 13: Usefulness of completing SPARC (Patient vs HCP views)    
Patient views  
 HCP views
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Figure 14: Possible reasons why no beneficial effect seen as a result of completing SPARC 
(Patient vs HCP views) 
Patient views  
HCP views  
205 
Chapter8
Thesissummaryanddiscussion8
In this concluding chapter, I will start by synthesising and discussing the key findings across 
the thesis chapters, including conclusions about the assessment and when it does and does not 
work. I will discuss some of the methodological and ethical challenges that were encountered 
and the strengths and limitations of this study. Next, I will discuss the findings of this study 
in the context of other studies, and what insights implementation theories/ models may add 
(e.g. Normalization Process Theory and PARiHS). I will then discuss the implications for 
future research and practice, which is followed by a separate conclusion section. Finally, I 
present the main clinical, methodological and theoretical contributions that this doctoral 
thesis makes to the existing knowledge and literature in this field.  
8.1 DiscussionofresultsofpilotRCT
This doctoral study was conducted within the context of a pragmatic randomised controlled 
trial and nested within the MRC framework for evaluating complex interventions. An 
embedded (or nested) concurrent mixed methods design was considered the most appropriate 
design for this study. The rationale for this design is discussed within this thesis. The primary 
objective was to design and undertake a pilot study to evaluate clinical outcomes associated 
with the use of SPARC. The trial itself focussed primarily on outcomes, not on the processes 
involved in implementing the intervention.  
The purpose of this PhD and a secondary objective of the trial, was to undertake a process 
evaluation. On reviewing the literature, it became increasingly apparent of the importance of 
combining quantitative and qualitative research methods approaches in the development and 
evaluation of complex interventions in palliative care research. The process evaluation study 
comprised of three additional strands of work namely: 1) analysis of semi-structured 
interviews with patients; 2) analysis of semi-structured interviews with health care 
professionals; and 3) retrospective case note reviews (presented under findings and analysis 
of Phase I: outcome evaluation, Chapter 4). The use of qualitative and secondary 
quantitative analysis approaches alongside randomised controlled trials of complex 
healthcare interventions, in order to gain a better understanding of ‘whether and how an 
intervention works (or does not work) and inform the design of subsequent studies’ is highly 
recommended (Craig et al., 2008a; Craig et al., 2008b; Ellard et al., 2011; Ezendam et al., 
2013; Farquhar et al., 2011; Flottorp et al., 2003; Francis et al., 2013; Grant et al., 2013; Hind 
et al., 2010; Moore et al., 2015; Toroyan et al., 2004; White, 2013).   
This study provided an opportunity to ‘test-drive’ SPARC with patients that have supportive 
and palliative care needs. The hypothesis was that the use of a validated multidimensional 
holistic screening tool for supportive and palliative care needs, namely; SPARC would lead 
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to improved recognition of supportive and palliative care needs, and improved health care 
outcomes for patients (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 2015). 
This was an open, pragmatic, randomised controlled trial. Patients (n=182) referred to        
the palliative care service were randomised to receive SPARC at baseline (n=87) or after a 
period of two weeks (waiting-list control n=95). Primary outcome measure is the difference 
in score between Measure Yourself Concerns and Wellbeing (MYCAW) patient-nominated 
Concern 1 on the patient self-scoring visual analogue scale at baseline and the two-week 
follow-up. Secondary outcomes include difference in scores in the MYCAW, EuroQoL   
(EQ5D), and Patient Enablement Instrument (PEI) scores at Weeks 2, 4, and 6. As part of a 
process evaluation, case notes were reviewed at week 8, and semi-structured interviews were 
undertaken with a sub-group of patients and health care professionals (Ahmed et al., 2015).
In this pragmatic randomised waiting-list controlled trial, a higher proportion of patients in 
the control group (34/70; 48.6%) showed an improvement in their MYCAW score from 
baseline to Week 2 compared with patients in the intervention group (19/66; 28.8%) 
(p=0.019). There was no positive effect of the intervention on either the primary or secondary 
outcome measures at two weeks. This was an unexpected finding and raises questions about 
the trial design, application of the intervention and the context in which SPARC is used 
(Ahmed et al., 2015). The secondary outcome measure of quality of consultation similarly 
failed to detect any effect of the intervention. This is supported by the interview data from 
patients that indicate that most patients felt no particular action or benefit followed from the 
completion of SPARC (Ahmed et al., 2015). Only a few patients who had no recent contact 
with palliative care service and scored high for some SPARC items were recalled by the 
service and reassessed.  
There were no meaningful or significant differences between the control and intervention 
groups in the scores for EQ5D and PEI at 2 weeks, 4 weeks or 6 weeks, suggesting that the 
intervention did not have a detectable effect.   
When data that applies to the study overall population (intervention plus controls) was 
considered, health-related quality of life as recorded in the general measure EQ5D is 
changing for the worse in this study population as would be expected of patients attending a 
palliative care service. However, the most important issue for patients as recorded in 
MYCAW appears to be improving suggesting that usual palliative care is having a beneficial 
effect in this respect. No change is observed in the quality of consultations as recorded in PEI 
throughout the duration of the study (Ahmed et al., 2015).   
A number of barriers were identified to the relief of distress highlighted by SPARC: these 
have been presented in considerable detail in Chapter 7. Only 5/164=3.0% patient notes 
made any direct reference to SPARC. This trial result identifies a potential negative effect of 
SPARC in specialist palliative care services, raising questions that standardised holistic needs 
assessment questionnaires may be counterproductive if not integrated with a clinical 
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assessment that informs the care plan (Ahmed et al., 2015). Overall, participants and health 
care professionals considered SPARC an acceptable and relevant tool for the clinical 
assessment of supportive and palliative care needs (EAPC abstract, 2015). 
The supplementary question on SPARC, endorsed the overall view that the questions were 
clear, well written, easy to understand and complete, appropriate and relevant. The 
underlying issues and reasons for little or no follow up; patient views (Chapter 6); and 
practitioner views (Chapter 7); and a comparative analysis has been presented in 
considerable detail in Chapter 7 (patient vs. practitioner views). For the small number of 
patients where completion of SPARC resulted in either referrals being made or consultations 
being undertaken in the form of a follow-up call, these took place after the study duration 
period, so one would not expect to see any changes in health outcomes during the first six 
weeks of the study. These are very important considerations that one must consider when 
designing any future study of the clinical utility of SPARC.  
8.2 Strengthsandlimitationsofthestudy
The main strength of this trial was that it was undertaken in a real setting rather than 
artificially controlled conditions or settings. When considering data quality, it can be 
concluded that the study design and methods were appropriate to the study population. The 
26.5% (225/850) recruitment rate is one indicator of this, as is the fact that out of 225 patients 
that consented, only 7 withdrew for reasons of burden of research assessments. The lack of 
differences between study arms for either demographic factors or baseline research 
assessment values is another indicator of good data quality and a successful randomisation. 
The strategy of stratification for baseline quality of life was added to the design to ensure 
equivalence between trial arms. It appears that this was successful with the exception of the 
number of hospital admissions in the 12 months prior to baseline. The difference was not 
statistically significant but may have had a bearing on changes in MYCAW scores; Group A 
(intervention) was 6.30 (median 4; SD =6.60) and in Group B (control) was 4.45 (median      
3 SD = 5.67), (Mann-Whitney Z= -1.593; p=0.111). This is reflected in the difference in the 
mean number of days in hospital in that time; Group A (intervention) 22.15 versus Group B 
(control) 15.51. This raises the question of using patients’ history of admission as a criterion 
for stratification. 
Although recruitment rates were very close to estimates in the study protocol, these tailed off 
towards the end of the data collection period. A total of 850 invitations were sent out, leading 
to consent obtained from 225 patients (225/850=26.5% response rate) and 182 patients  
returning baseline data. 152 patients completed the 2-week questionnaires as against 128 
required to achieve adequate power.  
In relation to the aim of the study concerning the feasibility of an RCT of early holistic needs 
assessment, using SPARC; it can be concluded that the estimates of recruitment rates were 
broadly correct. Instead of an estimated 75% attrition rate limiting the data returned at two 
weeks, a 32.4% attrition rate was observed from consent to two-week follow up in a 
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population largely made up of home care and out-patient clinic patients. This limited study 
population required the continuation of trial recruitment for a period of 5 months to allow 
data collection to the required power achieved with data from 128 patients at the crucial 
analysis of the primary outcome. 
The lack of success in recruiting patients within the hospital support service meant that the 
study sample had fewer patients with conditions other than cancer and a smaller proportion of 
patients acutely ill than the whole population of patients referred to the palliative care service 
(Ahmed et al., 2015). In fact, the poor recruitment in the hospital support team was due to a 
lack of credibility of the process amongst clinical team members, they were concerned that 
SPARC raised problems and expectations that could not be resolved. The consequence was 
that attrition in this study population was rather less than expected and it is possible that we 
missed an opportunity to allow the intervention longer to achieve an effect in individual 
patients. It would be recommended that future trials of SPARC carry out a first research 
assessment significantly later than two weeks following baseline assessment to allow clinical 
intervention related to SPARC returns.  
The lack of recruitment of patients with conditions other than cancer, in large numbers, has 
meant that the aim of comparing their difference in quality of life at baseline was impractical. 
However, it was possible to compare patients identified as cancer survivors with those cancer 
patients receiving end of life care. A significant difference was detected only in the EQ5D 
thermometer score, with cancer survivors reporting a better quality of life than those 
receiving end of life care. This finding is consistent with previous studies measuring a 
deteriorating quality of life as death approaches and highlights the continuing and increasing 
need to relieve distress in the terminal phase of cancer. However, no difference was detected 
between groups in the MYCAW first concern score, PEI or other EQ5D scores, suggesting 
that it is the quantity of distressing symptoms, rather than the intensity of particular concerns 
that worsens as life comes to an end.  
It is possible that the context of a specialist palliative care service is the most difficult 
environment to test a new holistic needs assessment technology, in that the existing 
assessments used by the trained clinicians may well be sufficient to detect all the issues that 
require attention and there are the skills within the service to do what can be done in terms of 
improving quality of life, with or without using SPARC (Ahmed et al., 2015). 
A further aspect of the design of the intervention, already identified as a possible weakness of 
the study, is that it was confined to administering the SPARC questionnaire and informing 
the attending health care professional of the results. It is possible that this is insufficient to 
change practice within a service; and without a change in behaviour (Campion-Smith et al., 
2011), no effect is possible. It was assumed that benefits follow from actions prompted by 
SPARC returns. The intervention may not have been sufficiently integrated within existing 
holistic needs assessment practice to impact on health care professionals’ perceptions of their 
patients’ needs, and therefore would not in itself prompt action. It is recommended that future 
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trials should link the revelation of SPARC data to the consultation, thus facilitating action on 
issues identified by the assessment. An alternative recommendation is for trials of SPARC in 
primary care or general hospital ward populations. Patients might also benefit from receiving 
SPARC at the point of referral to the palliative care service and at the point of discharge.   
It is also possible that a standardised intervention such as SPARC, will never supplement the 
quality of care unless it is properly integrated with the clinical methods and routine care 
planning procedures of the clinical team. Scandrett et al., 2010, propose that new methods to 
achieve practice change should be considered and evaluated when assessing such 
interventions (Ahmed et al., 2015).  
8.3 Resultsincontextofotherstudies
Several lines of research suggest that there is a wide variety of assessment tools currently 
used by health care professionals to assess patients’ needs, and there appears to be a 
considerable amount of questionnaire/tool validation research already undertaken (Ahmed et 
al., 2014; Richardson et al., 2007). Many of these tools have been developed primarily to 
address the needs of cancer patients. The feasibility and acceptability of these tools            
(i.e. patients’ views on being asked to complete an assessment questionnaire/tool, reasons for 
non-response, time needed to complete or administer, and practitioners’ views) to both 
patients and practitioners for use in routine clinical care is lacking, and identified as a severe 
limitation of all the cancer needs assessment tools (Richardson et al., 2007).  
There is a lack of good quality prospective trials in this area which is in need of urgent 
attention. Richardson et al., 2007, recommend that we now shift the focus of our attention on 
establishing the effectiveness and clinical utility of these tools i.e. how one might integrate 
these tools into routine care and practice and determine what impact these tools have on care 
processes and service utilisation.  
There is a need for greater transparency and documentation of the process of tool 
development, and all key stakeholders (e.g. health and social care professionals, patients, and 
relevant consumer groups) must be involved in all stages of tool development, to ensure that 
tools are not only feasible, relevant and acceptable but also ‘fit for purpose’. There must also 
be evidence that they are effective i.e. produce measurable beneficial outcomes in a broad 
range of patients (Cancer Action Team Holistic Common Assessment of Supportive and 
Palliative Care Needs for Adults with Cancer: Assessment Guidance, 2007; Richardson et al., 
2007).  
There are a number of assessment tools e.g. Problems and Needs in Palliative Care 
instrument (PNPC), SPARC, symptoms and concerns checklist and Needs at the End-of-life 
Screening Tool (NEST) that have been specifically developed to meet the needs of advanced 
cancer patients. These tools were developed for use in an outpatient clinic, with a few 
exceptions; the Needs Evaluation Questionnaire (NEQ) and the NEST, which were designed 
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for hospitalised cancer patients and the SPARC and symptoms and concerns checklist can 
also be used in a primary care setting (Richardson et al., 2007).  
It is important to recognise that not all of these tools will cover all of the domains considered 
important for a ‘holistic assessment’. We know from previous work undertaken in this field 
that the degree of coverage varies widely. The most comprehensive instruments with respect 
to health status (defined as covering to some degree the full range of needs related to health 
status) include the Problems and Needs in Palliative Care instrument (PNPC), Oncology 
Clinic Patient Checklist (OCPC), symptoms and concerns checklist, Supportive Care Needs 
Survey (SCNS), the Distress Management Tool and SPARC (Richardson et al., 2007).  
The importance of improving methods for the recognition of supportive and palliative care 
needs is widely acknowledged by the research community, however Richardson et al., 2007, 
argue that this does not necessarily lead to improved patient management or improved patient 
outcomes, without careful care planning, in other words systems and services must be in 
place to meet those identified needs in a timely manner. Furthermore, there appears to be a 
lack of coordination between the different practitioners both within and across disciplines for 
sharing of patient information leading to repeated and sometimes ‘unnecessary assessments’, 
or ‘duplication of efforts’ (Richardson et al., 2007).  
In the field of supportive and palliative care, it is important to improve clinical or patient-
centred outcomes which may include one or more of the following: improving a patients’ 
quality of life; reducing their levels of unmet need; improving patient–practitioner 
communication; and improving a patients’ well-being; or their satisfaction with the care 
received.  
The practitioners interviewed in this study were using assessment tools that they felt most 
comfortable using, or ones that had been developed ‘in-house’ or ‘custom designed’ by the 
team. There is some concern over this practice as not all of these tools have undergone 
rigorous psychometric testing and validation, and for some the clinical utility has not been 
established. There is a need to build the evidence base prior to using tools in routine care.  
To my knowledge, only two published studies have examined the clinical utility of holistic 
needs assessment tools. These two tools are: 1) The Initial Health Assessment (IHA), 
designed to improve the recognition and documentation of a patients’ supportive care needs 
(Crooks et al., 2004; Richardson et al., 2007); and 2) NEST13+ (Needs of a social nature; 
Existential concerns; Symptoms; and Therapeutic interaction), a screening tool for advanced 
illness care needs (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 2015; Richardson et al., 
2007; Scandrett et al., 2010). Although these two studies have measured changes in clinical 
outcomes following needs assessment, to my knowledge no controlled study has 
demonstrated an improvement in clinical or patient reported outcomes as a result of the 
intervention (administration of the tool) (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 
2015).  
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The Initial Health Assessment (IHA)   
The IHA is designed to improve the recognition and documentation of a patients’ supportive 
care needs. The form comprises of twenty-two supportive care items under eight domains of 
need: physical; psychological; daily living; social; financial; informational; special needs and 
personal resources.  
Crooks et al., 2004, undertook a study to determine whether the introduction of the IHA 
into clinical practice leads to an improvement in the assessment of a patients’ needs, personal 
resources available to meet the needs identified (primary outcome) and documentation of a 
management plan of care (secondary outcome) to meet unresolved needs as compared to 
routine practice. The IHA was introduced during a patients’ first visit to a comprehensive 
cancer centre (Hamilton Regional Cancer Centre). A before (i.e. pre-intervention evaluation; 
T1 over a 3-month period) and after (post-intervention evaluation; T2 over a 3-month period) 
study design was employed. The Charts of consecutive patients (n=306 charts evaluated; 153 
each in T1 and T2) with newly diagnosed cancer were randomly selected.  
The authors describe how the introduction of IHA significantly increased the mean 
documentation of supportive care needs and resources from 26% in T1 to 49% in T2 
(p=0.001), significant improvements were seen in all domains of need and this was most 
evident for psychological needs, increasing from 9% in T1 to 49% in T2 (p=0.0001). 
However, there was no significant improvement in the documentation of the management 
plan (outcome of secondary importance) for supportive care services delivery to meet unmet 
needs (28% in T1 versus 32% in T2, p=0.10). This was identified as one of the major 
limitations of the IHA. The authors concluded that while the results were encouraging and 
promising with respect to improving documentation of supportive care needs and resources, 
further work was necessary to establish the clinical utility of IHA. The authors argue that 
clinician behaviour is complex, and certain factors may have influenced this (e.g. their 
knowledge, attitudes and ability), and the introduction of the IHA into clinical practice and 
routine care is unlikely to change or motivate practitioners’ values, behaviours or practices 
without further support, training and education. Further support and training sessions (given 
to staff to complete the IHA, especially in the area of planning of supportive care service 
delivery), better time allocation for those who undertake an assessment and endorsement of 
IHA may help to improve the documentation, assessment and outcomes. These findings are 
not dissimilar from the findings of this doctoral study. The authors point out several other 
potential limitations, these include relying on a documentation in the patients’ chart as an 
indicator of assessment of patients’ supportive care needs, and not all needs are documented, 
and lack of need is just as important to document as the presence of a need, this is where a 
tool like SPARC would be useful. The before-after design was chosen to evaluate the IHA 
over an RCT design, mainly due to ‘logistic’ limitations in performing an RCT at a single 
centre (Crooks et al., 2004; Richardson et al., 2007).   
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NEST13+ (Needs of a social nature; Existential concerns; Symptoms; and Therapeutic 
interaction) 
Scandrett et al., 2010, assessed the feasibility and effectiveness of the NEST13+ (Needs of a 
social nature; Existential concerns; Symptoms; and Therapeutic interaction) as a screening 
tool for advanced illness care needs. The tool comprises of 13 initial screening questions and 
depending on the answers, the tool has the ability to evaluate identified needs in more detail 
with a potential to ask 48 questions. The authors describe the tool as a ‘comprehensive’ needs 
assessment tool, but brief enough for bedside administration. A controlled trial with 451 
patients hospitalised for cancer care at a comprehensive cancer center was undertaken. The 
primary objective of this study was to determine whether the introduction of NEST13+ into 
clinical practice, would lead to an improvement in the documentation of patients’ needs (e.g. 
social, emotional, physical, and care-system needs), and an improvement in clinical outcomes 
for cancer patients in tertiary care.  
Patients were asked 13 initial screening questions (intervention arm), followed by more in-
depth level of questioning (only asked if individuals exceeded a certain threshold level for the 
screening questions). In the intervention arm, clinical recommendations were generated for 
each dimension of need and results were conveyed to the clinical team caring for the patient. 
Subjects were assigned to either the intervention or control arm (subjects were blinded).  
A baseline assessment was undertaken in both groups, and further assessments undertaken at 
the pre-intervention phase and then again at the post-intervention stage, patients received 
usual care plus NEST13+ (yes and no answers, items rated 0-10 scale; 10 highest severity 
rating) and 48 follow-up evaluation questions (intervention arm), this was compared with 
usual care alone (control arm). Patients in the control arm were asked twelve questions about 
satisfaction with facilities and admission process (Control arm Sham interview), 
measurements included: documented needs; clinician response; patient perception of goals 
alignment; and overall quality of palliative care. The main finding from this study was that 
the introduction of NEST13+ tool in the clinical setting facilitated greater documentation of 
illness-related needs than routine clinical assessment i.e. significantly more needs were 
documented in the intervention group patients compared with patients in the control group  
(in 7 content areas), with physical needs being documented highly in all groups. The authors 
concluded that NEST13+ tool facilitated identification of a much wider range of important 
needs as compared with the ‘existing or traditional evaluation’. Interestingly, NEST13+ 
identified several important psychosocial needs. This led them to conclude that the ‘existing 
or traditional’ evaluation of patients’ needs may be in need of improvement. The quality of 
care as judged by expert chart review showed no significant differences between the two 
groups i.e. the intervention did not lead to any detectable improvements in care, changes in 
the clinician response were described as ‘modest’, and changes in outcomes were not 
significant (Scandrett et al., 2010). 
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One major limitation identified relates to the generalisability of the results to other patient 
settings because patients were recruited from a tertiary cancer inpatient center. There was 
also the possibility of some cross contamination of subjects in control and intervention 
groups (patients recruited from each of 4 oncology units treated by same clinical teams), and 
a large number of patients were ineligible due to the study inclusion criteria.  
The findings from this study, in many ways resemble and mirror the findings of this doctoral 
study. Firstly, uptake of recommendations from NEST13+ intervention was described as 
poor, secondly, the integration of identified problems, concerns and issues into a 
comprehensive care plan was incomplete, and thirdly, the outcomes of care remain 
unchanged, and like SPARC the clinical effectiveness of NEST13+ remains to be established.  
Limitations of these studies may include inadequate power to detect a change, the tools may 
not be appropriate or not comprehensive enough for holistic needs assessments, or the 
outcomes chosen may have been inappropriate (Ahmed, 2010; Ahmed et al., 2014; Ahmed et 
al., 2015; Hales et al., 2010; Salisbury et al., 1999; Zimmermann et al., 2008). Although 
many of these studies have shown an improvement in the documentation of needs, uptake of 
any recommendations from the intervention and assessment of needs have been described as 
poor, with no significant overall improvements in care outcomes (Ahmed, 2010; Ahmed et 
al., 2014; Ahmed et al., 2015).  
The precise reasons for these findings are unclear, but may be related to health care 
professionals’ attitudes, knowledge or skills, as well as timing of the recommendation and the 
availability or non-availability of services (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 
2015; Scandrett et al., 2010). As stated above, it is possible that a standardised intervention 
such as SPARC, will never supplement the quality of care unless it is properly integrated with 
the clinical methods and routine care planning procedures of the clinical team (Ahmed, 2010; 
Ahmed et al., 2014; Ahmed et al., 2015).  
8.4 Discussionofpatientsemi-structuredinterviews
A qualitative study concerning the views of patients about their experiences of completing 
SPARC was conducted within the context of a pragmatic randomised controlled trial and 
nested within the MRC framework for developing and evaluating complex interventions, it 
may help in the interpretation of the trial outcome results. Eliciting the views of patients 
represents an important phase in the development of SPARC (Hughes et al., 2015).   
In terms of ease of completion, appropriateness and relevance of SPARC, overall most 
patients interviewed found SPARC either quite easy to complete, fairly straightforward, 
simple, or they had no problems in completing it (EAPC, 2015), and many patients regarded 
the questions on SPARC to be either, suitable, appropriate, or relevant and applicable. 
Additionally, qualitative comments (supplementary question on SPARC) endorsed the overall 
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view that the questions were clear and well written, easy to understand and complete, 
appropriate and relevant.  
Only a small number of patients considered the questions on either religious and spiritual 
issues, worrying thoughts about death and dying, some family and social issues questions, 
and the psychological questions to be sensitive or too personal. However other patients 
valued these questions and the consensus view appears to be that these questions should be 
included, despite the sensitive or personal nature.  
Although the experiences of patients completing SPARC generated a wide variety of 
responses, overall most patients considered SPARC to be helpful, worthwhile completing, or 
generally a good idea or concept. Only a small minority of patients considered SPARC to be 
unhelpful, with some patients making reference to the negative impact of completing SPARC 
on other people, such as on family or carer/s. 
On the issue of timing of administering SPARC to patients, most patients appear to be in 
favour of SPARC being administered before or just after the patient goes to see the doctor or 
consultant; at the very beginning (perhaps not on the very first visit) or early stages of the 
illness; and perhaps then again at regular intervals as a follow-up. Many patients cited time 
constraints/limited time available to see a doctor or a health care professional in clinic.  
On the contrary, some patients felt that SPARC may not be entirely appropriate for newly 
referred patients, or for those patients going through the first or very early stages of the 
illness, with some suggesting that a more appropriate time to consider administering SPARC, 
would be after the patients have had a chance to accept the diagnosis and have had some time 
to come to terms with their illness. The sensitivity around which type of patients, in particular 
how and when patients should be approached requires careful consideration.  
A crucial finding in the context of the trial (EAPC abstract, 2015), was that most patients felt 
that no particular action or benefits followed from the completion of SPARC (Ahmed et al., 
2015; EAPC, 2015). Only a small number of patients that scored high for some SPARC items 
were contacted or recalled by the service and reassessed, there are numerous possible reasons 
as to why most patients interviewed felt no improvement or beneficial effect following 
SPARC administration, and these have been presented in considerable detail. 
What is clear from this interview data is that there is an urgent need to improve the way 
patients’ needs are identified and managed in a timely manner, in particular how best to 
follow-up patients discharged from the service. Furthermore, there are resource implications 
that one must also consider.  
Many patients talked about the general lack of information and poor levels of communication 
from health care professionals about their illness, treatment or care, with some patients 
suggesting that they would have benefited from more explanation from health care 
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professionals about their illness, that said, fifteen of the seventeen respondents praised the 
service, care, or treatment that they received, with many pleased with the level of care they 
received, particularly at the hospice.  
Although patients with a cancer diagnoses were the largest single category, previous work 
has demonstrated acceptability and relevance of SPARC across a range of disease and 
conditions (Hughes et al., 2015).  
This qualitative study has revealed useful insights into how SPARC might be used in practice 
(EAPC, 2015), and to the best of our knowledge is the first to explore the reasons as to why 
we may have observed no significant overall improvements in care outcomes following the 
administration of SPARC from the patients’ perspective (Ahmed et al., 2015). The results of 
this study, and others (Hughes et al., 2015), indicate that SPARC is a suitable, relevant, 
applicable and useful tool for the holistic assessment of supportive and palliative care needs, 
with the potential to improve health care professionals’ understanding of patients’ needs 
(Hughes et al., 2015).  
The availability of services and resources to respond to any identified needs requires careful 
consideration (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 2015; Pollock, 2015). 
Systems and services must be in place in order to address any identified needs in a timely and 
sensitive manner (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 2015; Barclay & Maher, 
2010; Bristowe et al., 2015), and we must consider and evaluate new methods to achieve 
practice change.  
Taken together, the findings from this component of the study, together with the qualitative 
feedback about patients’ experience of completing SPARC, would strongly point to an 
implementation failure rather than failure of the SPARC intervention itself (Ahmed et al., 
2015). The potential negative effect of SPARC in a specialist palliative care service could be 
due to the failure of health care professionals to act on identified needs in a timely manner, or 
related to the raising of patients’ expectations that are not subsequently met (Ahmed et al., 
2015). Further research is also needed on the effective integration of these tools into routine 
clinical care. Future work must therefore address these issues. The findings from this work 
serves as a useful guide for researchers designing future supportive and palliative care 
complex trials.  
8.5 Discussionofhealthcareprofessionalsemi-structuredinterviews
A qualitative study was undertaken to elicit the views of supportive and palliative care health 
and social care professionals about their experiences of using SPARC during the trial. The 
study was conducted within the context of a pragmatic RCT and nested within the MRC 
framework for developing and evaluating complex interventions (EAPC abstract, 2015), in 
order to help in the interpretation of the trial outcome results (Craig et al., 2008a; Craig et al., 
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2008b). Eliciting the views of health and social care professionals represents an important 
phase in the development of SPARC (Ahmed et al., 2009; Hughes et al., 2015).   
Although there are some similarities, particularly amongst the hospice staff in assessing 
patients’/families’ holistic needs, there appears to be no definitive method, model or any 
particular set of tools used for assessing patients’/families’ holistic needs. Assessment often 
involved a routine clinical/medical interview undertaken in a ‘conversational style’ that had a 
professional agenda as a structure, but was mainly described as being ‘patient-led’. Referral 
forms and discharge summaries from the wards were often used by health care professionals 
as guides and starting points for undertaking a holistic needs assessment. An holistic needs 
assessment document (covering all systems) appears to be the most commonly used 
model/template used by the hospice staff. Nearly all of the health care professionals 
interviewed were aware of SPARC before the study, and most had some experience of using 
SPARC prior to study commencement.  
Interestingly, just over half of the sample of health care professionals interviewed said that 
they had limited or no feedback from patients about using SPARC, or had not discussed it 
with them, generally the feedback received from those patients that gave it was positive. 
Health care professionals said that they used a combination of methods (by telephone, letter, 
or face to face) depending on the circumstances to discuss SPARC results with patients, 
however the preferred method appears to be face to face rather than phone 
discussion/consultation with patients. Health care professionals said that on most occasions 
the completion of SPARC by the patient often initiated another discussion with the patient. 
The majority of health care professionals stated reasons as to why completing SPARC 
resulted in no changes in actions taken for the better or for the worse. All 20 health care 
professionals taking part in the study had something positive to say about the usefulness of 
SPARC, comments on usefulness of SPARC were in the majority. Most participants 
welcomed this as another way for patients to communicate their problems, issues and 
concerns, with some suggesting that writing things down on a form may help patients feel 
more comfortable discussing and bringing up concerns, particularly in discussing the more 
sensitive issues/personal issues that they would have otherwise felt uncomfortable talking 
about. Just over a half of the sample of health care professionals interviewed stated reasons as 
to why it is, or why it could be potentially unhelpful or not worthwhile for patients to have 
completed SPARC, with some saying that you run the risk of reinforcing the situation and 
problems that can’t be solved, and others saying that sometimes it just adds to the burden to 
what patients are having to cope with anyway.
The majority of health care professionals commented on the most inappropriate/too 
personal/sensitive/invasive/offensive/upsetting/bothering questions on SPARC. These 
questions were identified as being the following: talking about sexual problems; questions 
about death or discussing death; end of life care issues; psychological aspects; the loss of 
independence; feeling that life is not worth living; advanced care planning; treatment issues; 
and the long-term effects of treatment. 
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The main barriers identified by most health care professionals to the relief of distress 
highlighted by SPARC were as follows: the availability of resources; referral to 
psychotherapy services/psychiatrist/psychological support; availability of time to discuss 
things/time to unpack problems in the outpatients setting; increased workloads; privacy on 
the wards; access to home care; availability of intensive home care nursing/24hr nursing 
support; the worry that if SPARC highlighted lots of issues; the health care professional 
wouldn’t have the skills to deal with those issues; identifying something that they can’t then 
fix; and opening up a can of worms that the health care professional is not equipped to deal 
with; or that it opens up a can of worms that the patients weren’t ready to open were some of 
the barriers identified. The majority of health care professionals commented on the timing of 
giving SPARC to patients, the main time points considered as important by health care 
professionals varied and have been presented. Some health care professionals made reference 
to the need for more education, training and skills around the use of SPARC. All 20 health 
care professionals said they would either use SPARC in the future or consider using it. It is 
fair to conclude that the vast majority of health care professionals interviewed in this study 
support the use of SPARC and there seems to be a lot of enthusiasm amongst teams and 
individual members of staff about using SPARC in the future.  
8.6 ImplementationofSPARCintoroutineclinicalpractice
What insights implementation theories/ models may add (e.g. Normalization Process 
Theory, and PARiHS)?  
There are numerous factors affecting implementation that require further exploration, these 
include: clinician attitudes; knowledge and skills; presence of local champions, timing of 
recommendation/s; and systemic barriers to responding clinically. There is a need to 
understand, identify and overcome barriers to change (NICE Guidance, 2013).
The NICE guidance, 2013, recognises that certain factors/conditions may be more conducive 
to facilitating change than others. These include organisations with strong leadership, and 
motivated staff, where the focus and desire is on the continuous improvement of patient care 
(Rycroft-Malone, 2004; Rycroft-Malone et al., 2013). I have identified certain barriers during 
this study e.g. lack of credibility of SPARC amongst some practitioners and concerns over 
changing established practice, which may prevent or impede progress in all organisations.    
In order to develop a successful strategy for change, we must understand all the different 
types of barriers identified during this study, and there is a need to put a clear system in place 
to support the implementation of evidence-based guidance (Rycroft-Malone, 2004; Rycroft-
Malone et al., 2013). This may require a tailored approach to overcoming these barriers 
depending on the organisation, in order to encourage changes in behaviour, but this requires 
further work (NICE guidance, 2013).  
The process evaluation guidance recommends the development of a logic model or 
explanatory model of an intervention i.e. more details about the intervention components and 
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pathways are required in order to deliver the desired outcomes (May et al., 2009; Rycroft-
Malone et al., 2013; Murray et., 2010).    
It is important to engage with key stakeholders including trialists, trial designers, recruiters, 
intervention developers, patient and public representatives, patients and health care 
professionals, and qualitative researchers, throughout the process of development of an 
intervention. Involving users in the design and conduct of evaluations may contribute to a 
better understanding of the processes by which change is achieved (MRC Guidance, 2008). 
The introduction of SPARC into clinical practice does not require a fundamental change from 
usual practices because most practitioners were using some form of assessment tool/guide on 
which to base their assessment process. Therefore one should not experience any major 
challenges in its implementation. However, it is important to consider the wider context in 
which a trial operates, because the context in which the intervention is implemented, 
economic climate, staff shortages, media scares, resources and structures required to achieve 
practice change and the services available to meet identified needs may have an impact on the 
implementation of an intervention (Rycroft-Malone, 2004; Rycroft-Malone et al., 2013).  
Despite the challenges faced, and concerns about the appropriateness of using RCT 
methodology particularly in palliative care research, the RCT methodology, provided it can 
be ethically justified, remains the best means of establishing whether an intervention like 
SPARC has a measurable impact (Bennett, 2007; Grande & Todd, 2000). However the 
importance of undertaking further feasibility work around the use of SPARC and 
implementation is urgently needed prior to embarking on a large scale costly study. Further 
work should focus more on intensive practitioner directed interventions and we must consider 
what insights implementation theories/ models may add (e.g. Normalization Process Theory 
and PARiHS). Additional research on the effective integration of SPARC into routine care is 
the vital next step (May et al., 2009; Murray et al., 2010; Rycroft-Malone et al., 2013).  
There has been considerable interest in the development and evaluation of complex 
interventions to improve health and the MRC complex interventions framework provides a 
useful framework for conducting and reporting of complex interventions (MRC Guidance, 
2008). However, as we have found during this study, for SPARC to have any significant 
impact on the health and well-being of patients and on healthcare, we have to demonstrate 
that SPARC is effective when tested and that it is capable of being widely implemented and 
‘normalized’ into routine care (May et al., 2009; Murray et al., 2010).  
The Normalization Process Theory 
The Normalization Process Theory (NPT) is considered to be an important and useful 
sociological action theory of the implementation, embedding, integration and evaluation of 
complex interventions, new technologies and organisational innovations. It was developed by 
Carl May, Tracy Finch, & colleagues between 2000 and 2009, and is one of the more popular 
theories in implementation science that can be applied to understanding implementation 
problems (May et al., 2009; Murray et al., 2010). NPT is concerned with what people actually 
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do and how they work (i.e. individual and group behaviour) as opposed to their attitudes, 
beliefs or organisation culture. Thus, the NPT focuses on how interventions or practices can 
become ‘routinely embedded or normalized’ in social contexts, hence the name 
‘normalization process theory’ (May et al., 2009; Murray et al., 2010).  
May et al., 2009, outline the four main NPT constructs that represent the different kinds of 
work that people do to implement an intervention/new practice/some new technology. These 
four key concepts are: 1) coherence of intervention (i.e. does it make sense?, how does it 
fit?); 2) cognitive participation of target group (i.e. how engaged and committed are 
providers?); 3) collective action to implement innovation (i.e. how will change occur and 
who will do what?); and 4) reflexive monitoring regarding use of innovation (i.e. appraisal 
work that people do to assess what change occurred?, why or why not?, and how it will affect 
them and others around them?). The gap between research and implementation remains 
problematic and the use of theories such as NPT could be used to address the factors needed 
for successful implementation and integration of interventions such as SPARC into routine 
work (May et al., 2009; Murray et al., 2010). 
The PARiHS framework (Promoting Action on Research Implementation in Health 
Services) 
The PARiHS framework (Promoting Action on Research Implementation in Health 
Services), is a multi-dimensional framework that was developed by The Royal College of 
Nursing Institute, UK, during the 1990’s to address the complexities of change processes and 
variability in success of implementation, and for guiding practitioners and researchers with 
implementing research evidence into routine clinical practice (Rycroft-Malone et al., 2004; 
Rycroft-Malone et al., 2013). The three main elements of the PARiHS framework that are 
known to play an important role in successful implementation are: 1) Evidence                
(sub-elements: research evidence, clinical experience, patient preferences and experiences, 
and the local knowledge/information); 2) Context (sub-elements: culture, leadership, and 
evaluation); and 3) Facilitation (sub-elements: characteristics of the facilitator, role, and 
style). The interaction and association of these elements (i.e. evidence, context and 
facilitation) will determine the overall success of the implementation (Rycroft-Malone et al., 
2004; Rycroft-Malone et al., 2013).  
The PARiHS framework makes reference to certain conditions that are necessary and more 
conducive to facilitating change and integrating evidence into practice (weak to strong 
support for implementation). Successful implementation is most likely to occur when the 
conditions set out in Table 37 are met (Kitson et al., 1998; Rycroft-Malone et al., 2004; and 
Ullrich, 2016).  
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Table 37: Conditions that are considered to be more conducive to integration of evidence 
into practice (Table Adapted from Kitson et al., 1998; Rycroft-Malone et al., 2004; and 
Ullrich, 2016)   
Elements Sub-Elements Criteria 
Strong support for 
implementation  
Weak support for 
implementation 
1) Evidence  
‘Scientific research evidence 
must be sound and fit in with 
professional and patient 
beliefs’ 
‘Well-conceived, designed 
and executed research’
Research evidence ‘RCT, evidence-based 
guidelines’ 
‘Anecdotal evidence, 
descriptive’ 
Clinical experience  ‘Consensus’ ‘Expert opinion is 
divided’   
Patient preferences 
and experiences  
‘Partnership with 
patients and HCPs, seen 
as part of a decision’ 
‘Patients not involved’  
Local information  ‘Information from the 
local context collected 
and analysed 
systematically and 
rigorously’  
‘Local information not 
collected and analysed’  
2) Context 
‘The health care context must 
be receptive to 
implementation of the 
intervention, and this 
requires supportive 
leadership, culture, and 
evaluative systems’
Culture  ‘Learning organisation, 
patient-centred creating 
learning cultures’ 
‘Receptiveness to 
change’  
‘Task-driven, low morale’
Leadership ‘Clear roles, effective 
teamwork and effective 
organisational 
structures’ 
‘Transformational 
leaders (ability to 
transform cultures or 
create), as opposed to 
those who command and 
control’  
‘Enabling/empowering 
approach to 
teaching/learning/ 
managing’  
‘Poor organisation, 
diffuse roles, no role 
clarity’  
Evaluation  ‘Routine audit and 
feedback’ 
‘Feedback on individual, 
team, and system 
performance (from 
multiple sources of 
information and use of 
multiple methods)’  
‘Absence of audit and 
feedback’  
3) Facilitation  
‘Appropriate mechanisms 
must be in place to facilitate 
implementation’ 
Characteristics (of 
the facilitator) 
‘High respect, 
credibility, empathy, 
enabling others, adult 
learning approach to 
teaching’  
‘Low respect, credibility, 
empathy’  
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Role  ‘Clear roles’ ‘Lack of role clarity’ 
Style, skills and 
attributes 
‘Flexible, consistent’  
‘Project management 
skills’ 
‘Technical skills’ 
‘Marketing skills’ 
‘Subject/technical/ 
clinical credibility’  
‘Inflexible, sporadic’  
8.7 Implicationsforfutureresearchandpractice
There are a number of feasibility questions that should be addressed prior to undertaking any 
further large-scale study using SPARC, preferably using qualitative research methods to 
explore further some of the uncertainties around using SPARC in clinical practice. Further 
qualitative work should address issues concerning SPARC acceptability, implementation, 
practicality and expansion to other contexts and different patient sub-groups. Some of these 
questions have been addressed during the course of this doctoral study and during the 
previous work undertaken by the team (Ahmed et al., 2009; Ahmed et al., 2014; Bestall et al., 
2004).  
O’Cathain et al., 2015, have identified a range of issues and questions that qualitative 
research can address in a feasibility study for a future trial or study. The authors emphasise 
the importance of considering the context in which an intervention is delivered during both a 
feasibility study and in the full trial. They argue that addressing these issues during the 
feasibility stage may help to optimise a pilot trial conduct and intervention rather than simply 
identifying problems with it. A process and resource assessment may also be necessary. 
Many of these questions should have been addressed in a feasibility type study and prior to 
undertaking this pilot study, and this perhaps was one of the main limitations of this study, 
while some issues and questions have been addressed as a result of undertaking the pilot 
study on the effectiveness of SPARC, some key questions remain unanswered and may have 
been overlooked. The key issues that any future feasibility study should address include:      
1) intervention content and delivery (e.g. intervention development, intervention components, 
mechanisms of action, perceived value, benefits, harms or unintended consequences of the 
intervention, acceptability of intervention in principle, feasibility and acceptability of 
intervention in practice, fidelity, reach and dose of intervention); 2) trial design, conduct and 
processes (e.g. recruitment and retention, diversity of participants, trial participation, 
acceptability of the trial in principle, acceptability of the trial in practice, ethical conduct, 
adaptation of trial conduct to local context, impact of trial on staff, researchers, participants 
and the health system, patient and public involvement); 3) outcomes (e.g. breadth and 
selection of outcomes); 4) measures (e.g. accuracy of measures, completion of measures, 
development of measures).  
The problems with the implementation of SPARC; experienced during this study are not 
dissimilar to those associated with the use of the Liverpool Care Pathway (LCP). The LCP 
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was developed in the UK, to support patients as they near death (Ellershaw, et al., 2010), in 
some circumstances the system was found to involve inappropriate withdrawal of medication, 
food and fluids, with poor communication and consultation with patients, their families and 
carers. (Neuberger, 2013). It can offer a peaceful and dignified death but there were problems 
with its implementation, the system requires a lot of training and education to put it in place 
and make it work properly (Chinthapalli, 2013; Hodgkinson et al., 2016; O’, Halloran, 2016; 
Sykes, 2015). My study has shown that there is a risk that without appropriate education and 
training and formal systems in place to act on assessments, SPARC could also potentially 
lead inadvertently to negative effects.  
This work supports the need to establish an effective holistic needs assessment system. Any 
discussions with palliative care and end of life care patients must take place in a timely and 
sensitive manner, preferably earlier on in the course of the illness, and be patient-led and 
patient-centred, as one size does not fit all. Hence, there is a need for more individualised, 
personalised care, needs-driven care tailored to meet individuals’ needs, and it is important to 
set realistic hopes and goals in a way that doesn’t raise patient expectations (Barclay & 
Maher, 2010; Bristowe et al., 2015). This could potentially lead to better patient outcomes, 
and improved patient satisfaction. This work also supports the need to undertake holistic 
needs assessments throughout the course of illness or disease trajectory (i.e. from the point of 
diagnosis, before and after treatments and during follow-up), and not just confined to any one 
point in the pathway (NICE Guidance, 2004; Snowden et al., 2015), as per guidance 2004; 
recommendations from the work commissioned by the Cancer Action Team (Richardson et 
al., 2007, Kings College London). Furthermore, it is important to emphasise that the use of 
holistic needs assessment tools; such as SPARC should complement and not replace the face-
to-face clinical assessment by healthcare professionals (Hughes et al., 2015). There is an 
urgent need to develop a system that allows ‘real time’ screening for supportive and palliative 
care needs (Ramchandran et al., 2015), potentially streamlining the process. One approach 
may be to make use of technology or an electronic holistic needs assessment system that 
would allow information from an electronic HNA to be relayed back to health care 
professionals in ‘real time’ i.e. a system that would flag up or raise red flags against 
problems, issues, or concerns that patients identified as most upsetting or distressing, this 
may go some way in reducing the delays in addressing patients’ needs. We also recommend 
that future trials should link revelation of SPARC data to consultations which should then be 
incorporated into a care plan, thus facilitating actions on issues identified by the assessment. 
For those patients that are in the community or that have been discharged or placed on an 
open-appointment system, better supported self-management and remote surveillance is 
needed (Nanton et al., 2016). However, this requires further investigation.  
It is possible that a standardised intervention such as SPARC, will never supplement the 
quality of care unless it is properly integrated with the clinical methods and routine care 
planning procedures of the clinical team (Ahmed, 2010; Ahmed et al., 2014; Ahmed et al., 
2015). Scandrett et al., 2010, propose that new methods to achieve practice change should be 
considered and evaluated when assessing such interventions (Ahmed et al., 2015). The 
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findings from this work serves as a useful guide for researchers designing future supportive 
and palliative care complex trials. The availability of services and resources to respond to any 
identified needs requires careful consideration (Ahmed, 2010; Ahmed et al., 2014; Ahmed et 
al., 2015; Pollock, 2015). Systems and services must be in place in order to address any 
identified needs in a timely and sensitive manner (Ahmed, 2010; Ahmed et al., 2014; Ahmed 
et al., 2015; Barclay & Maher, 2010; Bristowe et al., 2015), and we must consider and 
evaluate new methods to achieve practice change. Furthermore, there are resource 
implications that one must also consider.  
SPARC could be used to improve the identification and documentation of symptoms, issues, 
concerns and problems. SPARC guidance, 2004 needs updating, which should be periodically 
reviewed and updated to reflect the findings of this important piece of work. I would also 
recommend moving towards developing and testing an electronic version of SPARC           
(‘e-SPARC’).  
This study has generated findings of more than local importance, and I have presented this 
study and the research findings at local meetings and at national and international scientific 
conferences in the fields of supportive care, palliative care, cancer care and end of life care. 
This work has so far resulted in a number of reports submitted to Macmillan Cancer Support 
and a number of publications in international peer reviewed journals, and there are plans to 
disseminate further.   
8.8 Conclusion
Studies suggest that cancer and non-cancer patients have needs which are not being met fully 
at the moment. At present, there is no widely used systematic, evidence-based holistic 
approach to screening patients for supportive and palliative care needs. There is evidence to 
indicate a lack of studies on the clinical utility of tools. SPARC is a multidimensional holistic 
tool which provides a profile of needs (i.e. physical, psychological, social, and spiritual) to 
identify patients who may benefit from additional supportive or palliative care regardless of 
diagnosis or stage of disease.  
Despite rigorous psychometric development, preliminary field-testing, and validation, the 
clinical utility of SPARC has yet to be established. The study findings indicate no positive 
effect of the intervention on either the primary or secondary outcome measures at two, four or 
six weeks. The study findings indicate that the primary outcome was affected adversely by 
the intervention within two weeks.  
This trial result identifies a potential negative effect of SPARC in specialist palliative care 
services, raising questions that standardised holistic needs assessment questionnaires may be 
counterproductive if not integrated with a clinical assessment that informs the care plan. It 
may raise patient expectations that are not subsequently met.  
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This trial result calls into question the utility of SPARC in specialist palliative care services 
and raises important questions regarding the application as well as the context in which the 
SPARC intervention is used. It can be concluded that a larger trial with more power to detect 
an effect is highly unlikely to be positive. A larger trial in specialist outpatient or home care 
services, employing the same design and outcome measures is not feasible and unlikely to 
demonstrate any benefit without a different method of administering the intervention 
(SPARC) (Ahmed et al., 2015). It is nevertheless possible that SPARC has utility as a 
screening tool in primary care or general medical care for selection of patients who may 
benefit from a referral to specialist palliative care (Ahmed et al., 2015). Therefore an 
alternative recommendation may be to undertake trials of SPARC in primary care or with 
general hospital ward populations, as a screening tool for palliative care needs in a population 
before referral to specialist palliative care services (Ahmed, 2010; Ahmed et al., 2014; 
Ahmed et al., 2015).
8.9 Contributiontoknowledge
The main contribution to knowledge is that this study demonstrates that an assessment that is 
not linked to clinical method and care plan can be potentially harmful and detrimental to 
patient outcomes.  
In terms of methodological contributions to knowledge the use of qualitative and secondary 
quantitative analysis approaches alongside an RCT of a complex healthcare intervention 
(concurrent mixed methods research) worked well, to provide a better understanding of 
whether and how SPARC works (or does not work) to inform the design of subsequent 
studies and provided useful insights into how SPARC could be used in practice.  
The use of quality of life instruments where the most troublesome concern is nominated and 
scored, in this study e.g. MYCAW, appears to be more sensitive to changes than a generic 
multidimensional measure of health-related quality of life namely; EQ5D. EQ5D may be the 
standard in health economic evaluations (i.e. to assess the value for money of medical 
interventions), but not as sensitive to changes as a result of interventions. It is questionable 
whether health economists are using the correct tools in the context of palliative care. The 
MRC should set standards of how an intervention should be designed. The study provides a 
useful lesson for researchers. 
In terms of theoretical contributions to knowledge, theory has an important role when 
planning implementation research, and we should give more consideration and attention to 
the components of the intervention and the systems into which complex interventions are 
placed. We should focus more on the development of interventions and implementation 
phases, as well as on evaluation and also consider the social, political and geographical 
context in which interventions take place. While some aspects of good practice are clear, 
methods for developing, evaluating and implementing complex interventions are still being 
developed, and on many important issues there is no consensus yet on what is best practice.  
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Study design and protocol writing   
Research Governance and Ethics 
Service user consultation 
Familiarisation with the service and 
introducing staff/centres to study 
Data Collection (15 months) 
Interim Report 
Analysis 
Report writing 
Dissemination 
A no cost extension was approved by Macmillan Cancer Support. In the end recruitment period was 22 months. A final report was submitted on 
31st January 2013. 
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Appendix 18: Case note review data collection Proforma   
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Appendix 19: STH NHS Foundation Trust (Key facts and figures)  
Reference: Information taken directly from the Annual Report, Sheffield Teaching 
Hospitals (STH): Description about the Sheffield Palliative Care Service (context and 
settings) (Palliative Care Annual Report Summary STH 2011/12).  
Overview Sheffield Teaching Hospitals (STH) 
Description about the Sheffield Palliative Care Service (context and settings) 
 Provision of specialist supportive and palliative care service to patients (irrespective of diagnosis), their families and carers in order to 
improve symptom control and quality of life. 
 Settings and sites: Royal Hallamshire Hospital (RHH), Weston Park Hospital (WPH) & Northern General Hospital (NGH). Comprising: 
palliative care inpatient unit, acute hospital, hospital support team, consultant led outpatient clinics, intensive home nursing service 
(providing basic end of life care). 
 2300 patients treated per year. 
 Partnership work with other health professionals/community specialist palliative care services, provision of home care packages. 
 24/7 service on call rota palliative medicine cover (alongside colleagues in Chesterfield), available to patients in all care settings in the 
area. 
 Organisation's total income: £3.1 million, 100% NHS for palliative care. 
 Out of hours availability: Yes. 
Inpatient activity 
 NGH (MPCU): 302 admissions/year.
 Admitted directly from home: 37.4%. 
 National average for inpatient palliative care admissions ending in death in 2010-11: 55.5% (National Council for Palliative Care 
Minimum Data Set Figures, Nov 2011). 
 Mean bed occupancy (MPCU): 91.4% vs national average: 77.3%. 
Hospital Support Team Activity 
 Episodes of Hospital Support across the service: 2,253/year.
 Central campus vs Northern campus: proportionally younger caseload.  
 Northern campus vs Central campus: higher proportion of non-cancer referrals (higher than average percentage at NGH, a reflection 
of open access and flexible service provision).  
 National average for non-cancer referrals to hospital support teams in 2010-11:21.2%. 
 National average for hospital support episodes ending in death in 2010-11: 33.4% with 55.6% ending in discharge home.  
Outpatient activity 
 Outpatient consultations: 883/year.
 Nationally average numbers of attenders per clinic: 2.3 in 2010-11. 
Therapy Report  
 Occupational Therapy and Physiotherapy staff: provision of a wide range of support and interventions (MPCU), with active role in 
discharge planning. 
Bereavement Service 
 Telephone calls main form of bereavement support offered by nursing staff and volunteers.
End of life care pathway: (EOLCP) Facilitator 
 EOLCP Facilitator: role is to help further embed the EOLC Pathway into practice (by more direct clinical input).
 Responsible for Nursing/Medical EOLC education and training at Central and NGH Campus, also Community Nursing. 
 Champions on wards throughout the Trust. 
Cavendish Cancer Care at MPCU 
 Provision of supportive care and complementary therapies at bedside.
 125 people referred for therapy MPCU, NGH (1st April 2011-31st March 2012),114 patients, and 11 carers.
 Of the 114 patients referred, 72 (63%): female and 42 (37%): male.
 Age range: 29 to 98. Median age: 69.
 Non-malignant diagnosis (8/114) made up 7% of the total. 
Oral history and photography service (at MPCU) 
 Opportunity for patients to produce their own audio life story recordings and photographs with specialist support. 
Staffing at MPCU (NGH)  
 Consultant medical staff (n=6), SpRs (n=7), F2s & GP registrars (n=6), Clinical Nurse Specialists (CNSs) (n=9), Social Worker (n=1), 
Occupational Therapist (n=1), Physiotherapist (n=1), Pharmacy Team (n=6), Administrative team (n=4), MPCU Nursing Staff (n=3), Staff 
Nurses (n=26), Support Workers (n=9), Housekeeping (n=3), Oral History Project (n=2), Specialised Medicine Governance Team (n=4). 
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Appendix 20: SLH The Sheffield Hospice (Key facts and figures)  
Reference: Information taken directly from SLH Corporate Brochure 2011/2012 and the 
Minimum Data Set for 2011/2012 St. Luke’s The Sheffield Hospice: Description about 
the Sheffield Palliative Care Service (context and settings). 
Key facts 
 Opened in October 1971.
 Independent charity. 
 Provides support in three settings namely; a 20 bed inpatient unit, the Therapies and Rehabilitation Centre (day care patients), and in 
 the community via a team of 10 specialist palliative care community nurses who provide support to patients in their own homes, or to 
 those in nursing homes/care homes. 
 1,400 patients cared for per year, supports > 5,000 people (patients, families and carers). 
 Cares for adults regardless of age, culture, religion or ethnic background with life limiting illnesses irrespective of diagnosis 
 (cancer and non-cancer). 
 Service is free. 
 Provides specialist supportive and palliative care support to patients attending to their holistic needs, and extends support to their 
 families and carers.  
 Provides ongoing bereavement support (to families and carers). 
 Clinical staff breakdown: Clinical Nurse Specialists: n=10, 1.8 wte Consultants, 1 GP ass. spec. 
In Patient Unit 
 20 bed, service provision 24/, 365 days/year specialist inpatient intensive care.
 Approximately 50% patients discharged home/year. 
 2011-2012: 327 patients cared for in the inpatient unit. 
 Total patients referred: 294 
 Age, gender and diagnosis: 25-64 years: n=73, 65-74 years: n=81, 75-84 years: n=89, 85 years and over: n=51. Male: 141, 
 Female: 153, Cancer/malignant diagnosis: 272, other diagnosis: 22.  
 Ethnicity: White British 276, White Irish: 2, Other White: 5, Pakistani: 1, Other Asian: 3, Black Caribbean: 4, Black African 1, Not 
 Stated: 2. 
 Location after before admission: Patient’s own home (including relative’s or carer’s home): 224, Care Home: 5, Hospital 
 (Acute): 98. Location After end of stay: Died: 201, Patient’s own home (including relative’s or carer’s home): 95, Care  Home: 10, 
Hospital (Acute): 16.  
 Average length of stay: All Patients: 20.5 days, Cancer Patients: 20.3 days, Non-Cancer Patients: 23.1 days.  
Therapies and rehabilitation Centre (Day Care) 
 Provision of specialist therapies, treatments and advice tailored to meet individual holistic needs for patients (both inpatient and in 
 community). 
 Programmes are usually for a set period, patients attend centre once a week. 
 Number of GP referrals is on the increase, average attendance 18 patients/day-every week day. 
 Supports and helps approximately 350 patients to live independently in home/community. 
 2011-2012: 3,242 day-patient visits to the centre. 
 Total patients referred: 374, 19 re-referrals. 
 Age, gender and diagnosis: 25-64 years: n=91, 65-74 years: n=112, 75-84 years: n=111, 85 years and over: n=60. Male: 164, Female: 
 210, Cancer/malignant diagnosis: 338, other diagnosis: 36.  
 Ethnicity: White British 363, White Irish: 3, Other White: 2, Indian: 1, Other Asian: 2, Black Caribbean: 2, Black African 1. 
 Number of deaths: 277, continuing patients: 116. 
 Average length of stay (defined as average duration in days from date of first attendance to death or discharge): 139.  
Community Care 
 10 St.Luke’s Community Specialist Palliative Care Nurses (Community Team) working alongside GPs, district nurses, hospital 
consultants, specialist hospital nurses and other health professionals to provide tailored programmes of care to patients in their own 
homes/in community.  
 Also provide palliative care education/learning to care/nursing homes.  
 10 Community nurses care for around 400 patients in community at any one time point. 
 Can act as a single point of contact, can arrange intensive home nursing if needed via district nurse and Sheffield’s city-wide intensive 
 home nursing service. 
 2011-2012 4,108 patient visits made in total. 
 Total patients referred: 1241 
 Age, gender and diagnosis: 19-24: 1, 25-64 years: n=301, 65-74 years: n=356, 75-84 years: n=357, 85 years and over:  n=226. Male: 
 638, Female: 603, Cancer/malignant diagnosis: 1088, other diagnosis: 153.  
 Ethnicity: White British 1175, White Irish: 10, Other White: 12, Other Mixed: 2, Indian: 3, Pakistani: 11, Bangladeshi: 2, Other Asian: 
 10, Black Caribbean: 9, Black African: 5, Chinese: 2. 
 Deaths: 546, Discharges: 712, Continuing Patients: 200.  
 Patients died: Patient’s own home (including relative’s or carer’s home): 280, Care Home: 107, Hospital/Specialist Palliative Care Unit: 
 76, Acute Hospital: 83. 
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 Average (mean) length of period of home care (defined as average time in days from first visit to death/discharge): All 
 Patients: 55.6.  
Bereavement Support 
 Provision of bereavement Service (by community nurses).
 Hospice has its own hospitality service. 
 Total Service Users: 559.  
 Age, gender and diagnosis of users: 16-18 years: n=2, 19-24: 5, 25-64 years: n=211, 65-74 years: n=102, 75-84 years: n=44, 85 years 
 and over: n=5, Not Recorded: 190. Male: 144, Female: 415, Diagnosis of deceased relative/friend of service user, Cancer/malignant 
 diagnosis: 510, Other Diagnosis: 49, Total: 559.  
 Service Users Ethnicity: White British 379, White Irish: 1, Other White: 2, Indian: 1, Bangladeshi: 1, Not Stated: 175. 
 Service Users Discharged: 396, Number of Continuing Users: 169.   
 Average (mean) length of period of support (defined as average duration in days from date of first contact to date of last 
 contact before discharge): 102.  
Palliative Care Education  
 Commitment to palliative care education and training.
 Hospice staff provide training and education to medical, nursing students and speciality doctors. 
 2011-2012: 70 medical students were on placements, and 17 training doctors. 
Caring for carers and loved ones 
 Provision of care to loved ones, families, and carers.
 2011-2012: 2,135 contacts made with bereaved families and carers. 
Volunteers 
 Play an important role.
 400 of them, ages 16-78 assist with service delivery and with fundraising activities. 
 Many different roles: St.Luke’s shops, as patient companions, assist with fundraising events, and assist with patient transport. 
Financial challenges 
 Cost to run St.Luke’s Hospice/hour: £750 for 365 days/year.
 Only 1/3rd funding from NHS. 
 Significant financial challenges due to recession. 
 Requirement to raise > £4million/year to continue to deliver essential services, savings of > £1 million already made. 
Where the money came from 2011-2012 
 Total £6.872 million.
 Fundraising: 66%. 
 Primary Care Trust (NHS): 34%. 
Breakdown of fundraising income (£4.060 million) 
 Charity shops: 37%.
 Community, corporate, events, trusts, in memory, regular giving: 34%. 
 Legacies: 22%. 
 Lottery: 14%. 
Where the money went to 
 Direct patient care and services: 74%.
 Other costs: 26% (e.g. pay for nurses, HR services, communications, costs associated with fundraising). 
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Appendix 21: Patient invitation letter  
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Appendix 22: Patient information sheet     
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Appendix 23: Patient consent form and EQ5D (thermometer)     
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Thank you for completing this form 
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Appendix 24: Semi-structured interview schedule for patients   
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Appendix 25: Patient invitation letter for semi-structured interview
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Appendix 26: Patient opt-in form for semi-structured interview 
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Appendix 27: Patient consent form for semi-structured interview 
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Appendix 28: Coded interview transcript example (Patient)  
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Appendix 29: Patient thematic framework/charting example 
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Appendix 30: Semi-structured interview schedule for health care professionals 
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Appendix 31: HCP invitation letter for semi-structured interview   
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Appendix 32: HCP information sheet for semi-structured interview 
367 
368 
369 
370 
Appendix 33: HCP opt-in form for semi-structured interview   
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Appendix 34: HCP consent form for semi-structured interview 
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Appendix 36: HCP thematic framework/charting example   
